<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32794585</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>&quot;Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: results from the Italian Severe Asthma Registry&quot;.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14558</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Antonicelli</LastName>
                    <ForeName>Leonardo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tontini</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8437-8697</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Allergy Unit, Department of Internal Medicine, Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manzotti</LastName>
                    <ForeName>Giuseppina</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy outpatient clinic, Casa di Cura B. Palazzolo, Bergamo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ronchi</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Unit, ASST Franciacorta, &quot;Mellino Mellini&quot; Hospital, Chiari, BS, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vaghi</LastName>
                    <ForeName>Adriano</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Unit, ASST Rhodense, Garbagnate Milanese Hospital, Garbagnate Milanese, MI, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Former Pneumology Unit, ASST Rhodense, Garbagnate Milanese Hospital, Garbagnate Milanese, MI, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bini</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Unit, ASST Rhodense, Garbagnate Milanese Hospital, Garbagnate Milanese, MI, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scartabellati</LastName>
                    <ForeName>Alessandro</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Unit, ASST Crema, Maggiore Hospital, Crema, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Menzella</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Unit, Department of Medical Specialties, Arcispedale Santa Maria Nuova, Azienda USL di Reggio-Emilia IRCCS, Reggio Emilia, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De Michele</LastName>
                    <ForeName>Fausto</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology I and Respiratory Pathophysiology Unit, A. Cardarelli Hospital, Naples, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Musarra</LastName>
                    <ForeName>Antonino</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergology Department, Casa della Salute di Scilla, Scilla, RC, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Micheletto</LastName>
                    <ForeName>Claudio</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Unit, Cardio-Thoracic Department, Integrated University Hospital of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bilò</LastName>
                    <ForeName>M Beatrice</ForeName>
                    <Initials>MB</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9324-6039</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Allergy Unit, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">asthma treatment</Keyword>
            <Keyword MajorTopicYN="N">biologics</Keyword>
            <Keyword MajorTopicYN="N">infections</Keyword>
            <Keyword MajorTopicYN="N">virus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32794585</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14558</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32794408</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1524-4539</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Circulation</Title>
                <ISOAbbreviation>Circulation</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Notch3-Marked Subpopulation of Vascular Smooth Muscle Cells is the Cell of Origin for Occlusive Pulmonary Vascular Lesions.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1161/CIRCULATIONAHA.120.045750</ELocationID>
            <Abstract>
                <AbstractText><b>Background:</b> Pulmonary arterial hypertension (PAH) is a fatal disease characterized by profound vascular remodeling in which pulmonary arteries narrow due to medial thickening and occlusion by neointimal lesions, resulting in elevated pulmonary vascular resistance and right heart failure. Therapies targeting the neointima would represent a significant advance in PAH treatment, however our understanding of the cellular events driving neointima formation, and the molecular pathways that control them, remains limited. <b>Methods:</b> We comprehensively map the stepwise remodeling of pulmonary arteries in a robust, chronic inflammatory mouse model of pulmonary hypertension. This model demonstrates pathologic features of the human disease, including increased right ventricular pressures, medial thickening, neointimal lesion formation, elastin breakdown, increased anastomosis within the bronchial circulation, and perivascular inflammation. Using genetic lineage tracing, clonal analysis, multiplexed <i>in situ</i> hybridization, immunostaining, deep confocal imaging and staged pharmacologic inhibition we define the cell behaviors underlying each stage of vascular remodeling and identify a pathway required for neointima formation. <b>Results:</b> Neointima arises from smooth muscle cells (SMCs) and not endothelium. Medial SMCs proliferate broadly to thicken the media, after which a small number of SMCs are selected to establish the neointima. These neointimal founder cells subsequently undergoing massive clonal expansion to form occlusive neointimal lesions. The normal pulmonary artery SMC population is heterogeneous and we identify a Notch3-marked minority subset of SMCs as the major neointimal cell of origin. Notch signaling is specifically required for the selection of neointimal founder cells, and Notch inhibition significantly improves pulmonary artery pressure in animals with pulmonary hypertension. <b>Conclusions:</b> This work describes the first nongenetically driven murine model of PH that generates robust and diffuse occlusive neointimal lesions across the pulmonary vascular bed and does so in a stereotyped timeframe. We uncover distinct cellular and molecular mechanisms underlying medial thickening and neointima formation and highlight novel transcriptional, behavioral and pathogenic heterogeneity within pulmonary artery SMCs. In this model, inflammation is sufficient to generate characteristic vascular pathologies and physiologic measures of human PAH. We hope that identifying the molecular cues regulating each stage of vascular remodeling will open new avenues for therapeutic advancements in the treatment of PAH.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Steffes</LastName>
                    <ForeName>Lea C</ForeName>
                    <Initials>LC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Froistad</LastName>
                    <ForeName>Alexis A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andruska</LastName>
                    <ForeName>Adam</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boehm</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA; Universities of Giessen and Marburg Lung Center (UGMLC), JustusLiebig University Giessen, German Center for Lung Research (DZL), Giessen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGlynn</LastName>
                    <ForeName>Madeleine</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Wenming</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Xuefei</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miquerol</LastName>
                    <ForeName>Lucile</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Aix-Marseille University, CNRS, IBDM, Marseille, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nadeau</LastName>
                    <ForeName>Kari</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Metzger</LastName>
                    <ForeName>Ross J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spiekerkoetter</LastName>
                    <ForeName>Edda</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Maya E</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA; Vera Moulton Wall Center for Pulmonary Vascular Research, Stanford University School of Medicine, Stanford, CA; Sean N. Parker Center for Asthma and Allergy Research, Stanford University School of Medicine, Stanford, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Circulation</MedlineTA>
            <NlmUniqueID>0147763</NlmUniqueID>
            <ISSNLinking>0009-7322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cellular heterogeneity</Keyword>
            <Keyword MajorTopicYN="N">clonal analysis</Keyword>
            <Keyword MajorTopicYN="N">lineage tracing</Keyword>
            <Keyword MajorTopicYN="N">medial thickening</Keyword>
            <Keyword MajorTopicYN="N">notch signaling</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32794408</ArticleId>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.045750</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32794262</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1938-3673</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of leukocyte biology</Title>
                <ISOAbbreviation>J. Leukoc. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immature neutrophil signature associated with the sexual dimorphism of systemic juvenile idiopathic arthritis.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/JLB.6MA0720-015RR</ELocationID>
            <Abstract>
                <AbstractText>Juvenile idiopathic arthritis (JIA) is a group of inflammatory conditions of unknown etiology whose incidence is sex dependent. Although several studies have attempted to identify JIA-related gene signatures, none have systematically assessed the impact of sex on the whole blood transcriptomes of JIA patients. By analyzing over 400 unique pediatric gene expression profiles, we characterized the sexual differences in leukocyte composition of systemic JIA patients and identified sex-specific gene signatures that were related to immature neutrophils. Female systemic JIA patients presented higher activation of immature neutrophil-related genes compared to males, and these genes were associated with the response to IL-1 receptor blockade treatment. Also, we found that this immature neutrophil signature is sexually dimorphic across human lifespan and in adults with rheumatoid arthritis and asthma. These results suggest that neutrophil maturation is sexually dimorphic in rheumatic inflammation, and that this may impact disease progression and treatment.</AbstractText>
                <CopyrightInformation>©2020 Society for Leukocyte Biology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Prada-Medina</LastName>
                    <ForeName>Cesar Augusto</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peron</LastName>
                    <ForeName>Jean Pierre Schatzmann</ForeName>
                    <Initials>JPS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1638-8866</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakaya</LastName>
                    <ForeName>Helder I</ForeName>
                    <Initials>HI</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-5297-9108</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Scientific Platform Pasteur-USP, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Leukoc Biol</MedlineTA>
            <NlmUniqueID>8405628</NlmUniqueID>
            <ISSNLinking>0741-5400</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">gene expression</Keyword>
            <Keyword MajorTopicYN="N">juvenile idiopathic arthritis</Keyword>
            <Keyword MajorTopicYN="N">meta-analysis</Keyword>
            <Keyword MajorTopicYN="N">neutrophil maturation</Keyword>
            <Keyword MajorTopicYN="N">sexual dimorphism</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32794262</ArticleId>
            <ArticleId IdType="doi">10.1002/JLB.6MA0720-015RR</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>REFERENCES</Title>
            <Reference>
                <Citation>Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis - Why does it vary so much?. J Rheumatol. 2002;29(7):1520-1530.</Citation>
            </Reference>
            <Reference>
                <Citation>Prakken B, Albani S, Martini A. Juvenile idiopathic arthritis. Lancet. 2011;377(9783):2138-2149.</Citation>
            </Reference>
            <Reference>
                <Citation>Klatchoian DA, Len CA, Terreri M, et al. Quality of life of children and adolescents from São Paulo: reliability and validity of the Brazilian version of the Pediatric Quality of Life Inventory version 4.0 Generic Core Scales. J Pediatr (Rio J). 2008;84(4):308-315.</Citation>
            </Reference>
            <Reference>
                <Citation>Foster HE, Marshall N, Myers A, Dunkley P, Griffiths ID. Outcome in adults with juvenile idiopathic arthritis: a quality of life study. Arthritis Rheum. 2003;48(3):767-775.</Citation>
            </Reference>
            <Reference>
                <Citation>Davies R, Southwood TR, Kearsley-Fleet L, Lunt M, Hyrich KL. FRI0557 Standardised mortality rates are increased in patients with severe juvenile idiopathic arthritis. Ann Rheum Dis. 2014;73(Suppl 2):588.1-588.</Citation>
            </Reference>
            <Reference>
                <Citation>Ombrello MJ, Arthur VL, Remmers EF, et al. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis. 2017;76(5):906-913.</Citation>
            </Reference>
            <Reference>
                <Citation>Toplak N, Blazina Š, Avčin T. The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives. Drug Des Dev Ther. 2018;12:1633-1643.</Citation>
            </Reference>
            <Reference>
                <Citation>Cattalini M, Soliani M, Caparello MC, Cimaz R. Sex differences in pediatric rheumatology. Clin Rev Allergy Immunol. 2019;56(3):293-307.</Citation>
            </Reference>
            <Reference>
                <Citation>Favalli EG, Biggioggero M, Crotti C, Becciolini A, Raimondo MG, Meroni PL. Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol. 2019;56(3):333-345.</Citation>
            </Reference>
            <Reference>
                <Citation>Chiaroni-Clarke RC, Li YR, Munro JE, et al. The association of PTPN22 rs2476601 with juvenile idiopathic arthritis is specific to females. Genes Immun. 2015;16(7):495-498.</Citation>
            </Reference>
            <Reference>
                <Citation>Chiaroni-Clarke RC, Munro JE, Ellis JA. Sex bias in paediatric autoimmune disease - Not just about sex hormones? J Autoimmun. 2016;69:12-23.</Citation>
            </Reference>
            <Reference>
                <Citation>Ishikawa S, Mima T, Aoki C, et al. Abnormal expression of the genes involved in cytokine networks and mitochondrial function in systemic juvenile idiopathic arthritis identified by DNA microarray analysis. Ann Rheum Dis. 2009;68(2):264-272.</Citation>
            </Reference>
            <Reference>
                <Citation>Quartier P, Allantaz F, Cimaz R, et al. A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis. 2011;70(5):747-754.</Citation>
            </Reference>
            <Reference>
                <Citation>Brachat AH, Grom AA, Wulffraat N, et al. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Arthritis Res Ther. 2017;19(1):13.</Citation>
            </Reference>
            <Reference>
                <Citation>Put K, Vandenhaute J, Avau A, et al. Inflammatory gene expression profile and defective interferon-γ and granzyme K in natural killer cells from systemic juvenile idiopathic arthritis patients. Arthritis Rheum . 2017;69(1):213-224.</Citation>
            </Reference>
            <Reference>
                <Citation>Gaur P, Myles A, Misra R, Aggarwal A. Intermediate monocytes are increased in enthesitis-related arthritis, a category of juvenile idiopathic arthritis. Clin Exp Immunol. 2017;187(2):234-241.</Citation>
            </Reference>
            <Reference>
                <Citation>Cepika A-M, Banchereau R, Segura E, et al. A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis. J Exp Med. 2017;214(11):3449-3466.</Citation>
            </Reference>
            <Reference>
                <Citation>Moncrieffe H, Bennett MF, Tsoras M, et al. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate. Rheumatology (Oxford). 2017;56(9):1542-1551.</Citation>
            </Reference>
            <Reference>
                <Citation>Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based human protein atlas. Nat Biotechnol. 2010;28(12):1248-1250.</Citation>
            </Reference>
            <Reference>
                <Citation>Morita T, Shima Y, Wing JB, Sakaguchi S, Ogata A, Kumanogoh A. The proportion of regulatory T cells in patients with rheumatoid arthritis: a meta-analysis. PLoS One. 2016;11(9):e0162306.</Citation>
            </Reference>
            <Reference>
                <Citation>Grassi L, Pourfarzad F, Ullrich S, et al. Dynamics of transcription regulation in human bone marrow myeloid differentiation to mature blood neutrophils. Cell Rep. 2018;24(10):2784-2794.</Citation>
            </Reference>
            <Reference>
                <Citation>Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.</Citation>
            </Reference>
            <Reference>
                <Citation>Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.</Citation>
            </Reference>
            <Reference>
                <Citation>Lai S, Huang W, Xu Y, et al. Comparative transcriptomic analysis of hematopoietic system between human and mouse by Microwell-seq. Cell Discov. 2018;4:34.</Citation>
            </Reference>
            <Reference>
                <Citation>Gattorno M, Piccini A, Lasigliè D, et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2008;58(5):1505-1515.</Citation>
            </Reference>
            <Reference>
                <Citation>Tasaki S, Suzuki K, Kassai Y, et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat Commun. 2018;9(1):2755.</Citation>
            </Reference>
            <Reference>
                <Citation>Bigler J, Boedigheimer M, Schofield JPR, et al. A severe asthma disease signature from gene expression profiling of peripheral blood from U-BIOPRED cohorts. Am J Respir Crit Care Med. 2017;195(10):1311-1320.</Citation>
            </Reference>
            <Reference>
                <Citation>Kent JW, Göring HHH, Charlesworth JC, et al. Genotype×age interaction in human transcriptional ageing. Mech Ageing Dev. 2012;133(9-10):581-590.</Citation>
            </Reference>
            <Reference>
                <Citation>Hong S, Banchereau R, Maslow BSL, et al. Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J Exp Med. 2019;216(5):1154-1169.</Citation>
            </Reference>
            <Reference>
                <Citation>Ramanathan K, Glaser A, Lythgoe H, et al. Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes. Rheumatology (Oxford). 2018;57(3):488-498.</Citation>
            </Reference>
            <Reference>
                <Citation>Villanueva E, Yalavarthi S, Berthier CC, et al. Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol. 2011;187(1):538-552.</Citation>
            </Reference>
            <Reference>
                <Citation>Bennett L, Palucka AK, Arce E, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med. 2003;197(6):711-723.</Citation>
            </Reference>
            <Reference>
                <Citation>Denny MF, Yalavarthi S, Zhao W, et al. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J Immunol. 2010;184(6):3284-3297.</Citation>
            </Reference>
            <Reference>
                <Citation>de Coupade C, Gear RW, Dazin PF, Sroussi HY, Green PG, Levine JD. beta(2)-adrenergic receptor regulation of human neutrophil function is sexually dimorphic. Br J Pharmacol. 2004;143(8):1033-1041.</Citation>
            </Reference>
            <Reference>
                <Citation>Fuseini H, Cephus JY, Wu P, et al. ER alpha signaling increased IL-17A production in Th17 cells by upregulating IL-23R expression, mitochondrial respiration, and proliferation. Front Immunol. 2019;10.</Citation>
            </Reference>
            <Reference>
                <Citation>Al-Mossawi MH, Chen L, Fang H, et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat Commun. 2017;8.</Citation>
            </Reference>
            <Reference>
                <Citation>Dimitrijevic M, Arsenović-Ranin N, Kosec D, et al. Sexual dimorphism in Th17/Treg axis in lymph nodes draining inflamed joints in rats with collagen-induced arthritis. Brain Behav Immun. 2019;76:198-214.</Citation>
            </Reference>
            <Reference>
                <Citation>Ter Haar NM, Tak T, Mokry M, et al. Reversal of sepsis-like features of neutrophils by interleukin-1 blockade in patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2018;70(6):943-956.</Citation>
            </Reference>
            <Reference>
                <Citation>Swart JF, de Roock S, Prakken BJ. Understanding inflammation in juvenile idiopathic arthritis: how immune biomarkers guide clinical strategies in the systemic onset subtype. Eur J Immunol. 2016;46(9):2068-2077.</Citation>
            </Reference>
            <Reference>
                <Citation>Rothmund F, Gerss J, Ruperto N, et al. Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis. Arthritis Care Res. 2014;66(6):949-955.</Citation>
            </Reference>
            <Reference>
                <Citation>Carmona-Rivera C, Kaplan MJ. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity. Semin Immunopathol. 2013;35(4):455-463.</Citation>
            </Reference>
            <Reference>
                <Citation>Gautier L, Cope L, Bolstad BM, Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20(3):307-315.</Citation>
            </Reference>
            <Reference>
                <Citation>Davis CA, Hitz BC, Sloan CA, et al. The encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46(D1):D794-D801.</Citation>
            </Reference>
            <Reference>
                <Citation>Zhao Y, Li H, Fang S, et al. NONCODE 2016: an informative and valuable data source of long non-coding RNAs. Nucleic Acids Res. 2016;44(D1):D203-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Volders P-J, Helsens K, Wang X, et al. LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res. 2013;41(Database issue):D246-D251.</Citation>
            </Reference>
            <Reference>
                <Citation>de Lima DS, Cardozo LE, Maracaja-Coutinho V, et al. Long noncoding RNAs are involved in multiple immunological pathways in response to vaccination. PNAS. 2019;116(34):17121-17126.</Citation>
            </Reference>
            <Reference>
                <Citation>Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411-420.</Citation>
            </Reference>
            <Reference>
                <Citation>Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381-386.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32793706</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2305-5839</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>14</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of translational medicine</Title>
                <ISOAbbreviation>Ann Transl Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lung parenchymal and airway changes on CT imaging following allergen challenge and bronchoalveolar lavage in atopic and asthmatic subjects.</ArticleTitle>
            <Pagination>
                <MedlinePgn>862</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.21037/atm-20-1719</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Computed tomography (CT) imaging findings in the lungs in the setting of an acute allergic response and following bronchoalveolar lavage (BAL) are not well established. Our goals are to characterize the pulmonary CT findings of acute allergic response in both asthmatic and non-asthmatic subjects and, secondarily, to characterize the pulmonary imaging findings following BAL.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">In this prospective observational (cohort) study, we identified atopic, asthmatic (AA) and atopic, non-asthmatic (ANA) subjects. CT of the chest was performed following BAL and instillation of an allergen (AL) and of an inert diluent (DL). Two radiologists analyzed the CT examinations for airway and parenchymal changes.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">We had a cohort of 20 atopic subjects (AA=10, ANA=10; F=11, M=9; median age: 23.5 years, range: 18-48 years). Compared to diluent instillation and BAL, allergen instillation resulted in more significant bronchial wall thickening (AL=70%, DL=0%, BAL=0%, P&lt;0.01), consolidations (AL=55%, DL=0%, BAL=15%, P&lt;0.05), and septal thickening (AL=35%, DL=0%, BAL=0%, P&lt;0.01). When present, consolidations tended to be more common in asthmatic subjects compared to non-asthmatics following instillation of the allergen, although this did not reach statistical significance (AA=80% <i>vs</i>. ANA=30%; P=0.07). BAL, on the other hand, resulted in more ground-glass opacities (BAL=15/20, 75% <i>vs.</i> AL=2/20, 10%, <i>vs</i>. DL=0/20, 0%; P&lt;0.01).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Acute allergic response in the lungs can result in significant bronchial wall thickening, septal thickening, and consolidations in those with atopy, particularly those with asthma. Localized ground-glass opacities may be expected following BAL, and care should be taken so as to not misinterpret these as significant pathology.</AbstractText>
                <CopyrightInformation>2020 Annals of Translational Medicine. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mendoza</LastName>
                    <ForeName>Dexter P</ForeName>
                    <Initials>DP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kohli</LastName>
                    <ForeName>Puja</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nance</LastName>
                    <ForeName>John W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Ramandeep</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Josalyn</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Griffith</LastName>
                    <ForeName>Jason</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harris</LastName>
                    <ForeName>R Scott</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kelly</LastName>
                    <ForeName>Vanessa J</ForeName>
                    <Initials>VJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luster</LastName>
                    <ForeName>Andrew D</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Medoff</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Digumarthy</LastName>
                    <ForeName>Subba R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Division of Thoracic Imaging and Intervention, Massachusetts General Hospital, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Ann Transl Med</MedlineTA>
            <NlmUniqueID>101617978</NlmUniqueID>
            <ISSNLinking>2305-5839</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergy</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">bronchoscopy</Keyword>
            <Keyword MajorTopicYN="N">radiology</Keyword>
        </KeywordList>
        <CoiStatement>Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-1719). JWN reports other from Genentech and Boehringer-Ingelheim, outside the submitted work. SRD reports other from Merck, Pfizer, Bristol Mayer Squibb, Novartis, Roche, Polaris, Cascadian, Abbvie, Gradalis, Clinical Bay, Zai laboratories, and Siemens, outside the submitted work. The other authors have no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32793706</ArticleId>
            <ArticleId IdType="doi">10.21037/atm-20-1719</ArticleId>
            <ArticleId IdType="pii">atm-08-14-862</ArticleId>
            <ArticleId IdType="pmc">PMC7396741</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32793544</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2296-2565</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in public health</Title>
                <ISOAbbreviation>Front Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Social Determinants of Health on the Emerging COVID-19 Pandemic in the United States.</ArticleTitle>
            <Pagination>
                <MedlinePgn>406</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2020.00406</ELocationID>
            <Abstract>
                <AbstractText>A novel coronavirus (2019-nCoV) caused a global pandemic in the months following the first four cases reported in Wuhan, China, on December 29, 2019. The elderly, immunocompromised, and those with preexisting conditions-such as asthma, cardiovascular disease (CVD), hypertension, chronic kidney disease (CKD), or obesity-experience higher risk of becoming severely ill if infected with the virus. Systemic social inequality and discrepancies in socioeconomic status (SES) contribute to higher incidence of asthma, CVD, hypertension, CKD, and obesity in segments of the general population. Such preexisting conditions bring heightened risk of complications for individuals who contract the coronavirus disease (COVID-19) from the virus (2019-nCoV)-also known as &quot;severe acute respiratory syndrome coronavirus 2&quot; (SARS-CoV-2). In order to help vulnerable groups during times of a health emergency, focus must be placed at the root of the problem. Studying the social determinants of health (SDOH), and how they impact disadvantaged populations during times of crisis, will help governments to better manage health emergencies so that every individual has equal opportunity to staying healthy. This review summarizes the impact of social determinants of health (SDOH) during the COVID-19 pandemic.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Singu, Acharya, Challagundla and Byrareddy.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Singu</LastName>
                    <ForeName>Sravani</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Acharya</LastName>
                    <ForeName>Arpan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Challagundla</LastName>
                    <ForeName>Kishore</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Byrareddy</LastName>
                    <ForeName>Siddappa N</ForeName>
                    <Initials>SN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry and Molecular Biology, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, Cell Biology, and Anatomy, University of Nebraska Medical Centre, Omaha, NE, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Public Health</MedlineTA>
            <NlmUniqueID>101616579</NlmUniqueID>
            <ISSNLinking>2296-2565</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">SDOH</Keyword>
            <Keyword MajorTopicYN="N">economy</Keyword>
            <Keyword MajorTopicYN="N">education</Keyword>
            <Keyword MajorTopicYN="N">food</Keyword>
            <Keyword MajorTopicYN="N">public health</Keyword>
            <Keyword MajorTopicYN="N">social inequality</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32793544</ArticleId>
            <ArticleId IdType="doi">10.3389/fpubh.2020.00406</ArticleId>
            <ArticleId IdType="pmc">PMC7385373</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32793421</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2214-7500</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicology reports</Title>
                <ISOAbbreviation>Toxicol Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antibacterial and antioxidant potential of <i>Tetraena simplex</i> extracts of various polarities.</ArticleTitle>
            <Pagination>
                <MedlinePgn>925-929</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.toxrep.2020.07.014</ELocationID>
            <Abstract>
                <AbstractText>Nowadays, infectious and oxidative stress-related diseases are leading to many deaths worldwide. <i>Tetraena simplex</i>, a new species (synonym) that is mainly grown in Oman, has traditionally been used as a medicine for asthma. This study aimed to assess antioxidant and antibacterial activities of <i>T. simplex</i> extracts of various polarities using 2,2-diphenyl-1-picrylhydrazyl (DPPH) and agar gel diffusion assays. Among the six extracts prepared, ethyl acetate extract showed the highest antioxidant activity and hexane extract showed the lowest antioxidant activity. Antioxidant activity of the extracts decreased in the order of ethyl acetate &gt; dichloromethane &gt; water &gt; butanol &gt; methanol &gt; hexane. Similarly, antibacterial activities, indicated as inhibition zones, of the six extracts at four concentrations were assessed against two gram-positive bacteria (<i>Streptococcus pneumoniae</i> and <i>Staphylococcus aureus</i>) and three gram-negative bacteria (<i>Escherichia coli</i>, <i>Klebsiella pneumoniae</i>, and Proteus bacilli). No extract showed antibacterial activity against the tested bacteria at any concentration. Therefore, the ethyl acetate extract of <i>T. simplex</i> may be used as an antioxidant or a food supplement as an alternative to synthetic drugs.</AbstractText>
                <CopyrightInformation>© 2020 Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Abdulsattar</LastName>
                    <ForeName>Ahmed Moussad</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, P.O. Box 33, Postal Code 616, Nizwa, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hossain</LastName>
                    <ForeName>Mohammad Amzad</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, P.O. Box 33, Postal Code 616, Nizwa, Oman.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Toxicol Rep</MedlineTA>
            <NlmUniqueID>101630272</NlmUniqueID>
            <ISSNLinking>2214-7500</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Agar gel diffusion assays</Keyword>
            <Keyword MajorTopicYN="N">Antibacterial activity</Keyword>
            <Keyword MajorTopicYN="N">Antioxidant activity</Keyword>
            <Keyword MajorTopicYN="N">DPPH</Keyword>
            <Keyword MajorTopicYN="N">Tetraena simplex</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32793421</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxrep.2020.07.014</ArticleId>
            <ArticleId IdType="pii">S2214-7500(20)30359-0</ArticleId>
            <ArticleId IdType="pmc">PMC7408347</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32793232</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1664-3224</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in immunology</Title>
                <ISOAbbreviation>Front Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Epithelial-Mesenchymal Transition in Asthma Airway Remodeling Is Regulated by the IL-33/CD146 Axis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1598</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2020.01598</ELocationID>
            <Abstract>
                <AbstractText>Epithelial-mesenchymal transition (EMT) is essential in asthma airway remodeling. IL-33 from epithelial cells is involved in pulmonary fibrosis. CD146 has been extensively explored in cancer-associated EMT. Whether IL-33 regulates CD146 in the EMT process associated with asthma airway remodeling is still largely unknown. We hypothesized that EMT in airway remodeling was regulated by the IL-33/CD146 axis. House dust mite (HDM) extract increased the expression of IL-33 and CD146 in epithelial cells. Increased expression of CD146 in HDM-treated epithelial cells could be blocked with an ST2-neutralizing antibody. Moreover, HDM-induced EMT was dependent on the CD146 and TGF-β/SMAD-3 signaling pathways. IL-33 deficiency decreased CD146 expression and alleviated asthma severity. Similarly, CD146 deficiency mitigated EMT and airway remodeling in a murine model of chronic allergic airway inflammation. Furthermore, CD146 expression was significantly elevated in asthma patients. We concluded that IL-33 from HDM extract-treated alveolar epithelial cells stimulated CD146 expression, promoting EMT in airway remodeling in chronic allergic inflammation.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Sun, Ji, Ma, Zhu, Chen, Wang, Qian, Wu, Hu, Huang and Zhang.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Zhixiao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ji</LastName>
                    <ForeName>Ningfei</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Qiyun</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Ranran</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhongqi</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhengxia</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qian</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Chaojie</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Mao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Mingshun</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>NHC Key Laboratory of Antibody Technique, Department of Immunology, Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Immunol</MedlineTA>
            <NlmUniqueID>101560960</NlmUniqueID>
            <ISSNLinking>1664-3224</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CD146</Keyword>
            <Keyword MajorTopicYN="N">IL-33</Keyword>
            <Keyword MajorTopicYN="N">allergy</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">epithelial-mesenchymal transition</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32793232</ArticleId>
            <ArticleId IdType="doi">10.3389/fimmu.2020.01598</ArticleId>
            <ArticleId IdType="pmc">PMC7387705</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32792957</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1663-9812</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in pharmacology</Title>
                <ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Phosphodiesterase 4 Inhibitors in Allergic Rhinitis/Rhinosinusitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1135</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2020.01135</ELocationID>
            <Abstract>
                <AbstractText>Allergic rhinitis/rhinosinusitis (AR) is the most common allergic disease. It affects patients' quality of life and may influence the severity of lower airway disease such as asthma. Therefore, its treatment is of great importance. AR is treated by a combination of effective approaches; however, in some patients, the disease is uncontrolled. In the last several years, the concept of AR has shifted from increased T helper 2 (Th2) cell signaling and downstream inflammation to disease phenotypes with non-Th2-mediated inflammation. AR is a largely heterogenous group of airway diseases, and as such, research should not only focus on immunosuppressive agents (e.g., corticosteroids) but should also include targeted immunomodulatory pathways. Here, we provide an overview of novel therapies, focusing on the role of phosphodiesterase-4 (PDE4) inhibitors in AR. PDE4 inhibitors are potent anti-inflammatory agents that are used for the treatment of inflammatory airway diseases including AR. The PDE4 inhibitor roflumilast was shown to effectively control symptoms of AR in a randomized, placebo-controlled, double-blinded, crossover study in patients with a history of AR. However, only a few PDE4 inhibitors have proceeded to phase II and III clinical trials, due to insufficient clinical efficacy and adverse effects. Research is ongoing to develop more effective compounds with fewer side effects that target specific inflammatory pathways in disease pathogenesis and can provide more consistent benefit to patients with upper airway allergic diseases. Novel specific PDE4 inhibitors seem to fulfill these criteria.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Janosova, Calkovsky, Pedan, Behanova, Hajtman and Calkovska.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Janosova</LastName>
                    <ForeName>Viera</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, and Martin University Hospital, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Calkovsky</LastName>
                    <ForeName>Vladimir</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, and Martin University Hospital, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pedan</LastName>
                    <ForeName>Heiko</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, and Martin University Hospital, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Behanova</LastName>
                    <ForeName>Estera</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, and Martin University Hospital, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hajtman</LastName>
                    <ForeName>Andrej</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Otorhinolaryngology and Head and Neck Surgery, Jessenius Faculty of Medicine, Comenius University in Bratislava, and Martin University Hospital, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Calkovska</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, Martin, Slovakia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Pharmacol</MedlineTA>
            <NlmUniqueID>101548923</NlmUniqueID>
            <ISSNLinking>1663-9812</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">PDE4 inhibitor</Keyword>
            <Keyword MajorTopicYN="N">T helper cells</Keyword>
            <Keyword MajorTopicYN="N">allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">immunomodulation</Keyword>
            <Keyword MajorTopicYN="N">inflammation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32792957</ArticleId>
            <ArticleId IdType="doi">10.3389/fphar.2020.01135</ArticleId>
            <ArticleId IdType="pmc">PMC7387511</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32792879</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1642-395X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>37</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Postepy dermatologii i alergologii</Title>
                <ISOAbbreviation>Postepy Dermatol Alergol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Short-term effects of air pollution on exacerbations of allergic asthma in Užice region, Serbia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>377-383</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5114/ada.2020.96254</ELocationID>
            <Abstract>
                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Many time-series studies have shown a positive association between air pollution and asthma exacerbation. However, till now only one study in Serbia has examined this relationship.</AbstractText>
                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">To examine the associations between air pollution and asthma emergency department (ED) visits in the Užice region, Serbia.</AbstractText>
                <AbstractText Label="Material and methods" NlmCategory="UNASSIGNED">A time-stratified case-crossover design was applied to 424 ED visits for asthma exacerbation that occurred in the Užice region, Serbia, in 2012-2014. Data about ED visits were routinely collected in the Užice Health Centre. The daily average concentrations of particulate matter (PM<sub>2.5</sub> and PM<sub>10</sub>), sulphur dioxide (SO<sub>2</sub>), nitrogen dioxide (NO<sub>2</sub>), and black carbon (BC) were measured by automatic ambient air quality monitoring stations. Odds ratios and their corresponding 95% confidence intervals were estimated using conditional logistic regression adjusted for the potential confounding influence of weather variables (temperature, humidity and air pressure).</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Statistically significant associations were observed between ED visits for asthma and 3-day lagged exposure to BC (OR = 3.23; 95% CI: 1.05-9.95), and between ED visits for asthma with coexisting allergic rhinitis and 0-day lag exposure to NO<sub>2</sub> (OR = 1.57; 95% CI: 0.94-2.65), 2-day lag exposure to SO<sub>2</sub> (OR = 1.97; 95% CI: 1.02-3.80), and 3-day lag exposure to PM<sub>10</sub> (OR = 2.38; 95% CI: 1.17-4.84).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Exposure to ambient air pollution in the Užice region increases the risk of ED visits for asthma, particularly during the heating season.</AbstractText>
                <CopyrightInformation>Copyright: © 2020 Termedia Sp. z o. o.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kovačević</LastName>
                    <ForeName>Gordana</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Hospital Užice, Užice, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomić-Spirić</LastName>
                    <ForeName>Vesna</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinic of Allergology and Immunology, Clinical Centre of Serbia, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marinković</LastName>
                    <ForeName>Jelena</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Janković</LastName>
                    <ForeName>Slavenka</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Epidemiology, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Æirković</LastName>
                    <ForeName>Andja</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MiloševićDjerić</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Hospital Užice, Užice, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Erić</LastName>
                    <ForeName>Miloš</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Economics, Finance and Administration, Metropolitan University, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Janković</LastName>
                    <ForeName>Janko</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Social Medicine, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Poland</Country>
            <MedlineTA>Postepy Dermatol Alergol</MedlineTA>
            <NlmUniqueID>101168357</NlmUniqueID>
            <ISSNLinking>1642-395X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Serbia</Keyword>
            <Keyword MajorTopicYN="N">air pollution</Keyword>
            <Keyword MajorTopicYN="N">allergic asthma</Keyword>
            <Keyword MajorTopicYN="N">case-crossover design</Keyword>
            <Keyword MajorTopicYN="N">emergency department visits</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32792879</ArticleId>
            <ArticleId IdType="doi">10.5114/ada.2020.96254</ArticleId>
            <ArticleId IdType="pii">96254</ArticleId>
            <ArticleId IdType="pmc">PMC7394173</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32792567</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>De novo transcriptome analysis of Lantana camara L. revealed candidate genes involved in phenylpropanoid biosynthesis pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13726</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-70635-5</ELocationID>
            <Abstract>
                <AbstractText>Lantana camara L. is an economically important essential oil producing plant belonging to family Verbenaceae. It is used in medication for treating various diseases like cancer, ulcers, tumor, asthma and fever. The plant is a useful source of essential bioactive compounds such as steroids, flavonoids and phenylpropanoid glycosides etc. Nonetheless, very little is known about the genomic or transcriptomic resources of L. camara, and this might be the reason of hindering molecular studies leading to identification of improved lines. Here we used Illumina sequencing platform and performed the L. camara leaf (LCL) and root (LCR) de novo transcriptome analyses. A total of 70,155,594 and 84,263,224 clean reads were obtained and de novo assembly generated 72,877 and 513,985 unigenes from leaf (LCL) and root (LCR) respectively. Furthermore, the pathway analysis revealed the presence of 229 and 943 genes involved in the phenylpropanoid biosynthesis in leaf and root tissues respectively. Similarity search was performed against publically available genome databases and best matches were found with Sesamum indicum (67.5%) that were much higher than that of Arabidopsis thaliana (3.9%). To the best of our knowledge, this is the first comprehensive transcriptomic analysis of leaf and root tissues of this non-model plant from family Verbenaceae and may serve as a baseline for further molecular studies.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shah</LastName>
                    <ForeName>Muzammil</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8093-0256</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia. muzammilshah100@outlook.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alharby</LastName>
                    <ForeName>Hesham F</ForeName>
                    <Initials>HF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hakeem</LastName>
                    <ForeName>Khalid Rehman</ForeName>
                    <Initials>KR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ali</LastName>
                    <ForeName>Niaz</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany, Hazara University, Mansehra, KP, 21300, Pakistan. niazalitk25@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rahman</LastName>
                    <ForeName>Inayat Ur</ForeName>
                    <Initials>IU</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3312-7975</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Botany, Hazara University, Mansehra, KP, 21300, Pakistan. hajibotanist@outlook.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>William L. Brown Center, Missouri Botanical Garden, P.O. Box 299, St. Louis, MO, 63166-0299, USA. hajibotanist@outlook.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Munawar</LastName>
                    <ForeName>Mohd</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anwar</LastName>
                    <ForeName>Yasir</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Sciences, Faculty of Science, King Abdulaziz University, Jeddah, 21589, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32792567</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-020-70635-5</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-020-70635-5</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32792435</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2044-6055</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ open</Title>
                <ISOAbbreviation>BMJ Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emergency department visits and hospitalisations for emergent asthmatic symptoms from 2014 to 2016: cross-sectional study in Korea.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e036237</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2019-036237</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the characteristics of emergent patients with asthma who visited emergency departments (EDs) in Korea, and the consequences of these visits.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cross-sectional study.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">We used data from the National Emergency Department Information System database from 2014 to 2016. The data included reports collected from 408 EDs in Korea.</AbstractText>
                <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">We analysed the ED cases for asthma-related emergent symptoms that met the following inclusion criteria: (1) had a main diagnosis code of asthma (International Classification of Diseases 10th Revision code: J45/J46), and (2) recorded as an emergent symptom in the EDs.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">During 2014-2016, there were 58 713 ED visits related to an asthma diagnosis with emergent symptoms. Following an ED visit, 31.69% were hospitalised, of which 89.88% were admitted to the general wards, and 10.12% to the intensive care units (ICUs). More than 50% of the hospitalised cases included in the group ≥70 years of age. The incidence of death during hospitalisation generally increased with age and the proportion of death in ICU exceeded 10% among the group ≥70 years. The ratio of ICU/general ward admission at the arrival time of 0-03:00, in the ≥60 years age group was the highest compared with other times of the day and age groups.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We found that among all age groups, ED visits by older patients resulted in more ICU admissions. Our results can help in providing a better understanding of medical resource utilisation by emergent patients with asthma.</AbstractText>
                <CopyrightInformation>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Kyungseon</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Pusan National University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Han</LastName>
                    <ForeName>Sola</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Pusan National University, Busan, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suh</LastName>
                    <ForeName>Hae Sun</ForeName>
                    <Initials>HS</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3445-6607</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Pusan National University, Busan, South Korea haesun.suh@pusan.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Open</MedlineTA>
            <NlmUniqueID>101552874</NlmUniqueID>
            <ISSNLinking>2044-6055</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">accident &amp; emergency medicine</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">intensive &amp; critical care</Keyword>
            <Keyword MajorTopicYN="N">public health</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32792435</ArticleId>
            <ArticleId IdType="pii">bmjopen-2019-036237</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjopen-2019-036237</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791887</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2472-5625</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Modern rheumatology case reports</Title>
                <ISOAbbreviation>Mod Rheumatol Case Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asymptomatic coronary aneurysms in a patient with eosinophilic granulomatosis with polyangiitis who developed a digital gangrene.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-14</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/24725625.2020.1810404</ELocationID>
            <Abstract>
                <AbstractText>A 33-year-old male with a history of bronchial asthma and allergic rhinitis was diagnosed with eosinophilic granulomatosis with polyangiitis (EGPA) eight years ago. The diagnosis was based on the presence of fever, remarkable eosinophilia, and painful digital ulcer. His signs and symptoms improved with a moderate dose of glucocorticoids. Thereafter, he was lost to follow-up, failing to attend any of the scheduled appointments. Three years later, he presented with painful digital gangrene on the lateral fold of the right ring fingernail and abdominal pain triggered by meals. Angiography showed multiple occlusions and severe stenoses of the peripheral arteries and coronary aneurysms, which confirmed the diagnosis of medium vasculitis of the coronary and peripheral arteries due to flare up of EGPA. EGPA predominantly affects the small-sized vessels, but rarely the medium-sized vessels. Coronary vasculitis might occur asymptomatically, until the coronary stenosis becomes severe or myocardial infarction develops; hence, its prevalence is underestimated. In this case, a digital gangrene prompted us to perform a systemic angiography, leading to the diagnosis of coronary vasculitis. Careful observation for coronary lesions is necessary in patients with EGPA who develop digital gangrene.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sato</LastName>
                    <ForeName>Mayu</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshida</LastName>
                    <ForeName>Yusuke</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0774-0509</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugimoto</LastName>
                    <ForeName>Tomohiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kishimoto</LastName>
                    <ForeName>Shinji</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Medicine, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Omoto</LastName>
                    <ForeName>Takuji</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Rheumatology, Hiroshima Prefectural Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watanabe</LastName>
                    <ForeName>Hirofumi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tokunaga</LastName>
                    <ForeName>Tadahiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yukawa</LastName>
                    <ForeName>Kazutoshi</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kohno</LastName>
                    <ForeName>Hiroki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mokuda</LastName>
                    <ForeName>Sho</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nojima</LastName>
                    <ForeName>Takaki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirata</LastName>
                    <ForeName>Shintaro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugiyama</LastName>
                    <ForeName>Eiji</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mod Rheumatol Case Rep</MedlineTA>
            <NlmUniqueID>101761026</NlmUniqueID>
            <ISSNLinking>2472-5625</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">coronary aneurysm</Keyword>
            <Keyword MajorTopicYN="N">coronary vasculitis</Keyword>
            <Keyword MajorTopicYN="N">digital gangrene</Keyword>
            <Keyword MajorTopicYN="N">eosinophilic granulomatosis with polyangiitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791887</ArticleId>
            <ArticleId IdType="doi">10.1080/24725625.2020.1810404</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791878</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-4303</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
                <ISOAbbreviation>J Asthma</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Are adults with asthma less physically active? A systematic review and meta-analysis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-12</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2020.1810273</ELocationID>
            <Abstract>
                <AbstractText><b>Objective:</b> To systematically review the evidence on whether having current, ever asthma and asthma control is associated with levels of total, moderate and vigorous physical activity.<b>Methods:</b> We searched EMBASE, MEDLINE, and CINAHL databases, limiting searches to English language papers from inception until Oct 2019. We synthesized the evidence comparing levels of total, moderate and vigorous physical activity between adults with and without current asthma or ever asthma by random effects meta-analyses.<b>Results:</b> A total of 25 studies were included, with 18 of these included in meta-analyses. A meta-analysis of 4 case-control studies found that adults with current asthma were less active, with 942.12 steps fewer per day, than adults without current asthma (SMD=-0.39, 95%CI: -0.54, -0.24, I<sup>2</sup> =0). Meta-analysis of four-high quality cross-sectional studies found that those with current or ever asthma were more likely to be inactive than those without asthma (binary OR <sub>current asthma</sub> =0.85, 95%CI:0.82,0.89, I<sup>2</sup>=45.6%, and binary OR <sub>ever asthma</sub> =0.83, 0.75,0.91, I<sup>2</sup> =0, respectively). Meta-analysis, inclusive of all 10 cross-sectional studies with binary ORs, supported this finding. There was also some evidence that adults with current asthma and ever asthma (6 studies with categorical ORs) were less likely to exercise moderately and vigorously, but these meta-analyses were limited by high heterogeneity. No synthesis of the studies considering asthma control was possible.<b>Conclusion:</b> Adults with current or ever asthma had lower levels of total, moderate and vigorous physical activity than those without asthma and may be missing out on the health benefits of being physically active. The association between asthma control and physical activity warrants further investigation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lodge</LastName>
                    <ForeName>Caroline</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lowe</LastName>
                    <ForeName>Adrian</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dharmage</LastName>
                    <ForeName>Shyamali C</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Murdoch Children's Research Institute, Gastro and Allergy Group, Royal Children's Hospital, Flemington Road, Parkville, VIC, AUS 3052.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cassim</LastName>
                    <ForeName>Raisa</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Murdoch Children's Research Institute, Gastro and Allergy Group, Royal Children's Hospital, Flemington Road, Parkville, VIC, AUS 3052.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Russell</LastName>
                    <ForeName>Melissa A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, Faculty of Medicine, Dentistry and Health Sciences, 207 Bouverie Street, Parkville, The University of Melbourne, Victoria 3010 Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Murdoch Children's Research Institute, Gastro and Allergy Group, Royal Children's Hospital, Flemington Road, Parkville, VIC, AUS 3052.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Asthma</MedlineTA>
            <NlmUniqueID>8106454</NlmUniqueID>
            <ISSNLinking>0277-0903</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">epidemiology</Keyword>
            <Keyword MajorTopicYN="N">review</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791878</ArticleId>
            <ArticleId IdType="doi">10.1080/02770903.2020.1810273</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32791756</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1536-5964</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>99</Volume>
                    <Issue>30</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Medicine</Title>
                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Patients with spontaneous pneumothorax have a higher risk of developing lung cancer: A STROBE-compliant article.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e21411</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000021411</ELocationID>
            <Abstract>
                <AbstractText>Lung cancer is a common malignancy worldwide, and risk factors include bronchitis, asthma, tuberculosis, smoking, and air pollution. These are also risk factors for spontaneous pneumothorax, a benign disease. We hypothesized that patients who experience a spontaneous pneumothorax have a greater risk to develop lung cancer, and designed a study to determine if this is so.We used the population-based Taiwan Health Insurance Research Database to perform a retrospective cohort study. The database includes more than 99% of the population of Taiwan. We established a 27,405-person pneumothorax cohort and a 109,620 person comparison cohort with data from 2000 to 2009 to evaluate the relationship between spontaneous pneumothorax and lung cancer.Multivariable analysis showed that patients who have had a spontaneous pneumothorax have a greater relative risk to develop lung cancer. The overall hazard ratio was 2.09 (95% confidence interval 1.69-2.58) adjusted by age, gender, hypertension, diabetes mellitus, and chronic lung diseases such as chronic obstructive pulmonary disease, tuberculosis, asthma, bronchitis, and emphysema. A dose effect was present; a high frequency of spontaneous pneumothorax was associated with a greater relative risk to develop lung cancer. If the spontaneous pneumothorax frequency was greater than 2 times per year, the hazard ratio was 34.09 (95% confidence interval 22.74-51.10)Patients with spontaneous pneumothorax have an increased relative risk to develop lung cancer, especially among patients 35 to 49 years of age. The more frequent the occurrence of spontaneous pneumothorax, the greater the relative risk of lung cancer. If the spontaneous pneumothorax frequency was greater than 2 times per year, the increase in risk of lung cancer was more than 30-fold.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Chien-Kuang</ForeName>
                    <Initials>CK</Initials>
                    <AffiliationInfo>
                        <Affiliation>aDivision of Thoracic Surgery, Department of Surgery, China Medical University Hospital bGraduate Institute of Clinical Medical Science, China Medical University cManagement Office for Health Data, China Medical University Hospital dDivision of Thoracic Surgery, Department of Surgery, China Medical University Hospital eSchool of Medicine, China Medical University, Taichung, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Yen-Jung</ForeName>
                    <Initials>YJ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Hsin-Yuan</ForeName>
                    <Initials>HY</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Medicine (Baltimore)</MedlineTA>
            <NlmUniqueID>2985248R</NlmUniqueID>
            <ISSNLinking>0025-7974</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791756</ArticleId>
            <ArticleId IdType="doi">10.1097/MD.0000000000021411</ArticleId>
            <ArticleId IdType="pii">00005792-202007240-00102</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32791721</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1536-5964</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>99</Volume>
                    <Issue>30</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Medicine</Title>
                <ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Maternal bacteria to correct abnormal gut microbiota in babies born by C-section.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e21315</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000021315</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">There is evidence that caesarean section (CS) is associated with increased risk of childhood obesity, asthma, and coeliac disease. The gut microbiota of CS-born babies differs to those born vaginally, possibly due to reduced exposure to maternal vaginal bacteria during birth. Vaginal seeding is a currently unproven practice intended to reduce such differences, so that the gut microbiota of CS-born babies is similar to that of babies born vaginally. Our pilot study, which uses oral administration as a novel form of vaginal seeding, will assess the degree of maternal strain transfer and overall efficacy of the procedure for establishing normal gut microbiota development.</AbstractText>
                <AbstractText Label="METHODS AND ANALYSIS" NlmCategory="UNASSIGNED">Protocol for a single-blinded, randomized, placebo-controlled pilot study of a previously untested method of vaginal seeding (oral administration) in 30 CS-born babies. A sample of maternal vaginal bacteria is obtained prior to CS, and mixed with 5 ml sterile water to obtain a supernatant. Healthy babies are randomized at 1:1 to receive active treatment (3 ml supernatant) or placebo (3 ml sterile water). A reference group of 15 non-randomized vaginal-born babies are also being recruited. Babies' stool samples will undergo whole metagenomic shotgun sequencing to identify potential differences in community structure between CS babies receiving active treatment compared to those receiving placebo at age 1 month (primary outcome). Secondary outcomes include differences in overall gut community between CS groups (24 hours, 3 months); similarity of CS-seeded and placebo gut profiles to vaginally-born babies (24 hours, 1 and 3 months); degree of maternal vaginal strain transfer in CS-born babies (24 hours, 1 and 3 months); anthropometry (1 and 3 months) and body composition (3 months).</AbstractText>
                <AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="UNASSIGNED">Ethics approval by the Northern A Health and Disability Ethics Committee (18/NTA/49). Results will be published in peer-reviewed journals and presented at international conferences.</AbstractText>
                <AbstractText Label="REGISTRATION" NlmCategory="UNASSIGNED">Australian New Zealand Clinical Trials Registry (ACTRN12618000339257).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Butler</LastName>
                    <ForeName>Éadaoin M</ForeName>
                    <Initials>ÉM</Initials>
                    <AffiliationInfo>
                        <Affiliation>aA Better Start - National Science Challenge bLiggins Institute, University of Auckland, Auckland, New Zealand cNeonatal Intensive Care Unit, Pescara Public Hospital, Pescara, Italy dDepartment of Women's and Children's Health, Uppsala University, Uppsala, Sweden eEndocrinology Department, Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China fDepartment of Obstetrics and Gynaecology, Auckland City Hospital, Auckland District Health Board, New Zealand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiavaroli</LastName>
                    <ForeName>Valentina</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Derraik</LastName>
                    <ForeName>José G B</ForeName>
                    <Initials>JGB</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grigg</LastName>
                    <ForeName>Celia P</ForeName>
                    <Initials>CP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>Brooke C</ForeName>
                    <Initials>BC</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walker</LastName>
                    <ForeName>Nicholas</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>OʼSullivan</LastName>
                    <ForeName>Justin M</ForeName>
                    <Initials>JM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cutfield</LastName>
                    <ForeName>Wayne S</ForeName>
                    <Initials>WS</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Medicine (Baltimore)</MedlineTA>
            <NlmUniqueID>2985248R</NlmUniqueID>
            <ISSNLinking>0025-7974</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791721</ArticleId>
            <ArticleId IdType="doi">10.1097/MD.0000000000021315</ArticleId>
            <ArticleId IdType="pii">00005792-202007240-00067</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32791623</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2096-7993</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>34</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>May</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery</Title>
                <ISOAbbreviation>Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[A case of eosinophil otitis media with smear-negative middle ear effusion and literature review].</ArticleTitle>
            <Pagination>
                <MedlinePgn>465-467</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.13201/j.issn.2096-7993.2020.05.020</ELocationID>
            <Abstract>
                <AbstractText><b/> We report a case of eosinophil otitis media with smear-negative middle ear effusion. This case is a special type of otitis media characterized by highly viscous middle ear effusion associated with bronchial asthma and nasal polyposis. However, unlike the classical cases that tested positive for eosinophils, smear examination of middle ear effusion in this case showed unusual presence of neutrophils. The diagnosis was validated by pathological biopsy of granulation tissue in the tympanic cavity, showing predominantly eosinophils in the mucosa of the middle ear. Surgery, focal applications of corticosteroid and antibiotics to control inflammation and bacterial infection were effective to ameliorate the middle ear condition in this case.</AbstractText>
                <CopyrightInformation>Copyright© by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Pengjun</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Yue</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhengnong</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Yaqin</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Haibo</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Shankai</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
                <PublicationType UI="D004740">English Abstract</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi</MedlineTA>
            <NlmUniqueID>101303164</NlmUniqueID>
            <ISSNLinking>2096-7993</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">eosinophil otitis media</Keyword>
            <Keyword MajorTopicYN="N">smear</Keyword>
            <Keyword MajorTopicYN="N">tympanic cavity</Keyword>
        </KeywordList>
        <CoiStatement>The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791623</ArticleId>
            <ArticleId IdType="doi">10.13201/j.issn.2096-7993.2020.05.020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32791576</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2671-9525</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>35</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Environmental analysis, health and toxicology</Title>
                <ISOAbbreviation>Environ Anal Health Toxicol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Age-period-cohort analysis of asthma, allergic rhinitis, and atopic dermatitis prevalence in Japan.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e2020012-0</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5620/eaht.2020012</ELocationID>
            <Abstract>
                <AbstractText>This study aims to analyze the trends in the Japanese prevalence of asthma, allergic rhinitis, and atopic dermatitis by using age-period-cohort (APC) analysis. Data regarding the prevalence of diseases from 1999 to 2017 were collected from Patient Survey in Japan. The data were divided according to age groups ranging from 0-4 years old up to 65-69 years old in 5-year increments. A cohort was defined for each age group of each year with a one-year shift, and cohorts born from 1930-1934 up to 2013-2017 were examined. We used Bayesian APC analysis to decompose the changes in prevalence into age, period, and cohort effects. Results show that the period effect for asthma began to increase in 2008, and those of allergic rhinitis and atopic dermatitis began to increase in 1999. The cohort effects for asthma and atopic dermatitis increased rapidly in cohorts born from approximately 1950 to 1980 and then decreased thereafter. Furthermore, the cohort effect for allergic rhinitis increased from cohorts born in approximately the late 1970s for men and in 1990 for women. The time points with increasing cohort effects for asthma and atopic dermatitis are consistent with the history of air pollution accompanied by rapid economic growth in Japan. The onset of the increased cohort effect for allergic rhinitis was also relatively consistent with the time point at which the mass scattering of pollen began.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Okui</LastName>
                    <ForeName>Tasuku</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Information Center, Kyusyu University Hospital, Fukuoka city, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Environ Anal Health Toxicol</MedlineTA>
            <NlmUniqueID>101758126</NlmUniqueID>
            <ISSNLinking>2671-9525</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Age–period–cohort analysis</Keyword>
            <Keyword MajorTopicYN="N">Air pollution</Keyword>
            <Keyword MajorTopicYN="N">Allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">Prevalence</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791576</ArticleId>
            <ArticleId IdType="pii">eaht.2020012</ArticleId>
            <ArticleId IdType="doi">10.5620/eaht.2020012</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791560</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2053-1095</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Veterinary medicine and science</Title>
                <ISOAbbreviation>Vet Med Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression of xenobiotic metabolising enzymes in lungs of horses with or without histological evidence of lower airway inflammation.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/vms3.331</ELocationID>
            <Abstract>
                <AbstractText>Mild, moderate and severe equine asthma is a problem for equine welfare. The aetiology of the disease is not known in detail but is likely multi-factorial. One important factor may be inhaled dust which carries harmful substances which may be bioactivated and thus can lead to local inflammation in the airways. The aim of this study was to investigate gene expression and protein localisation of cytochrome P450 (CYP) enzymes, superoxide dismutase and glutathione-S-transferases (GST) involved in bioactivation and detoxification of harmful substances in lungs of horses with or without histological evidence of lower airway inflammation. Significantly lower gene expression of CYP2A13 and GSTM1 was observed in lungs from horses with histological evidence of lower airway inflammation compared with horses without. A higher expression, although not significant, was found for CYP1A1 in horses with histological evidence of lower airway inflammation. There were no differences in gene expression of GSTP1 and SOD3. The proteins were localised in the respiratory epithelium which is of relevance as a defence to local exposure of inhaled harmful substances. In conclusion, our study reports differential gene expression of enzymes involved in bioactivation and detoxification of foreign substances in the lungs of horses with histological evidence of lower airway inflammation compared with horses without.</AbstractText>
                <CopyrightInformation>© 2020 The Authors. Veterinary Medicine and Science published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Löfgren</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8020-3267</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Larsson</LastName>
                    <ForeName>Pia</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindberg</LastName>
                    <ForeName>Ronny</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1118-5533</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hörnaeus</LastName>
                    <ForeName>Katarina</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tydén</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6958-2692</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences and Veterinary Public Health, Swedish University of Agricultural Sciences, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>The Swedish-Norwegian Foundation for Equine Research</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Vet Med Sci</MedlineTA>
            <NlmUniqueID>101678837</NlmUniqueID>
            <ISSNLinking>2053-1095</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CYP</Keyword>
            <Keyword MajorTopicYN="N">GST</Keyword>
            <Keyword MajorTopicYN="N">SOD</Keyword>
            <Keyword MajorTopicYN="N">equine asthma</Keyword>
            <Keyword MajorTopicYN="N">gene expression</Keyword>
            <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791560</ArticleId>
            <ArticleId IdType="doi">10.1002/vms3.331</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>REFERENCES</Title>
            <Reference>
                <Citation>Aitken, A. E., Richardson, T. A., &amp; Morgan, E. T. (2006). Regulation of drug-metabolizing enzymes and transporters in inflammation. Annual Review of Pharmacology and Toxicology, 46, 123-149. https://doi.org/10.1146/annurev.pharmtox.46.120604.141059</Citation>
            </Reference>
            <Reference>
                <Citation>Anttila, S., Hirvonen, A., Vainio, H., Husgafvel-Pursiainen, K., Hayes, J. D., &amp; Ketterer, B. (1993). Immunohistochemical localization of glutathione S-transferases in human lung. Cancer Research, 53, 5643-5648.</Citation>
            </Reference>
            <Reference>
                <Citation>Art, T., Kirschvink, N., Smith, N., &amp; Lekeux, P. (1999). Indices of oxidative stress in blood and pulmonary epithelium lining fluid in horses suffering from recurrent airway obstruction. Equine Veterinary Journal, 31, 397-401. https://doi.org/10.1111/j.2042-3306.1999.tb03839.x</Citation>
            </Reference>
            <Reference>
                <Citation>Auerbach, A., &amp; Hernandez, M. L. (2012). The effect of environmental oxidative stress on airway inflammation. Current Opinion in Allergy and Clinical Immunology, 12, 133-139. https://doi.org/10.1097/ACI.0b013e32835113d6</Citation>
            </Reference>
            <Reference>
                <Citation>Bahari, A., Mehrzad, J., Mahmoudi, M., Bassami, M. R., &amp; Dehghani, H. (2014). Cytochrome P450 isoforms are differently up-regulated in aflatoxin B1-exposed human lymphocytes and monocytes. Immunopharmacology and Immunotoxicology, 36, 1-10. https://doi.org/10.3109/08923973.2013.850506</Citation>
            </Reference>
            <Reference>
                <Citation>Berg, T., Hegelund Myrbäck, T., Olsson, M., Seidegård, J., Werkström, V., Zhou, X.-H., … Nord, M. (2014). Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects. Pharmacology Research &amp; Perspectives, 2, e00054. https://doi.org/10.1002/prp2.54</Citation>
            </Reference>
            <Reference>
                <Citation>Bowatte, G., Lodge, C. J., Perret, J. L., Matheson, M. C., &amp; Dharmage, S. C. (2016). Interactions of GST polymorphisms in air pollution exposure and respiratory diseases and allergies. Current Allergy and Asthma Reports, 16, 85. https://doi.org/10.1007/s11882-016-0664-z</Citation>
            </Reference>
            <Reference>
                <Citation>Casarett, L. J., &amp; Klaassen, C. D. (2008). Casarett &amp; Doull`s toxicology: The basic science of poisons (7th ed.) C. D. Klaassen New York, United States: (ed). McGraw-Hill Medical.</Citation>
            </Reference>
            <Reference>
                <Citation>Caswell, J. L., &amp; Williams, K. J. (2007). The respiratory system. In G. Maxie (Ed.), Jubb, Kennedy and Palmer´s Pathology of Domestic Animals (vol. 2, 5th ed., pp. 560-561). Edinburgh, UK; New York: Elsevier Saunders.</Citation>
            </Reference>
            <Reference>
                <Citation>Cohen, G. M., &amp; d'Arcy Doherty, M. (1987). Free radical mediated cell toxicity by redox cycling chemicals. The British Journal of Cancer Supplement, 8, 46-52.</Citation>
            </Reference>
            <Reference>
                <Citation>Comhair, S. A. A., Bhathena, P. R., Dweik, R. A., Kavuru, M., &amp; Erzurum, S. C. (2000). Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. The Lancet, 355, 624. https://doi.org/10.1016/S0140-6736(99)04736-4</Citation>
            </Reference>
            <Reference>
                <Citation>Comhair, S. A. A., &amp; Erzurum, S. C. (2010). Redox control of asthma: Molecular mechanisms and therapeutic opportunities. Antioxidants &amp; Redox Signaling, 12, 93-124. https://doi.org/10.1089/ars.2008.2425</Citation>
            </Reference>
            <Reference>
                <Citation>Couëtil, L., Cardwell, J., Gerber, V., Lavoie, J. P., Léguillette, R., &amp; Richard, E. (2016). Inflammatory airway disease of horses-Revised consensus statement. Journal of Veterinary Internal Medicine, 30, 503-515. https://doi.org/10.1111/jvim.13824</Citation>
            </Reference>
            <Reference>
                <Citation>Dahl, M., Bowler, R. P., Juul, K., Crapo, J. D., Levy, S., &amp; Nordestgaard, B. G. (2008). Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. American Journal of Respiratory and Critical Care Medicine, 178, 906-912. https://doi.org/10.1164/rccm.200804-549OC</Citation>
            </Reference>
            <Reference>
                <Citation>Deaton, C. M. (2006). The role of oxidative stress in an equine model of human asthma. Redox Report, 11, 46-52. https://doi.org/10.1179/135100006X101057</Citation>
            </Reference>
            <Reference>
                <Citation>Ding, X., &amp; Kaminsky, L. S. (2003). Human extrahepatic cytochromes P450: Function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annual Review of Pharmacology and Toxicology, 43, 149-173. https://doi.org/10.1146/annurev.pharmtox.43.100901.140251</Citation>
            </Reference>
            <Reference>
                <Citation>Folz, R. J., Abushamaa, A. M., &amp; Suliman, H. B. (1999). Extracellular superoxide dismutase in the airways of transgenic mice reduces inflammation and attenuates lung toxicity following hyperoxia. The Journal of Clinical Investigation, 103, 1055-1066. https://doi.org/10.1172/JCI3816</Citation>
            </Reference>
            <Reference>
                <Citation>Gaurav, R., Varasteh, J. T., Weaver, M. R., Jacobson, S. R., Hernandez-Lagunas, L., Liu, Q., … Bowler, R. P. (2017). The R213G polymorphism in SOD3 protects against allergic airway inflammation. JCI Insight, 2, e95072. https://doi.org/10.1172/jci.insight.95072</Citation>
            </Reference>
            <Reference>
                <Citation>Hassett, P., Curley, G. F., Contreras, M., Masterson, C., Higgins, B. D., O’Brien, T., … Laffey, J. G. (2011). Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury. Intensive Care Medicine, 37, 1680-1687. https://doi.org/10.1007/s00134-011-2309-y</Citation>
            </Reference>
            <Reference>
                <Citation>Hukkanen, J., Pelkonen, O., Hakkola, J., &amp; Raunio, H. (2002). Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Critical Reviews in Toxicology, 32, 391-411. https://doi.org/10.1080/20024091064273</Citation>
            </Reference>
            <Reference>
                <Citation>Ivester, K. M., Couëtil, L. L., &amp; Zimmerman, N. J. (2014). Investigating the link between particulate exposure and airway inflammation in the horse. Journal of Veterinary Internal Medicine, 28, 1653-1665. https://doi.org/10.1111/jvim.12458</Citation>
            </Reference>
            <Reference>
                <Citation>Kirschvink, N., de Moffarts, B., &amp; Lekeux, P. (2008). The oxidant/antioxidant equilibrium in horses. The Veterinary Journal, 177, 178-191. https://doi.org/10.1016/j.tvjl.2007.07.033</Citation>
            </Reference>
            <Reference>
                <Citation>Korytina, G. F., Yanbaeva, D. G., Babenkova, L. I., Etkina, E. I., &amp; Victorova, T. V. (2005). Genetic polymorphisms in the cytochromes P-450 (1A1, 2E1), microsomal epoxide hydrolase and glutathione S-transferase M1, T1, and P1 genes, and their relationship with chronic bronchitis and relapsing pneumonia in children. Journal of Molecular Medicine, 83, 700-710. https://doi.org/10.1007/s00109-005-0660-6</Citation>
            </Reference>
            <Reference>
                <Citation>Larsson, P., Persson, E., Tydén, E., &amp; Tjälve, H. (2003). Cell-specific activation of aflatoxin B1 correlates with presence of some cytochrome P450 enzymes in olfactory and respiratory tissues in horse. Research in Veterinary Science, 74, 227-233. https://doi.org/10.1016/S0034-5288(02)00191-1</Citation>
            </Reference>
            <Reference>
                <Citation>Leclere, M., Lavoie-Lamoureux, A., &amp; Lavoie, J.-P. (2011). Heaves, an asthma-like disease of horses. Respirology, 16, 1027-1046. https://doi.org/10.1111/j.1440-1843.2011.02033.x</Citation>
            </Reference>
            <Reference>
                <Citation>Morgan, E. T. (1997). Regulation of cytochromes P450 during inflammation and infection. Drug Metabolism Reviews, 29, 1129-1188. https://doi.org/10.3109/03602539709002246</Citation>
            </Reference>
            <Reference>
                <Citation>Morgan, E. T. (2001). Regulation of cytochrome P450 by inflammatory mediators: Why and how? Drug Metabolism and Disposition, 29, 207-212.</Citation>
            </Reference>
            <Reference>
                <Citation>Morgan, E. T. (2009). Impact of infectious and inflammatory disease on cytochrome P450-mediated drug metabolism and pharmacokinetics. Clinical Pharmacology and Therapeutics, 85, 434-438. https://doi.org/10.1038/clpt.2008.302</Citation>
            </Reference>
            <Reference>
                <Citation>Nadeem, A., Chhabra, S. K., Masood, A., &amp; Raj, H. G. (2003). Increased oxidative stress and altered levels of antioxidants in asthma. Journal of Allergy and Clinical Immunology, 111, 72-78. https://doi.org/10.1067/mai.2003.17</Citation>
            </Reference>
            <Reference>
                <Citation>Oury, T. D., Chang, L.-Y., Marklund, S. L., Day, B. J., &amp; Crapo, J. D. (1994). Immunocytochemical localization of extracellular superoxide dismutase in human lung. Laboratory Investigation, 70, 889-898.</Citation>
            </Reference>
            <Reference>
                <Citation>Pirie, R. S. (2014). Recurrent airway obstruction: A review. Equine Veterinary Journal, 46, 276-288. https://doi.org/10.1111/evj.12204</Citation>
            </Reference>
            <Reference>
                <Citation>Rahman, I., &amp; Adcock, I. M. (2006). Oxidative stress and redox regulation of lung inflammation in COPD. European Respiratory Journal, 28, 219-242. https://doi.org/10.1183/09031936.06.00053805</Citation>
            </Reference>
            <Reference>
                <Citation>Saarikoski, S. T., Husgafvel-Pursiainen, K., Hirvonen, A., Vainio, H., Gonzalez, F. J., &amp; Anttila, S. (1998). Localization of CYP1A1 mRNA in human lung by in situ hybridization: Comparison with immunohistochemical findings. International Journal of Cancer, 77, 33-39. https://doi.org/10.1002/(SICI)1097-0215(19980703)77:1&lt;33:AID-IJC7&gt;3.0.CO;2-0</Citation>
            </Reference>
            <Reference>
                <Citation>Sahiner, U. M., Birben, E., Erzurum, S., Sackesen, C., &amp; Kalayci, O. (2011). Oxidative stress in asthma. World Allergy Organization Journal, 4, 151-158. https://doi.org/10.1097/WOX.0b013e318232389e</Citation>
            </Reference>
            <Reference>
                <Citation>Schmittgen, T. D., &amp; Livak, K. J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nature Protocols, 3, 1101-1108. https://doi.org/10.1038/nprot.2008.73</Citation>
            </Reference>
            <Reference>
                <Citation>Smith, L. J., Shamsuddin, M., Sporn, P. H. S., Denenberg, M., &amp; Anderson, J. (1997). Reduced superoxide dismutase in lung cells of patients with asthma. Free Radical Biology and Medicine, 22, 1301-1307. https://doi.org/10.1016/S0891-5849(96)00550-3</Citation>
            </Reference>
            <Reference>
                <Citation>Soffler, C. (2007). Oxidative stress. Veterinary Clinics: Equine Practice, 23, 135-157. https://doi.org/10.1016/j.cveq.2006.11.004</Citation>
            </Reference>
            <Reference>
                <Citation>Takano, H., Yanagisawa, R., Ichinose, T., Sadakane, K., Inoue, K.-I., Yoshida, S.-I., … Morita, M. (2002). Lung expression of cytochrome P450 1A1 as a possible biomarker of exposure to diesel exhaust particles. Archives of Toxicology, 76, 146-151. https://doi.org/10.1007/s00204-002-0323-0</Citation>
            </Reference>
            <Reference>
                <Citation>Terrier, P., Townsend, A. J., Coindre, J. M., Triche, T. J., &amp; Cowan, K. H. (1990). An immunohistochemical study of pi class glutathione S-transferase expression in normal human tissue. The American Journal of Pathology, 137, 845-853.</Citation>
            </Reference>
            <Reference>
                <Citation>Tomaki, M., Sugiura, H., Koarai, A., Komaki, Y., Akita, T., Matsumoto, T., … Ichinose, M. (2007). Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Pulmonary Pharmacology &amp; Therapeutics, 20, 596-605. https://doi.org/10.1016/j.pupt.2006.06.006</Citation>
            </Reference>
            <Reference>
                <Citation>Tydén, E., Löfgren, M., Hakhverdyan, M., Tjälve, H., &amp; Larsson, P. (2013). The genes of all seven CYP3A isoenzymes identified in the equine genome are expressed in the airways of horses. Journal of Veterinary Pharmacology and Therapeutics, 36, 370-375. https://doi.org/10.1111/jvp.12012</Citation>
            </Reference>
            <Reference>
                <Citation>Tydén, E., Olsén, L., Tallkvist, J., Tjälve, H., &amp; Larsson, P. (2008). Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse. Research in Veterinary Science, 85, 80-85. https://doi.org/10.1016/j.rvsc.2007.09.012</Citation>
            </Reference>
            <Reference>
                <Citation>Van Erck-Westergren, E., Franklin, S. H., &amp; Bayly, W. M. (2013). Respiratory diseases and their effects on respiratory function and exercise capacity. Equine Veterinary Journal, 45, 376-387. https://doi.org/10.1111/evj.12028</Citation>
            </Reference>
            <Reference>
                <Citation>Wu, H., Liu, Z., Ling, G., Lawrence, D., &amp; Ding, X. (2013). Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model. Toxicological Sciences, 135, 476-485. https://doi.org/10.1093/toxsci/kft165</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32791555</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1439-4413</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>145</Volume>
                    <Issue>16</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Deutsche medizinische Wochenschrift (1946)</Title>
                <ISOAbbreviation>Dtsch. Med. Wochenschr.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Occupational medical pneumology - what's new?]</ArticleTitle>
            <Pagination>
                <MedlinePgn>1174-1178</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1055/a-1090-5723</ELocationID>
            <Abstract>
                <AbstractText>In case of obstructive, interstitial and malignant respiratory and lung diseases, occupational causes must always be searched for. The sensitivity and specificity of specific IgE determinations in the diagnosis of occupational asthma are only slightly above 70 %, even for high-molecular allergens. If the patient's medical history is positive, further diagnostics must be carried out, if necessary up to specific exposure testing in specialised institutions. New data show that the serial FeNO determination after working days compared to days off contains additional information that can lead to a positive diagnostic classification. In case of interstitial lung diseases, (avoidable) occupational triggers must be searched for - a new questionnaire provides practical assistance. Patients with lung carcinoma should also be investigated for occupational causes. Here too, questionnaires and tables are available in simple language. In future lung cancer caused by long-term exposure to passive smoke will be considered an occupational disease.</AbstractText>
                <CopyrightInformation>© Georg Thieme Verlag KG Stuttgart · New York.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Nowak</LastName>
                    <ForeName>Dennis</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin LMU-Klinikum München.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Quartucci</LastName>
                    <ForeName>Caroline</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin LMU-Klinikum München.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Karrasch</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin LMU-Klinikum München.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>ger</Language>
            <PublicationTypeList>
                <PublicationType UI="D004740">English Abstract</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Arbeitsmedizinische Pneumologie – was gibt es Neues?</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Dtsch Med Wochenschr</MedlineTA>
            <NlmUniqueID>0006723</NlmUniqueID>
            <ISSNLinking>0012-0472</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <OtherAbstract Type="Publisher" Language="ger">
            <AbstractText Label="ASTHMA MIT ARBEITSPLATZBEZUG" NlmCategory="UNASSIGNED"> Sensitivität und Spezifität spezifischer IgE-Bestimmungen in der Diagnostik des Berufsasthmas liegen selbst für hochmolekulare Allergene nur bei etwas über 70 %. Bei positiver Anamnese muss daher weitere Diagnostik, z. B. die serielle FeNO-Bestimmung, erfolgen, ggf. bis zur spezifischen Expositionstestung in spezialisierten Einrichtungen. Der Unterlassungszwang bezüglich der angeschuldigten Tätigkeit wird u. a. bei den obstruktiven Atemwegserkrankungen wegfallen.</AbstractText>
            <AbstractText Label="INTERSTITIELLE LUNGENERKRANKUNGEN DURCH ARBEIT" NlmCategory="UNASSIGNED"> Bei interstitiellen Lungenerkrankungen ist nach (vermeidbaren) beruflichen Auslösern zu fahnden – ein neuer Fragebogen gibt hierfür praktische Hilfestellung.</AbstractText>
            <AbstractText Label="KREBSERKRANKUNGEN DER LUNGE UND PLEURA DURCH ARBEIT" NlmCategory="UNASSIGNED">Auch bei Patienten mit Lungenkarzinom ist nach beruflichen Ursachen zu recherchieren. Auch hier stehen Fragebögen und Tabellen in patientenverständlicher Sprache zur Verfügung. Lungenkrebserkrankungen durch langjährige Passivrauchexposition werden künftig als Berufskrankheit gelten.</AbstractText>
        </OtherAbstract>
        <CoiStatement>DN erklärt, dass er in den letzten 3 Jahren institutionelle Forschungsunterstützung von folgenden Förderern erhalten hat: DFG, BMG, DGUV, BGW, Verwaltungs-BG, Bundesarbeitsministerium, Bayerische Ministerien, Industrie (MAN, FMG, Siemens, Audi), Versicherungen, ADAC, ÖAMTC, Erzbischöfliches Ordinariat, Caritas. Vortragstätigkeit wurde honoriert von Berlin Chemie, Boehringer Ingelheim, GSK, Mundipharma, Novartis, Hexal, Lilly. Gutachterliche Tätigkeit erfolgt für Gerichte und Unfallversicherungsträger.CQ und SK geben an, dass kein Interessenkonflikt besteht.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791555</ArticleId>
            <ArticleId IdType="doi">10.1055/a-1090-5723</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791506</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0097</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International archives of allergy and immunology</Title>
                <ISOAbbreviation>Int. Arch. Allergy Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Effect of Bronchoconstriction by Methacholine Inhalation in a Murine Model of Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-11</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000509606</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Bronchoconstriction was recently shown to cause airway remodeling and induce allergic airway inflammation in asthma. However, the mechanisms how mechanical stress via bronchoconstriction could induce airway inflammation and remodeling remain unclear.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We investigated the effect of bronchoconstriction induced by methacholine inhalation in a murine model of asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">BALB/c female mice were sensitized and challenged with ovalbumin (OVA), followed by treatment with methacholine by a nebulizer twice a day for 7 days. Twenty-four hours after the last methacholine treatment, the bronchoalveolar lavage fluid (BALF) and lung tissues were collected. The BALF was analyzed for total and differential cell counts and cytokine levels. The lung tissues were analyzed for goblet cell metaplasia, thickness of the smooth muscle, and lung fibrosis. The expression of cytokines in the lung was also examined.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">OVA sensitization and challenge induced infiltration of total cells, macrophages, and eosinophils in the BALF along with goblet cell metaplasia and increased airway smooth muscle hypertrophy. Seven days after the last OVA challenge, untreated mice achieved reduction in airway inflammation, while methacholine maintained the number of BALF total cells, macrophages, and eosinophils. The percentage of goblet cells and the thickness of airway smooth muscle were also maintained by methacholine. Moreover, the treatment of methacholine induced the expression of transforming growth factor (TGF)-β in the lung. This result indicates that the production of TGF-β is involved in induction of airway remodeling caused by bronchoconstriction with methacholine.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Repeated bronchoconstriction caused by methacholine inhalation elicited allergic airway inflammation and airway remodeling.</AbstractText>
                <CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Miyata</LastName>
                    <ForeName>Yoshito</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ohta</LastName>
                    <ForeName>Shin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan, shinohta@med.showa-u.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tanaka</LastName>
                    <ForeName>Akihiko</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kashima</LastName>
                    <ForeName>Ayaka</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suganuma</LastName>
                    <ForeName>Hiromitsu</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uno</LastName>
                    <ForeName>Tomoki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sato</LastName>
                    <ForeName>Haruna</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ida</LastName>
                    <ForeName>Hitomi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kimura</LastName>
                    <ForeName>Tomoyuki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jinno</LastName>
                    <ForeName>Megumi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirai</LastName>
                    <ForeName>Kuniaki</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Homma</LastName>
                    <ForeName>Tetsuya</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Mayumi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watanabe</LastName>
                    <ForeName>Yoshio</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suzuki</LastName>
                    <ForeName>Shintaro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sagara</LastName>
                    <ForeName>Hironori</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int Arch Allergy Immunol</MedlineTA>
            <NlmUniqueID>9211652</NlmUniqueID>
            <ISSNLinking>1018-2438</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway remodeling</Keyword>
            <Keyword MajorTopicYN="N">Asthma model</Keyword>
            <Keyword MajorTopicYN="N">Bronchoconstriction</Keyword>
            <Keyword MajorTopicYN="N">Mechanical stress</Keyword>
            <Keyword MajorTopicYN="N">Methacholine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791506</ArticleId>
            <ArticleId IdType="pii">000509606</ArticleId>
            <ArticleId IdType="doi">10.1159/000509606</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791248</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Multidimensional assessment of asthma identifies clinically relevant phenotype overlap: a cross-sectional study.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30806-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.07.048</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma is a heterogenous disease with multiple phenotypes; however, the relevance of phenotype overlap remains largely unexplored.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To examine the relationship between phenotype overlap and clinical and inflammatory profiles of asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this cross-sectional study, adult participants with stable asthma (n=522) underwent multidimensional assessments. The 10 most common phenotypes of asthma were defined and then classified into those commonly associated with Type (T) 2 or non-T2 inflammation. Furthermore, phenotype overlap scores (POS), representing the cumulative concomitant phenotypes, were used to analyze its association with clinical and inflammatory asthmatic profiles.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 522 participants, 73.4% (n=383) had phenotype overlap, and mixed T2 and non-T2 inflammation coexisted in 47.5% (n=248). T2 POS was positively associated with eosinophils, IgE, and FeNO, and negatively with AQLQ, sputum neutrophils, IL-17A, IL-8, and TNF-α. Non-T2 POS was positively associated with ACQ, neutrophils and sputum IL-8, and negatively with AQLQ, FEV<sub>1</sub>, blood eosinophils, IgE, and FeNO (all P&lt;0.05). Patients with phenotypes that are associated with mixed T2 and non-T2 inflammation had elevated T2 inflammation biomarkers but worse asthma control. Both T2 (adjusted β = -0.191, P=0.035) and non-T2 (adjusted β = 0.310, P&lt;0.001) POSs were significantly associated with severe exacerbations.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Phenotype overlap is extremely common in asthmatic patients and significantly associated with clinical and inflammatory profiles. Patients with phenotypes associated with mixed T2 and non-T2 inflammation might be unresponsive to medications owing to increased non-T2 inflammation. Multidimensional asthma assessment identifies clinically relevant phenotype overlap.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Yu Yu</ForeName>
                    <Initials>YY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Ji</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China; West China School of Medicine, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliver</LastName>
                    <ForeName>Brian G</ForeName>
                    <Initials>BG</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Life Sciences, University of Technology Sydney, Ultimo, NSW, 2007, Australia; Respiratory Cellular and Molecule Biology, Woolcock Institute of Medical Research, The University of Sydney, NSW 2017, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Hong Ping</ForeName>
                    <Initials>HP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>De Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Pneumology Group, Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qiu</LastName>
                    <ForeName>Zhi Xin</ForeName>
                    <Initials>ZX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Wei Min</ForeName>
                    <Initials>WM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Clinical Research Center for Respiratory Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China; Lab of Lung Immuno-inflammation, Frontiers Science Center for Disease-related Molecular Network, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: wcums-respiration@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">exacerbation</Keyword>
            <Keyword MajorTopicYN="N">overlap</Keyword>
            <Keyword MajorTopicYN="N">phenotype</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791248</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30806-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.07.048</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791247</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Oral corticosteroids and risk of preterm birth in the California Medicaid Program.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30805-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.07.047</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is limited information regarding the impact of dose and gestational timing of oral corticosteroid (OCS) use on preterm birth (PTB), especially among women with asthma.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate OCS dose and timing on PTB for asthma and, as a comparison, systemic lupus erythematosus (SLE).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We used healthcare data from California Medicaid enrollees linked to birth certificates (2007-2013), identifying women with asthma (n=22,084) and SLE (n=1,174). We estimated risk ratios (RR) for OCS cumulative dose trajectories and other disease-related medications before gestational day 140 and hazard ratios (HR) for time-varying exposures after day 139.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">For asthma, PTB risk was 14.0% for no OCS exposure and 14.3%, 16.8%, 20.5%, and 32.7% in low, medium, medium-high, and high cumulative dose trajectory groups during the first 139 days. The high dose group remained associated with PTB after adjustment (adjusted (a)RR: 1.46 (95% CI: 1.00, 2.15)). OCS dose after day 139 was not clearly associated with PTB, nor were controller medications. For SLE, PTB risk for no OCS exposure was 24.9% and was 39.1% in low and 61.2% in high dose trajectory groups. aRRs were 1.80 (95% CI: 1.34, 2.40) for high and 1.24 (95% CI: 0.97, 1.58) for low groups. Only prednisone equivalent dose &gt;20mg/day after day 139 was associated with increased PTB (aHR: 2.54 (95% CI: 1.60, 4.03)).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For asthma, higher OCS doses early in pregnancy, but not later, were associated with increased PTB. For SLE, higher doses early and later in pregnancy were associated with PTB.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Palmsten</LastName>
                    <ForeName>Kristin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>HealthPartners Institute, Minneapolis, MN; Department of Pediatrics, University of California, San Diego, La Jolla, CA. Electronic address: Kristin.K.Palmsten@HealthPartners.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bandoli</LastName>
                    <ForeName>Gretchen</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, University of California, San Diego, La Jolla, CA; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watkins</LastName>
                    <ForeName>Jim</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research and Analytic Studies Division, California Department of Health Services, Sacramento, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vazquez-Benitez</LastName>
                    <ForeName>Gabriela</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>HealthPartners Institute, Minneapolis, MN.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gilmer</LastName>
                    <ForeName>Todd P</ForeName>
                    <Initials>TP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chambers</LastName>
                    <ForeName>Christina D</ForeName>
                    <Initials>CD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, University of California, San Diego, La Jolla, CA; Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">adrenergic beta-2 receptor agonists</Keyword>
            <Keyword MajorTopicYN="N">antirheumatic agents</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">glucocorticoids</Keyword>
            <Keyword MajorTopicYN="N">inflammatory bowel disease</Keyword>
            <Keyword MajorTopicYN="N">leukotriene antagonist</Keyword>
            <Keyword MajorTopicYN="N">oral corticosteroids</Keyword>
            <Keyword MajorTopicYN="N">pregnancy</Keyword>
            <Keyword MajorTopicYN="N">preterm birth</Keyword>
            <Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791247</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30805-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.07.047</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791209</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2139</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Brain, behavior, and immunity</Title>
                <ISOAbbreviation>Brain Behav. Immun.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Depressive and anxiety symptomatology among people with asthma or atopic dermatitis: a population-based investigation using the UK Biobank data.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0889-1591(20)30486-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbi.2020.08.003</ELocationID>
            <Abstract>
                <AbstractText>The present study investigated the association of depression and anxiety symptomatology (DAS) with asthma and atopic dermatitis (AD) diagnosis during mid-adult years. The study employed data from 502,641 participants in the UK Biobank. Neutrophils to Lymphocytes Ratios (NLRs) of patients with asthma and AD were calculated and evaluated in relation to DAS, measured via the Patient Health Questionnaire-4 (PHQ-4). Age of asthma or AD onset association with DAS were also estimated. Multivariable regression analyses were implemented among participants with asthma or AD, compared to those without these disorders. Out of 58,833 participants with asthma and 13,462 with AD, the prevalence of DAS was 11.7% and 2.7%, respectively. DAS increased among participants with either asthma or AD, being highest within patients having both (β= 0.41, 95% confidence interval (95%CI), 0.34,0.49). NLR showed a linear increase with PHQ scores in asthma patients, (tertile 1, β= 0.30, 95% CI, 0.27,0.34; tertile 2, β= 0.36, 95%CI, 0.32,0.39, and tertile 3, β= 0.43, 95%CI, 0.39,0.46). An inverted U-shaped association was seen between age of asthma onset and PHQ, with the 40-59 age group (β= 0.54, 95%CI, 0.48,0.59) showing the highest risk followed by the 60+ (β= 0.43, 95%CI, 0.34,0.51 and 20-39 groups (β= 0.32, 95%CI, 0.27,0.38). Similar patterns emerged within AD. Asthma and AD were associated with increased DAS during mid-adult years, being strongest among participants reporting both disorders. A dose-response relationship between NLR and DAS was observed. Asthma or AD onset during mid-adult years (40-59) were associated with the highest increment in DAS.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hussain</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom; School of Psychology, Victoria University of Wellington, Wellington, New Zealand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ronaldson</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arias de la Torre</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom; CIBER Epidemiology and Public Health (CIBERESP), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sima</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>USAMV, Cluj-Napoca, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hatch</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hotopf</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dregan</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychological Medicine, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, United Kingdom. Electronic address: alexandru.dregan@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Brain Behav Immun</MedlineTA>
            <NlmUniqueID>8800478</NlmUniqueID>
            <ISSNLinking>0889-1591</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anxiety</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">Depression</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Mental health</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791209</ArticleId>
            <ArticleId IdType="pii">S0889-1591(20)30486-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbi.2020.08.003</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791187</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-4596</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Free radical biology &amp; medicine</Title>
                <ISOAbbreviation>Free Radic. Biol. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>OXYGEN-MEDIATED LUNG injury in mice Lacking the gene for NRF2: Rescue with the cytochrome P4501A-INDUCER, beta-naphthoflavone (BNF), and differential sex-specific effects.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0891-5849(20)31163-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.freeradbiomed.2020.07.027</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute respiratory distress syndrome (ARDS) leads to progressive lung injury, which significantly impacts patient morbidity and mortality but may differ clinically between the sexes. Cytochrome P450 (CYP) 1A enzymes are protective against hyperoxic lung injury and may contribute to sex-dependent pathology. NRF2 is a critical transcriptional regulator of antioxidants and loss of NRF2 leads to severe hyperoxic lung injury and mortality in mice. NRF2 deficiencies and polymorphisms have been observed in patients with pulmonary diseases such as chronic obstructive pulmonary disease and severe asthma. No prior studies have evaluated whether there are sex-specific differences in oxygen-mediated lung injury in Nrf2<sup>-/-</sup> mice and there are few rescue studies.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To test the hypothesis that hyperoxia induces greater lung injury and inflammation in Nrf2<sup>-/-</sup> mice compared to wild type (WT) that differs between sexes, and that this phenotype will be rescued by the administration of the cytochrome P450 (CYP) 1A inducer beta-naphthoflavone (BNF).</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">/Methods: Male and female 8-10-week-old WT or Nrf2<sup>-/-</sup> C57BL/6 mice were pre-treated with BNF (40 mg/kg) or corn oil control and exposed to hyperoxia (95% O<sub>2</sub>) for 68 hours. Survival, pulmonary edema, neutrophil recruitment, and lung injury scores were evaluated. Gene expression of phase II detoxification enzymes, pulmonary cytokines, and Cyp1a1/2 was quantified. CYP1A1/2 protein expression and catalytic activities were also measured.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Hyperoxia exposure greatly reduced survival in Nrf2<sup>-/-</sup> mice, particularly in females. BNF treatment improved survival by 182.8% in Nrf2<sup>-/-</sup> females and by 41.4% in Nrf2<sup>-/-</sup> males as well as in WT females by 85.7%. Females had greater pulmonary edema as measured by lung weight to body weight ratios but was attenuated in all groups except Nrf2<sup>-/-</sup> females by BNF. Neutrophils doubled in Nrf2<sup>-/-</sup> lungs compared to WT in hyperoxia but were decreased in BNF-treated females of both genotypes. Pulmonary cytokine gene expression including Il-6 and Tnf-α increased in hyperoxia especially in Nrf2<sup>-/-</sup> mice and was unaffected by BNF. Pulmonary and hepatic Nqo1 gene expression w-as decreased in Nrf2<sup>-/-</sup> mice and was largely unaffected by BNF; however pulmonary Ho-1 did not vary significantly between the genotypes and was decreased in WT animals treated with BNF. Activities and protein expression of pulmonary and hepatic CYP1A1/2 were induced via BNF across all groups. Although hepatic Cyp1a2 gene expression was higher in Nrf2<sup>-/-</sup> males, the catalytic activity was higher in Nrf2<sup>-/-</sup> females.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hyperoxia augmented lung injury in Nrf2<sup>-/-</sup> mice, and pre-treatment with BNF was protective against mortality and injury, eliminating the sex-dependent survival difference in both genotypes. Our results support the hypothesis that NRF2 protects mice against lung injury, and the fact that BNF rescues the lung injury phenotype in Nrf2<sup>-/-</sup> mice suggests that augmented CYP1A expression by BNF may contribute to the beneficial effects. Further studies could lead to the development of BNF and other flavonoids for the prevention/treatment of hyperoxic lung injury, particularly in vulnerable patients with relative NRF2 deficiency, regardless of sex.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Callaway</LastName>
                    <ForeName>Danielle A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030. Electronic address: callawayd@email.chop.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Weiwu</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030. Electronic address: wxjiang@texaschildrens.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Lihua</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lingappan</LastName>
                    <ForeName>Krithika</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030. Electronic address: lingappa@bcm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moorthy</LastName>
                    <ForeName>Bhagavatula</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Neonatology, Department of Pediatrics, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX, 77030. Electronic address: bmoorthy@bcm.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Free Radic Biol Med</MedlineTA>
            <NlmUniqueID>8709159</NlmUniqueID>
            <ISSNLinking>0891-5849</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ARDS</Keyword>
            <Keyword MajorTopicYN="N">CYP1A</Keyword>
            <Keyword MajorTopicYN="N">NRF2</Keyword>
            <Keyword MajorTopicYN="N">hyperoxia</Keyword>
            <Keyword MajorTopicYN="N">oxygen-mediated lung injury</Keyword>
            <Keyword MajorTopicYN="N">sex differences</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791187</ArticleId>
            <ArticleId IdType="pii">S0891-5849(20)31163-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.07.027</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791163</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J. Allergy Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Allergome-wide peptide microarrays enable epitope deconvolution in allergen-specific immunotherapy.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0091-6749(20)31108-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2020.08.002</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The interaction of allergens and allergen-specific IgE initiates the allergic cascade after crosslinking of receptors on effector cells. Antibodies of other isotypes may modulate such a reaction. Receptor crosslinking requires binding of antibodies to multiple epitopes on the allergen. Limited information is available on the complexity of the epitope structure of most allergens.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To allow description of the complexity of IgE, IgG4 and IgG epitope recognition at a global, allergome-wide level during allergen-specific immunotherapy (AIT).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We generated an allergome-wide microarray comprising 731 allergens in the form of &gt;172.000 overlapping 16-mer peptides. Allergen recognition by IgE, IgG4 and IgG was examined in serum samples collected from subjects undergoing AIT against pollen allergy.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Extensive induction of linear peptide-specific Phl p 1- and Bet v 1-specific humoral immunity was demonstrated in subjects undergoing a 3 year-long AIT against grass and birch-pollen allergy, respectively. Epitope profiles differed between subjects but were largely established already after 1 year of AIT, suggesting that dominant allergen-specific antibody clones remained as important contributors to humoral immunity following their initial establishment during the early phase of AIT. Complex, subject-specific patterns of allergen isoform and group cross-reactivities in the repertoires were observed, patterns that may indicate different levels of protection against different allergen sources.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The study highlights the complexity and subject-specific nature of allergen epitopes recognized following AIT. We envisage that epitope deconvolution will be an important aspect of future efforts to describe and analyse the outcomes of AIT in a personalized manner.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mikus</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden; Unit of Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zandian</LastName>
                    <ForeName>Arash</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sjöberg</LastName>
                    <ForeName>Ronald</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamsten</LastName>
                    <ForeName>Carl</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Forsström</LastName>
                    <ForeName>Björn</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Systems Biology, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andersson</LastName>
                    <ForeName>Morgan</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head &amp; Neck Surgery, Skåne University Hospital, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greiff</LastName>
                    <ForeName>Lennart</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head &amp; Neck Surgery, Skåne University Hospital, Lund, Sweden; Dept. of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uhlén</LastName>
                    <ForeName>Mathias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Systems Biology, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levin</LastName>
                    <ForeName>Mattias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunotechnology, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nilsson</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology &amp; SciLifeLab, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Hage</LastName>
                    <ForeName>Marianne</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ohlin</LastName>
                    <ForeName>Mats</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunotechnology, Lund University, Lund, Sweden. Electronic address: mats.ohlin@immun.lth.se.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IgE</Keyword>
            <Keyword MajorTopicYN="N">IgG</Keyword>
            <Keyword MajorTopicYN="N">IgG4</Keyword>
            <Keyword MajorTopicYN="N">allergen</Keyword>
            <Keyword MajorTopicYN="N">allergen reactivity</Keyword>
            <Keyword MajorTopicYN="N">allergen-specific immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">antibody</Keyword>
            <Keyword MajorTopicYN="N">epitope</Keyword>
            <Keyword MajorTopicYN="N">linear epitope</Keyword>
            <Keyword MajorTopicYN="N">peptide microarray</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791163</ArticleId>
            <ArticleId IdType="pii">S0091-6749(20)31108-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.08.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791102</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asthma Emphysema Overlap in Non-Smokers.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30564-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.010</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gelb</LastName>
                    <ForeName>Arthur F</ForeName>
                    <Initials>AF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary Division, Department of Medicine, Lakewood Regional Medical Center (LRMC), Lakewood, California, Geffen School of Medicine at UCLA Medical Center, Los Angeles, California. Electronic address: afgelb@msn.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Alfred</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, LRMC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verbeken</LastName>
                    <ForeName>Eric</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Katholieke Univeritair Ziekenhuis Gasthuisberg, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grigorian</LastName>
                    <ForeName>Stephan R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Glenpath Diagnostics, Glendale, California.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nadel</LastName>
                    <ForeName>Jay A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiovascular Research Institute and Pulmonary Division, Departments of Medicine, Physiology, and Radiology, University of California, San Francisco Medical Center, San Francisco, California.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Emphysema</Keyword>
            <Keyword MajorTopicYN="N">Non-Smokers</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791102</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30564-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.010</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791025</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2162-2906</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the Air &amp; Waste Management Association (1995)</Title>
                <ISOAbbreviation>J Air Waste Manag Assoc</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluating an Air Quality Health Index (AQHI) amendment for communities impacted by residential woodsmoke in British Columbia, Canada.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/10962247.2020.1797927</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Smoke from burning biomass is an important source of fine particulate matter (PM<sub>2.5</sub>), but the health risks may not be fully captured by the Canadian Air Quality Health Index (AQHI). In May 2018, the province of British Columbia launched an evidence-based amendment (AQHI-Plus) to improve AQHI performance for wildfire smoke, but the AQHI-Plus was not developed or tested on data from the residential woodsmoke season. This study assesses how the AQHI and AQHI-Plus are associated with acute health outcomes during the cooler seasons of 2010-2017 in British Columbia, Canada.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Monthly and daily patterns of temperature and PM<sub>2.5</sub> concentrations were used to identify Local Health Areas (LHAs) that were impacted by residential woodsmoke. The effects of the AQHI and AQHI-Plus on five acute health outcomes (including non-accidental mortality, outpatient physician visits, and medical dispensations for cardiopulmonary conditions) were estimated using generalized linear mixed effect models with Poisson distributions adjusted for long- and short-term temperature trends. Values of the Akaike information criterion (AIC) were compared to evaluate whether the AQHI or AQHI-Plus was better fitted to each health outcome.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven LHAs were categorized as woodsmoke-impacted. In these LHAs, the AQHI and AQHI-Plus associations with acute health outcomes were sensitive to temperature adjustments. After temperature adjustments, the most consistent associations were observed for the two asthma-specific outcomes where the AQHI-Plus was better fitted than the AQHI.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The improved performance of the AQHI-Plus for susceptible populations with asthma is consistent between communities impacted by residential woodsmoke and wildfire smoke. Implication Statement Canada's Air Quality Health Index (AQHI) is a three pollutant index used to communicate the short term health impact of degraded air quality. As fine particulate matter (PM<sub>2.5</sub>) is the lowest weighted pollutant in the AQHI, the index is poorly reflective of woodsmoke impacts. The present analysis found that an AQHI amendment developed for improved sensitivity to PM<sub>2.5</sub> during wildfire seasons (AQHI-Plus) is also more predictive of acute asthma-related health outcomes in communities impacted by residential woodsmoke. The BC Ministry of Environment and Climate Change Strategy has piloted the AQHI-Plus year-round. Other jurisdictions should consider whether their air quality indices are reflective of the risks posed by woodsmoke.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Trieu</LastName>
                    <ForeName>Jeffrey</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Environmental Health Services, British Columbia Centre for Disease Control , 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yao</LastName>
                    <ForeName>Jiayun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Environmental Health Services, British Columbia Centre for Disease Control , 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McLean</LastName>
                    <ForeName>Kathleen E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Environmental Health Services, British Columbia Centre for Disease Control , 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stieb</LastName>
                    <ForeName>Dave M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Environmental Health Science and Research Bureau, Health Canada , 420-757 West Hastings St. - Federal Tower, Vancouver, BC V6C 1A1, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Henderson</LastName>
                    <ForeName>Sarah B</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Environmental Health Services, British Columbia Centre for Disease Control , 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Air Waste Manag Assoc</MedlineTA>
            <NlmUniqueID>9503111</NlmUniqueID>
            <ISSNLinking>1096-2247</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Air Quality Health Index (AQHI)</Keyword>
            <Keyword MajorTopicYN="N">Residential wood burning</Keyword>
            <Keyword MajorTopicYN="N">air quality</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">biomass smoke</Keyword>
            <Keyword MajorTopicYN="N">woodsmoke</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791025</ArticleId>
            <ArticleId IdType="doi">10.1080/10962247.2020.1797927</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32791002</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-4970</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of respiratory and critical care medicine</Title>
                <ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Urine - A Lens for Asthma Pathogenesis and Treatment?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.202007-2899ED</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Peebles</LastName>
                    <ForeName>R Stokes</ForeName>
                    <Initials>RS</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Vanderbilt University School of Medicine, Nashville, Tennessee, United States; stokes.peebles@vanderbilt.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Respir Crit Care Med</MedlineTA>
            <NlmUniqueID>9421642</NlmUniqueID>
            <ISSNLinking>1073-449X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">eicosanoids</Keyword>
            <Keyword MajorTopicYN="N">leukotriene</Keyword>
            <Keyword MajorTopicYN="N">prostaglandin</Keyword>
            <Keyword MajorTopicYN="N">urine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32791002</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.202007-2899ED</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32790948</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1752-699X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The clinical respiratory journal</Title>
                <ISOAbbreviation>Clin Respir J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association of circadian clock TIMELESS variants and expression with asthma risk in children.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13260</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Bronchial asthma is a chronic respiratory disease characterized by airway inflammation, allergen-induced hypersensitivity and dyspnea. Most asthmatic patients demonstrate oscillations of disease symptoms within 24 hours regulated by circadian clock genes. We hypothesized that these genes may be regulators of childhood asthma risk.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim was to investigate whether single nucleotide polymorphisms (SNPs) in the circadian clock genes are associated with childhood asthma risk. We also aimed to analyze the mRNA level of clock genes in the blood of asthmatic children and NHBE cells stimulated with IL-13.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Peripheral blood was collected from 165 asthmatic and 138 healthy Polish children. NHBE cells were culture at air-liquid interface (ALI) with IL-13 as an in vitro model of allergic inflammation. Using TaqMan probes, we genotyped 32 SNPs in: CLOCK, BMAL1, PER3 and TIMELESS. Expression analysis for TIMELESS was performed using real-time PCR with SYBR Green. For haplotype and genotype statistical analysis we used Haploview 4.2 and STATISTICA version 12, respectively. Gene expression analysis was done in DataAssist v3.01.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that 3 polymorphisms in TIMELESS (rs2291739, rs10876890, rs11171856) and two haplotypes (TTTT and CTAC) were associated with asthma risk. We also found significantly decreased expression of TIMELESS in the blood of asthmatic children as compared to the healthy children (p=0.0289) and in NHBE cells stimulated with IL-13 (p=0.0302).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In our study we showed for the first time that TIMELESS variants and expression may be associated with childhood asthma.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Langwinski</LastName>
                    <ForeName>Wojciech</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4906-7225</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sobkowiak</LastName>
                    <ForeName>Paulina</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2737-8946</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Narozna</LastName>
                    <ForeName>Beata</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wojsyk-Banaszak</LastName>
                    <ForeName>Irena</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dmitrzak-Węglarz</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatric Genetics, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stachowiak</LastName>
                    <ForeName>Zuzanna</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nowakowska</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bręborowicz</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szczepankiewicz</LastName>
                    <ForeName>Aleksandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pediatric Pulmonology, Allergy and Clinical Immunology, Poznan University of Medical Sciences, 27/33 Szpitalna St, 60-572, Poznan, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Respir J</MedlineTA>
            <NlmUniqueID>101315570</NlmUniqueID>
            <ISSNLinking>1752-6981</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">gene expression</Keyword>
            <Keyword MajorTopicYN="N">genotyping</Keyword>
            <Keyword MajorTopicYN="N">polymorphism</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32790948</ArticleId>
            <ArticleId IdType="doi">10.1111/crj.13260</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32790902</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1752-699X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The clinical respiratory journal</Title>
                <ISOAbbreviation>Clin Respir J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human bocavirus and metapneumovirus in acute wheezing in children - is there a link with atopy?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13261</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Viral respiratory tract infections are leading cause of acute wheezing in children with significant risk of hospital admission, risk of recurrence and subsequent asthma.Human respiratory syncytial virus (RSV) and human rhinovirus (RV) in childhood wheezing are widely studied, however, accessible PCR assays enabled diagnosis of other pathogens, including bocavirus (hBOV) and metapneumovirus (hMPV).</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the study was to evaluate prevalence of respiratory viruses in children hospitalized for acute wheezing along with demographic and clinical data.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 101 children, n=50 (49.5%) with wheezy bronchitis, n=34 (33.7%) with acute bronchiolitis and n=17 (16.8%) with exacerbation of asthma; (median age 1.41±2.84 years). Multiplex real-time PCR assay was used for virus detection.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">One or more viruses were detected in 83.2% subjects: RSV in 44.6%, followed by RV (23.8%), hBOV and hMPV (both 11.9%); other viruses were less frequent (&lt;8%). Viral coinfection was found in 38 (37.6%) of children. ANCOVA analysis revealed significantly higher total IgE concentrations in hMPV-positive subgroup compared to RSV (34 KU/l vs 12.7 KU/l; p=0.009) and RV (13.3 KU/l, p=0.022). For both hMPV and hBOV anassociation with atopic dermatitis (AD) was observed: aOR for hMPV and AD was 5.6 (95%CI: 1.4-22.7; p=0.016) and 4.7 for hBOV and AD (95%CI: 1.3-18; p=0.024).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Viral detection ratio in wheezy respiratory tract infections in Polish children ishigh (83.2%), with both hBOV and hMPV at 11.9% The results also suggest possible relationship of hBOV wheezy infection with nonspecific markers of atopy in children.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sobkowiak</LastName>
                    <ForeName>Paulina</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2737-8946</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumonology, Allergology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mikoś</LastName>
                    <ForeName>Marcin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumonology, Allergology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bręborowicz</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumonology, Allergology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szczepankiewicz</LastName>
                    <ForeName>Aleksandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumonology, Allergology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Cell Biology, Department of Pneumonology, Allergology and Clinical Immunology, Poznań University of Medical Sciences, Poznań, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Respir J</MedlineTA>
            <NlmUniqueID>101315570</NlmUniqueID>
            <ISSNLinking>1752-6981</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">bocavirus</Keyword>
            <Keyword MajorTopicYN="N">bronchiolitis</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">metapneumovirus</Keyword>
            <Keyword MajorTopicYN="N">wheezing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32790902</ArticleId>
            <ArticleId IdType="doi">10.1111/crj.13261</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32790752</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Telemedicine in the OECD: An umbrella review of clinical and cost-effectiveness, patient experience and implementation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0237585</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0237585</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Patients and policy makers alike have high expectations for the use of digital technologies as tools to improve health care service quality at a sustainable cost. Many countries within the Organisation for Economic Co-operation and Development (OECD) are investing in telemedicine initiatives, and a large and growing body of peer-reviewed studies on the topic has developed, as a consequence. Nonetheless, telemedicine is still not used at scale within the OECD. Seeking to provide a snapshot of the evidence on the use of telemedicine in the OECD, this umbrella review of systematic reviews summarizes findings on four areas of policy relevance: clinical and cost-effectiveness, patient experience, and implementation.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This review followed a prior written, unregistered protocol. Four databases (PubMed/Medline, CRD, and Cochrane Library) were searched for systematic reviews or meta-analyses published between January 2014 and February 2019. Based on the inclusion criteria, 98 systematic reviews were selected for analysis. Due to substantial heterogeneity, a meta-analysis was not conducted. The quality of included reviews was assessed using the AMSTAR 2 tool.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Most reviews (n = 53) focused on effectiveness, followed by cost-effectiveness (n = 18), implementation (n = 17) and patient experience (n = 15). Eighty-three percent of clinical effectiveness reviews found telemedicine at least as effective as face-to-face care, and thirty-nine percent of cost-effectivenss reviews found telemedicine to be cost saving or cost-effective. Patients reported high acceptance of telemedicine and the most common barriers to implementation were usability and lack of reimbursement. However, the methodological quality of most reviews was low to critically low which limits generalizability and applicability of findings.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This umbrella review finds that telemedicine interventions can improve glycemic control in diabetic patients; reduce mortality and hospitalization due to chronic heart failure; help patients manage pain and increase their physical activity; improve mental health, diet quality and nutrition; and reduce exacerbations associated with respiratory diseases like asthma. In certain disease and specialty areas, telemedicine may be a less effective way to deliver care. While there is evidence that telemedicine can be cost-effective, generalizability is hindered by poor quality and reporting standards. This umbrella review also finds that patients report high levels of acceptance and satisfaction with telemedicine interventions, but that important barriers to wider use remain.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Eze</LastName>
                    <ForeName>Nkiruka D</ForeName>
                    <Initials>ND</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0749-4915</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Health Research, Health Economics at Lancaster, Lancaster University, Lancaster, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mateus</LastName>
                    <ForeName>Céu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Health Research, Health Economics at Lancaster, Lancaster University, Lancaster, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cravo Oliveira Hashiguchi</LastName>
                    <ForeName>Tiago</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Division Organisation for Economic Co-operation and Development, Directorate for Employment, Labour and Social Affairs, Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>We have no competing interests to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32790752</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0237585</ArticleId>
            <ArticleId IdType="pii">PONE-D-20-02481</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32790241</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1099-0496</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric pulmonology</Title>
                <ISOAbbreviation>Pediatr. Pulmonol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Cost-Utility of Intravenous Magnesium Sulfate for Treating Asthma Exacerbations in Children.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.25024</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although evidence supports the use of intravenous magnesium sulfate (MS) in asthma exacerbations, MS continues to be considered a second-line drug for managing pediatric asthma exacerbations. This study aimed to evaluate the cost-utility of MS in asthma exacerbations.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We used a decision tree model to estimate the cost-utility of MS compared to treatment without MS (control group) in children with asthma exacerbations. Cost data were obtained from a retrospective study from tertiary centers in Rionegro, Colombia, while utilities were collected from the literature. Probabilistic sensitivity analysis was carried out using the Monte Carlo technique with a simulation of a hypothetical cohort of 10,000 patients to generate expected cost utilities with 95% confidence intervals. We used a cost-effectiveness acceptability curve to evaluate the uncertainty surrounding the cost-utility of MS.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The model showed that MS had a lower total cost than the control group (US $1,149 vs US $1,598 average cost per patient) and higher quality-adjusted life years (0.60 vs 0.52 average per patient), showing dominance. The probability that MS provides a more cost-effective use of resources compared with standard therapy exceeds 99% for all willingness-to-pay thresholds CONCLUSION: Intravenous magnesium sulfate was lesswas less expensive and more effective than treatment without intravenous MS in children with asthma exacerbations. Our study provides evidence that should be used by decision-makers to improve clinical practice guidelines and should be replicated to validate its results in other middle-income countries. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Buendía</LastName>
                    <ForeName>Jefferson Antonio</ForeName>
                    <Initials>JA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2404-6612</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Toxicology, School of Medicine, Research Group in Pharmacology and Toxicology (INFARTO). Universidad de Antioquia, Medellín, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Acuña-Cordero</LastName>
                    <ForeName>Ranniery</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Neumología Pediátrica, Hospital Militar Central, Departamento de Pediatría, Facultad de Medicina, Universidad Militar Nueva Granada, Bogotá, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodriguez-Martinez</LastName>
                    <ForeName>Carlos E</ForeName>
                    <Initials>CE</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2560-6693</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, School of Medicine, Universidad Nacional de Colombia, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Pulmonology and Pediatric Critical Care Medicine, School of Medicine, Universidad El Bosque, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Pediatr Pulmonol</MedlineTA>
            <NlmUniqueID>8510590</NlmUniqueID>
            <ISSNLinking>1099-0496</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">health economics</Keyword>
            <Keyword MajorTopicYN="N">healthcare</Keyword>
            <Keyword MajorTopicYN="N">public health</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32790241</ArticleId>
            <ArticleId IdType="doi">10.1002/ppul.25024</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32789792</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-9546</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Purinergic signalling</Title>
                <ISOAbbreviation>Purinergic Signal.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Limonene-induced activation of A<sub>2A</sub> adenosine receptors reduces airway inflammation and reactivity in a mouse model of asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11302-020-09697-z</ELocationID>
            <Abstract>
                <AbstractText>Animal models of asthma have shown that limonene, a naturally occurring terpene in citrus fruits, can reduce inflammation and airway reactivity. However, the mechanism of these effects is unknown. We first performed computational and molecular docking analyses that showed limonene could bind to both A<sub>2A</sub> and A<sub>2B</sub> receptors. The pharmacological studies were carried out with A<sub>2A</sub> adenosine receptor knock-out (A<sub>2A</sub>KO) and wild-type (WT) mice using ovalbumin (OVA) to generate the asthma phenotype. We investigated the effects of limonene on lung inflammation and airway responsiveness to methacholine (MCh) and NECA (nonselective adenosine analog) by administering limonene as an inhalation prior to OVA aerosol challenges in one group of allergic mice for both WT and KO. In whole-body plethysmography studies, we observed that airway responsiveness to MCh in WT SEN group was significantly lowered upon limonene treatment but no effect was observed in A<sub>2A</sub>KO. Limonene also attenuated NECA-induced airway responsiveness in WT allergic mice with no effect being observed in A<sub>2A</sub>KO groups. Differential BAL analysis showed that limonene reduced levels of eosinophils in allergic WT mice but not in A<sub>2A</sub>KO. However, limonene reduced neutrophils in sensitized A<sub>2A</sub>KO mice, suggesting that it may activate A<sub>2B</sub> receptors as well. These data indicate that limonene-induced reduction in airway inflammation and airway reactivity occurs mainly via activation of A<sub>2A</sub>AR but A<sub>2B</sub> receptors may also play a supporting role.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Mehaben</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Narke</LastName>
                    <ForeName>Deven</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kurade</LastName>
                    <ForeName>Mangesh</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frey</LastName>
                    <ForeName>Kathleen M</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Fairleigh Dickinson University School of Pharmacy and Health Sciences, Teaneck, NJ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rajalingam</LastName>
                    <ForeName>Sahith</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siddiquee</LastName>
                    <ForeName>Armaan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mustafa</LastName>
                    <ForeName>S Jamal</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology and Pharmacology, West Virginia University, Morgantown, WV, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ledent</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ponnoth</LastName>
                    <ForeName>Dovenia S</ForeName>
                    <Initials>DS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutical Sciences Arnold &amp; Marie Schwartz College of Pharmacy &amp; Health Sciences, Long Island University, Brooklyn, NY, USA. dponnoth@osteo.wvsom.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, West Virginia School of Osteopathic Medicine, WV, Lewisburg, USA. dponnoth@osteo.wvsom.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>HL027339</GrantID>
                    <Acronym>NH</Acronym>
                    <Agency>NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>Startup funds</GrantID>
                    <Agency>Long Island University</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Purinergic Signal</MedlineTA>
            <NlmUniqueID>101250499</NlmUniqueID>
            <ISSNLinking>1573-9538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">A2A adenosine receptors</Keyword>
            <Keyword MajorTopicYN="N">Airway inflammation</Keyword>
            <Keyword MajorTopicYN="N">Airway responsiveness</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Limonene</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789792</ArticleId>
            <ArticleId IdType="doi">10.1007/s11302-020-09697-z</ArticleId>
            <ArticleId IdType="pii">10.1007/s11302-020-09697-z</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32789546</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2190-3948</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Drug delivery and translational research</Title>
                <ISOAbbreviation>Drug Deliv Transl Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Intranasal administration of budesonide-loaded nanocapsule microagglomerates as an innovative strategy for asthma treatment.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13346-020-00813-5</ELocationID>
            <Abstract>
                <AbstractText>The co-existence with rhinitis limits the control of asthma. Compared with oral H<sub>1</sub> receptor antagonists, intranasal corticosteroids have been demonstrated to provide greater relief of all symptoms of rhinitis and are recommended as first-line treatment for allergic rhinitis. Intrinsic limitations of nasal delivery, such as the presence of the protective mucous layer, the relentless mucociliary clearance, and the consequent reduced residence time of the formulation in the nasal cavity, limit budesonide efficacy to the treatment of local nasal symptoms. To overcome these limitations and to enable the treatment of asthma via nasal administration, we developed a budesonide-loaded lipid-core nanocapsule (BudNC) microagglomerate powder by spray-drying using a one-step innovative approach. BudNC was obtained, as a white powder, using L-leucine as adjuvant with 75 ± 6% yield. The powder showed a bimodal size distribution curve by laser diffraction with a principal peak just above 3 μm and a second one around 0.45 μm and a drug content determined by HPLC of 8.7 mg of budesonide per gram. In vivo after nasal administration, BudNC showed an improved efficacy in terms of reduction of immune cell influx; production of eotaxin-1, the main inflammatory chemokine; and arrest of airways remodeling when compared with a commercial budesonide product in both short- and long-term asthma models. In addition, data showed that the results in the long-term asthma model were more compelling than the results obtained in the short-term model. Graphical abstract.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ortiz</LastName>
                    <ForeName>Manoel</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, Porto Alegre, 90610-000, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Sa Coutinho</LastName>
                    <ForeName>Diego</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ciambarella</LastName>
                    <ForeName>Bianca Torres</ForeName>
                    <Initials>BT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Souza</LastName>
                    <ForeName>Everton Tenorio</ForeName>
                    <Initials>ET</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>D'Almeida</LastName>
                    <ForeName>Ana Paula Leite</ForeName>
                    <Initials>APL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Durli</LastName>
                    <ForeName>Taís Lusa</ForeName>
                    <Initials>TL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, Porto Alegre, 90610-000, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodrigues E Silva</LastName>
                    <ForeName>Patrícia Machado</ForeName>
                    <Initials>PM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bernardi</LastName>
                    <ForeName>Andressa</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sonvico</LastName>
                    <ForeName>Fabio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dipartimento di Scienze degli Alimenti e del Farmaco, Università degli studi di Parma, Parco Area delle Scienze, 27/A, 43124, Parma, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pohlmann</LastName>
                    <ForeName>Adriana Raffin</ForeName>
                    <Initials>AR</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-5222-1807</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, Porto Alegre, 90610-000, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Química Orgânica, Instituto de Química, Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, Porto Alegre, 91501-970, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martins</LastName>
                    <ForeName>Marco Aurelio</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratório de Inflamação, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil, 4365, Rio de Janeiro, 21040-360, Brazil. mmartins@ioc.fiocruz.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guterres</LastName>
                    <ForeName>Sílvia Stanisçuaski</ForeName>
                    <Initials>SS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6085-6826</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, Porto Alegre, 90610-000, Brazil. silvia.guterres@ufrgs.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>465687/2014-8</GrantID>
                    <Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>16/2551-0000467-6</GrantID>
                    <Agency>Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2014/50928-2</GrantID>
                    <Agency>FAPESP</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Drug Deliv Transl Res</MedlineTA>
            <NlmUniqueID>101540061</NlmUniqueID>
            <ISSNLinking>2190-393X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Bronchoalveolar lavage fluid</Keyword>
            <Keyword MajorTopicYN="N">Budesonide</Keyword>
            <Keyword MajorTopicYN="N">Cytokines</Keyword>
            <Keyword MajorTopicYN="N">Eotaxin-1</Keyword>
            <Keyword MajorTopicYN="N">Lung histology</Keyword>
            <Keyword MajorTopicYN="N">Polymeric nanocapsules</Keyword>
            <Keyword MajorTopicYN="N">Spray-drying</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789546</ArticleId>
            <ArticleId IdType="doi">10.1007/s13346-020-00813-5</ArticleId>
            <ArticleId IdType="pii">10.1007/s13346-020-00813-5</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32789118</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2233-8276</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asia Pacific allergy</Title>
                <ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IgE recognition profile of aeroallergen components in young children sensitized to dogs.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e33</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2020.10.e33</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Pet ownership is increasing rapidly and as growing numbers of dogs in household, clinicians are facing more allergic patients and so as in young children.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">This study aims to profile the IgE recognition patterns to aeroallergen components in young children sensitized to dogs.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Through retrospective chart reviews, we evaluated the clinical, environmental, and laboratory findings of patients sensitized to dogs in early life. We further evaluated specific IgE to dog component allergens (Can f 1, Can f 2, and Can f 3) and other aeroallergens using a microarray.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The median age of 28 patients sensitized to dogs (dog-specific IgE ≥ 0.35 kU/L; 0.38-101 kU/L) was 61 months and underlying diseases included doctor diagnosed atopic dermatitis (n = 17), asthma (n = 7), and allergic rhinitis (n = 5). Twenty patients (71.4%) had experienced self-reported dog allergy and 70.0% of them were symptomatic after exposed to dogs from others. Component-resolved diagnosis was performed on 18 patients. Can f 1 positivity was the most common (77.8%) but had no value in symptom prediction. The most common cosensitized aeroallergen was house dust mites (44.5%). The symptomatic group tended to be poly-sensitized to Can f 1, Can f 2, and Can f 3.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Can f 1 was dominantly detected and poly-sensitized to Can f 2 and/or Can f 3 simultaneously tend to develop hypersensitivity to dogs in young children. Most of them were exposed to dogs not living with.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jeongmin</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1672-7445</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Wonju College of Medicine, Yonsei University, Wonju, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeong</LastName>
                    <ForeName>Kyunguk</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1261-4507</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeon</LastName>
                    <ForeName>Se-Ah</ForeName>
                    <Initials>SA</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8955-7440</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Sooyoung</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1734-4101</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Ajou University School of Medicine, Suwon, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Asia Pac Allergy</MedlineTA>
            <NlmUniqueID>101561954</NlmUniqueID>
            <ISSNLinking>2233-8276</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Can f 1</Keyword>
            <Keyword MajorTopicYN="N">Child</Keyword>
            <Keyword MajorTopicYN="N">Component-resolved diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Dog allergy</Keyword>
            <Keyword MajorTopicYN="N">Microarray</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest: We thank Thermo Fisher Scientific Inc. (Uppsala, Sweden) for providing the kits used for component-resolved diagnosis.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789118</ArticleId>
            <ArticleId IdType="doi">10.5415/apallergy.2020.10.e33</ArticleId>
            <ArticleId IdType="pmc">PMC7402952</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32789115</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2233-8276</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asia Pacific allergy</Title>
                <ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Natural history of asthma symptoms after epidemic thunderstorm asthma: a 3-year longitudinal study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e30</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2020.10.e30</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">The world's most catastrophic epidemic thunderstorm asthma event (ETSA) affected Melbourne in 2016. Little is known about the natural history of individuals affected by such extreme events.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">In this single center prospective 3-year longitudinal study, symptomatology and behaviors of individuals affected by ETSA were assessed.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Standardized telephone questionnaire was used to evaluate frequency of asthma symptoms, inhaled corticosteroid preventer use, asthma action plan ownership, and healthcare utilization. Questionnaires were administered at 12, 24, and 36 months after 2016 ETSA. Subgroup analyses of the 'current', 'past', 'possible,' and 'no asthma' subgroups were also conducted.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Two hundred and eight, 164, and 112 completed questionnaires were analyzed in 2017, 2018, and 2019, respectively. Seventy to eighty five percent of respondents reported ongoing asthma symptoms in any given year, of which 20%-28% experienced weekly symptoms. Nearly 50% of respondents were prescribed preventers, with approximately 45% adherent at least 5 days a week. Less than 40% had an asthma action plan and 15%-20% sought urgent medical attention for asthma over the follow-up period. Among 106 individuals with 3 consecutive years of completed questionnaires, those with no prior doctor diagnosis of asthma were significantly more likely to be asymptomatic on follow-up than those with a prior doctor diagnosis of asthma (<i>p</i> = 0.02). Subgroup analyses suggest that large proportions of respondents with 'past' and 'no asthma' continue to remain symptomatic throughout the 36-month period.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">In individuals affected by ETSA, we found evidence of ongoing loss of asthma control in those with previously well controlled asthma, and the persistence of symptoms suggestive of asthma in those with no history or symptoms suggestive of prior asthma, even after 36 months from initial ETSA. Low rates of inhaler adherence and asthma action plan ownership may contribute to increased morbidity and mortality from future ETSA events. Further research is required to confirm these findings.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Foo</LastName>
                    <ForeName>Chuan T</ForeName>
                    <Initials>CT</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1497-9830</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fernando</LastName>
                    <ForeName>Sonali</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Naomi</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adabi</LastName>
                    <ForeName>Golsa</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Cheryl M T</ForeName>
                    <Initials>CMT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Young</LastName>
                    <ForeName>Alan C</ForeName>
                    <Initials>AC</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0718-1564</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thien</LastName>
                    <ForeName>Francis</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0925-6566</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Asia Pac Allergy</MedlineTA>
            <NlmUniqueID>101561954</NlmUniqueID>
            <ISSNLinking>2233-8276</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Environment</Keyword>
            <Keyword MajorTopicYN="N">Epidemics</Keyword>
            <Keyword MajorTopicYN="N">Natural history</Keyword>
            <Keyword MajorTopicYN="N">Pathophysiology</Keyword>
            <Keyword MajorTopicYN="N">Public health</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of Interest: The authors have no financial conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789115</ArticleId>
            <ArticleId IdType="doi">10.5415/apallergy.2020.10.e30</ArticleId>
            <ArticleId IdType="pmc">PMC7402954</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32789112</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2233-8276</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asia Pacific allergy</Title>
                <ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Allergic bronchopulmonary aspergillosis misdiagnosed as recurrent pneumonia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e27</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2020.10.e27</ELocationID>
            <Abstract>
                <AbstractText>Allergic bronchopulmonary aspergillosis (ABPA) is a disease of the lungs resulting from a hypersensitivity reaction to <i>Aspergillus fumigatus</i>. The disease remains underdiagnosed and as many as 57% of patients are misdiagnosed as pulmonary tuberculosis, pneumonia, pulmonary abscess in China. Here we report the case of a 13-year-old girl with ABPA who presented with productive cough, wheezing, bronchiectasis and decline in lung function, total IgE was 25,180 KU/L, <i>Aspergillus</i>-specific IgE was 34.7 kUA/L. Chest high-resolution computed tomography (CT) showed infiltration, central bronchiectasis, and high-attenuation mucus in the left lower lobe and lingula. On bronchoscopy, a large amount of purulent material and brownish sputum plugs were seen. This case has been diagnosed as pneumonia 3 times before the ABPA diagnosis. For the treatment, corticosteroid (prednisone 0.5 mg/kg/day) plus itraconazole (200 mg, twice a day) were initiated. The girl responded well to the therapy. Two weeks later, she was free of symptoms. Lung function nearly improved to normal. One month later, peripheral eosinophil percentage and IgE decreased to 0.7% and 1,3451 KU/L (46% reduction), respectively. However, the trend of <i>A. fumigatus-</i>specific IgE persistently increased during treatment (from 34.7 KU/L to above 100 KU/L). Chest CT showed improvement in pulmonary infiltration. The present case emphasizes the importance of considering the diagnosis of ABPA in children with uncontrolled pneumonia, hypereosinophilia, and bronchiectasis with a previous history of asthma. Total serum IgE is a useful marker of disease activity and success of therapy while the serum <i>A. fumigatus</i>-specific IgE has limited utility in the follow-up of patients with ABPA.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Nannan</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4395-2266</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Allergy, Beijing Children's Hospital, Children's National Medical Center, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiang</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4273-7601</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Allergy, Beijing Children's Hospital, Children's National Medical Center, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Asia Pac Allergy</MedlineTA>
            <NlmUniqueID>101561954</NlmUniqueID>
            <ISSNLinking>2233-8276</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic bronchopulmonary aspergillosis</Keyword>
            <Keyword MajorTopicYN="N">Aspergillus fumigatus</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of Interest: The authors have no financial conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789112</ArticleId>
            <ArticleId IdType="doi">10.5415/apallergy.2020.10.e27</ArticleId>
            <ArticleId IdType="pmc">PMC7402949</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32789110</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2233-8276</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asia Pacific allergy</Title>
                <ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Importance of microbial extracellular vesicle in the pathogenesis of asthma and chronic obstructive pulmonary disease and its diagnostic potential.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e25</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2020.10.e25</ELocationID>
            <Abstract>
                <AbstractText>There are rising evidences of the human microbiome as a potentially influential player that is actively engaged in shaping the pathogenetic processes and other unresolved issues both in asthma and other chronic respiratory diseases, particularly of the airways. The biological components such as microbiome in inhaled air can induce immune dysfunction and inflammation, leading to inflammatory pulmonary disorders such as asthma and chronic obstructive pulmonary disease (COPD). Microbe-derived extracellular vesicles (EVs) with biologically active information or functions can reprogram their respective target cells and EV may have a role for the development of asthma and COPD. To evaluate the role of microbe-derived EV in the pathogenesis of asthma and COPD and its role in diagnosis, the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement method was used for the study. An electronic search was performed using PubMed, PubMed Central, and Embase up to 2020. EVs serve as an intercellular transporter of miRNAs for cell-to-cell communication in the lungs. Bacteria-derived EVs have distinctive characteristics in the lungs of patients with asthma and COPD compared to healthy controls. Furthermore, bacterial EV IgG antibody titers in serum were significantly higher in patients with asthma and COPD than in healthy controls, suggesting that antibacterial EV antibodies titers can be used as a diagnostic tool for lung disease. Taken together, microbial EVs and miRNAs have important roles in the pathogenesis of asthma and COPD and they can provide novel diagnostic biomarkers for asthma and COPD.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>You-Young</ForeName>
                    <Initials>YY</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2762-4617</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Asthma Allergy Center, National Medical Center, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joh</LastName>
                    <ForeName>Joon Sung</ForeName>
                    <Initials>JS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5044-2742</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, National Medical Center, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Ji Yeon</ForeName>
                    <Initials>JY</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7026-8235</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, National Medical Center, Seoul, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Asia Pac Allergy</MedlineTA>
            <NlmUniqueID>101561954</NlmUniqueID>
            <ISSNLinking>2233-8276</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Chronic obstructive pulmonary disease</Keyword>
            <Keyword MajorTopicYN="N">Extracellular vesicles</Keyword>
            <Keyword MajorTopicYN="N">Microbiome</Keyword>
            <Keyword MajorTopicYN="N">miRNA</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of Interest: The authors have no financial conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789110</ArticleId>
            <ArticleId IdType="doi">10.5415/apallergy.2020.10.e25</ArticleId>
            <ArticleId IdType="pmc">PMC7402947</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32789109</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2233-8276</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Asia Pacific allergy</Title>
                <ISOAbbreviation>Asia Pac Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hypereosinophilic syndrome with abundant Charcot-Leyden crystals in spleen and lymph nodes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e24</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.5415/apallergy.2020.10.e24</ELocationID>
            <Abstract>
                <AbstractText>Hypereosinophilic syndrome, which is characterized by eosinophilia in the peripheral blood, often causes various organ disorders. Charcot-Leyden crystals are recognized features of various diseases, such as parasite infection and asthma, and are known to be classic hallmarks of eosinophilic inflammation. Our recent study revealed the mechanism of Charcot-Leyden crystal formation (i.e., galectin-10 crystallization), namely the involvement of eosinophil extracellular trap cell death, a nonapoptotic cell death. Here we report an autopsy case of a 57-year-old man who had died of hypereosinophilic syndrome. We found numerous eosinophil extracellular trap cell death-associated Charcot-Leyden crystals in the spleen and lymph nodes. Observation of abdominal lymph nodes by electron microscopy revealed eosinophil extracellular traps and free extracellular granules, which are characteristic of typical eosinophil extracellular trap cell death. In this case, we observed various sizes of Charcot-Leyden crystals that were stained with anti-galectin-10 immunofluorescent staining. Further studies are required to understand the pathophysiological roles of Charcot-Leyden crystals and these may lead to the development of novel therapeutic modalities for severe eosinophilic inflammation.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Asia Pacific Association of Allergy, Asthma and Clinical Immunology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Takeda</LastName>
                    <ForeName>Masahide</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7028-7073</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ueki</LastName>
                    <ForeName>Shigeharu</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3537-7735</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Yohei</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4108-7627</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Pathology and Tumor Pathology, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nara</LastName>
                    <ForeName>Miho</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fukuchi</LastName>
                    <ForeName>Mineyo</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1161-9074</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakayama</LastName>
                    <ForeName>Katsutoshi</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0141-7081</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Omori</LastName>
                    <ForeName>Yasufumi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Pathology and Tumor Pathology, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Takahashi</LastName>
                    <ForeName>Naoto</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6758-3787</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirokawa</LastName>
                    <ForeName>Makoto</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Internal Medicine and Clinical Laboratory Medicine, Akita University Graduate School of Medicine, Akita, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>Asia Pac Allergy</MedlineTA>
            <NlmUniqueID>101561954</NlmUniqueID>
            <ISSNLinking>2233-8276</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Charcot-Leyden crystal</Keyword>
            <Keyword MajorTopicYN="N">ETosis</Keyword>
            <Keyword MajorTopicYN="N">Eosinophils</Keyword>
            <Keyword MajorTopicYN="N">Galectin-10</Keyword>
            <Keyword MajorTopicYN="N">Hypereosinophilic syndrome</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of Interest: SU received honoraria for lectures from AstraZeneca; and has received grant support from AstraZeneca and Maruho Co. Ltd. NT received honoraria for lectures from Novartis Pharmaceuticals, Pfizer, and Otsuka Pharmaceutical; and has received grant support from Astellas Pharma, Asahi Kasei Pharma, Otsuka Pharmaceutical, and Ono Pharmaceutical. The other authors declare no competing financial interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789109</ArticleId>
            <ArticleId IdType="doi">10.5415/apallergy.2020.10.e24</ArticleId>
            <ArticleId IdType="pmc">PMC7402945</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32789027</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2090-1844</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2020</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Pulmonary medicine</Title>
                <ISOAbbreviation>Pulm Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Clinical Factors on Generic and Disease-Specific Quality of Life in COPD and Asthma-COPD Overlap with Exacerbations.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6164343</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1155/2020/6164343</ELocationID>
            <Abstract>
                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">The health-related quality of life (HRQL) in chronic obstructive pulmonary disease (COPD) is worsened by frequent exacerbations, and it can be affected by the concomitant presence of bronchial asthma (asthma-COPD overlap (ACO)). The impacts of clinical factors associated with HRQL have not been compared in patients with COPD and ACO experiencing exacerbations. <i>Patients and Methods</i>. Patients with COPD (<i>N</i> =705) and ACO (<i>N</i> =148) belonging to C and D groups according to GOLD 2017 were recruited in stable condition. Demographic and clinical data were collected, spirometry was performed, and patients rated the intensity of respiratory symptoms during the previous week. The COPD Assessment Test (CAT) and the EQ-5D 3 level version (dimensions and visual analogue scale (VAS)) were used to assess disease-specific and generic HRQL, respectively. Fisher's exact test, <i>χ</i><sup>2</sup> test, ANOVA, and Pearson correlation were used for analysis (mean ± SD). Multiple linear regression was applied to identify variables related to CAT and EQ-5D VAS scores.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The CAT and EQ-5D VAS scores showed similarly low HRQL in COPD and ACO (20.7 ± 6.7 vs. 21.1 ± 6.3 (<i>p</i> = 0.52) and 56.2 ± 17.8 vs. 53.7 ± 18.2 (<i>p</i> = 0.11)). There was a weak correlation between CAT and EQ-5D VAS scores (COPD: <i>r</i> = -0.345, <i>p</i> &lt; 0.001; ACO: <i>r</i> = -0.245, <i>p</i> = 0.003). More patients with COPD had problems related to anxiety/depression in EQ-5D (63.7% vs. 55.4%, <i>p</i> = 0.06). Pack-years exerted a negative effect on HRQL measures both in ACO and COPD. Low HRQL in COPD was associated with female gender, dyspnea, cough, gastroesophageal reflux disease, and arrhythmia, while in ACO, it was related to arrhythmia, hypertension, and cough, but less to dyspnea.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Patients with COPD and ACO experiencing exacerbations have low quality of life, which is influenced by smoking history, symptoms, and comorbidities. These findings have important implications for the development of therapeutic strategies to improve the health status of patients with these conditions.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Zsófia Lázár et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lázár</LastName>
                    <ForeName>Zsófia</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2444-9040</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dept. Pulmonology, Semmelweis University, 25-29 Tömő Str. 1083 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Horváth</LastName>
                    <ForeName>Alpár</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0183-0180</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dept. Pulmonology, Semmelweis University, 25-29 Tömő Str. 1083 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Chiesi Hungary Ltd., Dunavirág u. 2, 1138 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomisa</LastName>
                    <ForeName>Gábor</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dept. Pulmonology, Semmelweis University, 25-29 Tömő Str. 1083 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Chiesi Hungary Ltd., Dunavirág u. 2, 1138 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tamási</LastName>
                    <ForeName>Lilla</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3477-6125</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dept. Pulmonology, Semmelweis University, 25-29 Tömő Str. 1083 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Müller</LastName>
                    <ForeName>Veronika</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1398-3187</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dept. Pulmonology, Semmelweis University, 25-29 Tömő Str. 1083 Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>25</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Egypt</Country>
            <MedlineTA>Pulm Med</MedlineTA>
            <NlmUniqueID>101558762</NlmUniqueID>
            <ISSNLinking>2090-1844</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32789027</ArticleId>
            <ArticleId IdType="doi">10.1155/2020/6164343</ArticleId>
            <ArticleId IdType="pmc">PMC7334771</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32788950</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2045-7022</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>10</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical and translational allergy</Title>
                <ISOAbbreviation>Clin Transl Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The association between airborne pollen monitoring and sensitization in the hot desert climate.</ArticleTitle>
            <Pagination>
                <MedlinePgn>35</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13601-020-00339-6</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Pollen is a major cause of allergic respiratory diseases. In Qatar, data on the presence and prevalence of allergenic airborne types of pollen is quite limited.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The study aimed to determine and correlate the most frequently implicated airborne pollen detected by aerobiological monitoring samplers in respiratory allergy symptoms. An aerobiological survey was started on May 8, 2017. Airborne pollen was collected using two Hirst type seven-day recorder volumetric traps. Skin prick test in patients attending allergy clinics in Doha using commercial extracts was conducted.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Twenty-five pollen types representing the native, as well as the introduced plants, with a relatively low daily mean concentration were observed from May 2017 to May 2019. The highest pollen concentrations were reached by Amaranthaceae (58.9%), followed by Poaceae (21.7%). SPT revealed a comparatively higher degree of sensitization to pollen. Among 940 patients, 204 were sensitized to pollen (54% female) with 135 (66.2%) and 114 (55.8%) to Amaranthaceae and Poaceae, respectively. Some patients had polysensitization. There was a statistically significant association between Amaranthaceae, and asthma (r = 0.169, <i>P </i>= 0.016) and allergic rhinitis (r = 0.177, <i>P </i>= 0.012).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">This is the first study to monitor airborne pollen in the state of Qatar. The main pollen detected were Amaranthaceae and Poaceae. Pollen may represent a possible exacerbating factor in adult patients with allergic diseases such as asthma and allergic rhinitis.</AbstractText>
                <CopyrightInformation>© The Author(s) 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Al-Nesf</LastName>
                    <ForeName>Maryam A</ForeName>
                    <Initials>MA</Initials>
                    <Identifier Source="ORCID">0000-0001-9354-0214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gharbi</LastName>
                    <ForeName>Dorra</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Plant Biology, University of Malaga, Campus de Teatinos, Malaga, Spain.</Affiliation>
                        <Identifier Source="GRID">grid.10215.37</Identifier>
                        <Identifier Source="ISNI">0000 0001 2298 7828</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mobayed</LastName>
                    <ForeName>Hassan M</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dason</LastName>
                    <ForeName>Blessing Reena</ForeName>
                    <Initials>BR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohammed Ali</LastName>
                    <ForeName>Ramzy</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taha</LastName>
                    <ForeName>Salma</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy and Immunology Section, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tuffaha</LastName>
                    <ForeName>Amjad</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidra Medicine, Doha 26999, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adeli</LastName>
                    <ForeName>Mehdi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidra Medicine, Doha 26999, Qatar.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sattar</LastName>
                    <ForeName>Hisham A</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary Division, Department of Medicine, Hamad Medical Corporation, Doha 3050, Qatar.</Affiliation>
                        <Identifier Source="GRID">grid.413548.f</Identifier>
                        <Identifier Source="ISNI">0000 0004 0571 546X</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trigo</LastName>
                    <ForeName>Maria Del Mar</ForeName>
                    <Initials>MDM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Plant Biology, University of Malaga, Campus de Teatinos, Malaga, Spain.</Affiliation>
                        <Identifier Source="GRID">grid.10215.37</Identifier>
                        <Identifier Source="ISNI">0000 0001 2298 7828</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Transl Allergy</MedlineTA>
            <NlmUniqueID>101576043</NlmUniqueID>
            <ISSNLinking>2045-7022</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aerobiology</Keyword>
            <Keyword MajorTopicYN="N">Allergy</Keyword>
            <Keyword MajorTopicYN="N">Pollen</Keyword>
            <Keyword MajorTopicYN="N">Qatar</Keyword>
            <Keyword MajorTopicYN="N">Skin prick test</Keyword>
        </KeywordList>
        <CoiStatement>Competing interestsThere are no commercial associations that might pose a conflict of interest. We wish to confirm that there are no known conflicts of interest associated with this publication, and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of the authors listed in the manuscript has been approved by all of the authors. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In doing so, we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. We understand that the corresponding author is the sole contact for the editorial process (including the editorial manager and direct communications with the office). She is responsible for communicating with the other authors about the progress, submission of revisions, and the final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the corresponding author.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788950</ArticleId>
            <ArticleId IdType="doi">10.1186/s13601-020-00339-6</ArticleId>
            <ArticleId IdType="pii">339</ArticleId>
            <ArticleId IdType="pmc">PMC7416415</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32788543</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1349-7235</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Internal medicine (Tokyo, Japan)</Title>
                <ISOAbbreviation>Intern. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bronchial Asthma and Rest Angina: Is It Safe to Perform Acetylcholine Spasm Provocation Tests in These Patients?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.5071-20</ELocationID>
            <Abstract>
                <AbstractText>Objectives Acetylcholine (ACh) use in patients with bronchial asthma (BA) is contraindicated. We examined the clinical usefulness and safety of ACh spasm provocation tests in rest angina patients with BA. Patients The study subjects were 495 rest angina patients (mean age: 64.4±10.9 years old, male: 81.0%). Organic stenosis was found in 69 patients (13.9%). Methods We investigated 495 rest angina patients who underwent ACh spasm provocation tests. ACh was injected in incremental doses of 20/50/100/200 μg into the left coronary artery and 20/50/80 μg into the right coronary artery. Provoked positive spasm was defined as transient ≥ 90% luminal narrowing and usual chest pain or ischemic electrocardiogram changes. Results Among 495 rest angina patients, 13 (2.6%) were complicated with BA. Eleven patients with BA were controlled under medications, and two patients had a history of medication for BA. The clinical characteristics were not markedly different between rest angina patients with and without BA. The rate of multi-vessel spasm was markedly higher in patients with BA than that in those without BA. No complications during ACh spasm provocation tests were recognized in rest angina patients with BA, whereas major complications in those without BA were observed in eight patients including two ventricular fibrillations, three non-sustained ventricular tachycardias, and three shocks. We were able to perform all 495 ACh spasm provocation tests without any irreversible complications, while electrical defibrillation was necessary for 2 patients without BA. Conclusions We were able to perform ACh spasm provocation tests in rest angina patients with BA irrespective of the off-label use of ACh.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sueda</LastName>
                    <ForeName>Shozo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Ehime Prefectural Niihama Hospital, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Intern Med</MedlineTA>
            <NlmUniqueID>9204241</NlmUniqueID>
            <ISSNLinking>0918-2918</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">acetylcholine spasm provocation test</Keyword>
            <Keyword MajorTopicYN="N">bronchial asthma</Keyword>
            <Keyword MajorTopicYN="N">complications</Keyword>
            <Keyword MajorTopicYN="N">coronary spastic angina</Keyword>
            <Keyword MajorTopicYN="N">rest angina</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788543</ArticleId>
            <ArticleId IdType="doi">10.2169/internalmedicine.5071-20</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32788528</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1349-7235</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Internal medicine (Tokyo, Japan)</Title>
                <ISOAbbreviation>Intern. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Spasm Provocation Test Using Acetylcholine in Patients with Bronchial Asthma: An Important Step Forward.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2169/internalmedicine.5568-20</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Teragawa</LastName>
                    <ForeName>Hiroki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Medicine, JR Hiroshima Hospital,, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Japan</Country>
            <MedlineTA>Intern Med</MedlineTA>
            <NlmUniqueID>9204241</NlmUniqueID>
            <ISSNLinking>0918-2918</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">acetylcholine</Keyword>
            <Keyword MajorTopicYN="N">bronchial asthma</Keyword>
            <Keyword MajorTopicYN="N">coronary artery spasm</Keyword>
            <Keyword MajorTopicYN="N">coronary spastic angina</Keyword>
            <Keyword MajorTopicYN="N">spasm provocation test</Keyword>
            <Keyword MajorTopicYN="N">vasospastic angina</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788528</ArticleId>
            <ArticleId IdType="doi">10.2169/internalmedicine.5568-20</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32788482</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1119-3077</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>23</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nigerian journal of clinical practice</Title>
                <ISOAbbreviation>Niger J Clin Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Atopy in HIV-infected children attending the pediatric antiretroviral clinic of LAUTECH Teaching Hospital, Osogbo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1061-1067</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4103/njcp.njcp_359_19</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Atopy is poorly researched in HIV children living in the developing countries. There is no previous report on this subject in Nigeria and this pioneering study is undertaken to create an awareness of the burden of this disease among health practitioners.</AbstractText>
                <AbstractText Label="Aims" NlmCategory="UNASSIGNED">The aim of this study was to document the atopic diseases present among HIV-infected children attending the antiretroviral (ARV) clinic of a Nigerian tertiary hospital.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Information was obtained from consecutive consenting caregiver/HIV-infected child attending the pediatric ARV clinic, by the use of a proforma specifically designed for the study. The data obtained were analyzed using Statistical Package for the Social Sciences (SPSS) software program, version 16.0.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Seventy patients were studied and their ages ranged between 2 and 17 years. These 70 were constituted by 34 (48.6%) boys and 36 (51.4%) girls. Ten (14.3%) of the 70 studied, had atopic diseases. Nine (12.9%) patients had allergic conjunctivitis and 1 (1.4%) had allergic rhinitis. The single patient with allergic rhinitis also had bronchial asthma. No case of atopic eczema, or food allergy was recorded. Atopic disease conditions were more commonly recorded among the male sex and those whose parents have atopic diseases (P &lt; 0.05). Atopic diseases were also more common among children without advanced HIV diseases and those with eosinophilia. Cosmetic and psychological embarrassment from eye discoloration and itching were the negative impacts on the quality of living.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Allergic conjunctivitis is common in HIV-infected Nigerian children. Atopies are more common in boys and children with parental atopies.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oyedeji</LastName>
                    <ForeName>O A</ForeName>
                    <Initials>OA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Child Health, Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Osun State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Afolabi</LastName>
                    <ForeName>A A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Child Health, Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Osun State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Odeyemi</LastName>
                    <ForeName>A O</ForeName>
                    <Initials>AO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Child Health, Ladoke Akintola University of Technology Teaching Hospital, Osogbo, Osun State, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kayode</LastName>
                    <ForeName>V O</ForeName>
                    <Initials>VO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Unit, Morning Star International Hospital, D/Line, Port Harcourt, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Agelebe</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Child Health, Bowen Teaching Hospital, Ogbomoshoc, Nigeria.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>Niger J Clin Pract</MedlineTA>
            <NlmUniqueID>101150032</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergy</Keyword>
            <Keyword MajorTopicYN="N">HIV-infections</Keyword>
            <Keyword MajorTopicYN="N">familial</Keyword>
            <Keyword MajorTopicYN="N">pediatrics</Keyword>
        </KeywordList>
        <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788482</ArticleId>
            <ArticleId IdType="pii">NigerJClinPract_2020_23_8_1061_291856</ArticleId>
            <ArticleId IdType="doi">10.4103/njcp.njcp_359_19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32788477</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1119-3077</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>23</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Nigerian journal of clinical practice</Title>
                <ISOAbbreviation>Niger J Clin Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluation of corticophobia in asthmatic patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1033-1038</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4103/njcp.njcp_341_19</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Inhaler corticosteroids (ICS) are the most commonly used antiinflammatory drugs in the treatment of asthma. Although systemic adverse effects are minimal, patients hesitate to use ICS for a long time because of corticophobia. There is no study evaluating corticophobia via Likert-type appendix among the asthmatic patients.</AbstractText>
                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">In this study, it was aimed to evaluate the fears and beliefs about ICS in asthmatic patients.</AbstractText>
                <AbstractText Label="Subjects and Methods" NlmCategory="UNASSIGNED">Between December 2017 and January 2018, 150 stable asthmatic patients were included in the study. Demographic data (age, education, smoking history, etc.) and asthma-related data (pulmonary function test, drug use) were recorded. The appendix of TOPICOP study applied to the patients with asthma which was composed of 10 questions (five questions about fear of ICS and five questions about beliefs of ICS).</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The rate of ICS maintain in stable asthmatic patients was found to be 66.6%. According to the survey results, 68% of the patients believed that ICS may lead to weight gain, 52% believed that ICS may lead to infection, 73% believed that ICS may pass into bloodstream, and 67.3% believed that ICS may damage the lungs. It was also found that 90.7% needed to be informed about ICS and 67.3% wanted to cut the ICS drug as soon as possible.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">We found that treatment adherence may increase, if physicians allocate more time to asthma patients to inform about ICS beneficial effects at the initiating of ICS treatment and control visits.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yakar</LastName>
                    <ForeName>H I</ForeName>
                    <Initials>HI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chest Disease, Faculty of Medicine, Tokat Gaziosmanpasa University, Tokat, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kanbay</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chest Disease, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>Niger J Clin Pract</MedlineTA>
            <NlmUniqueID>101150032</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">appendix</Keyword>
            <Keyword MajorTopicYN="N">corticophobia</Keyword>
            <Keyword MajorTopicYN="N">inhaled corticosteroid</Keyword>
            <Keyword MajorTopicYN="N">treatment</Keyword>
        </KeywordList>
        <CoiStatement>None</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788477</ArticleId>
            <ArticleId IdType="pii">NigerJClinPract_2020_23_8_1033_291834</ArticleId>
            <ArticleId IdType="doi">10.4103/njcp.njcp_341_19</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32788176</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2052-4897</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>BMJ open diabetes research &amp; care</Title>
                <ISOAbbreviation>BMJ Open Diabetes Res Care</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Obesity susceptible novel DNA methylation marker on regulatory region of inflammation gene: results from the Korea Epigenome Study (KES).</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">e001338</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjdrc-2020-001338</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Obesity is growing global health concern and highly associated with increased risk of metabolic diseases including type 2 diabetes. We aimed to discover new differential DNA methylation patterns predisposing obesity and prioritize surrogate epigenetic markers in Koreans.</AbstractText>
                <AbstractText Label="RESEARCH DESIGN AND METHODS" NlmCategory="METHODS">We performed multistage epigenome-wide analyses to identify differentially expressed CpGs in obesity using the Illumina HumanMethylationEPIC array (EPIC). Forty-eight CpGs showed significant differences across three phases: 902 whole blood DNAs from two cohorts (phase 1: n=450, phase 2: n=377) and a hospital-based sample (phase 3: n=75). Samples from phase III participants were used to examine whether the 48 CpGs are significant in the fat tissue and influenced gene expression. Furthermore, we investigated the epigenetic effect of CpG loci in childhood obesity (n=94).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven of the 48 CpGs exhibited similar changes in the fat tissue along with gene expression changes. In particular, hypomethylated CpG (cg13424229) on the GATA1 transcription factor cluster of CPA3 promoter was related to its increased gene expression and showed consistent effect in childhood obesity. Interestingly, subsequent analysis using RNA sequencing data from 21 preadipocytes and 26 adipocytes suggested CPA3 as a potential obesity-related gene. Moreover, expression patterns from RNA sequencing and public Gene Expression Omnibus showed the correlation between CPA3 and type 2 diabetes (T2D) and asthma.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our finding prioritizes influential genes in obesity and provides new evidence for the role of CPA3 linking obesity, T2D, and asthma.</AbstractText>
                <CopyrightInformation>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Koh</LastName>
                    <ForeName>In-Uk</ForeName>
                    <Initials>IU</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Nak-Hyeon</ForeName>
                    <Initials>NH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Kibaick</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Ho-Yeong</ForeName>
                    <Initials>HY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yun</LastName>
                    <ForeName>Jun Ho</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Jin-Hwa</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hyo Jin</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrine and Metabolic Diseases, Center for Biomedical Sciences, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Song</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, AMIST, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Song Cheol</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, Asan Medical Center, AMIST, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, South Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Bong-Jo</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea moon.sanghoon@daum.net kbj6181@korea.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moon</LastName>
                    <ForeName>Sanghoon</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5987-9505</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Genome Research, Center for Genome Science, Korea National Institute of Health, Cheongju-si, Chungcheongbuk-do, South Korea moon.sanghoon@daum.net kbj6181@korea.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMJ Open Diabetes Res Care</MedlineTA>
            <NlmUniqueID>101641391</NlmUniqueID>
            <ISSNLinking>2052-4897</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cohort</Keyword>
            <Keyword MajorTopicYN="N">inflammation markers</Keyword>
            <Keyword MajorTopicYN="N">metabolism</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32788176</ArticleId>
            <ArticleId IdType="pii">8/1/e001338</ArticleId>
            <ArticleId IdType="doi">10.1136/bmjdrc-2020-001338</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32787967</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1465-993X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>21</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Respiratory research</Title>
                <ISOAbbreviation>Respir. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry.</ArticleTitle>
            <Pagination>
                <MedlinePgn>214</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12931-020-01460-7</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe asthma (SA) may require frequent courses or chronic use of oral corticosteroids (OCS), inducing many known side effects and complications. Therefore, it is important to identify risk factors of chronic use of OCS in SA, considering the heterogeneity of clinical and inflammatory asthma phenotypes. Another aim of the present analysis is to characterize a subpopulation of severe asthmatics, in whom blood eosinophil counts (BEC) remain elevated despite chronic OCS treatment.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In a cross-sectional analysis of 982 SA patients enrolled in the Belgian Severe Asthma Registry (BSAR) between March 2009 and February 2019, we investigated the characteristics of the OCS treated patients with special attention to their inflammatory profile.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">At enrollment, 211 (21%) SA patients were taking maintenance OCS (median dose: 8 [IQR: 5-10]) mg prednisone equivalent). BEC was high (&gt; 400/mm<sup>3</sup>) in 44% of the OCS treated population. Multivariable logistic regression analysis showed that risk factors for chronic use of OCS in SA were late-onset asthma (i.e. age of onset &gt; 40 yr), frequent exacerbations (i.e. ≥2 exacerbations in the previous year) and non-atopic asthma. Late-onset asthma was also a predictor for persistently high BEC in OCS treated SA patients.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data showed a significant association between a persistently high BEC and late-onset asthma in OCS treated SA patients. Whether it is poor compliance to treatment or corticosteroid insensitivity the reasons for this association warrants further investigation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Graff</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2060-689X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium. sgraff@uliege.be.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vanwynsberghe</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brusselle</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hanon</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sohy</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Centre Hospitalier Universitaire UCL Namur, Université Catholique de Louvain, Yvoir, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dupont</LastName>
                    <ForeName>L J</ForeName>
                    <Initials>LJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Katholieke Universiteit Leuven, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peche</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, CHU-Charleroi, A. Vésale Hospital, Charleroi, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Michils</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pilette</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cliniques Universitaires St-Luc and Institute of Experimental and Clinical Research, Université Catholique de Louvain, Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joos</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Division, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Louis</LastName>
                    <ForeName>R E</ForeName>
                    <Initials>RE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, CHU Sart-Tilman, I3GIGA Research Group, University of Liege, Liege, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schleich</LastName>
                    <ForeName>F N</ForeName>
                    <Initials>FN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, CHU Sart-Tilman, I3GIGA Research Group, University of Liege, Liege, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>Belgian Science Policy (P7/30)</GrantID>
                    <Agency>Interuniversity Attraction Poles Program (IUAP)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Respir Res</MedlineTA>
            <NlmUniqueID>101090633</NlmUniqueID>
            <ISSNLinking>1465-9921</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Blood eosinophils</Keyword>
            <Keyword MajorTopicYN="N">Oral corticosteroids</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32787967</ArticleId>
            <ArticleId IdType="doi">10.1186/s12931-020-01460-7</ArticleId>
            <ArticleId IdType="pii">10.1186/s12931-020-01460-7</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32787770</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2589-9783</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current drug research reviews</Title>
                <ISOAbbreviation>Curr Drug Res Rev</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapeutic Potential of Antileukotriene drug-Camellia sinensis extract co-formulation on Histamine induced Asthma in Guinea Pigs.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.2174/2589977512666200812151620</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study therapeutic potential of Antileukotriene drug- Camellia sinensis extract co-formulation on histamine induced asthma in guinea pigs.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">SRSD of Montelukast sodium was prepared by solvent evaporation method. Lyophilized aqueous extract of Camellia sinensis leaves and SRSD mixture was filled in capsule and capsule shell was coated to achieve initial release lag time. In vitro and pharmacokinetic study of capsules was done and compared with commercial tablets. Further role of green tea, as an antioxidant adjunct for asthma management has been analyzed by lung histology, mast cell count and oxidative stress assay in serum of control and experimental animals.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The drug release from commercial tablet was immediate and rapid but capsule has shown initial 3.5 hr lag time followed by sustained action up to 8 hr. Pharmacokinetic results shows that studied formulations are bioequivalent with respect to Cmax and AUC, while rest parameters showed significance difference. Mast cells count in lung tissue were increased (p&lt;0.001) in experimental group along with glycoprotein deposition in asthmatic bronchioles. Level of SOD and GPX were decreased (p&lt;0.05) while CAT is increased (p&lt;0.04) in asthma group in comparison to control.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In the experimental animal model, co-formulation was effective in modulating allergic inflammation and contributing to a better control of the inflammatory response. Our findings suggest that Camellia sinensis leaves extract may be used as an adjunct for future improvements in asthma treatment and prevention.</AbstractText>
                <CopyrightInformation>Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Neelam</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutics, ITS College of Pharmacy, NH-58, Ghaziabad, 201206. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kulkarni</LastName>
                    <ForeName>Giriraj T</ForeName>
                    <Initials>GT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Amity Institute of Pharmacy, Amity University Uttar Pradesh, Sector 125, Noida 201303. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Yatendra</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutics, ITS College of Pharmacy, NH-58, Ghaziabad, 201206. India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United Arab Emirates</Country>
            <MedlineTA>Curr Drug Res Rev</MedlineTA>
            <NlmUniqueID>101735701</NlmUniqueID>
            <ISSNLinking>2589-9775</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">adjunct</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">green tea</Keyword>
            <Keyword MajorTopicYN="N">oxidative stress</Keyword>
            <Keyword MajorTopicYN="N">sustained release solid dispersion
</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32787770</ArticleId>
            <ArticleId IdType="pii">CDRR-EPUB-109067</ArticleId>
            <ArticleId IdType="doi">10.2174/2589977512666200812151620</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32787142</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-4804</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medicinal chemistry</Title>
                <ISOAbbreviation>J. Med. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl Core.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.jmedchem.0c00745</ELocationID>
            <Abstract>
                <AbstractText>Various heteroaryl and bicyclo-aliphatic analogues of zwitterionic biaryl P2Y<sub>14</sub> receptor (P2Y<sub>14</sub>R) antagonists were synthesized, and affinity was measured in P2Y<sub>14</sub>R-expressing Chinese hamster ovary cells by flow cytometry. Given this series' low water solubility, various polyethylene glycol derivatives of the distally binding piperidin-4-yl moiety of moderate affinity were synthesized. Rotation of previously identified 1,2,3-triazole attached to the central <i>m</i>-benzoic acid core (<b>25</b>) provided moderate affinity but not indole and benzimidazole substitution of the aryl-triazole. The corresponding P2Y<sub>14</sub>R region is predicted by homology modeling as a deep, sterically limited hydrophobic pocket, with the outward pointing piperidine moiety being the most flexible. Bicyclic-substituted piperidine ring derivatives of naphthalene antagonist <b>1</b>, e.g., quinuclidine <b>17</b> (MRS4608, IC<sub>50</sub> ≈ 20 nM at hP2Y<sub>14</sub>R/mP2Y<sub>14</sub>R), or of triazole <b>2</b>, preserved affinity. Potent antagonists <b>1</b>, <b>7a</b>, <b>17</b>, and <b>23</b> (10 mg/kg) protected in an ovalbumin/<i>Aspergillus</i> mouse asthma model, and PEG conjugate <b>12</b> reduced chronic pain. Thus, we expanded P2Y<sub>14</sub>R antagonist structure-activity relationship, introducing diverse physical-chemical properties.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jung</LastName>
                    <ForeName>Young-Hwan</ForeName>
                    <Initials>YH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Jinha</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wen</LastName>
                    <ForeName>Zhiwei</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0821-1369</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salmaso</LastName>
                    <ForeName>Veronica</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karcz</LastName>
                    <ForeName>Tadeusz P</ForeName>
                    <Initials>TP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina 27709, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Jagiellonian University, Kraków31-007, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phung</LastName>
                    <ForeName>Ngan B</ForeName>
                    <Initials>NB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhoumou</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Boulevard, Saint Louis, Missouri 63104, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duca</LastName>
                    <ForeName>Sierra</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bennett</LastName>
                    <ForeName>John M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dudas</LastName>
                    <ForeName>Steven</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salvemini</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Physiology and the Henry and Amelia Nasrallah Center for Neuroscience, Saint Louis University School of Medicine, 1402 South Grand Boulevard, Saint Louis, Missouri 63104, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Zhan-Guo</ForeName>
                    <Initials>ZG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cook</LastName>
                    <ForeName>Donald N</ForeName>
                    <Initials>DN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunity, Inflammation, and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, Durham, North Carolina 27709, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacobson</LastName>
                    <ForeName>Kenneth A</ForeName>
                    <Initials>KA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8104-1493</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Med Chem</MedlineTA>
            <NlmUniqueID>9716531</NlmUniqueID>
            <ISSNLinking>0022-2623</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32787142</ArticleId>
            <ArticleId IdType="doi">10.1021/acs.jmedchem.0c00745</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32786158</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14552</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hernandez-Pacheco</LastName>
                    <ForeName>Natalia</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6313-1847</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gorenjak</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jurgec</LastName>
                    <ForeName>Staša</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Biochemistry, Molecular Biology and Genomics, Faculty for Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Corrales</LastName>
                    <ForeName>Almudena</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jorgensen</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, University of Liverpool, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karimi</LastName>
                    <ForeName>Leila</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1746-3314</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vijverberg</LastName>
                    <ForeName>Susanne J</ForeName>
                    <Initials>SJ</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4579-4081</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Respiratory Medicine and Allergy, Emma's Children Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berce</LastName>
                    <ForeName>Vojko</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, University Medical Centre Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schieck</LastName>
                    <ForeName>Maximilian</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO), Regensburg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Genetics, Hannover Medical School, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Acosta-Herrera</LastName>
                    <ForeName>Marialbert</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cellular Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra (IPBLN), Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kerick</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cellular Biology and Immunology, Institute of Parasitology and Biomedicine López-Neyra (IPBLN), Consejo Superior de Investigaciones Científicas (CSIC), Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Samedy-Bates</LastName>
                    <ForeName>Lesly-Anne</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of California, San Francisco, California, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tavendale</LastName>
                    <ForeName>Roger</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Population Pharmacogenetics Group, Biomedical Research Institute, Ninewells Hospital, and Medical School, University of Dundee, Dundee, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Villar</LastName>
                    <ForeName>Jesús</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Multidisciplinary Organ Dysfunction Evaluation Research Network, Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Keenan Research Center for Biomedical Science at the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukhopadhyay</LastName>
                    <ForeName>Somnath</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Population Pharmacogenetics Group, Biomedical Research Institute, Ninewells Hospital, and Medical School, University of Dundee, Dundee, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Academic Department of Paediatrics, Brighton and Sussex Medical School, Royal Alexandra Children's Hospital, Brighton, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pirmohamed</LastName>
                    <ForeName>Munir</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mc Verhamme</LastName>
                    <ForeName>Katia</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kabesch</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0697-1871</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Pneumology and Allergy, University Children's Hospital Regensburg (KUNO), Regensburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hawcutt</LastName>
                    <ForeName>Daniel B</ForeName>
                    <Initials>DB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alder Hey Children's Hospital, Liverpool, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turner</LastName>
                    <ForeName>Steve</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8393-5060</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Child Health, University of Aberdeen, Aberdeen, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Palmer</LastName>
                    <ForeName>Colin N</ForeName>
                    <Initials>CN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Population Pharmacogenetics Group, Biomedical Research Institute, Ninewells Hospital, and Medical School, University of Dundee, Dundee, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burchard</LastName>
                    <ForeName>Esteban G</ForeName>
                    <Initials>EG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of California, San Francisco, California, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, California, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maitland-van der Zee</LastName>
                    <ForeName>Anke H</ForeName>
                    <Initials>AH</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6261-9445</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University, Utrecht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Respiratory Medicine and Allergy, Emma's Children Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Flores</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-5352-069X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Genomics Division, Instituto Tecnológico y de Energías Renovables (ITER), Santa Cruz de Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Potočnik</LastName>
                    <ForeName>Uroš</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Human Molecular Genetics and Pharmacogenomics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Biochemistry, Molecular Biology and Genomics, Faculty for Chemistry and Chemical Engineering, University of Maribor, Maribor, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pino-Yanes</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0332-437X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Research Unit, Hospital Universitario N.S. de Candelaria, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Genomics and Health Group, Department of Biochemistry, Microbiology, Cell Biology and Genetics, Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Instituto de Tecnologías Biomédicas (ITB), Universidad de La Laguna, San Cristóbal de La Laguna, Santa Cruz de Tenerife, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>PiCA, SysPharmPedia consortia</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32786158</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14552</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32786104</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1399-3038</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title>
                <ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Can serum periostin, YKL-40, and osteopontin levels in pre-school children with recurrent wheezing predict later development of asthma?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.13329</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Currently, there are no reliable clinical tools available for predicting asthma in preschool-aged children with recurrent wheezing.The aim of this study is to evaluate the usefulness of serum periostin, YKL-40 and osteopontinbiomarkers in wheezy preschool-aged children for predicting the development of asthma in school-ages.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The study was prospectively conducted between 2011 and 2017. The clinical features of the preschool-aged children with recurrent wheezing and the levels of serum periostin, YKL-40, osteopontinwere measured. The same participantswere re-evaluated in school-age period andparticipants with asthma were identified. Relative risk (RR) for the development of asthma were analyzed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 197 preschool-aged children with recurrent wheezing who were re-evaluated in school age years, 32% of them had asthma. Serum periostin, YKL-40, osteopontinlevels at admission could not predict participantswho would have asthma symptoms in school age years. The RR for continuing of asthma symptoms were higher in participants who had their first wheezing episode before 1 year of age, preterm birth, cesarean section delivery, prenatal smoking exposure, multi-trigger wheezing, parental asthma, modified asthma predictive index positivity, prophylactic vitamin D intake≤12 months, breastfeeding time≤12 month, and aeroallergen sensitivity [RR (95% CI) and P value: 2.813(1.299-6.091), 0.002; 1.972(1.274-3.052), 0.009; 1.929(1.195-3.114), 0.004; 2.232(1.463-3.406), &lt;0.001; 3.152(1.949-5.097), &lt;0.001; 1.730(1.144-2.615), 0.016; 2.427(1.559-3.777), &lt;0.001; 2.955(1.558-5.604), &lt;0.001; 1.767(1.084-2.881), 0.016; 0.765(0.556-1.053), 0.016; respectively].</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Results has shown that clinical features were more valuable than biomarkers in predicting having asthma in school-age years inparticipantswho had recurrent wheezing in preschool-age period.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Guvenir</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7659-5221</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buyuktiryaki</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0088-913X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy, Koc University, Faculty of Medicine, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kulhas Celik</LastName>
                    <ForeName>I</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Civelek</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kilic Suloglu</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Zoology Section, Hacettepe University, Faculty of Science, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karaaslan</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Molecular Biology Section, Hacettepe University, Faculty of Science, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Genc</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Molecular Biology Section, Hacettepe University, Faculty of Science, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Misirlioglu</LastName>
                    <ForeName>E Dibek</ForeName>
                    <Initials>ED</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toyran</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2490-0551</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ginis</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kocabas</LastName>
                    <ForeName>C N</ForeName>
                    <Initials>CN</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8859-7187</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Allergy and Immunology, Mugla Sitki Kocman UniversityFaculty of Medicine, Mugla, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Pediatr Allergy Immunol</MedlineTA>
            <NlmUniqueID>9106718</NlmUniqueID>
            <ISSNLinking>0905-6157</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">YKL-40</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">biomarker</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">osteopontin</Keyword>
            <Keyword MajorTopicYN="N">periostin</Keyword>
            <Keyword MajorTopicYN="N">wheezing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32786104</ArticleId>
            <ArticleId IdType="doi">10.1111/pai.13329</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32786099</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1399-3038</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology</Title>
                <ISOAbbreviation>Pediatr Allergy Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Behind the scene: paracetamol hypersensitivity in children.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/pai.13330</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paracetamol, a nonsteroidal anti-inflammatory drug, is commonly being used for fever and pain relief worldwide. The aim of this study is to evaluate children with suspected history of paracetamol hypersensitivity.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Sixty patients who were referred to our clinic in between January 2015-December 2018 with suspected history of paracetamol hypersensitivity were included. Reactions were classified according to the European Network for Drug Allergy (ENDA)/Global Allergy and Asthma European Network classification and European Academy of Allergy and Clinical Immunology (EAACI)/ENDA position paper. Diagnoses were confirmed by skin tests and oral challenge tests (OCTs). In those with verified paracetamol hypersensitivity, an OCT with a strong COX-1 inhibitor was performed to classify the type of the reaction to refer as either selective- or cross-intolerance-hypersensitivity. A subsequent OCT with a selective COX-2-inhibitor was performed in those cross-intolerant patients to find out a safe alternative drug.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty OCTs with paracetamol were performed to patients with a median age of 8.5 years, and hypersensitivity to paracetamol was verified in 8 patients. Four children were classified as selective responders and 3 were classified as cross-intolerant after OCT with a COX-1 inhibitor. Overall, skin test positivity for paracetamol was detected in only one patient, in whom OCT with paracetamol was negative. In all 3 cross-intolerant patients a safe alternative non-steroidal anti-inflammatory drug was identified after an OCT with a selective COX-2 inhibitor.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">OCT stands as the gold-standard procedure in verifying the diagnosis of patients with paracetamol-induced drug hypersensitivity, as well as, in defining the type of reactions and finding out safe alternative drugs.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sipahi Cimen</LastName>
                    <ForeName>Sevgi</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3026-0906</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yucel</LastName>
                    <ForeName>Esra</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozceker</LastName>
                    <ForeName>Deniz</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0032-6727</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Okmeydani Training and Research Hospital, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suleyman</LastName>
                    <ForeName>Ayse</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hizli Demirkale</LastName>
                    <ForeName>Zeynep</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sayili</LastName>
                    <ForeName>Ugurcan</ForeName>
                    <Initials>U</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5925-2128</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University Cerrahpasa, Cerrahpasa Faculty of Medicine, Department of Public Health, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guler</LastName>
                    <ForeName>Nermin</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozdemir</LastName>
                    <ForeName>Cevdet</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9284-4520</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Institute of Child Health, Department of Pediatric Basic Sciences, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tamay</LastName>
                    <ForeName>Zeynep</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Istanbul University, Istanbul Faculty of Medicine, Department of Pediatrics, Division of Pediatric Allergy and Immunology, Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Pediatr Allergy Immunol</MedlineTA>
            <NlmUniqueID>9106718</NlmUniqueID>
            <ISSNLinking>0905-6157</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">hypersensitivity</Keyword>
            <Keyword MajorTopicYN="N">nonsteroidal anti-inflammatory drugs</Keyword>
            <Keyword MajorTopicYN="N">oral challenge test</Keyword>
            <Keyword MajorTopicYN="N">paracetamol</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32786099</ArticleId>
            <ArticleId IdType="doi">10.1111/pai.13330</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32785871</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-3610</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of community health</Title>
                <ISOAbbreviation>J Community Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Environmental Health Consults in Children Hospitalized with Respiratory Infections.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10900-020-00886-w</ELocationID>
            <Abstract>
                <AbstractText>Indoor air pollutants contribute to respiratory infections and asthma exacerbations in children. Rural Alaska Native children experience some of the highest U.S. rates of respiratory hospitalizations, which are associated with lack of in-home running water, household crowding, and woodstove use. In our previous study, in-home education and modifications reduced respiratory symptoms, and medical visits. In this study, we evaluated the feasibility of providing in-hospital environmental health consults for parents/guardians of children &lt; 5 years old hospitalized at the Alaska Native Medical Center with respiratory infections or asthma. Environmental health specialists conducted 92 in-hospital consults and mailed Healthy Homes Toolkits to households. Local housing authorities completed low-cost home modifications in 47 eligible households. Participants reported changes in household behaviors that were specifically addressed in the consult or included in the Toolkit (e.g. allergen-impermeable pillow covers). Reported respiratory symptoms were decreased at the 6-month follow-up. Over a 2 year period the median overall medical costs for respiratory illness in study children were $70,500. Children with in-home piped water had half the daily overall medical costs than children without in-home piped water ($74 compared to $144). In this study, we demonstrate that it is feasible to provide environmental consults, mail Toolkits, and arrange home modifications to the homes of children hospitalized with respiratory illness. These findings, along with the high costs of medical care for these children, suggest in-hospital environmental health consults are a cost-effective intervention.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nelson</LastName>
                    <ForeName>Abigail</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8790-6168</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Community Environment and Health, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA. aenelson@anthc.org.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA. aenelson@anthc.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salkoski</LastName>
                    <ForeName>Aaron J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Community Environment and Health, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Richards</LastName>
                    <ForeName>Bailey</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Community Environment and Health, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elliott</LastName>
                    <ForeName>Whitney</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Alaska Native Medical Center (ANMC), 4315 Diplomacy Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Southcentral Foundation, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan Cadogan</LastName>
                    <ForeName>Christine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Alaska Native Medical Center (ANMC), 4315 Diplomacy Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Southcentral Foundation, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hirschfeld</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Maternal Child Health Services, Southcentral Foundation, 4501 Diplomacy Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Southcentral Foundation, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Day</LastName>
                    <ForeName>Gretchen</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Research Services, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Holck</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Research Services, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peterson</LastName>
                    <ForeName>Jonathon</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, University of Washington, 1959 NE Pacific St., Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singleton</LastName>
                    <ForeName>Rosalyn</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Community Health Services, Alaska Native Tribal Health Consortium (ANTHC), 4000 Ambassador Dr., Anchorage, AK, 99508, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Alaska Native Tribal Health Consortium, Anchorage, AK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>SI17051000</GrantID>
                    <Agency>Alaska Native Tribal Health Consortium</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Community Health</MedlineTA>
            <NlmUniqueID>7600747</NlmUniqueID>
            <ISSNLinking>0094-5145</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alaska native</Keyword>
            <Keyword MajorTopicYN="N">Children</Keyword>
            <Keyword MajorTopicYN="N">Indoor</Keyword>
            <Keyword MajorTopicYN="N">Piped water</Keyword>
            <Keyword MajorTopicYN="N">Respiratory illness</Keyword>
            <Keyword MajorTopicYN="N">Ventilation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785871</ArticleId>
            <ArticleId IdType="doi">10.1007/s10900-020-00886-w</ArticleId>
            <ArticleId IdType="pii">10.1007/s10900-020-00886-w</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32785791</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-0460</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Dysphagia</Title>
                <ISOAbbreviation>Dysphagia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Oropharyngeal Swallowing Dynamic Findings in People with Asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00455-020-10168-1</ELocationID>
            <Abstract>
                <AbstractText>Airflow obstruction in people with asthma, similar to COPD, may interfere with swallowing, increasing the risk of food or liquid entrance into the lower airways, and favoring the uncontrolled disease. To describe the complaints and findings of the oropharyngeal swallowing mechanisms in patients with mild and severe asthma, a cross-sectional study was performed. A total of 135 participants with asthma were studied, of whom 97 had severe asthma and 38 had mild asthma. All subjects answered a questionnaire with demographic information, disease exacerbations, Asthma Control Questionnaire 6 (ACQ6-Juniper 1999), GastroEsophageal Reflux Disease Symptoms Questionnaire (GERD-SQ-Fornari et al. 2004), and Eating Assessment Tool 10 (EAT-10-Gonçalves et al., 2013). The oral and pharyngeal swallowing assessment occurred via videofluoroscopic swallowing evaluation. The age range of the participants was from 19 to 80 years, with a predominance of females (78.6%). Uncontrolled asthma was observed in 50 (52%) of the patients with severe asthma and in 11 (29%) of the patients with mild asthma (ACQ6 &gt; 1.5). The GERD-SQ and EAT-10 scores were similar in both groups. In the bivariate analysis, the group with severe asthma presented with more changes when compared to the group with mild asthma in the following events: atypical lingual movement during the swallowing of liquid in the volumes of 5 ml (p = 0.003) and 10 ml (p = 0.001), and solid (p = 0.009); oral transit time increased in swallowing of liquid in the volumes of 5 ml (p = 0.003) and 20 ml (p = 0.026); beginning of the pharyngeal swallowing phase below the mandibular ramus (p = 0.003); pharyngeal residue (p = 0.017) of solid consistency; laryngeal penetration of 5 ml (p = 0.050) and 20 ml (p = 0.032) of liquid; increased transition time between the oral and pharyngeal swallowing phases (p = 0.035) and increased pharyngeal transit time (p = 0.045) of solid consistency. Tracheal aspiration was observed only in the group with severe asthma. After the multivariate analysis, atypical tongue movement maintained a statistically significant difference between the two groups. Oropharyngeal swallowing alternations were frequent in the studied sample and more markedly present in patients with severe asthma. Multivariate regression revealed atypical lingual movement, which was greater in patients with severe asthma. The clinical significance of these findings should be further investigated.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Scarpel</LastName>
                    <ForeName>Renata D'Arc</ForeName>
                    <Initials>RD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5068-9008</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Post-Graduate Program Interactive Processes of Organs and Systems, Institute of Health Sciences, Federal University of Bahia (UFBA), Avenida Orlando Gomes, 2002, 78, Piatã, Salvador, Bahia, Zipcode 41650-010, Brazil. renatascarpel@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nóbrega</LastName>
                    <ForeName>Ana Caline</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Speech-Language Pathology, Federal University of Bahia (UFBA) and of the Postgraduate Program Interactive Processes of Organs and Systems, Institute of Health Sciences-UFBA, Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pinho</LastName>
                    <ForeName>Patrícia</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Speech-Language Pathologist of the Division of Neurology and Epidemiology, Federal University of Bahia (UFBA), Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Almeida Menezes</LastName>
                    <ForeName>Ivina Thaiana</ForeName>
                    <Initials>IT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Speech-Language Pathologist of the Division of Neurology and Epidemiology, Federal University of Bahia (UFBA), Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Souza-Machado</LastName>
                    <ForeName>Adelmir</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomorphology, Professor of the Postgraduate Interactive Processes Program of Organs and Systems, Institute of Health Sciences, Federal University of Bahia (UFBA), Institute of Health Sciences - UFBA and Coordinator of the Asthma Control in Bahia Program (ProAR - UFBA), Salvador, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>028/2010</GrantID>
                    <Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico (BR)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Dysphagia</MedlineTA>
            <NlmUniqueID>8610856</NlmUniqueID>
            <ISSNLinking>0179-051X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Deglutition disorders</Keyword>
            <Keyword MajorTopicYN="N">Dysphagia</Keyword>
            <Keyword MajorTopicYN="N">Respiratory diseases</Keyword>
            <Keyword MajorTopicYN="N">Swallowing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785791</ArticleId>
            <ArticleId IdType="doi">10.1007/s00455-020-10168-1</ArticleId>
            <ArticleId IdType="pii">10.1007/s00455-020-10168-1</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32785633</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2574-3805</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>3</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA network open</Title>
                <ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Cross-Sectional Analysis of Community Water Fluoridation and Prevalence of Pediatric Dental Surgery Among Medicaid Enrollees.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e205882</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.5882</ELocationID>
            <Abstract>
                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Dental surgery under general anesthesia (DGA) is an ineffective, costly treatment for caries. Interventions to reduce the need for DGA are challenging because children's parents may not seek care until surgery is required. Community water fluoridation (CWF) effectively prevents early childhood caries, but its effectiveness in reducing severe early childhood caries is unknown.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To determine whether access to CWF is associated with the prevalence of DGA.</AbstractText>
                <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">This is a cross-sectional analysis of Medicaid claims data from 2011 to 2012. Deidentified data were derived from Medicaid claims and enrollee files for Massachusetts, Texas, Connecticut, Illinois, and Florida for children aged 9 years and younger enrolled in either a fee-for-service or managed care plan through their state's Medicaid program. Linear regression models tested for associations between CWF and covariates. Multivariable linear regression models tested for associations between CWF and outcomes. Regression models included clustered SEs at the county level. Data analysis was performed from December 2018 to March 2020.</AbstractText>
                <AbstractText Label="Exposures" NlmCategory="UNASSIGNED">Access to CWF was determined by estimating the proportion of a county's total population that had access to a fluoridated public water system.</AbstractText>
                <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">The main outcome was county-level DGA prevalence. Other outcomes were caries-related visit prevalence and patient quality indicators (asthma and diabetes). Covariates included county-level demographic, socioeconomic, and dental practitioner variables.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 436 counties within 5 states per year (872 county-year observations), were included in the analysis. Adjusted analysis revealed that a 10% increase in the proportion of county's population access to CWF was associated with lower caries-related visit prevalence (-0.45 percentage points; 95% CI, -0.59 to -0.31 percentage points; P &lt; .001). Increasing CWF access in 10% increments was associated with decreased DGA prevalence in unadjusted analysis (-0.39 percentage points; 95% CI, -0.67 to -0.12 percentage points; P = .006) but not in adjusted analysis (-0.23 percentage points; 95% CI, -0.49 to 0.02 percentage points; P = .07). Increasing the proportion of county's access to CWF by 10% was not associated with the prevalence of asthma-related exacerbations (-0.02 percentage points; 95% CI, -0.10 to 0.05 percentage points; P = .53) or diabetes-related exacerbations (-0.0003 percentage points; 95% CI, -0.0014 to 0.0009 percentage points; P = .66).</AbstractText>
                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">This study extends our understanding of CWF's benefits for children's oral health. Specifically, these findings suggest that increasing a population's access to CWF's is associated with decreased caries-related visits and may also be associated with use of dental surgical services within high-risk populations.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Helen H</ForeName>
                    <Initials>HH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesiology, University of Illinois at Chicago, Chicago.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faundez</LastName>
                    <ForeName>Luis</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Economics, University of Illinois at Chicago, Chicago.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>LoSasso</LastName>
                    <ForeName>Anthony T</ForeName>
                    <Initials>AT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Economics, DePaul University, Chicago, Illinois.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Netw Open</MedlineTA>
            <NlmUniqueID>101729235</NlmUniqueID>
            <ISSNLinking>2574-3805</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785633</ArticleId>
            <ArticleId IdType="pii">2769230</ArticleId>
            <ArticleId IdType="doi">10.1001/jamanetworkopen.2020.5882</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32785610</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2380-6591</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA cardiology</Title>
                <ISOAbbreviation>JAMA Cardiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Chest Pain in a Middle-aged Woman With Asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamacardio.2020.2808</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Patti</LastName>
                    <ForeName>Karl Gordon</ForeName>
                    <Initials>KG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bennett</LastName>
                    <ForeName>Ari J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McNamara</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Frederik Meijer Heart &amp; Vascular Institute, Spectrum Health, Grand Rapids, Michigan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Cardiol</MedlineTA>
            <NlmUniqueID>101676033</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785610</ArticleId>
            <ArticleId IdType="pii">2769174</ArticleId>
            <ArticleId IdType="doi">10.1001/jamacardio.2020.2808</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32785232</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0237186</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0237186</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Multimorbidity is a global health challenge that is associated with polypharmacy, increasing the risk of potentially inappropriate prescribing (PIP). There are tools to improve prescription, such as implicit and explicit criteria.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To estimate the prevalence of PIP in a population aged 65 to 74 years with multimorbidity and polypharmacy, according to American Geriatrics Society Beers Criteria® (2015, 2019), the Screening Tool of Older Person's Prescription -STOPP- criteria (2008, 2014), and the Medication Appropriateness Index -MAI- criteria in primary care.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This was an observational, descriptive, cross-sectional study. The sample included 593 community-dwelling elderly aged 65 to 74 years, with multimorbidity and polypharmacy, who participated in the MULTIPAP trial. Socio-demographic, clinical, professional, and pharmacological-treatment variables were recorded. Potentially inappropriate prescribing was detected by computerized prescription assistance system, and family doctors evaluated the MAI. The MAI-associated factors were analysed using a logistic regression model.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4,386 prescriptions were evaluated. The mean number of drugs was 7.4 (2.4 SD). A total of 94.1% of the patients in the study had at least one criterion for drug inappropriateness according to the MAI. Potentially inappropriate prescribing was detected in 57.7%, 43.6%, 68.8% and 71% of 50 patients according to the explicit criteria STOPP 2014, STOPP 2008, Beers 2019 and Beers 2015 respectively. For every new drug taken by a patient, the MAI score increased by 2.41 (95% CI 1.46; 3.35) points. Diabetes, ischaemic heart disease and asthma were independently associated with lower summated MAI scores.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The prevalence of potentially inappropriate prescribing detected in the sample was high and in agreement with previous literature for populations with multimorbidity and polypharmacy. The MAI criteria detected greater inappropriateness than did the explicit criteria, but their application was more complex and difficult to automate.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lopez-Rodriguez</LastName>
                    <ForeName>Juan A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Primary Healthcare Center General Ricardos, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Specialties and Public Health Department, School of Health Sciences, University Rey Juan Carlos Alcorcón, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Research Support Unit, Primary Care Management, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rogero-Blanco</LastName>
                    <ForeName>Eloísa</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8732-6120</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Primary Healthcare Center General Ricardos, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Specialties and Public Health Department, School of Health Sciences, University Rey Juan Carlos Alcorcón, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aza-Pascual-Salcedo</LastName>
                    <ForeName>Mercedes</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Primary Care Direction, Sector Zaragoza III, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopez-Verde</LastName>
                    <ForeName>Fernando</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7870-0793</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Distrito Málaga/Guadalhorce, Málaga, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Primary Healthcare Center Las Delicias, Málaga, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pico-Soler</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>EpiChron Research Group, IIS Aragón, Aragon Health Sciences Institute, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Primary Healthcare Center Torrero-La Paz, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leiva-Fernandez</LastName>
                    <ForeName>Francisca</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6919-4817</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Distrito Málaga/Guadalhorce, Málaga, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prados-Torres</LastName>
                    <ForeName>J Daniel</ForeName>
                    <Initials>JD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5204-7781</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Unidad Docente Multiprofesional de Atención Familiar y Comunitaria Distrito Málaga/Guadalhorce, Málaga, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Institute of Malaga (IBIMA), Malaga, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prados-Torres</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>EpiChron Research Group, IIS Aragón, Aragon Health Sciences Institute, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Miguel Servet University Hospital, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cura-González</LastName>
                    <ForeName>Isabel</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Specialties and Public Health Department, School of Health Sciences, University Rey Juan Carlos Alcorcón, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Research Support Unit, Primary Care Management, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Health Services Research on Chronic Patients Network (REDISSEC), Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>MULTIPAP group</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785232</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0237186</ArticleId>
            <ArticleId IdType="pii">PONE-D-20-04779</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32785173</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2077-0383</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical medicine</Title>
                <ISOAbbreviation>J Clin Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Laparoscopic Outcomes after Normal Clinical and Ultrasound Findings in Young Women with Chronic Pelvic Pain: A Cross-Sectional Study.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E2593</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9082593</ELocationID>
            <Abstract>
                <AbstractText>Chronic pelvic pain (CPP) is one of the most common chronic pain problems experienced by women, with prevalence rates comparable to asthma and back pain. However, it is poorly understood and causative pathology is only seldom found. We aimed to establish prevalence of abnormal findings at diagnostic laparoscopy in young women with CPP after normal findings at clinical examination and pelvic ultrasound scan. Information was retrospectively collected on all laparoscopies undertaken on women aged 16-30 years with normal preoperative findings over a 24-month period. One-hundred-and-fifty women (mean age 25 years and BMI 24.5) were included with laparoscopic examination revealing normal anatomy in 110 (73.3%) and pathology in 40 (27.2%). Endometriosis was detected in 30 (20%); 25 (16.7%) stage 1, 2 (1.3%) stage 2, 2 (1.3%) stage 3 and 1 (0.7%) stage 4. Most laparoscopies carried out on young women with CPP and normal clinical examination and pelvic ultrasound scan showed no significant clinical stigmata of pelvic disease. Women should be fully informed of the multifactorial nature of CPP and there should be a comprehensive management pathway for these women, as proceeding with invasive laparoscopy does not provide additional benefit when investigating CPP in the context of risk, cost and effect on long-term wellbeing.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tempest</LastName>
                    <ForeName>Nicola</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Liverpool Women's Hospital NHS Foundation Trust, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Efstathiou</LastName>
                    <ForeName>Ekaterina</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petros</LastName>
                    <ForeName>Zena</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hapangama</LastName>
                    <ForeName>Dharani K</ForeName>
                    <Initials>DK</Initials>
                    <Identifier Source="ORCID">0000-0003-0270-0150</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Liverpool Women's Hospital NHS Foundation Trust, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, member of Liverpool Health Partners affiliations, Liverpool L8 7SS, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>RTF510</GrantID>
                    <Agency>Wellbeing of Women</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>J Clin Med</MedlineTA>
            <NlmUniqueID>101606588</NlmUniqueID>
            <ISSNLinking>2077-0383</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">chronic pelvic pain</Keyword>
            <Keyword MajorTopicYN="N">endometriosis</Keyword>
            <Keyword MajorTopicYN="N">investigation</Keyword>
            <Keyword MajorTopicYN="N">laparoscopy</Keyword>
            <Keyword MajorTopicYN="N">young women</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32785173</ArticleId>
            <ArticleId IdType="pii">jcm9082593</ArticleId>
            <ArticleId IdType="doi">10.3390/jcm9082593</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32784825</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1660-4601</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>16</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of environmental research and public health</Title>
                <ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bibliometric Studies and Worldwide Research Trends on Global Health.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E5748</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17165748</ELocationID>
            <Abstract>
                <AbstractText>Global health, conceived as a discipline, aims to train, research and respond to problems of a transboundary nature in order to improve health and health equity at the global level. The current worldwide situation is ruled by globalization, and therefore the concept of global health involves not only health-related issues but also those related to the environment and climate change. Therefore, in this Special Issue, the problems related to global health have been addressed from a bibliometric approach in four main areas: environmental issues, diseases, health, education and society.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Salmerón-Manzano</LastName>
                    <ForeName>Esther</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Law, Universidad Internacional de La Rioja (UNIR), Av. de la Paz, 137, 26006 Logroño, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manzano-Agugliaro</LastName>
                    <ForeName>Francisco</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">0000-0002-0085-030X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Engineering, University of Almeria, ceiA3, 04120 Almeria, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int J Environ Res Public Health</MedlineTA>
            <NlmUniqueID>101238455</NlmUniqueID>
            <ISSNLinking>1660-4601</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">HIV/AIDS</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">climate change</Keyword>
            <Keyword MajorTopicYN="N">diabetes</Keyword>
            <Keyword MajorTopicYN="N">medicinal plants</Keyword>
            <Keyword MajorTopicYN="N">microplastics</Keyword>
            <Keyword MajorTopicYN="N">musculoskeletal risks</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
            <Keyword MajorTopicYN="N">patents</Keyword>
            <Keyword MajorTopicYN="N">pulmonary disease</Keyword>
            <Keyword MajorTopicYN="N">social networks</Keyword>
            <Keyword MajorTopicYN="N">wastewater treatment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784825</ArticleId>
            <ArticleId IdType="pii">ijerph17165748</ArticleId>
            <ArticleId IdType="doi">10.3390/ijerph17165748</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32784684</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2076-393X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccines</Title>
                <ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluating the Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to High-Dose Trivalent and Other Egg-Based Influenza Vaccines among Older Adults in the US during the 2017-2018 Influenza Season.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E446</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines8030446</ELocationID>
            <Abstract>
                <AbstractText>The influenza-related disease burden is highest among the elderly. We evaluated the relative vaccine effectiveness (rVE) of adjuvanted trivalent influenza vaccine (aTIV) compared to other egg-based influenza vaccines (high-dose trivalent (TIV-HD), quadrivalent (QIVe-SD), and standard-dose trivalent (TIVe-SD)) against influenza-related and cardio-respiratory events among subjects aged ≥65 years for the 2017-2018 influenza season. This retrospective cohort analysis used prescription claims, professional fee claims, and hospital charge master data. Influenza-related hospitalizations/ER visits and office visits and cardio-respiratory events were assessed post-vaccination. Inverse probability of treatment weighting (IPTW) and Poisson regression were used to evaluate the adjusted rVE of aTIV compared to other vaccines. In an economic analysis, annualized follow-up costs were compared between aTIV and TIV-HD. The study was composed of 234,313 aTIV, 1,269,855 TIV-HD, 212,287 QIVe-SD, and 106,491 TIVe-SD recipients. aTIV was more effective in reducing influenza-related office visits and other respiratory-related hospitalizations/ER visits compared to the other vaccines. For influenza-related hospitalizations/ER visits, aTIV was associated with a significantly higher rVE compared to QIVe-SD and TIVe-SD and was comparable to TIV-HD. aTIV was also associated with a significantly higher rVE compared to TIVe-SD against hospitalizations/ER visits related to pneumonia and asthma/COPD/bronchial events. aTIV and TIV-HD were associated with comparable annualized all-cause and influenza-related costs. Adjusted analyses demonstrated a significant benefit of aTIV against influenza- and respiratory-related events compared to the other egg-based vaccines.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pelton</LastName>
                    <ForeName>Stephen I</ForeName>
                    <Initials>SI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Boston University Schools of Medicine, Boston, MA 02118, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Maxwell Finland Laboratories, Boston Medical Center, Boston, MA 02118, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Divino</LastName>
                    <ForeName>Victoria</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Economics &amp; Outcomes Research, Real-World Evidence, IQVIA, Falls Church, VA 22042, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shah</LastName>
                    <ForeName>Drishti</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Economics &amp; Outcomes Research, Real-World Evidence, IQVIA, Falls Church, VA 22042, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mould-Quevedo</LastName>
                    <ForeName>Joaquin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Global Market Access, Seqirus Vaccines Ltd., Summit, NJ 07901, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>DeKoven</LastName>
                    <ForeName>Mitch</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Economics &amp; Outcomes Research, Real-World Evidence, IQVIA, Falls Church, VA 22042, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krishnarajah</LastName>
                    <ForeName>Girishanthy</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Global Market Access, Seqirus Vaccines Ltd., Summit, NJ 07901, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Postma</LastName>
                    <ForeName>Maarten J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of PharmacoTherapy, -Epidemiology &amp; -Economics (PTE2), Department of Pharmacy, University of Groningen, 9700 Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Sciences, University of Groningen, University Medical Centre Groningen (UMCG), 9700 Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Economics, Econometrics &amp; Finance, University of Groningen, Faculty of Economics &amp; Business, 9700 Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>NA</GrantID>
                    <Agency>Seqirus Vaccines Ltd., Summit, NJ, USA</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Vaccines (Basel)</MedlineTA>
            <NlmUniqueID>101629355</NlmUniqueID>
            <ISSNLinking>2076-393X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">adjuvanted influenza vaccine</Keyword>
            <Keyword MajorTopicYN="N">elderly</Keyword>
            <Keyword MajorTopicYN="N">influenza</Keyword>
            <Keyword MajorTopicYN="N">influenza vaccine</Keyword>
            <Keyword MajorTopicYN="N">relative vaccine effectiveness</Keyword>
            <Keyword MajorTopicYN="N">retrospective studies</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784684</ArticleId>
            <ArticleId IdType="pii">vaccines8030446</ArticleId>
            <ArticleId IdType="doi">10.3390/vaccines8030446</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32784573</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2077-0383</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical medicine</Title>
                <ISOAbbreviation>J Clin Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Extra-Esophageal Presentation of Gastroesophageal Reflux Disease: 2020 Update.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E2559</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm9082559</ELocationID>
            <Abstract>
                <AbstractText>Gastroesophageal reflux disease (GERD) is defined by the presence of symptoms induced by the reflux of the stomach contents into the esophagus. Although clinical manifestations of GERD typically involve the esophagus, extra-esophageal manifestations are widespread and less known. In this review, we discuss extra-esophageal manifestations of GERD, focusing on clinical presentations, diagnosis, and treatment. Common extra-esophageal manifestations of GERD include chronic cough, asthma, laryngitis, dental erosions, and gingivitis. Extra-esophageal involvement can be present also when classic GERD symptoms are absent, making the diagnosis more challenging. Although available clinical studies are heterogeneous and frequently of low quality, a trial with proton pump inhibitors can be suggested as a first-line diagnostic strategy in case of suspected extra-esophageal manifestations of GERD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Durazzo</LastName>
                    <ForeName>Marilena</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lupi</LastName>
                    <ForeName>Giulia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cicerchia</LastName>
                    <ForeName>Francesca</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferro</LastName>
                    <ForeName>Arianna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barutta</LastName>
                    <ForeName>Federica</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beccuti</LastName>
                    <ForeName>Guglielmo</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gruden</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Turin, C.so A.M. Dogliotti 14, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3th Internal Medicine Unit, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pellicano</LastName>
                    <ForeName>Rinaldo</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Gastroenterology, Città della Salute e della Scienza Hospital, C.so Bramante 88, 10126 Turin, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>J Clin Med</MedlineTA>
            <NlmUniqueID>101606588</NlmUniqueID>
            <ISSNLinking>2077-0383</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">chest pain</Keyword>
            <Keyword MajorTopicYN="N">cough</Keyword>
            <Keyword MajorTopicYN="N">gastroesophageal reflux</Keyword>
            <Keyword MajorTopicYN="N">laryngo-pharyngeal reflux</Keyword>
            <Keyword MajorTopicYN="N">tooth erosions</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784573</ArticleId>
            <ArticleId IdType="pii">jcm9082559</ArticleId>
            <ArticleId IdType="doi">10.3390/jcm9082559</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32784540</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1660-4601</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>16</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of environmental research and public health</Title>
                <ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>First-Year Antibiotics Exposure in Relation to Childhood Asthma, Allergies, and Airway Illnesses.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E5700</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17165700</ELocationID>
            <Abstract>
                <AbstractText><i>Background</i>: Associations of early antibiotics exposures with childhood asthma, allergies, and airway illnesses are debated. <i>Objectives</i>: We aimed to investigate associations of first-year antibiotics exposure with childhood asthma, allergies, and airway illnesses. <i>Methods</i>: A cross-sectional study was conducted among preschoolers in Shanghai, China during 2011-2012. A questionnaire regarding household environment and lifestyles and childhood health outcomes was reported by the child's parents. <i>Results</i>: In total, 13,335 questionnaires (response rate: 85.3%) were analyzed and 3049 (24.1%) children had first-year antibiotics exposure. In the multivariate logistic regression analyses, first-year antibiotics exposure had significant associations with the higher odds of lifetime-ever pneumonia (adjusted OR, 95% CI: 2.15, 1.95-2.37), croup (1.46, 1.24-1.73), wheeze (1.44, 1.30-1.60), asthma (1.38, 1.19-1.61), food allergy (1.29, 1.13-1.46), and allergic rhinitis (1.23, 1.07-1.41), and as well as current (one year before the survey) common cold (≥3 times) (1.38, 1.25-1.52), dry cough (1.27, 1.13-1.42), atopic dermatitis (1.25, 1.09-1.43), wheeze (1.23, 1.10-1.38), and rhinitis symptoms (1.15, 1.04-1.26). These associations were different in children with different individual characteristics (age, sex, family history of atopy, and district) and other early exposures (breastfeeding, home decoration, pet-keeping, and environmental tobacco smoke). <i>Conclusions</i>: Our results indicate that first-year antibiotics exposure could be a strong risk factor for childhood pneumonia, asthma, allergies, and their related symptoms. The individual characteristics and other early exposures may modify effects of early antibiotic exposure on childhood allergies and airway illnesses.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Zhijun</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Building Environment and Energy Engineering, School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">0000-0001-9863-4332</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute for Health and Environment, Chongqing University of Science and Technology, Chongqing 401331, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Building Environment and Energy Engineering, School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Chanjuan</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Building Environment and Energy Engineering, School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jialing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Building Environment and Energy Engineering, School of Environment and Architecture, University of Shanghai for Science and Technology, Shanghai 200093, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>182001002</GrantID>
                    <Agency>Research start-up fund for new faculty of Chongqing University of science and Technology</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2017YFC0702700</GrantID>
                    <Agency>National Key Research and Development Program of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>13201907</GrantID>
                    <Agency>Special Foundation for Postdoctoral Fellow in Chongqing</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>17YF1412800</GrantID>
                    <Agency>Shanghai Sailing Program</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int J Environ Res Public Health</MedlineTA>
            <NlmUniqueID>101238455</NlmUniqueID>
            <ISSNLinking>1660-4601</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">China</Keyword>
            <Keyword MajorTopicYN="N">allergies</Keyword>
            <Keyword MajorTopicYN="N">antibiotics</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">preschooler</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784540</ArticleId>
            <ArticleId IdType="pii">ijerph17165700</ArticleId>
            <ArticleId IdType="doi">10.3390/ijerph17165700</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32784298</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0097</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International archives of allergy and immunology</Title>
                <ISOAbbreviation>Int. Arch. Allergy Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Supplementation with Tetrahydrocurcumin Enhances the Therapeutic Effects of Dexamethasone in a Murine Model of Allergic Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000509367</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Tetrahydrocurcumin (THC) is the major active metabolite of curcumin, which is a dietary factor derived from Curcuma species. Our previous study demonstrated a significant beneficial effect of THC in mice with allergic asthma. Glucocorticosteroids (GCs) are commonly used drugs in asthma. Whether THC supplementation could promote the beneficial effects of GC therapy on asthma has not yet been reported. The current study aimed to investigate the combined efficacy of GC and THC treatment in a mouse model of allergic asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">BALB/c mice were randomly divided into 5 groups: the control group, ovalbumin (OVA)-induced group, and OVA-induced mice treated with dietary THC only, intraperitoneal injection of dexamethasone (DEX) only, or THC combined with DEX. The nasal symptoms, histopathological alterations of lung tissues, lung cytokine production, and Th cell subsets were assessed.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">THC or DEX had beneficial effects on nasal symptoms and pathological lung changes, and the therapeutic effects between THC and DEX treatment were comparable. Importantly, compared to the monotherapy groups (THC or DEX only), the combination of THC and DEX showed a significantly reduced nasal rubbing frequency, lower mucus hyperproduction, lower Th2 and Th17 cell numbers as well as lower related cytokine levels (IL-4, IL-5, and IL-17A).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Supplementation with THC can enhance the therapeutic effects of DEX to alleviate airway symptoms, lung inflammation, and the Th2 response. Our findings suggest that dietary administration of THC could act as an add-on therapy for asthma treated with GCs.</AbstractText>
                <CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Yin Fan</ForeName>
                    <Initials>YF</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yan Qiu</ForeName>
                    <Initials>YQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children Medical Centre, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Xiao Yan</ForeName>
                    <Initials>XY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zuo</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Yi Lin</ForeName>
                    <Initials>YL</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Xing Yue</ForeName>
                    <Initials>XY</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chun Wei</ForeName>
                    <Initials>CW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, hi_chunwei@aliyun.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Food, Nutrition and Health, School of Public Health, Sun Yat-sen University (Guangzhou Campus), Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Engineering Technology Research Center of Nutrition Translation, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int Arch Allergy Immunol</MedlineTA>
            <NlmUniqueID>9211652</NlmUniqueID>
            <ISSNLinking>1018-2438</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway inflammation</Keyword>
            <Keyword MajorTopicYN="N">Asthmatic mouse model</Keyword>
            <Keyword MajorTopicYN="N">Dexamethasone</Keyword>
            <Keyword MajorTopicYN="N">Tetrahydrocurcumin</Keyword>
            <Keyword MajorTopicYN="N">Therapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784298</ArticleId>
            <ArticleId IdType="pii">000509367</ArticleId>
            <ArticleId IdType="doi">10.1159/000509367</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32784051</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>130</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aster tataricus attenuates asthma efficiently by simultaneously inhibiting tracheal ring contraction and inflammation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110616</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(20)30809-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2020.110616</ELocationID>
            <Abstract>
                <AbstractText>Asthma is an airway chronic inflammatory disease with significant morbidity, mortality and huge social economic burden. Previous research demonstrated that the root of Aster tataricus (RA) may have the potential to treat asthma, but the efficacy and mechanism were not clear. In this study, preliminary results in vitro showed that Fr-75 eluted from RA extract could not only completely inhibit the tracheal ring contraction raised by KCl in 20 min, but also effectively affect the tracheal ring contraction induced by KCl-, Ach- and His in a concentration-dependent manner (3.91-250 μg/mL). Further results on cells exhibited that Fr-75 could decrease the concentration of intracellular Ca<sup>2+</sup> as well. These results revealed the underlying mechanism in vitro that the inhibition of tracheal ring contraction might be due to the decline of the intracellular Ca<sup>2+</sup> concentration, which caused by suppressing calcium channel, antagonizing the muscarinic and histamine receptors. Also, results in vivo exhibited that Fr-75 could distinctly ease the symptoms of ovalbumin-sensitized mice, including relieving the pathological injury, increasing the latency to preconvulsive dyspnea and to enhanced pause, reducing the inflammatory cells, chemokines and cytokines in BALF and lung tissue. In general, it could be speculated that RA fraction may attenuate asthma through dilating the tracheal ring contraction and alleviating the lung inflammation simultaneously.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yijun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China; Beijing Key Laboratory of Syndrome Prescription Basic Research, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Hao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yueting</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>Zhixin</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Wenjuan</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Hongbin</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center of Chinese Medicine Analysis and Transformation, Beijing University of Chinese Medicine, Beijing, 100029, China; Beijing Key Laboratory of Syndrome Prescription Basic Research, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: hbxiao69@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Beijing Key Laboratory of Syndrome Prescription Basic Research, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: wangwei26960@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-inflammatory activity</Keyword>
            <Keyword MajorTopicYN="N">Antiasthmatic ability</Keyword>
            <Keyword MajorTopicYN="N">Aster tataricus</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationship that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32784051</ArticleId>
            <ArticleId IdType="pii">S0753-3322(20)30809-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2020.110616</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783990</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-9629</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pulmonary pharmacology &amp; therapeutics</Title>
                <ISOAbbreviation>Pulm Pharmacol Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glabridin attenuates airway inflammation and hyperresponsiveness in a mice model of ovalbumin-induced asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>101936</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1094-5539(20)30140-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pupt.2020.101936</ELocationID>
            <Abstract>
                <AbstractText>Asthma is an inflammatory disease of the airways of the lungs, which is characterized by airflow obstruction and bronchospasms. Glabridin is a major flavonoid, especially found in root of Glycyrrhiza glabra, and has several pharmacological activities, including antioxidant and anti-inflammatory effects. The anti-asthmatic effect and possible mechanism of glabridin, however, have not been revealed so far. The aim of this study is to investigate the effects and possible mechanisms of glabridin against ovalbumin (OVA)-induced airway hyperresponsiveness (AHR) and inflammation in mice. In male BALB/c mice, asthma was induced by intraperitoneal (i.p) injection of OVA mixed with 2 mg aluminium hydroxide on days 0, 14 and boosted with OVA aerosol challenge on days 21, 22, 23. Mice were either treated with dexamethasone (i.p, 1 mg/kg) or glabridin (10, 20, and 30 mg/kg) from days 18 to 23. Pulmonary function parameters such as peak inspiratory flow, peak expiratory flow, tidal volume, expiratory volume, the frequency of breathing, enhanced pause values were evaluated by using whole-body plethysmography. Measurements were performed at baseline and following methacholine (50 mg/mL) challenges. In addition, white blood cells (WBC) count, total protein, and IgE levels were measured in bronchial alveolar lavage fluid (BALF), lung, and serum, respectively. Glabridin (20 or 30 mg/kg) significantly attenuated (p&lt;0.05) OVA-induced alteration in respiratory parameters. Elevated counts of total WBC, differential WBC (neutrophils, lymphocytes, monocytes, and eosinophils) in BALF and the total protein in lungs and BALF were significantly decreased (p&lt;0.05) by glabridin (20 or 30 mg/kg). It also significantly attenuated the increased serum IgE levels (p&lt;0.05). As glabridin reduces the level of serum IgE, the total protein and the count of WBC and improves respiratory function, it may be a novel therapeutic agent in asthma.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dogan</LastName>
                    <ForeName>Muhammed Fatih</ForeName>
                    <Initials>MF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medicine, Pamukkale University, Denizli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Parlar</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medicine, Adiyaman University, Adiyaman, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cam</LastName>
                    <ForeName>Saliha Aysenur</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tosun</LastName>
                    <ForeName>Elif Merve</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Experimental Animals Production Application and Research Center, Adiyaman University, Adiyaman, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uysal</LastName>
                    <ForeName>Fatma</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arslan</LastName>
                    <ForeName>Seyfullah Oktay</ForeName>
                    <Initials>SO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medicine, Ankara Yildirim Beyazit University, Ankara, Turkey. Electronic address: soarslan@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Pulm Pharmacol Ther</MedlineTA>
            <NlmUniqueID>9715279</NlmUniqueID>
            <ISSNLinking>1094-5539</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Glabridin</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">ovalbumin</Keyword>
            <Keyword MajorTopicYN="N">plethysmography</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783990</ArticleId>
            <ArticleId IdType="pii">S1094-5539(20)30140-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.pupt.2020.101936</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783912</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1521-7035</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical immunology (Orlando, Fla.)</Title>
                <ISOAbbreviation>Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transcriptional changes in peanut-specific CD4+ T cells over the course of oral immunotherapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>108568</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1521-6616(20)30728-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clim.2020.108568</ELocationID>
            <Abstract>
                <AbstractText>Oral immunotherapy (OIT) can successfully desensitize allergic individuals to offending foods such as peanut. Our recent clinical trial (NCT02103270) of peanut OIT allowed us to monitor peanut-specific CD4+ T cells, using MHC-peptide Dextramers, over the course of OIT. We used a single-cell targeted RNAseq assay to analyze these cells at 0, 12, 24, 52, and 104 weeks of OIT. We found a transient increase in TGFβ-producing cells at 52 weeks in those with successful desensitization, which lasted until 117 weeks. We also performed clustering and identified 5 major clusters of Dextramer+ cells, which we tracked over time. One of these clusters appeared to be anergic, while another was consistent with recently described TFH13 cells. The other 3 clusters appeared to be Th2 cells by their coordinated production of IL-4 and IL-13, but they varied in their expression of STAT signaling proteins and other markers. A cluster with high expression of STAT family members also showed a possible transient increase at week 24 in those with successful desensitization. Single cell TCRαβ repertoire sequences were too diverse to track clones over time. Together with increased TGFβ production, these changes may be mechanistic predictors of successful OIT that should be further investigated.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Weiqi</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation, Infection, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lyu</LastName>
                    <ForeName>Shu-Chen</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ji</LastName>
                    <ForeName>Xuhuai</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation, Infection, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Sheena</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation, Infection, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manohar</LastName>
                    <ForeName>Monali</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dhondalay</LastName>
                    <ForeName>Gopal K R</ForeName>
                    <Initials>GKR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chinthrajah</LastName>
                    <ForeName>Sharon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andorf</LastName>
                    <ForeName>Sandra</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boyd</LastName>
                    <ForeName>Scott D</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Pathology and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tibshirani</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Data Science, Department of Statistics, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galli</LastName>
                    <ForeName>Stephen J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America; Departments of Pathology and of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nadeau</LastName>
                    <ForeName>Kari C</ForeName>
                    <Initials>KC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sean Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, CA 94305, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maecker</LastName>
                    <ForeName>Holden T</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Immunity, Transplantation, Infection, Stanford University School of Medicine, Stanford, CA 94305, United States of America. Electronic address: maecker@stanford.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Clin Immunol</MedlineTA>
            <NlmUniqueID>100883537</NlmUniqueID>
            <ISSNLinking>1521-6616</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">CD4+ T cell</Keyword>
            <Keyword MajorTopicYN="Y">Food allergy</Keyword>
            <Keyword MajorTopicYN="Y">OIT</Keyword>
            <Keyword MajorTopicYN="Y">Peanut allergy</Keyword>
            <Keyword MajorTopicYN="Y">RNAseq</Keyword>
            <Keyword MajorTopicYN="Y">Single cell</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783912</ArticleId>
            <ArticleId IdType="pii">S1521-6616(20)30728-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.clim.2020.108568</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM">
        <PMID Version="1">32783854</PMID>
        <DateCompleted>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1026</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>737</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Oct</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Science of the total environment</Title>
                <ISOAbbreviation>Sci. Total Environ.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Are convergence lines associated with high asthma presentation days? A case-control study in Melbourne, Australia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>140263</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0048-9697(20)33784-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.scitotenv.2020.140263</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">In epidemic thunderstorm asthma (ETSA) events a large number of people develop asthma symptoms over a short period of time. This is thought to occur because of a unique combination of high amounts of pollen and certain meteorological conditions. However, the exact cause and mechanism of epidemic thunderstorm asthma remains unclear.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The objective of this study was to test the hypothesis that convergence lines may be a causative factor in ETSA events, by investigating whether convergence line weather events are associated with the occurrence of high asthma presentations days during the Victorian grass pollen season (October-December).</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A case control method was used. All public hospitals within 75 km of the Melbourne weather radar were included, and data were taken from 2009 to 2017 during the Victorian grass pollen season. Cases hospital days were hospitals with a high number of asthma presentations within a 24-h period, and controls were hospitals with an expected number of asthma presentations. Exposure was defined as geographical proximity of a convergence line to the hospital case or control.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-one case hospital days and 157 hospital day controls were included in the study. The odds of exposure to a convergence line were significantly higher for cases than for controls at all exposure distances. At 4 km, 80 of the 81 cases had been exposed to a convergence line.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Convergence lines appear to be a necessary, but not sufficient, element in the cause of epidemic thunderstorm asthma. This is the first study to show a clear link between epidemic thunderstorm asthma and convergence lines.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bannister</LastName>
                    <ForeName>Tony</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Severe Weather Section, Victorian State Office, Australian Bureau of Meteorology, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Csutoros</LastName>
                    <ForeName>Danny</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection, Victorian Department of Health and Human Services, Melbourne, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arnold</LastName>
                    <ForeName>Anna-Lena</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection, Victorian Department of Health and Human Services, Melbourne, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Black</LastName>
                    <ForeName>Jim</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection, Victorian Department of Health and Human Services, Melbourne, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feren</LastName>
                    <ForeName>Geoffrey</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Australian Bureau of Meteorology, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Russell</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Severe Weather Section, Victorian State Office, Australian Bureau of Meteorology, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watson</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Australian Bureau of Meteorology, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Scott</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Australian Bureau of Meteorology, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Silver</LastName>
                    <ForeName>Jeremy David</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Earth Sciences, The University of Melbourne, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hughes</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Protection, Victorian Department of Health and Human Services, Melbourne, Victoria, Australia. Electronic address: Nicole.m.hughes@dhhs.vic.gov.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Sci Total Environ</MedlineTA>
            <NlmUniqueID>0330500</NlmUniqueID>
            <ISSNLinking>0048-9697</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000485">Allergens</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000485" MajorTopicYN="Y">Allergens</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D011058" MajorTopicYN="N">Pollen</DescriptorName>
                <QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D014887" MajorTopicYN="N">Weather</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Epidemic thunderstorm asthma</Keyword>
            <Keyword MajorTopicYN="N">Thunderstorm</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783854</ArticleId>
            <ArticleId IdType="pii">S0048-9697(20)33784-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.scitotenv.2020.140263</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783778</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-4970</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of respiratory and critical care medicine</Title>
                <ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Conundrums of Exercise Related Breathing Problems; Epiglottic, Laryngeal or Bronchial Obstruction?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201910-1921IM</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Halvorsen</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1471-0225</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Haukeland University Hospital, Pediatric, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Bergen, Faculty of Medicine, Department of Clinical Science, Bergen, Norway; thomas.halvorsen@helse-bergen.no.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clemm</LastName>
                    <ForeName>Hege Synnøve Havstad</ForeName>
                    <Initials>HSH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Haukeland Universitetssjukehus, 60498, Department of Pediatrics, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Universitetet i Bergen, 1658, Department of Clinical Science, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vollsæter</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Haukeland Universitetssjukehus, 60498, Pediatrics, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Røksund</LastName>
                    <ForeName>Ola Drange</ForeName>
                    <Initials>OD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hogskulen pa Vestlandet, 1657, The Faculty of Health and Social Sciences, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Haukeland University Hospital, Pediatric, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Respir Crit Care Med</MedlineTA>
            <NlmUniqueID>9421642</NlmUniqueID>
            <ISSNLinking>1073-449X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Asthma inhalers</Keyword>
            <Keyword MajorTopicYN="N">Exercise induced bronchial obstruction (EIB)</Keyword>
            <Keyword MajorTopicYN="N">Exercise induced laryngeal obstruction (EILO)</Keyword>
            <Keyword MajorTopicYN="N">Vocal cord dysfunction (VCD)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783778</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.201910-1921IM</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783632</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-1504</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of physiology. Lung cellular and molecular physiology</Title>
                <ISOAbbreviation>Am. J. Physiol. Lung Cell Mol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>World Lung Day; what, why and where to?</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajplung.00364.2020</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fong</LastName>
                    <ForeName>Kwun M</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Thoracic Medicine, Prince Charles Hospital, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Welte</LastName>
                    <ForeName>Tobias</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine/Infectious Diseases, Hannover Medical School, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Physiol Lung Cell Mol Physiol</MedlineTA>
            <NlmUniqueID>100901229</NlmUniqueID>
            <ISSNLinking>1040-0605</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Acute pulmonary infections</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">COPD</Keyword>
            <Keyword MajorTopicYN="N">Lung Cancer</Keyword>
            <Keyword MajorTopicYN="N">Tuberculosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783632</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00364.2020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783625</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-1504</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of physiology. Lung cellular and molecular physiology</Title>
                <ISOAbbreviation>Am. J. Physiol. Lung Cell Mol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In utero Exposure to Nicotine Containing Electronic Cigarettes Increases the Risk of Allergic Asthma in Female Offspring.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajplung.00230.2019</ELocationID>
            <Abstract>
                <AbstractText>E-cigarettes (eCig) are being considered as an alternative to quit cigarette smoking while their long-term effect on lung pathophysiology are unknown. Maternal eCig-vaping may be promoted and considered as a safer cigarette smoking-replacement during pregnancy thus needing further assessment. Using murine models of in utero vaping and allergic asthma with complementary in vitro experiments we tested whether maternal eCig vaping enhances features of allergic asthma in offspring. Female BALB/c mice were exposed to either eCig vapor (± nicotine) or room air. Female offspring from these mothers were subjected to an ovalbumin (OVA)-induced allergic asthma model. Lung function and airway inflammation was assessed. Tissues were histologically assessed with H&amp;E, Periodic Acid-Schiff and Masson's trichrome. Mitochondrial homeostasis protein expression was measured using immunohistochemistry while human airway smooth muscle (ASM) and Beas-2B cells were used to further measure cellular function and mitochondrial respiration. Allergen-challenge in mice lead to significant increase in airway inflammation, development of airway hyperresponsiveness (AHR) and increase in mucus and airway wall thickening (hallmark features of allergic asthma). Allergic asthma features were significantly enhanced in offspring from eCig (+Nicotine)-exposed mothers and were mainly reliant upon Th2-dependent inflammation with complementary changes in mitochondrial homeostasis. Further, in vitro data demonstrated that eCig (±Nicotine)-exposure impaired airway cell homeostasis and perturbed mitochondrial function. Collectively, maternal eCig vaping enhanced and worsened features of allergic asthma and this could partly be attributed to aberrant mitochondrial function.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>McAlinden</LastName>
                    <ForeName>Kielan Darcy</ForeName>
                    <Initials>KD</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Tasmania, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Naidu</LastName>
                    <ForeName>Vgm</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacology, NIPER Guwahati, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sohal</LastName>
                    <ForeName>Sukhwinder Singh</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Translational Research Group, School of Health Sciences, University of Tasmania, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Pawan</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, Thomas Jefferson University, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>PG2018113</GrantID>
                    <Agency>Rebecca Cooper Foundation</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Physiol Lung Cell Mol Physiol</MedlineTA>
            <NlmUniqueID>100901229</NlmUniqueID>
            <ISSNLinking>1040-0605</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">e-cigarette</Keyword>
            <Keyword MajorTopicYN="N">maternal exposure</Keyword>
            <Keyword MajorTopicYN="N">vaping</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783625</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00230.2019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783621</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-1504</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of physiology. Lung cellular and molecular physiology</Title>
                <ISOAbbreviation>Am. J. Physiol. Lung Cell Mol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prenatal smoke exposure dysregulates lung epithelial cell differentiation in mouse offspring - Role for AREG-induced EGFR signaling.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajplung.00209.2020</ELocationID>
            <Abstract>
                <AbstractText>Prenatal smoke exposure is a risk factor for impaired lung development in children. Recent studies have indicated that Amphiregulin (AREG), which is a ligand of the epidermal growth factor receptor (EGFR), has a regulatory role in airway epithelial cell differentiation. In this study, we investigated the effect of prenatal smoke exposure on lung epithelial cell differentiation and linked this with AREG-EGFR signaling in 1-day old mouse offspring. Bronchial and alveolar epithelial cell differentiation were assessed by immunohistochemistry. Areg, Egf as well as mRNA expression of specific markers for bronchial and alveolar epithelial cells were assessed by RT-qPCR. Results in neonatal lungs were validated in an AREG-treated 3D mouse lung organoid model. We found that prenatal smoke exposure reduced the number of ciliated cells and the expression of the cilia-related transcription factor Foxj1, whereas it resulted in higher expression of mucus-related transcription factors Spdef and Foxm1 in lung. Moreover, prenatally smoke exposed offspring had higher numbers of alveolar epithelial type II cells (AECII) and lower expression of the AECI-related Pdpn and Gramd2 markers. This was accompanied by higher expression of Areg and lower expression of Egf in prenatal smoke exposed offspring. In bronchial organoids, AREG treatment resulted in fewer ciliated cells and more basal cells when compared non-treated bronchiolar organoids. In alveolar organoids, AREG treatment led to more AECII cells than non-treated AECII cells. Taken together, the observed impaired bronchial and alveolar cell development in prenatally smoke-exposed neonatal offspring may be induced by increased AREG-EGFR signaling.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lkhagvadorj</LastName>
                    <ForeName>Khosbayar</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology and Medical biology, University Medical Center Groningen, University of Groningen, University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands., Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Zhijun</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Medical College Groningen, Groningen Research Institute for Asthma and COPD.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry and Molecular Cell Biology, Shanghai Jiao Tong University School of Medicine, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinders-Luinge</LastName>
                    <ForeName>Marjan</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Groningen, University Medical Center Groningen, Pathology Section, Department of Pathology and Medical Biology, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kooistra</LastName>
                    <ForeName>Wierd</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Shanshan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Groningen, Groningen Research Institute for Pharmacy, Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands., University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands., Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krauss-Etschmann</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Leibniz Lung Center and Christian Albrechts University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melgert</LastName>
                    <ForeName>Barbro N</ForeName>
                    <Initials>BN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Pharmacology, University of Groningen, Groningen, The Netherlands, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Junjun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Environmental Medicine and Developmental Toxicology, Shantou, China., Shantou University Medical College, Laboratory of Environmental Medicine and Developmental Toxicology, Shantou, China., China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hylkema</LastName>
                    <ForeName>Machteld N</ForeName>
                    <Initials>MN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology and Medical Biology, University Medical Center of Groningen, University Medical Center of Groningen, Groningen Research Institute for Asthma and COPD, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Physiol Lung Cell Mol Physiol</MedlineTA>
            <NlmUniqueID>100901229</NlmUniqueID>
            <ISSNLinking>1040-0605</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Amphiregulin</Keyword>
            <Keyword MajorTopicYN="N">Epithelial cell differentiation</Keyword>
            <Keyword MajorTopicYN="N">Lung organoids</Keyword>
            <Keyword MajorTopicYN="N">Prenatal smoke exposure</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783621</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00209.2020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783620</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-4970</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of respiratory and critical care medicine</Title>
                <ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Supraglottic Lung Microbiome Taxa Are Associated with Pulmonary Abnormalities in an HIV Longitudinal Cohort.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.202004-1086LE</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Jin J</ForeName>
                    <Initials>JJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7983-0274</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona, Epidemiology and Biostatistics, Tucson, Arizona, United States; jzhou@email.arizona.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhai</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona, Asthma and Airway Disease Research Center, Tucson, Arizona, United States.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona Mel and Enid Zuckerman College of Public Health, 48710, Epidemiology and Biostatistics, Tucson, Arizona, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Hua</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of California Los Angeles, 8783, Los Angeles, California, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hamner Institutes for Health Sciences, Biological Sciences, RTP, North Carolina, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guerra</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona, Tucson, Arizona, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Robey</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona, 8041, Tucson, Arizona, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weinstock</LastName>
                    <ForeName>George M</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Washington University School of Medicine, The Genome Institute, St. Louis, Missouri, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weinstock</LastName>
                    <ForeName>Erica</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Washington University School of Medicine, The Genome Institute, St. Louis, Missouri, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Qunfeng</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Loyola University Chicago, Public Health Sciences, Maywood, Illinois, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Knox</LastName>
                    <ForeName>Kenneth S</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Indiana University, Pulmonary Division, Indianapolis, Indiana, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Twigg Iii</LastName>
                    <ForeName>Homer L</ForeName>
                    <Initials>HL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Indiana University, Department of Medicine, Indianapolis, Indiana, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Respir Crit Care Med</MedlineTA>
            <NlmUniqueID>9421642</NlmUniqueID>
            <ISSNLinking>1073-449X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chemokine</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Lavage</Keyword>
            <Keyword MajorTopicYN="N">Reconstitution</Keyword>
            <Keyword MajorTopicYN="N">Supraglottic</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783620</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.202004-1086LE</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783617</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-1504</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of physiology. Lung cellular and molecular physiology</Title>
                <ISOAbbreviation>Am. J. Physiol. Lung Cell Mol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Quantification of bronchoalveolar neutrophil extracellular traps and phagocytosis in murine pneumonia.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajplung.00316.2020</ELocationID>
            <Abstract>
                <AbstractText>The past two decades have witnessed a resurgence in neutrophil research, inspired in part by the discovery of neutrophil extracellular traps (NETs) and their myriad roles in health and disease. Within the lung, dysregulation of neutrophils and NETosis have been linked to an array of diseases including pneumonia, cystic fibrosis, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), and severe asthma. However, our understanding of pathologic neutrophil responses in the lung remains incomplete. Two methodologic issues have contributed to this gap: first, an emphasis on studying neutrophils from blood rather than the lung; and second, the technical difficulties of interrogating neutrophil responses in mice, which has largely restricted basic murine research to specialized laboratories. To address these limitations, we have developed a suite of techniques for studying neutrophil effector functions specifically in the mouse lung. These include ex vivo assays for phagocytosis and NETosis using bronchoalveolar neutrophils, and in situ evaluation of NETosis in a murine model of pneumonia. Throughout, we have prioritized technical ease and robust, quantitative readouts. We hope these assays will help to standardize research on lung neutrophils and improve accessibility to this burgeoning field.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gautam</LastName>
                    <ForeName>Samir</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stahl</LastName>
                    <ForeName>Yannick</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Young</LastName>
                    <ForeName>Grant M</ForeName>
                    <Initials>GM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale University, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Howell</LastName>
                    <ForeName>Rebecca</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chemistry, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cohen</LastName>
                    <ForeName>Avi J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsang</LastName>
                    <ForeName>Derek A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martin</LastName>
                    <ForeName>Tommy</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Lokesh</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dela Cruz</LastName>
                    <ForeName>Charles S</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Internal Medicine, Yale School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>T32-HL007778</GrantID>
                    <Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>5R01HL126094-05</GrantID>
                    <Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>1I01BX004661-01</GrantID>
                    <Agency>Health Services Research and Development (Veterans Health Administration HSR and D)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Physiol Lung Cell Mol Physiol</MedlineTA>
            <NlmUniqueID>100901229</NlmUniqueID>
            <ISSNLinking>1040-0605</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bronchoalveolar neutrophils</Keyword>
            <Keyword MajorTopicYN="N">Neutrophil extracellular traps</Keyword>
            <Keyword MajorTopicYN="N">Phagocytosis</Keyword>
            <Keyword MajorTopicYN="N">Pneumonia</Keyword>
            <Keyword MajorTopicYN="N">Pseudomonas aeruginosa</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783617</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00316.2020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783616</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1522-1504</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of physiology. Lung cellular and molecular physiology</Title>
                <ISOAbbreviation>Am. J. Physiol. Lung Cell Mol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapeutic Efficacy of IL-17A Neutralization with Corticosteroid Treatment in a Model of Antigen-Driven Mixed Granulocytic Asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1152/ajplung.00204.2020</ELocationID>
            <Abstract>
                <AbstractText>Many mouse models of allergic asthma exhibit eosinophil-predominant cellularity rather than the mixed granulocytic cytology in steroid-unresponsive severe disease. Therefore, we sought to implement a novel mouse model of antigen-driven, mixed-granulocytic, severe allergic asthma to determine biomarkers of the disease process and potential therapeutic targets. C57BL/6J, IL-6-/-, and IL-6R-/- mice were injected with an emulsion of Complete Freund's Adjuvant and House Dust Mite antigen (CFA/HDM) on day 1. Dexamethasone, a lymphocyte-depleting biological, or anti-IL-17A were administered during intranasal HDM challenge on days 19-22. On day 23, the CFA/HDM model elicited mixed bronchoalveolar lavage (BAL) cellularity (typically 80% neutrophils and 10% eosinophils), airway hyperresponsiveness (AHR) to methacholine, diffusion impairment, lung damage, body weight loss, corticosteroid resistance, and elevated levels of serum amyloid A (SAA), pro-inflammatory cytokines, and Th1/Th17 cytokines compared to eosinophilic models of HDM-driven allergic airway disease. BAL cells in IL-6- or IL-6R-deficient mice were predominantly eosinophilic and associated with elevated Th2 and reduced Th1/Th17 cytokine production, along with an absence of SAA. Nevertheless, AHR remained in IL-6-deficient mice even when administered dexamethasone. However, combined administration of anti-IL-17A and systemic corticosteroid significantly attenuated both overall and neutrophilic airway inflammation, and also reduced AHR and body weight loss. Inhibition of IL-17A combined with systemic corticosteroid treatment during antigen-driven exacerbations may provide a novel therapeutic approach to prevent the pathological pulmonary and constitutional changes that greatly impact patients with the mixed-granulocytic endotype of severe asthma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Menson</LastName>
                    <ForeName>Katherine E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mank</LastName>
                    <ForeName>Madeleine M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reed</LastName>
                    <ForeName>Leah F</ForeName>
                    <Initials>LF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Walton</LastName>
                    <ForeName>Camille J</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Der Vliet</LastName>
                    <ForeName>Katherine E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ather</LastName>
                    <ForeName>Jennifer L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Vermont.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chapman</LastName>
                    <ForeName>David G</ForeName>
                    <Initials>DG</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Technology Sydney, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Bradford J</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Colorado Anschutz School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rincon</LastName>
                    <ForeName>Mercedes</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology &amp; Microbiology, University of Colorado Anschutz School of Medicine, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poynter</LastName>
                    <ForeName>Matthew E</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicine, University of Vermont, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01HL142081</GrantID>
                    <Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R01HL133920</GrantID>
                    <Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R01HL10729</GrantID>
                    <Agency>HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R56AI116255</GrantID>
                    <Agency>HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Physiol Lung Cell Mol Physiol</MedlineTA>
            <NlmUniqueID>100901229</NlmUniqueID>
            <ISSNLinking>1040-0605</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IL-17</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">corticosteroids</Keyword>
            <Keyword MajorTopicYN="N">mice</Keyword>
            <Keyword MajorTopicYN="N">neutrophils</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>14</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783616</ArticleId>
            <ArticleId IdType="doi">10.1152/ajplung.00204.2020</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32783099</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1861-0692</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical research in cardiology : official journal of the German Cardiac Society</Title>
                <ISOAbbreviation>Clin Res Cardiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19 among heart transplant recipients in Germany: a multicenter survey.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00392-020-01722-w</ELocationID>
            <Abstract>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Heart transplantation may represent a particular risk factor for severe coronavirus infectious disease 2019 (COVID-19) due to chronic immunosuppression and frequent comorbidities. We conducted a nation-wide survey of all heart transplant centers in Germany presenting the clinical characteristics of heart transplant recipients with COVID-19 during the first months of the pandemic in Germany.</AbstractText>
                <AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">A multicenter survey of all heart transplant centers in Germany evaluating the current status of COVID-19 among adult heart transplant recipients was performed. A total of 21 heart transplant patients with COVID-19 was reported to the transplant centers during the first months of the pandemic in Germany. Mean patient age was 58.6 ± 12.3 years and 81.0% were male. Comorbidities included arterial hypertension (71.4%), dyslipidemia (71.4%), diabetes mellitus (33.3%), chronic kidney failure requiring dialysis (28.6%) and chronic-obstructive lung disease/asthma (19.0%). Most patients received an immunosuppressive drug regimen consisting of a calcineurin inhibitor (71.4%), mycophenolate mofetil (85.7%) and steroids (71.4%). Eight of 21 patients (38.1%) displayed a severe course needing invasive mechanical ventilation. Those patients showed a high mortality (87.5%) which was associated with right ventricular dysfunction (62.5% vs. 7.7%; p = 0.014), arrhythmias (50.0% vs. none; p = 0.012), and thromboembolic events (50.0% vs. none; p = 0.012). Elevated high-sensitivity cardiac troponin T- and N-terminal prohormone of brain natriuretic peptide were significantly associated with the severe form of COVID-19 (p = 0.017 and p &lt; 0.001, respectively).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Severe course of COVID-19 was frequent in heart transplanted patients. High mortality was associated with right ventricular dysfunction, arrhythmias, thromboembolic events, and markedly elevated cardiac biomarkers.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rivinius</LastName>
                    <ForeName>Rasmus</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaya</LastName>
                    <ForeName>Ziya</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schramm</LastName>
                    <ForeName>René</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boeken</LastName>
                    <ForeName>Udo</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiac Surgery, Düsseldorf University Hospital, Düsseldorf, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Provaznik</LastName>
                    <ForeName>Zdenek</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Surgery, Regensburg University Hospital, Regensburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heim</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Surgery, Erlangen University Hospital, Erlangen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Knosalla</LastName>
                    <ForeName>Christoph</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schoenrath</LastName>
                    <ForeName>Felix</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rieth</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Kerckhoff Hospital, Bad Nauheim, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berchtold-Herz</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Surgery, University Heart Center Freiburg-Bad Krozingen, Freiburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barten</LastName>
                    <ForeName>Markus J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiovascular Surgery, University Heart and Vascular Center, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rauschning</LastName>
                    <ForeName>Dominic</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Bundeswehr Central Hospital, Koblenz, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mücke</LastName>
                    <ForeName>Victoria T</ForeName>
                    <Initials>VT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine I, Frankfurt University Hospital, Frankfurt, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heyl</LastName>
                    <ForeName>Stephan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine III, Frankfurt University Hospital, Frankfurt, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pistulli</LastName>
                    <ForeName>Rudin</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology I - Coronary and Peripheral Vascular Disease, Heart Failure, Münster University Hospital, Münster, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grinninger</LastName>
                    <ForeName>Carola</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiac Surgery, Munich University Hospital, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hagl</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiac Surgery, Munich University Hospital, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gummert</LastName>
                    <ForeName>Jan F</ForeName>
                    <Initials>JF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Thoracic and Cardiovascular Surgery, Heart and Diabetes Center NRW, Bad Oeynhausen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Warnecke</LastName>
                    <ForeName>Gregor</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiac Surgery, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schulze</LastName>
                    <ForeName>P Christian</ForeName>
                    <Initials>PC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Jena University Hospital, Jena, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Katus</LastName>
                    <ForeName>Hugo A</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kreusser</LastName>
                    <ForeName>Michael M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany. michael.kreusser@med.uni-heidelberg.de.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany. michael.kreusser@med.uni-heidelberg.de.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Infection Research (DZIF), Partner Site Heidelberg, Heidelberg, Germany. michael.kreusser@med.uni-heidelberg.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raake</LastName>
                    <ForeName>Philip W</ForeName>
                    <Initials>PW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Clin Res Cardiol</MedlineTA>
            <NlmUniqueID>101264123</NlmUniqueID>
            <ISSNLinking>1861-0684</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Heart transplantation</Keyword>
            <Keyword MajorTopicYN="N">Immunosuppression</Keyword>
            <Keyword MajorTopicYN="N">Mortality</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32783099</ArticleId>
            <ArticleId IdType="doi">10.1007/s00392-020-01722-w</ArticleId>
            <ArticleId IdType="pii">10.1007/s00392-020-01722-w</ArticleId>
            <ArticleId IdType="pmc">PMC7418884</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Antiviral Res. 2018 Jul;155:89-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29772254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2020 May 7;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32378314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dtsch Med Wochenschr. 2020 May;145(10):670-674</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32344440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Viruses. 2013 May 22;5(5):1250-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23698397</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 2020 Jul;191:145-147</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32291094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2018 Feb;107(2):138-147</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29098378</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Pathog. 2011 Oct;7(10):e1002331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22046132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2020 Jul;20(7):1800-1808</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32330343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Cardiol. 2020 May;17(5):259-260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32139904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transplant. 2020 Jul;20(7):1925-1929</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32319218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2018 May;107(5):413-420</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29294144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2020 Jun;109(6):700-713</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31630214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2020 Jun 22;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32572551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 May 2;395(10234):1417-1418</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32325026</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2017 Dec 7;38(46):3411-3413</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29232449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 Jun;18(6):1421-1424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32271988</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Res Cardiol. 2020 May;109(5):531-538</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32161990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chim Acta. 2020 Jun;505:15-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32061575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Res. 2020 Apr 15;21(1):83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32293449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Jun 18;382(25):2475-2477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32329975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull World Health Organ. 2001;79(4):373-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11357217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cleve Clin J Med. 2020 May 5;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32371557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virus Res. 2012 Apr;165(1):112-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22349148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2020 Jun 4;135(23):2033-2040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32339221</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Heart Lung Transplant. 2020 May;39(5):412-417</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32362392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Heart Lung Transplant. 2020 May;39(5):496-497</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32362394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Virol. 2019 May 29;93(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30918074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 2020 Jul;191:9-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32353746</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31986264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Heart Fail. 2018 Nov;20(11):1505-1535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29806100</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32782791</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1828-695X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>15</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jan</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Multidisciplinary respiratory medicine</Title>
                <ISOAbbreviation>Multidiscip Respir Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Global Usability Score Short-Form for the simplified assessment of dry powder inhalers (DPIs) usability.</ArticleTitle>
            <Pagination>
                <MedlinePgn>659</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4081/mrm.2020.659</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">The choice of the Dry Powder Inhaler (DPI) to prescribe is a critical issue. The estimation of DPIs usability depends on the objective assessment of several indices related to both subjective and objective determinants. The Global Usability Score (GUS) Questionnaire is a comprehensive tool usable for checking, comparing, and ranking inhalers' usability objectively in real life, but it takes some time to fill.</AbstractText>
                <AbstractText Label="Aim" NlmCategory="UNASSIGNED">The aim of this study was to favour the quicker check of DPIs usability in clinical practice by means of a simplified short-form GUS (S-GUS) Questionnaire, while maintaining the high specificity and sensitivity of the original, extended version of the Questionnaire (O-GUS questionnaire).</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The usability of the six most prescribed DPIs was assessed in 222 patients with persistent airway obstruction and needing long-term inhalation treatments. LASSO regression and multicollinearity test were used to select the subset of questions of the O-GUS questionnaire, with the highest information power. Each item was then scored using the corresponding coefficient in the linear regression (normalized at 50 as the O-GUS score). Agreement between the original and the short-form questionnaire was evaluated using the Cohen's kappa statistic (κ). The overall S-GUS values obtained for each DPI were then compared to those from the O-GUS, in the same patients, using a Bayesian indirect comparison (IC) model.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">After the statistical selection of the items mostly contributing to the overall score, the novel S-GUS questionnaire consists of twelve items only. Nine items are related to patients' opinion before DPIs handling, and three to the nurse's assessment after DPIs practicality. O-GUS and S-GUS score were strongly correlated (R<sup>2</sup>=0.9843, <i>p</i>&lt;0.0001) and the usability score calculated for each DPI by means of the O- and of S- GUS overlapped almost completely (κ=84.5%, 95% CI 81.3% to 89.2%). Furthermore, S-GUS was much faster to complete than O-GUS (mean time 6.1 <i>vs</i> 23.4 minutes, <i>p</i>&lt;0.001). Estimates of S-GUS, obtained from the IC model, allowed to propose a simple classification of usability: &quot;good&quot; by GUS values &gt;25; &quot;pretty good&quot; by values ≤25≥15, and &quot;insufficient&quot; by values &lt;15.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">The S-GUS proves as much specific and suitable as the extended O-GUS questionnaire in measuring DPIs usability, while maintaining the same high sensitivity. As the time required for its use is quite shorter, S-GUS is also particularly suitable and helpful in current clinical practice.</AbstractText>
                <CopyrightInformation>©Copyright: the Author(s).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Povero</LastName>
                    <ForeName>Massimiliano</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>AdRes Health Economics and Outcome Research, Turin.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Turco</LastName>
                    <ForeName>Paola</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research &amp; Clinical Governance, Verona.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bonadiman</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dal Negro</LastName>
                    <ForeName>Roberto W</ForeName>
                    <Initials>RW</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Respiratory Pharmacoeconomics and Pharmacoepidemiology, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>Multidiscip Respir Med</MedlineTA>
            <NlmUniqueID>101477642</NlmUniqueID>
            <ISSNLinking>1828-695X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COPD</Keyword>
            <Keyword MajorTopicYN="N">GUS</Keyword>
            <Keyword MajorTopicYN="N">GUS short-form</Keyword>
            <Keyword MajorTopicYN="N">Inhalation devices</Keyword>
            <Keyword MajorTopicYN="N">bronchial asthma</Keyword>
            <Keyword MajorTopicYN="N">dry powder inhalers</Keyword>
            <Keyword MajorTopicYN="N">global usability score</Keyword>
            <Keyword MajorTopicYN="N">usability</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest: The authors declare that they have no competing interests. RWD is Associate Editor of Multidisciplinary Respiratory Medicine.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32782791</ArticleId>
            <ArticleId IdType="doi">10.4081/mrm.2020.659</ArticleId>
            <ArticleId IdType="pmc">PMC7385528</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Chron Obstruct Pulmon Dis. 2016 Aug 05;11:1845-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27540287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Chron Obstruct Pulmon Dis. 2009;4:381-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19888356</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Decis Making. 2013 Jul;33(5):607-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23104435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2000 May;94(5):496-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10868714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract Suppl. 2005 Dec;(149):33-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16280002</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Health Syst Pharm. 2011 Jul 1;68(13):1221-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21690428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2002 May;96(5):293-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12113378</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Chron Obstruct Pulmon Dis. 2011;6:353-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21760722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Biomed. 2007 Dec;78(3):233-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18330086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 1989 Jul;8(7):771-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2672226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2007 Oct;44(8):593-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17943567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract Suppl. 2005 Dec;(149):19-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16279999</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2008 Jan;102(1):10-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17923402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Multidiscip Respir Med. 2019 Sep 13;14:30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31528340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2004 Nov;26(11):1791-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15639691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Pract Suppl. 2005 Dec;(149):13-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16279998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Drug Deliv. 2013 Aug;10(8):1023-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23745954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pneumonol Alergol Pol. 2015;83(5):365-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26378998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Drug Deliv Rev. 2003 Jul 18;55(7):879-923</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12842606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Treat Respir Med. 2005;4(1):41-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15725049</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2011 Feb;64(2):163-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20688472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Bronconeumol. 2008 Jul;44(7):346-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18727886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respiration. 2008;75(1):18-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17911976</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):321-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18823257</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung India. 2014 Oct;31(4):366-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25378845</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32782790</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1828-695X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>15</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jan</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Multidisciplinary respiratory medicine</Title>
                <ISOAbbreviation>Multidiscip Respir Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RP EBUS as a guide for transbronchial pulmonary biopsy in the diagnosis of organizing pneumonia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>658</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4081/mrm.2020.658</ELocationID>
            <Abstract>
                <AbstractText>Diffuse parenchymal lung diseases (DPLDs) include a wide variety of manifestations characterized by different degrees of inflammation and fibrosis with various patterns of secondary lobule alterations, such that the diagnosis often requires histopathological confirmation in addition to clinical and radiological data. Radial probe endobronchial ultrasonography (RP EBUS) can be used as a guide for transbronchial pulmonary biopsy (TBPB) to obtain tissue samples, and thus can be a useful tool in the diagnostic management of peripheral pulmonary lesions. Organizing pneumonia (OP) is a particular type of DPLD characterized by lung inflammation and scarring that obstruct the small airways and air sacs of the lung. In this study, we describe how and when RP EBUS can be used to guide TBPB and significantly help in the diagnosis of OP.</AbstractText>
                <CopyrightInformation>©Copyright: the Author(s).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cicchitto</LastName>
                    <ForeName>Gaetano</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Endoscopic Unit, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Polverino</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Endoscopic Unit, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Capuozzo</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Endoscopic Unit, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cacace</LastName>
                    <ForeName>Luigi</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pathology, Ospedale &quot;A. Tortora&quot;, Pagani (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cavallera</LastName>
                    <ForeName>Antonietta</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mauro</LastName>
                    <ForeName>Imma</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Endoscopic Unit, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferrigno</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Endoscopic Unit, Ospedale &quot;M. Scarlato&quot;, Scafati (SA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Polverino</LastName>
                    <ForeName>Francesca</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Asthma and Airway Disease Center, University of Arizona, Tucson, AZ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Italy</Country>
            <MedlineTA>Multidiscip Respir Med</MedlineTA>
            <NlmUniqueID>101477642</NlmUniqueID>
            <ISSNLinking>1828-695X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Flexible bronchoscopy</Keyword>
            <Keyword MajorTopicYN="N">organizing pneumonia</Keyword>
            <Keyword MajorTopicYN="N">radial probe endobronchial ultrasonography</Keyword>
            <Keyword MajorTopicYN="N">transbronchial pulmonary biopsy</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest: None of the authors have conflicts of interest to disclose. MP is Coordinator of the Editorial Board of Multidisciplinary Respiratory Medicine; FP is a member of the Editorial Board of Multidisciplinary Respiratory Medicine.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32782790</ArticleId>
            <ArticleId IdType="doi">10.4081/mrm.2020.658</ArticleId>
            <ArticleId IdType="pmc">PMC7385527</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Respirology. 2017 Apr;22(3):443-453</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28177181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thorac Dis. 2019 Jan;11(1):329-334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30863611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2002 Oct;20(4):972-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12412691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11790668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med Case Rep. 2014 Mar 15;12:19-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26029530</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1999 Apr;54 Suppl 1:S1-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11006787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2016 May 15;193(10):1161-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26646481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2017 May;151(5):1131-1140</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27471113</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2017 20th Jan;130(2):236-238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28091418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2002 Dec;122(6):1887-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12475821</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2015 Jun;45(6):1661-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25573408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2007 Apr;101(4):738-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17015004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1995 Jul;108(1):131-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7606947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2004 Sep;126(3):959-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15364779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2007 Jun;131(6):1788-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17565021</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pol Arch Intern Med. 2018 Apr 30;128(4):259-262</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29708957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respiration. 2004 Mar-Apr;71(2):107-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15031564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tuberc Respir Dis (Seoul). 2019 Jul;82(3):201-210</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31172702</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32782442</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1476-7961</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>18</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical and molecular allergy : CMA</Title>
                <ISOAbbreviation>Clin Mol Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>15</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12948-020-00130-9</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Asthma affects up to nearly 40% of patients with allergic rhinitis (AR). Poor control of AR symptoms is associated with poor asthma control. The goal of this study was to evaluate the effect of AR treatment with MP-AzeFlu on symptoms of AR as well as symptoms of asthma.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">This prospective study used a visual analog scale (VAS) to assess symptoms of AR and asthma before and after treatment with MP-AzeFlu (Dymista<sup>®</sup>; azelastine hydrochloride plus fluticasone propionate; 1 spray in each nostril twice daily for 2 weeks). Participants suffered from moderate-to-severe AR according to Allergic Rhinitis and its Impact on Asthma criteria, with acute AR symptoms (AR-VAS scores ≥ 50 mm) on inclusion day. In addition to symptom assessment, patients recorded the impact of AR symptoms on quality-of-life measures before, during, and at the conclusion of the treatment period (approximately 14 days). Patients self-reported change in frequency of their usage of asthma reliever medication on the last day of treatment.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Of 1103 study participants, 267 (24.2%) had comorbid asthma. These participants reported using a mean of 5.1 puffs of asthma reliever medication in the week before treatment with MP-AzeFlu. A total of 81.8% of patients with comorbid asthma responded to AR therapy (AR-VAS &lt; 50 mm on at least 1 study day). Among patients with AR and comorbid asthma, MP-AzeFlu was associated with improved VAS scores across all study parameters, including AR symptom severity, asthma symptom severity, sleep quality, daily work or school activities, daily social activities, and daily outdoor activities. Asthma symptom severity decreased from a mean of 48.9 mm to 24.1 mm on the VAS. Self-reported frequency of asthma reliever medication use was reduced for 57.6% of participants (n = 139/241).</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">MP-AzeFlu used to relieve AR symptoms was associated with reduced asthma symptom VAS scores and frequency of asthma reliever medication usage. Changes in overall symptoms of AR and asthma were correlated.</AbstractText>
                <CopyrightInformation>© The Author(s) 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Price</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">0000-0002-9728-9992</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, AB25 2ZD UK.</Affiliation>
                        <Identifier Source="GRID">grid.7107.1</Identifier>
                        <Identifier Source="ISNI">0000 0004 1936 7291</Identifier>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Optimum Patient Care, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Observational and Pragmatic Research Institute (OPRI), Pte | #02-05 883 North Bridge Road, Singapore, 198785 Singapore.</Affiliation>
                        <Identifier Source="GRID">grid.500407.6</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Klimek</LastName>
                    <ForeName>Ludger</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zentrum für Rhinologie und Allergologie, Wiesbaden, Germany.</Affiliation>
                        <Identifier Source="GRID">grid.500035.3</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gálffy</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonology Hospital, Törökbálint, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Emmeluth</LastName>
                    <ForeName>Melanie</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>MEDA Pharma GmbH &amp; Co. KG (A Mylan Company), Bad Homburg, Germany.</Affiliation>
                        <Identifier Source="GRID">grid.476483.a</Identifier>
                        <Identifier Source="ISNI">0000 0004 0499 6052</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koltun</LastName>
                    <ForeName>Arkady</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mylan, Inc, Canonsburg, PA USA.</Affiliation>
                        <Identifier Source="GRID">grid.476548.c</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kopietz</LastName>
                    <ForeName>Ferdinand</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>MEDA Pharma GmbH &amp; Co. KG (A Mylan Company), Bad Homburg, Germany.</Affiliation>
                        <Identifier Source="GRID">grid.476483.a</Identifier>
                        <Identifier Source="ISNI">0000 0004 0499 6052</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen</LastName>
                    <ForeName>Duc Tung</ForeName>
                    <Initials>DT</Initials>
                    <AffiliationInfo>
                        <Affiliation>MEDA Pharma GmbH &amp; Co. KG (A Mylan Company), Bad Homburg, Germany.</Affiliation>
                        <Identifier Source="GRID">grid.476483.a</Identifier>
                        <Identifier Source="ISNI">0000 0004 0499 6052</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Weissenbruch</LastName>
                    <ForeName>Ranny</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wilhelmina Ziekenhuis Assen, Assen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pohl</LastName>
                    <ForeName>Wolfgang</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Karl Landsteiner Gesellschaft, Institut für Klinische und experimentelle Pneumologie, Vienna, Austria.</Affiliation>
                        <Identifier Source="GRID">grid.487248.5</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuhl</LastName>
                    <ForeName>Hans-Christian</ForeName>
                    <Initials>HC</Initials>
                    <AffiliationInfo>
                        <Affiliation>MEDA Pharma GmbH &amp; Co. KG (A Mylan Company), Bad Homburg, Germany.</Affiliation>
                        <Identifier Source="GRID">grid.476483.a</Identifier>
                        <Identifier Source="ISNI">0000 0004 0499 6052</Identifier>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scadding</LastName>
                    <ForeName>Glenis</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Royal National Ear, Nose Throat Hospital, London, England.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mullol</LastName>
                    <ForeName>Joaquim</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rhinology Unit &amp; Smell Clinic, ENT Department, Hospital Clínic Barcelona, IDIBAPS, Universitat de Barcelona, CIBERES, Barcelona, Catalonia Spain.</Affiliation>
                        <Identifier Source="GRID">grid.5841.8</Identifier>
                        <Identifier Source="ISNI">0000 0004 1937 0247</Identifier>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Mol Allergy</MedlineTA>
            <NlmUniqueID>101152195</NlmUniqueID>
            <ISSNLinking>1476-7961</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Comorbidity</Keyword>
            <Keyword MajorTopicYN="N">Daily activity</Keyword>
            <Keyword MajorTopicYN="N">MP-AzeFlu</Keyword>
            <Keyword MajorTopicYN="N">Sleep quality</Keyword>
            <Keyword MajorTopicYN="N">Visual analog scale</Keyword>
        </KeywordList>
        <CoiStatement>Competing interestsDP has board membership with Amgen, AstraZeneca, Boehringer Ingelheim, Chiesi, Circassia, Mylan, Mundipharma, Napp, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, and Teva Pharmaceuticals; consultancy agreements with Amgen, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Mylan, Mundipharma, Napp, Novartis, Pfizer, Teva Pharmaceuticals, and Theravance; grants and unrestricted funding for investigator-initiated studies (conducted through The Observational &amp; Pragmatic Research Institute Pte Ltd) from AKL Research and Development Ltd, AstraZeneca, Boehringer Ingelheim, British Lung Foundation, Chiesi, Circassia, Mylan, Mundipharma, Napp, Novartis, Pfizer, Regeneron Pharmaceuticals, Respiratory Effectiveness Group, Sanofi Genzyme, Teva Pharmaceuticals, Theravance, UK National Health Service, and Zentiva (Sanofi Generics); payment for lectures/speaking engagements from AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, GlaxoSmithKline, Kyorin, Mylan, Merck, Mundipharma, Novartis, Pfizer, Regeneron Pharmaceuticals, Sanofi Genzyme, and Teva Pharmaceuticals; payment for manuscript preparation from Mundipharma and Teva Pharmaceuticals; payment for the development of educational materials from Mundipharma and Novartis; payment for travel/accommodation/meeting expenses from AstraZeneca, Boehringer Ingelheim, Circassia, Mundipharma, Napp, Novartis, and Teva Pharmaceuticals; funding for patient enrollment or completion of research from Chiesi, Novartis, Teva Pharmaceuticals, and Zentiva (Sanofi Generics); stock/stock options from AKL Research and Development Ltd, which produces phytopharmaceuticals; owns 74% of the social enterprise Optimum Patient Care Ltd (Australia and United Kingdom) and 74% of The Observational &amp; Pragmatic Research Institute Pte Ltd (Singapore); and is peer reviewer for grant committees of the Efficacy and Mechanism Evaluation Programme and Health Technology Assessment. JM has conducted research/received research grant support or speaker/consultancy fees from Mylan-Meda Pharma within this work. He has conducted research/received research grant support or speaker/consultancy fees from Allakos, ALK-Abelló, AstraZeneca, Genentech – Roche, GlaxoSmithKline, Mylan-Meda Pharma, Menarini Group, Mitsubishi-Tanabe, MSD, Novartis, SANOFI-Genzyme &amp; Regeneron, UCB Pharma, and Uriach Group outside this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32782442</ArticleId>
            <ArticleId IdType="doi">10.1186/s12948-020-00130-9</ArticleId>
            <ArticleId IdType="pii">130</ArticleId>
            <ArticleId IdType="pmc">PMC7412849</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Allergy Clin Immunol. 1993 Jan;91(1 Pt 1):97-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8423275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2007 Apr;62(4):367-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17362246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2018 May;73(5):1084-1093</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29121401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2008 Apr;63 Suppl 86:8-160</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18331513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prim Care Respir J. 2008 Mar;17(1):7-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18253678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2005 Mar;35(3):282-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15784104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2013 Jun;50(5):514-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23506422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Head Neck Surg. 2007 Jun;136(6 Suppl):S107-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17512862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prim Care Respir J. 2009 Dec;18(4):300-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19562233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Allergy Clin North Am. 2004 Feb;24(1):19-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15062425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2013 Aug;43(8):881-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23889242</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2017 Apr 28;13:24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28465694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma Allergy. 2016 Jul 11;9:135-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27468241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Aug;138(2):367-374.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27260321</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Allergy. 2017 Jun 1;7:17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28572918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2010;153(4):395-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20559006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2002 Jan;109(1):57-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11799366</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2013;161(4):369-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23652808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2009 Oct;64(10):1516-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19624554</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2017 Jun;72(6):959-966</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27886391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Allergy. 2015 Nov 18;5:39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26583068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2013;68(5):569-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23590215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Manag Care Spec Pharm. 2016 Dec;22(12):1426-1436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27882840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2017 Oct;140(4):950-958</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28602936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prim Care Respir J. 2010 Sep;19(3):266-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20571732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Forum Allergy Rhinol. 2017 Mar;7(3):287-292</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27888645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1997 Feb;111(2 Suppl):11S-16S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9042022</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergo J Int. 2017;26(1):16-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28217433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):172-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24607045</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Care. 2016 Jan;61(1):23-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26420899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2018 Dec 18;14:86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30574167</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32782262</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Efficient variance components analysis across millions of genomes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4020</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-17576-9</ELocationID>
            <Abstract>
                <AbstractText>While variance components analysis has emerged as a powerful tool in complex trait genetics, existing methods for fitting variance components do not scale well to large-scale datasets of genetic variation. Here, we present a method for variance components analysis that is accurate and efficient: capable of estimating one hundred variance components on a million individuals genotyped at a million SNPs in a few hours. We illustrate the utility of our method in estimating and partitioning variation in a trait explained by genotyped SNPs (SNP-heritability). Analyzing 22 traits with genotypes from 300,000 individuals across about 8 million common and low frequency SNPs, we observe that per-allele squared effect size increases with decreasing minor allele frequency (MAF) and linkage disequilibrium (LD) consistent with the action of negative selection. Partitioning heritability across 28 functional annotations, we observe enrichment of heritability in FANTOM5 enhancers in asthma, eczema, thyroid and autoimmune disorders.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pazokitoroudi</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Yue</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burch</LastName>
                    <ForeName>Kathryn S</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hou</LastName>
                    <ForeName>Kangcheng</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Aaron</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pasaniuc</LastName>
                    <ForeName>Bogdan</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sankararaman</LastName>
                    <ForeName>Sriram</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1586-9641</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, UCLA, Los Angeles, CA, 90095, USA. sriram@cs.ucla.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA. sriram@cs.ucla.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Computational Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA. sriram@cs.ucla.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R35GM125055</GrantID>
                    <Agency>U.S. Department of Health &amp; Human Services | NIH | National Institute of General Medical Sciences (NIGMS)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>III-1705121</GrantID>
                    <Agency>NSF | Directorate for Computer &amp; Information Science &amp; Engineering | Division of Information and Intelligent Systems (Information &amp; Intelligent Systems)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32782262</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-020-17576-9</ArticleId>
            <ArticleId IdType="pii">10.1038/s41467-020-17576-9</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32782012</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2046-4053</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Systematic reviews</Title>
                <ISOAbbreviation>Syst Rev</ISOAbbreviation>
            </Journal>
            <ArticleTitle>How we teach children with asthma to use their inhaler: a scoping review protocol.</ArticleTitle>
            <Pagination>
                <MedlinePgn>178</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13643-020-01430-6</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">One reason that asthma remains poorly controlled in children is poor inhaler technique. Current guidelines recommend checking inhaler technique at each clinical visit. However, they do not specify how best to train children to mastery of correct inhaler technique. Currently, many children are simply shown how to use inhalers (brief intervention) which results in less than 50% with correct inhaler technique. The aim of this scoping review is to explore published literature on teaching methods used to train children to master correct inhaler technique.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This scoping review will follow the Arksey and O'Malley framework and the Joanna Briggs Institute guidelines. We will search (from inception onwards) MEDLINE, Embase, Scopus, Web of Science, CINAHL and the Cochrane library. We will include quantitative studies (e.g. randomised controlled trials, cohort studies and case-control studies), published from the year 1956 to present, on teaching the skill of inhaler technique to children with asthma. Two reviewers will complete all screening and data abstraction independently. Data will be extracted onto a data charting table to create a descriptive summary of the results. Data will then be synthesised with descriptive statistics and visual mapping.</AbstractText>
                <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">This scoping review will provide a broad overview of currently used educational methods to improve inhaler technique in children with asthma. The analysis will allow us to refine future research in this area by focusing on the most effective methods and optimising them.</AbstractText>
                <AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="UNASSIGNED">Open Science Framework ( osf.io/n7kcw ).</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>McCrossan</LastName>
                    <ForeName>Patrick</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5242-4866</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Paediatrics, Royal Belfast Hospital for Sick Children, Belfast, UK. mccrossp@tcd.ie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mallon</LastName>
                    <ForeName>Orla</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Queen's University Belfast School of Medicine, Dentistry and Biomedical Sciences, Belfast, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shields</LastName>
                    <ForeName>Michael D</ForeName>
                    <Initials>MD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Paediatrics, Royal Belfast Hospital for Sick Children, Belfast, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Queen's University Belfast School of Medicine, Dentistry and Biomedical Sciences, Belfast, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Donoghue</LastName>
                    <ForeName>Dara</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Paediatrics, Royal Belfast Hospital for Sick Children, Belfast, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Queen's University Belfast School of Medicine, Dentistry and Biomedical Sciences, Belfast, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Syst Rev</MedlineTA>
            <NlmUniqueID>101580575</NlmUniqueID>
            <ISSNLinking>2046-4053</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32782012</ArticleId>
            <ArticleId IdType="doi">10.1186/s13643-020-01430-6</ArticleId>
            <ArticleId IdType="pii">10.1186/s13643-020-01430-6</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32781996</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2466</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC pulmonary medicine</Title>
                <ISOAbbreviation>BMC Pulm Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Puzzling onsets of pneumonia sequentially after each session of bronchial thermoplasty: a case report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>211</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-020-01243-2</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Bronchial thermoplasty (BT) is a novel bronchoscopic intervention for severe persistent asthma. An increase in transient respiratory adverse events associated with BT were noted over the treatment periods, however, these events appear sporadic and should not always recur in a single individual and BT-related pneumonia has rarely been reported.</AbstractText>
                <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">We present a case of uncontrolled severe asthma who developed puzzling pneumonia sequentially after each session of BT procedures. After each operation of three sequential BT procedures, she developed cough and purulent expectoration when her chest radiology showed new infiltrates right in the treatment regions. After empirical use of antibacterial agents plus physiotherapy and postural sputum drainage, her symptoms vanished and chest imaging resumed normal.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The originality of our case report is related to the recurrence of pneumonia after three sequential BT procedures. To date, similar report has not been available in the literature. We hope to prompt alerts for post-BT respiratory infections, although most of them, along with other adverse events, are mild and tractable.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nong</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Jiang-Tao</ForeName>
                    <Initials>JT</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0228-572X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China. jiangtao_l@263.net.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2016-1-4061</GrantID>
                    <Agency>Capital Key Science Program for Health Development</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Pulm Med</MedlineTA>
            <NlmUniqueID>100968563</NlmUniqueID>
            <ISSNLinking>1471-2466</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Bronchoscopy</Keyword>
            <Keyword MajorTopicYN="N">Case report</Keyword>
            <Keyword MajorTopicYN="N">Pneumonia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781996</ArticleId>
            <ArticleId IdType="doi">10.1186/s12890-020-01243-2</ArticleId>
            <ArticleId IdType="pii">10.1186/s12890-020-01243-2</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32781775</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2226-4787</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmacy (Basel, Switzerland)</Title>
                <ISOAbbreviation>Pharmacy (Basel)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Learn Today-Apply Tomorrow: The SMART Pharmacist Program.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E139</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmacy8030139</ELocationID>
            <Abstract>
                <AbstractText>The SMART Pharmacist Program was initiated by the Accreditation Council for Pharmacy Education (ACPE) and Pharma Expert in 2014. It was designed to introduce a new continuing education model for pharmacists for the Turkish Pharmacists' Association, and to support development of competencies for future practice. After successful implementation in Turkey, the Program spread to 16 additional countries. To assure quality, globally adopted and validated tools and best practices were used, respecting the national context. National competency frameworks and quality indicators for pharmaceutical care delivery were developed. Pharmacists' learning portfolios were introduced and patient care modules created. Under the sub-title &quot;Learn Today-Apply Tomorrow,&quot; the changes in practice were introduced under the leadership of national host organizations. The Program showed an impact on the patient level in several countries, especially in areas of patient care in Asthma and Chronic Obstructive Pulmonary Disease (COPD), Hypertension and Dyslipidemia, Diabetes, and the patient care process in general (e.g., identifying drug-related problems, improving patient safety, collaborating with medical doctors). Changes are visible at the individual (pharmacists) and organizational levels. Barriers and facilitators to the change-management process during Program implementation are identified. In some countries, the Program is recognized as one of the most important initiatives in pharmacy education and practice, with visible support of national medicines agencies, academia, government, and WHO regional offices.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rouse</LastName>
                    <ForeName>Michael J</ForeName>
                    <Initials>MJ</Initials>
                    <Identifier Source="ORCID">0000-0003-0640-9184</Identifier>
                    <AffiliationInfo>
                        <Affiliation>International Services Program, Accreditation Council for Pharmacy Education (ACPE), Chicago, IL 60603, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meštrović</LastName>
                    <ForeName>Arijana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharma Expert Consultancy and Education, Deščevec 56, 10040 Zagreb, Croatia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Pharmacy (Basel)</MedlineTA>
            <NlmUniqueID>101678532</NlmUniqueID>
            <ISSNLinking>2226-4787</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">SMART Pharmacist</Keyword>
            <Keyword MajorTopicYN="N">competencies</Keyword>
            <Keyword MajorTopicYN="N">continuing professional development</Keyword>
            <Keyword MajorTopicYN="N">indicators of quality</Keyword>
            <Keyword MajorTopicYN="N">pharmacist portfolio</Keyword>
            <Keyword MajorTopicYN="N">pharmacy education</Keyword>
            <Keyword MajorTopicYN="N">pharmacy services</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781775</ArticleId>
            <ArticleId IdType="pii">pharmacy8030139</ArticleId>
            <ArticleId IdType="doi">10.3390/pharmacy8030139</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32781576</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">1999-4923</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmaceutics</Title>
                <ISOAbbreviation>Pharmaceutics</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapeutic Efficacy of Curcumin Enhanced by Microscale Discoidal Polymeric Particles in a Murine Asthma Model.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E739</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/pharmaceutics12080739</ELocationID>
            <Abstract>
                <AbstractText>Curcumin is considered a potential anti-asthmatic agent owing to its anti-inflammatory properties. The objective of the present study was to prepare curcumin-containing poly(lactic-<i>co</i>-glycolic acid)-based microscale discoidal polymeric particles (Cur-PLGA-DPPs) and evaluate their anti-asthmatic properties using a murine asthma model. Cur-PLGA-DPPs were prepared using a top-down fabrication method. The prepared Cur-PLGA-DPPs had a mean particle size of 2.5 ± 0.4 μm and a zeta potential value of -34.6 ± 4.8 mV. Ex vivo biodistribution results showed that the Cur-PLGA-DPPs mainly accumulated in the lungs and liver after intravenous injection. Treatment with Cur-PLGA-DPPs effectively suppressed the infiltration of inflammatory cells in bronchoalveolar lavage fluid, and reduced bronchial wall thickening and goblet-cell hyperplasia compared to those in the phosphate-buffered-saline-treated control group. No significant changes in hematology and blood biochemistry parameters were observed after treatment with Cur-PLGA-DPPs. At equal curcumin concentrations, treatment with Cur-PLGA-DPPs exhibited better therapeutic efficacy than treatment with free curcumin. Our results suggest that the microscale Cur-PLGA-DPPs can be potentially used as a lung-targeted asthma therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jun Young</ForeName>
                    <Initials>JY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Ga Eul</ForeName>
                    <Initials>GE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Sanghyo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Yonsei University, Gangwon-do, Wonju 26493, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Chaewon</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Yonsei University, Gangwon-do, Wonju 26493, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aryal</LastName>
                    <ForeName>Susmita</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Yonsei University, Gangwon-do, Wonju 26493, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Won Jun</ForeName>
                    <Initials>WJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Won Gil</ForeName>
                    <Initials>WG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy, Yonsei University Wonju College of Medicine, 20 Ilsan-ro, Wonju 26426, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Key</LastName>
                    <ForeName>Jaehong</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">0000-0002-3453-2123</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Engineering, Yonsei University, Gangwon-do, Wonju 26493, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2017R1A5A2015369</GrantID>
                    <Agency>National Research Foundation of Korea</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2018R1D1A1B07042339</GrantID>
                    <Agency>National Research Foundation of Korea</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2019K2A9A2A08000123</GrantID>
                    <Agency>National Research Foundation of Korea</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Pharmaceutics</MedlineTA>
            <NlmUniqueID>101534003</NlmUniqueID>
            <ISSNLinking>1999-4923</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">curcumin</Keyword>
            <Keyword MajorTopicYN="N">discoidal polymeric particle</Keyword>
            <Keyword MajorTopicYN="N">drug delivery system</Keyword>
            <Keyword MajorTopicYN="N">microparticle</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>13</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781576</ArticleId>
            <ArticleId IdType="pii">pharmaceutics12080739</ArticleId>
            <ArticleId IdType="doi">10.3390/pharmaceutics12080739</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781454</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0259</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Ophthalmic research</Title>
                <ISOAbbreviation>Ophthalmic Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asthma Promotes Choroidal Neovascularization via the Transforming Growth Factor beta1/Smad Signaling Pathway in a Mouse Model.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000510778</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The association between age-related macular degeneration (AMD) and asthma is controversial. Transforming growth factor beta (TGF-β), which plays a critical role in asthma, has been extensively studied with regard to its function in choroidal neovascularization (CNV). In the present study, we aimed to investigate the role of TGF-β and the possible mechanism of CNV formation complicated with asthma and to explore the effect of a TGF-β inhibitor on CNV development in asthma mouse models.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Laser-induced CNV and ovalbumin-induced asthma mouse models were divided into five groups: control group, acute asthma group, chronic asthma group, inhibitor-treated acute asthma group, and inhibitor-treated chronic asthma group. The gene expression patterns of angiogenic cytokines, vascular endothelial growth factor (VEGF) receptors and inflammasomes in the control group, acute asthma group and chronic asthma group were detected using a QuantiGene Plex 6.0 Reagent System. Fundus fluorescein angiography (FFA) and histology of CNV lesions stained with haematoxylin-eosin (HE) were performed to evaluate CNV formation. Quantitative real-time PCR and western blotting were used to assess TGF-β1, TGF-β2, and VEGF expression and Smad2/3, AKT, p38 MAPK, and ERK1/2 signal transduction and phosphorylation in retinal and choroidal tissue from each group.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In this study, we verified that laser treatment led to more CNV and vascular leakage in asthmatic mice than that in control mice. The changes were particularly notable in the chronic asthma group. The respective TGF-β1, VEGF, and phosphorylated Smad2/3 (p-Smad2/3) mRNA and protein levels in retinal and choroidal tissue were significantly upregulated in both the acute and chronic asthma groups. After injection of a TGF-β inhibitor, a distinct decline in VEGF, TGF-β1, and p-Smad2/3 protein and mRNA levels was observed, and the mean CNV area also decreased.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We provide new evidence that asthma could be a risk factor for CNV development via the TGF-β1/Smad signalling pathway. A TGF-β inhibitor can be applied as a useful, adjunctive therapeutic strategy for preventing CNV formation in asthmatic patients.</AbstractText>
                <CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Yaoyao</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bai</LastName>
                    <ForeName>Yujing</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Shanshan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Lvzhen</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiaoxin</ForeName>
                    <Initials>X</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Ophthalmic Res</MedlineTA>
            <NlmUniqueID>0267442</NlmUniqueID>
            <ISSNLinking>0030-3747</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781454</ArticleId>
            <ArticleId IdType="pii">000510778</ArticleId>
            <ArticleId IdType="doi">10.1159/000510778</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781284</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-1186</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pharmacological research</Title>
                <ISOAbbreviation>Pharmacol. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hydrogen sulfide: an endogenous regulator of the immune system.</ArticleTitle>
            <Pagination>
                <MedlinePgn>105119</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1043-6618(20)31427-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.phrs.2020.105119</ELocationID>
            <Abstract>
                <AbstractText>Hydrogen sulfide (H<sub>2</sub>S) is now recognized as an endogenous signaling gasotransmitter in mammals. It is produced by mammalian cells and tissues by various enzymes - predominantly cystathionine β-synthase (CBS), cystathionine γ-lyase (CSE) and 3-mercaptopyruvate sulfurtransferase (3-MST) - but part of the H<sub>2</sub>S is produced by the intestinal microbiota (colonic H<sub>2</sub>S-producing bacteria). Here we summarize the available information on the production and functional role of H<sub>2</sub>S in the various cell types typically associated with innate immunity (neutrophils, macrophages, dendritic cells, natural killer cells, mast cells, basophils, eosinophils) and adaptive immunity (T and B lymphocytes) under normal conditions and as it relates to the development of various inflammatory and immune diseases. Special attention is paid to the physiological and the pathophysiological aspects of the oral cavity and the colon, where the immune cells and the parenchymal cells are exposed to a special &quot;H<sub>2</sub>S environment&quot; due to bacterial H<sub>2</sub>S production. H<sub>2</sub>S has many cellular and molecular targets. Immune cells are &quot;surrounded&quot; by a &quot;cloud&quot; of H<sub>2</sub>S, as a result of endogenous H<sub>2</sub>S production and exogenous production from the surrounding parenchymal cells, which, in turn, importantly regulates their viability and function. Downregulation of endogenous H<sub>2</sub>S producing enzymes in various diseases, or genetic defects in H<sub>2</sub>S biosynthetic enzyme systems either lead to the development of spontaneous autoimmune disease or accelerate the onset and worsen the severity of various immune-mediated diseases (e.g. autoimmune rheumatoid arthritis or asthma). Low, regulated amounts of H<sub>2</sub>S, when therapeutically delivered by small molecule donors, improve the function of various immune cells, and protect them against dysfunction induced by various noxious stimuli (e.g. reactive oxygen species or oxidized LDL). These effects of H<sub>2</sub>S contribute to the maintenance of immune functions, can stimulate antimicrobial defenses and can exert anti-inflammatory therapeutic effects in various diseases.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dilek</LastName>
                    <ForeName>Nahzli</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chair of Pharmacology, Section of Medicine, University of Fribourg, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Papapetropoulos</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Pharmacology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toliver-Kinsky</LastName>
                    <ForeName>Tracy</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szabo</LastName>
                    <ForeName>Csaba</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chair of Pharmacology, Section of Medicine, University of Fribourg, Switzerland; Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA. Electronic address: csaba.szabo@unifr.ch.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Pharmacol Res</MedlineTA>
            <NlmUniqueID>8907422</NlmUniqueID>
            <ISSNLinking>1043-6618</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cytokines</Keyword>
            <Keyword MajorTopicYN="N">gasotransmitter</Keyword>
            <Keyword MajorTopicYN="N">immunity</Keyword>
            <Keyword MajorTopicYN="N">inflammation</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest None of the authors have any conflicting interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781284</ArticleId>
            <ArticleId IdType="pii">S1043-6618(20)31427-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.phrs.2020.105119</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781242</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>CHRONIC ADULT FOOD PROTEIN-INDUCED ENTEROCOLITIS SYNDROME (FPIES).</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30561-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.009</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gonzalez-Delgado</LastName>
                    <ForeName>Purificación</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Section, Alicante University Hospital, Alicante, Spain; UMH-ISABIAL, licante University Hospital, Alicante, Spain. Electronic address: purifica60@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ruano-Zaragoza</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Section, Alicante University Hospital, Alicante, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Casbas</LastName>
                    <ForeName>Ana Gutierrez</ForeName>
                    <Initials>AG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurology Section, Alicante University Hospital, Alicante, Spain; UMH-ISABIAL, licante University Hospital, Alicante, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonzalez</LastName>
                    <ForeName>Fatima López</ForeName>
                    <Initials>FL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neurology Section, Alicante University Hospital, Alicante, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sanchez</LastName>
                    <ForeName>Javier Fernandez</ForeName>
                    <Initials>JF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Section, Alicante University Hospital, Alicante, Spain; UMH-ISABIAL, licante University Hospital, Alicante, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FPIES</Keyword>
            <Keyword MajorTopicYN="N">adult FPIES</Keyword>
            <Keyword MajorTopicYN="N">chronic FPIES</Keyword>
            <Keyword MajorTopicYN="N">food protein-induced enterocolitis</Keyword>
            <Keyword MajorTopicYN="N">vitamin B12 deficiency</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781242</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30561-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.009</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781241</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Merging Electronic Medical Records on Penicillin Allergy Relabeling.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30567-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.011</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Norris</LastName>
                    <ForeName>Matthew R</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Overlook Medical Center, Summit, New Jersey. Electronic address: Matthew.Norris@Atlantichealth.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bielory</LastName>
                    <ForeName>Leonard</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hackensack Meridian School of Medicine at Seton Hall University, Nutley, New Jersey; Rutgers University Center for Environmental Prediction, New Brunswick, New Jersey; Thomas Jefferson University Sidney Kimmel School of Medicine, Philadelphia, Pennsylvania.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergy delabeling</Keyword>
            <Keyword MajorTopicYN="N">Allergy relabeling</Keyword>
            <Keyword MajorTopicYN="N">Electronic medical record</Keyword>
            <Keyword MajorTopicYN="N">Penicillin</Keyword>
            <Keyword MajorTopicYN="N">Penicillin allergy testing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781241</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30567-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.011</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781240</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Group 2 innate lymphoid cells in nasal polyposis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30557-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.001</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by a chronic type 2 inflammatory response in the paranasal sinuses. Group 2 innate lymphoid cells (ILC2) are potent innate immune cells that contribute to type 2 inflammation by producing cytokines such as IL-4, IL-5 and IL-13. There is increasing evidence suggesting that ILC2 play an important role in CRSwNP pathogenesis.</AbstractText>
                <AbstractText Label="DATA SOURCES" NlmCategory="METHODS">We reviewed published literature obtained through PubMed inquiries.</AbstractText>
                <AbstractText Label="STUDY SELECTIONS" NlmCategory="METHODS">Studies relevant to the presence, function, and activation of ILC2 in CRSwNP were included.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Nasal polyps (NP) are one of the first tissues in which human ILC2 were discovered and many groups have since reported these cells are significantly elevated in NP. ILC2 in NP are also highly activated and produce type 2 cytokines in vivo . Mediators known to activate ILC2 including RANK-L, TSLP, various lipid mediators (including prostaglandin D 2 and cysteinyl leukotrienes), IL-4, and IL-13 have also been shown to be elevated in NP compared to healthy sinonasal tissue. Other well- known ILC2 activators, IL-25 and IL-33 are sometimes elevated in NP in some countries. Furthermore, activation of ILC2 via four distinct transcriptional pathways (NF-kB, NFAT, STAT5 and STAT6) is needed for the most robust generation of type 2 cytokines.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ILC2-mediated type 2 inflammation plays a crucial role in the pathogenesis of CRSwNP. Targeting upstream mediators responsible for activating ILC2 as well as downstream products these cells release may play an important role in modifying the inflammatory response and improving clinical outcomes in CRSwNP.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Stevens</LastName>
                    <ForeName>Whitney W</ForeName>
                    <Initials>WW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kato</LastName>
                    <ForeName>Atsushi</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address: a-kato@northwestern.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IL-13</Keyword>
            <Keyword MajorTopicYN="N">IL-5</Keyword>
            <Keyword MajorTopicYN="N">ILC2</Keyword>
            <Keyword MajorTopicYN="N">nasal polyps</Keyword>
            <Keyword MajorTopicYN="N">type 2 inflammation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781240</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30557-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781063</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0631</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Life sciences</Title>
                <ISOAbbreviation>Life Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diosgenin, a steroidal saponin, and its analogues: Effective therapies against different chronic diseases.</ArticleTitle>
            <Pagination>
                <MedlinePgn>118182</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0024-3205(20)30934-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2020.118182</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Chronic diseases are a major cause of mortality worldwide and despite the recent development in treatment modalities, synthetic drugs have continued to show toxic side effects and development of chemoresistance, thereby limiting their application. The use of phytochemicals has gained attention as they show minimal side effects. Diosgenin is one such phytochemical which has gained importance for its efficacy against the life-threatening diseases such as cardiovascular diseases, cancer, nervous system disorders, asthma, arthritis, diabetes and many more.</AbstractText>
                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the literature available on the potential of diosgenin and its analogues in modulating different molecular targets leading to the prevention and treatment of chronic diseases.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">A detailed literature search has been carried out on PubMed for gathering information related to the sources, biosynthesis, physicochemical properties, biological activities, pharmacokinetics, bioavailability and toxicity of diosgenin and its analogues.</AbstractText>
                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">The literature search resulted in many in vitro, in vivo and clinical trials that reported the efficacy of diosgenin and its analogues in modulating important molecular targets and signaling pathways such as PI3K/AKT/mTOR, JAK/STAT, NF-κB, MAPK, etc., which play a crucial role in the development of most of the diseases. Reports have also revealed the safety of the compound and the adaptation of nanotechnological approaches for enhancing its bioavailability and pharmacokinetic properties.</AbstractText>
                <AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Thus, the review summarises the efficacy of diosgenin and its analogues for developing as a potent drug against several chronic diseases.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Parama</LastName>
                    <ForeName>Dey</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boruah</LastName>
                    <ForeName>Monikongkona</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell and Molecular Biology Lab, Department of Zoology, Cotton University, Guwahati, Assam 781001, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumari</LastName>
                    <ForeName>Yachna</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rana</LastName>
                    <ForeName>Varsha</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Banik</LastName>
                    <ForeName>Kishore</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harsha</LastName>
                    <ForeName>Choudhary</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thakur</LastName>
                    <ForeName>Krishan Kumar</ForeName>
                    <Initials>KK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dutta</LastName>
                    <ForeName>Uma</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell and Molecular Biology Lab, Department of Zoology, Cotton University, Guwahati, Assam 781001, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arya</LastName>
                    <ForeName>Aditya</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Therapeutics, School of Medicine, Faculty of Health and Medical Sciences, Taylor's University, Subang Jaya, Malaysia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mao</LastName>
                    <ForeName>Xinliang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, 12 Jichang Road, Baiyun District, Guangzhou 510405, China; Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, 199 Ren'ai Road, Suzhou, Jiangsu 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahn</LastName>
                    <ForeName>Kwang Seok</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Science in Korean Medicine, College of Korean Medicine, Kyung Hee University, 24 Kyungheedae-ro, Dongdaemun-gu, Seoul 02447, Republic of Korea. Electronic address: ksahn@khu.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kunnumakkara</LastName>
                    <ForeName>Ajaikumar B</ForeName>
                    <Initials>AB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Laboratory and DBT-AIST International Center for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India. Electronic address: kunnumakkara@iitg.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Life Sci</MedlineTA>
            <NlmUniqueID>0375521</NlmUniqueID>
            <ISSNLinking>0024-3205</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Analogues</Keyword>
            <Keyword MajorTopicYN="N">Bioavailability</Keyword>
            <Keyword MajorTopicYN="N">Cancer</Keyword>
            <Keyword MajorTopicYN="N">Chronic diseases</Keyword>
            <Keyword MajorTopicYN="N">Dioscin</Keyword>
            <Keyword MajorTopicYN="N">Diosgenin</Keyword>
            <Keyword MajorTopicYN="N">Molecular targets</Keyword>
            <Keyword MajorTopicYN="N">Pharmacokinetics</Keyword>
            <Keyword MajorTopicYN="N">Toxicology</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of competing interest The authors express no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781063</ArticleId>
            <ArticleId IdType="pii">S0024-3205(20)30934-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2020.118182</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781049</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Role of Immunotherapy and Biologic Treatments in Occupational Allergic Disease.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30800-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.07.042</ELocationID>
            <Abstract>
                <AbstractText>Occupational exposures are estimated to account for 15-25% of all adult asthma in the general population. In some cases, workplace allergen exposures can be reduced but not entirely eliminated. Given the potentially significant impact of job change, some workers may choose to continue working in a job where there is an ongoing occupational allergen exposure. In these cases, a combined approach including personal safety measures, pharmacotherapy, and allergen immunotherapy (AIT) may result in the best clinical outcomes. This review presents existing evidence for the use of immunotherapy and biologic treatments in occupational allergic disease for a variety of occupational allergens, including wheat flour, mammalian proteins, natural rubber latex, and hymenoptera venom. There is increasing but modest evidence on beneficial short-term and long-term effects of AIT and safety in worker populations. Available data suggest that AIT can reduce skin and respiratory symptoms and therefore allow workers to continue their current occupation.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Associates of Utah, Murray, UT. Electronic address: andrew.smithmd@utahallergies.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sastre</LastName>
                    <ForeName>Joaquín</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Allergy, Fundación Jiménez Díaz, Madrid, Department of Medicine, Universidad Autónoma de Madrid, Madrid. CIBERES, Instituto de Salud Carlos III, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">occupational asthma</Keyword>
            <Keyword MajorTopicYN="N">occupational rhinitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781049</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30800-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.07.042</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32781035</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1678-4782</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Jornal de pediatria</Title>
                <ISOAbbreviation>J Pediatr (Rio J)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IL-4-C-590T locus polymorphism and susceptibility to asthma in children: a meta-analysis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0021-7557(20)30195-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jped.2020.05.005</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The study aimed to evaluate the link between the IL-4-C590T polymorphism and asthma susceptibility in children by meta-analysis.</AbstractText>
                <AbstractText Label="SOURCES" NlmCategory="METHODS">The study collected all the case-control studies found in PubMed, Embase, CNKI, Wanfang, VIP, and other databases until September 2019. Stata v. 15.0 was used to conduct meta-analysis, calculate the combined OR and its 95% CI, and then conduct subgroup analysis.</AbstractText>
                <AbstractText Label="SUMMARY OF THE FINDINGS" NlmCategory="RESULTS">Seven studies were included in the study, containing 860 cases and 810 controls. Relative to the C allele, the T allele at the IL-4-C590T locus was associated with susceptibility to asthma in children (OR = 1.45, 95% CI: 1.05-2.01). The results of ethnicity subgroup analysis showed that there was statistical significance, with OR = 1.61 (95% CI: 1.01-2.57) in the Asian population. In the dominant and recessive genetic models, the overall test and the Asian population subgroup analysis were statistically significant. In the homozygous model, there was statistical significance, but no statistical significance in heterozygous model.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The IL-4-C590T polymorphism was associated with asthma susceptibility, and T allele and TT genotype may increase the risk of asthma susceptibility in children, especially in the Asian population.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Editora Ltda.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jin</LastName>
                    <ForeName>Xiaosheng</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tongde Hospital of Zhejiang Province, Department of Respiration, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Jisheng</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tongde Hospital of Zhejiang Province, Department of Respiration, Hangzhou, China. Electronic address: zhengjisheng1234@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Brazil</Country>
            <MedlineTA>J Pediatr (Rio J)</MedlineTA>
            <NlmUniqueID>2985188R</NlmUniqueID>
            <ISSNLinking>0021-7557</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">IL-4</Keyword>
            <Keyword MajorTopicYN="N">Meta-analysis</Keyword>
            <Keyword MajorTopicYN="N">Polymorphism</Keyword>
            <Keyword MajorTopicYN="N">rs2243250</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32781035</ArticleId>
            <ArticleId IdType="pii">S0021-7557(20)30195-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jped.2020.05.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32780952</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1565-4753</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>17</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric endocrinology reviews : PER</Title>
                <ISOAbbreviation>Pediatr Endocrinol Rev</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Many Facets of Vitamin D in the Pediatric Population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>293-301</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.17458/per.vol17.2020.srb.vitamindpediatricpopulation</ELocationID>
            <Abstract>
                <AbstractText>Vitamin D is important for skeletal growth, bone mineralization and dental health. Vitamin D deficiency is reported in many countries, may have several causes and can cause rickets in children. A guideline with recommendations of vitamin D supplementation to prevent nutritional rickets was published recently. The vitamin D receptor is present in many cells of the body including cells of the immune system. Many studies have been published on associations between vitamin D deficiency and extra skeletal effects, mainly without proof of causality in intervention studies. This review aims to summarize available evidence of the skeletal and extra-skeletal effects of vitamin D. For the extra-skeletal effects there is proof that vitamin D supplementation can prevent acute respiratory infections in children with vitamin D deficiency and can reduce the rate of asthma exacerbations requiring corticosteroids in children with vitamin D deficiency. The evidence of benefit of vitamin D supplementation is too limited for pediatric patients with other infectious, inflammatory, and autoimmune diseases.</AbstractText>
                <CopyrightInformation>Copyright© of YS Medical Media ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Scheffer-Rath</LastName>
                    <ForeName>Mirjam Ea</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>fellow pediatric endocrinology, Department of Pediatric Endocrinology, University Medical Center Groningen - Beatrix Children's Hospital, University of Groningen, PO Box 30001, 9700 RB Groningen, The Netherlands, E-mail: m.e.a.schefferrath@umcg.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boot</LastName>
                    <ForeName>Annemieke M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatric Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Israel</Country>
            <MedlineTA>Pediatr Endocrinol Rev</MedlineTA>
            <NlmUniqueID>101202124</NlmUniqueID>
            <ISSNLinking>1565-4753</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Autoimmune diseases</Keyword>
            <Keyword MajorTopicYN="N">Bone health</Keyword>
            <Keyword MajorTopicYN="N">Children</Keyword>
            <Keyword MajorTopicYN="N">Dental health</Keyword>
            <Keyword MajorTopicYN="N">Inflammatory diseases</Keyword>
            <Keyword MajorTopicYN="N">Vitamin D</Keyword>
            <Keyword MajorTopicYN="N">Vitamin D deficiency</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780952</ArticleId>
            <ArticleId IdType="pii">IdType=&quot;doi&quot;&gt;10.17458/per.vol17.2020.srb.vitamindpediatricpopulation</ArticleId>
            <ArticleId IdType="doi">10.17458/per.vol17.2020.srb.vitamindpediatricpopulation</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780932</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1752-699X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The clinical respiratory journal</Title>
                <ISOAbbreviation>Clin Respir J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluating non adherence to preventer inhaler therapy in severe asthmatic patients receiving omalizumab.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/crj.13252</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma is one of the most common chronic diseases worldwide and can often be controlled by existing treatments, but in the 5-10% of patients with severe asthma, control is frequently more challenging. The aim of this paper is to evaluate the adherence to preventer inhaler therapy in severe asthmatic patients receiving omalizumab, a recombinant humanized monoclonal anti-IgE antibody indicated for moderate-to-severe asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This study included 29 patients who were receiving omalizumab treatment as maintenance therapy. All patients completed the six questionTurkish Modified Morisky Scale. In addition, patients were classifiedby adherence to their prescribed preventer therapy, based on pharmaceutical and medical device institution records from the preceding one year.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 29 enrolled patients, 24.1% had NSAID-exacerbated respiratory disease; 75.9% were female, and median age was 47.2±12.99 years.Severe asthma patients demonstrated high levels of motivation (98.8%,n=28) and knowledge (86.2%, n=22) about asthma treatment. Nevertheless, the rate of non-adherence to preventer inhaler therapy was only 34.5% (n=10). There were no significant differences amongst the characteristics of the patients that might affect the adherence to inhaler therapy.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In patients with severe asthma, suboptimal adherence to preventer inhaler therapy is common before and after omalizumab treatment. Although patients have high levels of motivation and knowledge about asthma treatment, adherence to inhaler preventer therapy declined after omalizumab therapy. Given these findings, it is important to decide whether preventer inhaler therapy should be continued as monotherapy or be discontinued inpatients exhibiting impaired adherence to biological agents, such as omalizumab.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Erdoğan</LastName>
                    <ForeName>Tuba</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3143-2442</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Osmangazi University, Faculty of Medicine, Department of Chest Disease, Division of Immunology and Allergy, Eskişehir, Turkey, 26600.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Clin Respir J</MedlineTA>
            <NlmUniqueID>101315570</NlmUniqueID>
            <ISSNLinking>1752-6981</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Omalizumab</Keyword>
            <Keyword MajorTopicYN="N">asthma phenotypes</Keyword>
            <Keyword MajorTopicYN="N">inhaler treatment</Keyword>
            <Keyword MajorTopicYN="N">omalizumab</Keyword>
            <Keyword MajorTopicYN="N">severe asthma</Keyword>
            <Keyword MajorTopicYN="N">treatment adherence</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780932</ArticleId>
            <ArticleId IdType="doi">10.1111/crj.13252</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780875</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1468-3083</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
                <ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evidence for different immune signatures and sensitization patterns in sub-Saharan versus central European Atopic Dermatitis patients.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/jdv.16871</ELocationID>
            <Abstract>
                <AbstractText>Atopic dermatitis (AD) has only recently been recognized as a major public health issue in sub-Saharan Africa (sSA) (1, 2). In contrast to Afro-American or South African AD patients, data on clinical and immune-related features on sSA AD patients are scarce (1-3). In this study, we wanted to explore immune phenotypes of SsA vs. central European (CE) AD patients and put them into context to environmental influences by assessing sensitization patterns.The study was approved by the local Ethics Committees (EK 2016-00301).</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lang</LastName>
                    <ForeName>Ccvcv</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0469-7661</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Dermatology, University Hospital Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masenga</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Regional Dermatology Training Center (RDTC) at KCMUC, Moshi, Tanzania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Semango</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Regional Dermatology Training Center (RDTC) at KCMUC, Moshi, Tanzania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaderbhai</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Regional Dermatology Training Center (RDTC) at KCMUC, Moshi, Tanzania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0026-8739</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Dermatology, University Hospital Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Functional Genomics Center Zurich, ETH Zurich/University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heider</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guttmann-Yasski</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Dermatology, Mount Sinai Hospital New York, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grimm</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Parasitology, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmid-Grendelmeier</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Dermatology, University Hospital Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brüggen</LastName>
                    <ForeName>M C</ForeName>
                    <Initials>MC</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8607-6254</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dpt of Dermatology, University Hospital Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Hochgebirgsklinik Davos, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
            <NlmUniqueID>9216037</NlmUniqueID>
            <ISSNLinking>0926-9959</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">immune phenotypes</Keyword>
            <Keyword MajorTopicYN="N">sensitization patterns</Keyword>
            <Keyword MajorTopicYN="N">sub-Saharan Africa</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780875</ArticleId>
            <ArticleId IdType="doi">10.1111/jdv.16871</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780793</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2168-6114</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA internal medicine</Title>
                <ISOAbbreviation>JAMA Intern Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.3862</ELocationID>
            <Abstract>
                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">There is limited information about the clinical course and viral load in asymptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To quantitatively describe SARS-CoV-2 molecular viral shedding in asymptomatic and symptomatic patients.</AbstractText>
                <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">A retrospective evaluation was conducted for a cohort of 303 symptomatic and asymptomatic patients with SARS-CoV-2 infection between March 6 and March 26, 2020. Participants were isolated in a community treatment center in Cheonan, Republic of Korea.</AbstractText>
                <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">Epidemiologic, demographic, and laboratory data were collected and analyzed. Attending health care personnel carefully identified patients' symptoms during isolation. The decision to release an individual from isolation was based on the results of reverse transcription-polymerase chain reaction (RT-PCR) assay from upper respiratory tract specimens (nasopharynx and oropharynx swab) and lower respiratory tract specimens (sputum) for SARS-CoV-2. This testing was performed on days 8, 9, 15, and 16 of isolation. On days 10, 17, 18, and 19, RT-PCR assays from the upper or lower respiratory tract were performed at physician discretion. Cycle threshold (Ct) values in RT-PCR for SARS-CoV-2 detection were determined in both asymptomatic and symptomatic patients.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Of the 303 patients with SARS-CoV-2 infection, the median (interquartile range) age was 25 (22-36) years, and 201 (66.3%) were women. Only 12 (3.9%) patients had comorbidities (10 had hypertension, 1 had cancer, and 1 had asthma). Among the 303 patients with SARS-CoV-2 infection, 193 (63.7%) were symptomatic at the time of isolation. Of the 110 (36.3%) asymptomatic patients, 21 (19.1%) developed symptoms during isolation. The median (interquartile range) interval of time from detection of SARS-CoV-2 to symptom onset in presymptomatic patients was 15 (13-20) days. The proportions of participants with a negative conversion at day 14 and day 21 from diagnosis were 33.7% and 75.2%, respectively, in asymptomatic patients and 29.6% and 69.9%, respectively, in symptomatic patients (including presymptomatic patients). The median (SE) time from diagnosis to the first negative conversion was 17 (1.07) days for asymptomatic patients and 19.5 (0.63) days for symptomatic (including presymptomatic) patients (P = .07). The Ct values for the envelope (env) gene from lower respiratory tract specimens showed that viral loads in asymptomatic patients from diagnosis to discharge tended to decrease more slowly in the time interaction trend than those in symptomatic (including presymptomatic) patients (β = -0.065 [SE, 0.023]; P = .005).</AbstractText>
                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">In this cohort study of symptomatic and asymptomatic patients with SARS-CoV-2 infection who were isolated in a community treatment center in Cheonan, Republic of Korea, the Ct values in asymptomatic patients were similar to those in symptomatic patients. Isolation of asymptomatic patients may be necessary to control the spread of SARS-CoV-2.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Seungjae</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Tark</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Eunjung</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Cheolgu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hojung</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Emergency Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rhee</LastName>
                    <ForeName>Heejeong</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Family Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Se Yoon</ForeName>
                    <Initials>SY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Son</LastName>
                    <ForeName>Hyo-Ju</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Shinae</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jung Wan</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choo</LastName>
                    <ForeName>Eun Ju</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Suyeon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loeb</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Tae Hyong</ForeName>
                    <Initials>TH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Intern Med</MedlineTA>
            <NlmUniqueID>101589534</NlmUniqueID>
            <ISSNLinking>2168-6106</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780793</ArticleId>
            <ArticleId IdType="pii">2769235</ArticleId>
            <ArticleId IdType="doi">10.1001/jamainternmed.2020.3862</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780605</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1941-2703</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of aerosol medicine and pulmonary drug delivery</Title>
                <ISOAbbreviation>J Aerosol Med Pulm Drug Deliv</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Does Bilevel Noninvasive Ventilation Have a Bronchodilating Effect and Alter Respiratory Mechanics in Asthmatic Individuals After Bronchoprovocation? Randomized, Crossover Study.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1089/jamp.2020.1608</ELocationID>
            <Abstract>
                <AbstractText><b>
                        <i>Background:</i>
                    </b> Noninvasive ventilation (NIV) has an additional important effect that does not occur with medicinal therapy: a reduction in the work of breathing. Understanding the mechanical effects of these therapies is of considerable importance and can affect clinical decision making. <b>
                        <i>Objective:</i>
                    </b> Evaluate the effects of NIV compared to albuterol on lung function and respiratory mechanics in asthmatic adolescents and young adults after bronchoprovocation and determine the effects of a hypertonic saline solution on lung function respiratory mechanics. <b>
                        <i>Methods:</i>
                    </b> A randomized crossover study was conducted involving individuals with a diagnosis of asthma. Evaluations were performed with optoelectronic plethysmography (OEP) and spirometry at baseline, after the bronchial provocation test with 4.5% saline solution and after the intervention. The order of the procedures (bilevel NIV and albuterol) was randomized, with the participants crossing over to the other treatment after a 1-week washout period. Inspiratory positive airway pressure (IPAP) 12 and expiratory positive airway pressure (EPAP) 8 cmH<sub>2</sub>O were set for 10 minutes and the dose of albuterol was 400 μg. <b>
                        <i>Results:</i>
                    </b> Forty individuals were included in the study (mean age: 21.6 ± 4 years; 24 females). The recovery of FEV<sub>1</sub>% was 87.9% (80.8 ± 35 to 101.1 ± 46.1, <i>p</i> &lt; 0.05) after NIV and 95.9% (84.4 ± 42.4 to 110.3 ± 44.3, <i>p</i> &lt; 0.05) after albuterol. Inspiratory capacity (IC; L) reduced 12% to 15% after bronchoprovocation, with 100% recovery using NIV (2.1 ± 0.7 to 2.42.4 ± 0.6, <i>p</i> &lt; 0.05) and 107.6% using albuterol (2.2 ± 0.8 to 2.8 ± 1.1, <i>p</i> &lt; 0.05). Regarding OEP variables, tidal volume had greater participation in the thoracic compartment. NIV led to an increase in minute volume and a return to the baseline value, which did not occur with albuterol. <b>
                        <i>Conclusion:</i>
                    </b> NIV recovered FEV<sub>1</sub> and improves signs of hyperinflation by improving IC. Bronchoprovocation with a hypertonic solution reduced FEV<sub>1</sub> by 20% and reduced IC. NIV led to a faster recovery of minute volume and reduced the contraction velocity of the muscles of the rib cage compared to albuterol, although the effects on lung function were less intense.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gomes</LastName>
                    <ForeName>Evelim Leal de Freitas Dantas</ForeName>
                    <Initials>ELFD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cavassini</LastName>
                    <ForeName>Carla Lima Feitosa</ForeName>
                    <Initials>CLF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>David</LastName>
                    <ForeName>Maisi Cabral Muniz</ForeName>
                    <Initials>MCM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luiz</LastName>
                    <ForeName>Josiane Germano</ForeName>
                    <Initials>JG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santos</LastName>
                    <ForeName>Adriana do Carmo</ForeName>
                    <Initials>ADC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Capeletti</LastName>
                    <ForeName>Aldenice Magalhães</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Costa</LastName>
                    <ForeName>Dirceu</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rehabilitation Sciences Program, Universidade Nove de Julho (UNINOVE), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Aerosol Med Pulm Drug Deliv</MedlineTA>
            <NlmUniqueID>101475057</NlmUniqueID>
            <ISSNLinking>1941-2711</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>T</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">bronchoconstriction</Keyword>
            <Keyword MajorTopicYN="N">bronchodilators agents</Keyword>
            <Keyword MajorTopicYN="N">noninvasive ventilation</Keyword>
            <Keyword MajorTopicYN="N">respiratory mechanics</Keyword>
            <Keyword MajorTopicYN="N">saline hypertonic solution</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780605</ArticleId>
            <ArticleId IdType="doi">10.1089/jamp.2020.1608</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780581</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-4970</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of respiratory and critical care medicine</Title>
                <ISOAbbreviation>Am. J. Respir. Crit. Care Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Birth Cohort Studies - Their Next Coming of Age.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.202007-2808ED</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Turner</LastName>
                    <ForeName>Steve</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8393-5060</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University of Aberdeen, Department of Child Health, Aberdeen, United Kingdom of Great Britain and Northern Ireland; s.w.turner@abdn.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Respir Crit Care Med</MedlineTA>
            <NlmUniqueID>9421642</NlmUniqueID>
            <ISSNLinking>1073-449X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adult</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Infant</Keyword>
            <Keyword MajorTopicYN="N">Longitudinal Studies</Keyword>
            <Keyword MajorTopicYN="N">Respiratory Function Testing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780581</ArticleId>
            <ArticleId IdType="doi">10.1164/rccm.202007-2808ED</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780483</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Component-resolved microarray analysis of IgE sensitization profiles to Culicoides recombinant allergens in horses with insect bite hypersensitivity.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14556</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Allergy to bites of blood sucking insects, including biting midges can affect both human and veterinary patients. Horses are often suffering from an IgE-mediated allergic dermatitis caused by bites of midges (Culicoides spp). With the aim to improve allergen immunotherapy (AIT) numerous Culicoides allergens have been produced as recombinant (r-) proteins. This study aims to test a comprehensive panel of differently expressed Culicoides r-allergens on a cohort of IBH-affected and control horses using an allergen microarray.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">IgE levels to 27 Culicoides r-allergens, including 8 previously unpublished allergens, of which 11 were expressed in more than one expression system, were determined in sera from 347 horses. ROC analyses were carried out, cut-offs selected using a specificity of 95% and sero-positivity rates compared between horses affected with insect bite hypersensitivity (IBH) and control horses. The combination of r-allergens giving the best performing test was determined using logistic regression analysis.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sero-positivity was significantly higher in IBH horses compared to controls for 25 r-allergens. Nine Culicoides r-allergens were major allergens for IBH with seven of them binding IgE in sera from &gt;70% of the IBH-affected horses. Combination of these top seven r-allergens could diagnose &gt;90% of IBH-affected horses with a specificity of &gt;95%. Correlation between differently expressed r-allergens was usually high (mean = 0.69, range 0.28-0.91).</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This microarray will be a powerful tool for development of component-resolved, patient-tailored AIT for IBH and could be useful for the study of allergy to biting midges in humans and other species.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Novotny</LastName>
                    <ForeName>Ella N</ForeName>
                    <Initials>EN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>White</LastName>
                    <ForeName>Samuel</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3675-7545</Identifier>
                    <AffiliationInfo>
                        <Affiliation>School of Biosciences, University of Nottingham, Loughborough, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>A D</ForeName>
                    <Initials>AD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Veterinary Pathology, Infection and Immunity, University of Bristol, Langford, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stefánsdóttir</LastName>
                    <ForeName>Sara B</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Pathology, Biomedical Center, University of Iceland, Reykjavik, Iceland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tijhaar</LastName>
                    <ForeName>Edwin</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell Biology and Immunology Group, Wageningen University, De Elst 1, 6708 WD, Wageningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jonsdottir</LastName>
                    <ForeName>Sigridur</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frey</LastName>
                    <ForeName>Rebekka</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>AniCura Norsholms Djursjukhus, Norsholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reiche</LastName>
                    <ForeName>Dania</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Boehringer Ingelheim Vetmedica GmbH, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rose</LastName>
                    <ForeName>Horst</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Boehringer Ingelheim Vetmedica GmbH, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rhyner</LastName>
                    <ForeName>Claudio</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schüpbach-Regula</LastName>
                    <ForeName>Gertraud</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torsteinsdottir</LastName>
                    <ForeName>Sigurbjörg</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute for Experimental Pathology, Biomedical Center, University of Iceland, Reykjavik, Iceland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alcocer</LastName>
                    <ForeName>Marcos</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Biosciences, University of Nottingham, Loughborough, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marti</LastName>
                    <ForeName>Eliane</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1284-4350</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research and VPH, Vetsuisse Faculty, University of Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Culicoides allergens</Keyword>
            <Keyword MajorTopicYN="N">IgE</Keyword>
            <Keyword MajorTopicYN="N">equine insect bite hypersensitivity</Keyword>
            <Keyword MajorTopicYN="N">microarray</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780483</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14556</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780113</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2168-6114</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA internal medicine</Title>
                <ISOAbbreviation>JAMA Intern Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Filtration Efficiency of Hospital Face Mask Alternatives Available for Use During the COVID-19 Pandemic.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1001/jamainternmed.2020.4221</ELocationID>
            <Abstract>
                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Procuring respiratory protection for clinicians and other health care workers has become a major challenge of the coronavirus disease 2019 (COVID-19) pandemic and has resulted in nonstandard practices such as the use of expired respirators and various decontamination processes to prolong the useful life of respirators in health care settings. In addition, imported, non-National Institute for Occupational Safety and Health (NIOSH)-approved respirators have been donated or acquired by hospitals as a potential replacement for limited NIOSH-approved N95 respirators.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To assess fitted filtration efficiencies (FFEs) for face mask alternatives used during the COVID-19 pandemic.</AbstractText>
                <AbstractText Label="Design, Setting, and Participants" NlmCategory="UNASSIGNED">For this quality-improvement study conducted between April and June 2020, we used the Occupational Safety and Health Administration's Quantitative Fit Testing Protocol for Filtering Facepiece Respirators in a laboratory atmosphere supplemented with sodium chloride particles to assess the FFEs of a variety of respirators worn by a male volunteer and female volunteer.</AbstractText>
                <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">The FFEs of respirators commonly worn by clinicians and other health care workers and available respirator alternatives during the COVID-19 pandemic.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Of the 29 different fitted face mask alternatives tested on 1 man and 1 woman, expired N95 respirators with intact elastic straps and respirators subjected to ethylene oxide and hydrogen peroxide sterilization had unchanged FFE (&gt;95%). The performance of N95 respirators in the wrong size had slightly decreased performance (90%-95% FFE). All of the respirators not listed as approved in this evaluation (n = 6) failed to achieve 95% FFE. Neither of the 2 imported respirators authorized for use by the Centers for Disease Control and Prevention that were not NIOSH-approved tested in this study achieved 95% FFE, and the more effective of the 2 functioned at approximately 80% FFE. Surgical and procedural face masks had filtering performance that was lower relative to that of N95 respirators (98.5% overall FFE), with procedural face masks secured with elastic ear loops showing the lowest efficiency (38.1% overall FFE).</AbstractText>
                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">This quality-improvement study evaluating 29 face mask alternatives for use by clinicians interacting with patients during the COVID-19 pandemic found that expired N95 respirators and sterilized, used N95 respirators can be used when new N95 respirators are not available. Other alternatives may provide less effective filtration.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sickbert-Bennett</LastName>
                    <ForeName>Emily E</ForeName>
                    <Initials>EE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Prevention Department, UNC Health Care, Chapel Hill, North Carolina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Samet</LastName>
                    <ForeName>James M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, North Carolina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clapp</LastName>
                    <ForeName>Phillip W</ForeName>
                    <Initials>PW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Environmental Medicine, Asthma and Lung Biology, School of Medicine, University of North Carolina at Chapel Hill.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Hao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oak Ridge Institute for Science Education, Oak Ridge, Tennessee.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berntsen</LastName>
                    <ForeName>Jon</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>TRC, Raleigh, North Carolina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeman</LastName>
                    <ForeName>Kirby L</ForeName>
                    <Initials>KL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Environmental Medicine, Asthma and Lung Biology, School of Medicine, University of North Carolina at Chapel Hill.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tong</LastName>
                    <ForeName>Haiyan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Public Health and Environmental Assessment, US Environmental Protection Agency, Research Triangle Park, North Carolina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weber</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infection Prevention Department, UNC Health Care, Chapel Hill, North Carolina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bennett</LastName>
                    <ForeName>William D</ForeName>
                    <Initials>WD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Environmental Medicine, Asthma and Lung Biology, School of Medicine, University of North Carolina at Chapel Hill.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JAMA Intern Med</MedlineTA>
            <NlmUniqueID>101589534</NlmUniqueID>
            <ISSNLinking>2168-6106</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780113</ArticleId>
            <ArticleId IdType="pii">2769443</ArticleId>
            <ArticleId IdType="doi">10.1001/jamainternmed.2020.4221</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780014</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1550-9397</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</Title>
                <ISOAbbreviation>J Clin Sleep Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Which older adults receive sleep medicine specialty care? Predictors of being seen by a board-certified sleep medicine provider.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.5664/jcsm.8722</ELocationID>
            <Abstract>
                <AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">To characterize older adult Medicare beneficiaries seen by board-certified sleep medicine providers (BCSMPs) and identify predictors of being seen by a BCSMP.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Our data source was a random 5% sample of Medicare administrative claims data (2006-2013). BCSMPs were identified using a cross-matching procedure based on national provider identifiers (NPIs) available within the Medicare database and assigned based on the first sleep disorder diagnosis received. Sleep disorders (insomnia, sleep-related breathing disorders, hypersomnias, circadian rhythm sleep-wake disorders, parasomnias, and restless legs syndrome) were operationalized as International Classification of Disease, Ninth Revision, Clinical Modification diagnostic codes. The number of sleep disorders per beneficiary was computed and compared between BCSMPs and non-specialists. Logistic regression was employed to identify medical and demographic predictors of being seen by a BCSMP.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 57,209 beneficiaries received one or more sleep disorder diagnoses during the study period. Of these, 1,279 (2.2%) were initially diagnosed by a BCSMP. Relative to individuals seen by non-specialists, beneficiaries treated by a BCSMP were more likely to have ≥2 sleep disorders (9.0% vs 24.1%, p&lt;0.001). The most common diagnosis assigned by BCSMPs was obstructive sleep apnea (OSA; 70.4% of patients seen by BCSMPs were diagnosed with OSA). The most common diagnosis assigned by non-specialists was insomnia (48.2% of patients seen by non-specialists were diagnosed with insomnia). In a fully adjusted regression model, male sex (odds ratio (OR) 1.53; 95% confidence interval (CI) 1.36, 1.72), asthma (OR 1.50; 95% CI 1.30, 1.73), and heart failure (OR 1.24; 95% CI 1.10, 1.41) were positively associated with being treated by a BCSMP. Conversely, depression (OR 0.85, 95% CI 0.73, 1.00), anxiety (OR 0.69, 95% CI 0.59, 0.82), Alzheimer's and related dementias (OR 0.80, 95% CI 0.65, 0.99), and anemia (OR 0.88, 95% CI 0.78, 0.99) were associated with reduced likelihood of being seen by a BCSMP.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Relative to older adults seen by non-specialists those seen by BCSMPs are more medically but less psychiatrically complex and diagnosed with a greater number of sleep disorders. These results suggest the possibility that medically complex patients are referred for specialty care, whereas psychiatrically complex patients might be seen at the non-specialist level. Further, these results demonstrate the value of board certification in sleep medicine in caring for complex sleep patients.</AbstractText>
                <CopyrightInformation>© 2020 American Academy of Sleep Medicine.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wickwire</LastName>
                    <ForeName>Emerson M</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jobe</LastName>
                    <ForeName>Sophia L</ForeName>
                    <Initials>SL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Parthasarathy</LastName>
                    <ForeName>Sairam</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Arizona Health Sciences, Center for Sleep and Circadian Sciences and Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Arizona, Tucson, Arizona.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Collen</LastName>
                    <ForeName>Jacob</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniformed Services University of the Health Sciences, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Capaldi</LastName>
                    <ForeName>Vincent F</ForeName>
                    <Initials>VF</Initials>
                    <Suffix>2nd</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Behavioral Biology, Walter Reed Army Institute of Research, Silver Spring, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johnson</LastName>
                    <ForeName>Abree</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmaceutical Research Computing, Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vadlamani</LastName>
                    <ForeName>Aparna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levri</LastName>
                    <ForeName>John M</ForeName>
                    <Initials>JM</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scharf</LastName>
                    <ForeName>Steven M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sleep Disorders Center, Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Albrecht</LastName>
                    <ForeName>Jennifer S</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Clin Sleep Med</MedlineTA>
            <NlmUniqueID>101231977</NlmUniqueID>
            <ISSNLinking>1550-9389</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Medicare</Keyword>
            <Keyword MajorTopicYN="N">board certification</Keyword>
            <Keyword MajorTopicYN="N">health services</Keyword>
            <Keyword MajorTopicYN="N">older adults</Keyword>
            <Keyword MajorTopicYN="N">sleep</Keyword>
            <Keyword MajorTopicYN="N">sleep medicine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780014</ArticleId>
            <ArticleId IdType="doi">10.5664/jcsm.8722</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32780011</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1550-9397</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine</Title>
                <ISOAbbreviation>J Clin Sleep Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of the novel coronavirus disease (COVID-19) on treatment adherence and sleep duration in patients with obstructive sleep apnea treated with positive airway pressure.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.5664/jcsm.8746</ELocationID>
            <Abstract>
                <AbstractText Label="STUDY OBJECTIVES" NlmCategory="OBJECTIVE">The study objective was to examine the effect of COVID-19 on treatment adherence and self-reported sleep duration among patients with Obstructive Sleep Apnea (OSA) treated with positive airway pressure (PAP) therapy.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">This was a retrospective review of medical records of patients seen in the Sleep and Circadian Clinic at Brigham Health during the immediate period of one month after the national lockdown was announced on March 15, 2020. Patients with OSA were included only if PAP adherence data was available in the 12- months prior and in the month after the lockdown. Patients with other sleep disorders and OSA patients without the adherence data were excluded.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Mean age was 63.5± 13.9 years, 55% of the participants were men, and mean BMI was 31.8 ± 7.9 kg/m². Severe OSA was noted among 59.5% compared to 29.3% moderate, and 11.2% mild OSA. Increased number of patients reported insomnia after the lockdown (41% vs 48%, p= 0.02). Gender stratification noted worsening insomnia only among women. There was no significant difference in PAP adherence as measured by the hours of use, self-reported sleep duration or in the use of sleep medications.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Post COVID-19 lockdown had a negative impact on sleep as evidenced by increased reporting of insomnia particularly among women, but no impact on PAP adherence or self-reported sleep duration.</AbstractText>
                <CopyrightInformation>© 2020 American Academy of Sleep Medicine.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Batool-Anwar</LastName>
                    <ForeName>Salma</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Sleep and Circadian Disorders, Brigham Health and Harvard Medical School, Boston, MA, Asthma and Airways Research Center, University of Arizona, Tucson, AZ.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Omobomi</LastName>
                    <ForeName>Olabimpe S</ForeName>
                    <Initials>OS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Sleep and Circadian Disorders, Brigham Health and Harvard Medical School, Boston, MA, Asthma and Airways Research Center, University of Arizona, Tucson, AZ.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quan</LastName>
                    <ForeName>Stuart F</ForeName>
                    <Initials>SF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Sleep and Circadian Disorders, Brigham Health and Harvard Medical School, Boston, MA, Asthma and Airways Research Center, University of Arizona, Tucson, AZ.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Clin Sleep Med</MedlineTA>
            <NlmUniqueID>101231977</NlmUniqueID>
            <ISSNLinking>1550-9389</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">covid-19</Keyword>
            <Keyword MajorTopicYN="N">insomnia</Keyword>
            <Keyword MajorTopicYN="N">obstructive sleep apnea</Keyword>
            <Keyword MajorTopicYN="N">positive airway pressure</Keyword>
            <Keyword MajorTopicYN="N">sleep duration</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32780011</ArticleId>
            <ArticleId IdType="doi">10.5664/jcsm.8746</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32779950</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1744-7682</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Expert opinion on biological therapy</Title>
                <ISOAbbreviation>Expert Opin Biol Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Biologics in severe asthma: The overlap endotype - Opportunities and challenges.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14712598.2020.1809651</ELocationID>
            <Abstract>
                <AbstractText><u>Introduction:</u> Patients with severe asthma experience a significant burden of symptoms, disease exacerbations and medication side-effects. Severe asthma interferes with the patients' quality of life and has high health-care costs. New targeted biologic therapies have improved the management of severe asthma by significantly reducing exacerbations and maintenance corticosteroid use, and also improving lung function and patient quality of life. <u>Areas covered:</u> Not all severe asthmatics are eligible for such therapies. Those with allergic and eosinophilic asthma, usually referred to as &quot;T2-high&quot; asthma benefit from anti-IgE and anti-IL-5/5R antibodies respectively, whereas some asthmatics are eligible for both: &quot;overlap&quot; endotype. In this review, we present briefly the monoclonal antibodies that have been approved in the management of severe asthma and we focus on the &quot;overlap&quot; endotype. <u>Expert Opinion:</u> Since these therapies are costly, it is extremely important to choose the right treatment for the right patient especially in the &quot;overlapping&quot; one. The decision is mainly based on the judgment of the clinician and is often driven by the most easily obtainable biomarker, thus the blood eosinophil count. Comorbidities, patient's input and administration frequency may aid the decision of choosing one over another biologic.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bakakos</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>1st University Department. of Respiratory Medicine, National and Kapodistrian University of Athens , Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loukides</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>2 University Department. of Respiratory Medicine, National and Kapodistrian University of Athens , Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Usmani</LastName>
                    <ForeName>O S</ForeName>
                    <Initials>OS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Airways Disease Section, National Heart and Lung Institute, Imperial College London, &amp; Royal Brompton Hospital , UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bakakos</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>1st University Department. of Respiratory Medicine, National and Kapodistrian University of Athens , Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Expert Opin Biol Ther</MedlineTA>
            <NlmUniqueID>101125414</NlmUniqueID>
            <ISSNLinking>1471-2598</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IgE</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">biologicals</Keyword>
            <Keyword MajorTopicYN="N">eosinophils</Keyword>
            <Keyword MajorTopicYN="N">severe asthma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32779950</ArticleId>
            <ArticleId IdType="doi">10.1080/14712598.2020.1809651</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32779943</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-4303</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
                <ISOAbbreviation>J Asthma</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2020.1804578</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To provide a summary of the management of asthma in the current COVID-19 pandemic by examining and comparing the recommendations from various professional bodies.</AbstractText>
                <AbstractText Label="DATA SOURCES AND STUDY SELECTION" NlmCategory="METHODS">Websites of known respiratory professional bodies were searched for COVID-19 guidance related to asthma. Subject matter experts were also consulted for useful resources. Resources that were targeted at healthcare professionals were included, while those targeting patients and the general public were excluded.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There is currently little data to suggest that asthma protects from or increases the risk of COVID-19, nor is there any data to support strong recommendations for or against specific asthma treatments. Physicians should continue to manage asthma according to existing accepted asthma guidelines and recommendations. All prescribed medications, especially inhaled corticosteroids, should be continued, and, where indicated, oral corticosteroids and biologic therapies should still be used. Nebulizers and spirometry should be avoided where possible to reduce the risk of viral transmission. A detailed history should be taken to differentiate asthma exacerbations from COVID-19.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Understanding similarities and differences among the recommendations of the various professional bodies will aid in medical decision-making in managing asthma in the COVID-19 pandemic. Health professionals should also consider the individual needs, preferences and values of their patients and the unique characteristics of their local healthcare systems.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ong</LastName>
                    <ForeName>Kheng Yong</ForeName>
                    <Initials>KY</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4272-4993</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Singapore General Hospital, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Tze Lee</ForeName>
                    <Initials>TL</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6487-5672</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Edinburgh Clinic, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Adrian Kwok Wai</ForeName>
                    <Initials>AKW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Karen Li Leng</ForeName>
                    <Initials>KLL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koh</LastName>
                    <ForeName>Mariko Siyue</ForeName>
                    <Initials>MS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1230-0129</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Asthma</MedlineTA>
            <NlmUniqueID>8106454</NlmUniqueID>
            <ISSNLinking>0277-0903</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">novel coronavirus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32779943</ArticleId>
            <ArticleId IdType="doi">10.1080/02770903.2020.1804578</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32779108</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-2443</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neurovirology</Title>
                <ISOAbbreviation>J. Neurovirol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A COVID-19 patient with intense burning pain.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s13365-020-00887-4</ELocationID>
            <Abstract>
                <AbstractText>A woman in her forties with asthma and COPD was admitted to a general medical floor with respiratory symptoms, body aches, and anosmia. Reverse transcription polymerase chain reaction detected severe acute respiratory syndrome coronavirus-2. Admission labs, including biomarkers of the systemic immunological dysfunction seen in many cases of coronavirus disease 2019 (COVID-19), were within normal ranges. On the second day of admission, she developed neck and back pain that was constant, burning in quality, and exacerbated by light touch and heat. Wearing clothing caused pain and interfered with her sleep. The area was tender to light finger stroke. The patient was given acetaminophen, NSAIDs, and opioids with no relief of pain. However, gabapentin was effective. At follow-up 1 month later, her symptoms were improved and still relieved by gabapentin. Neuropathic pain was seen in over 2% of COVID-19 patients in one observational study. The pain seen in our case was bilateral, involved an area innervated by multiple levels of spinal nerves, and was limited to the back. While it is rare, a significant number of COVID-19 patients are afflicted by neuropathic pain, and our case illustrates that gabapentin may be effective.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aksan</LastName>
                    <ForeName>Feyzullah</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Montefiore Wakefield Campus, 600 East 233rd Street, Bronx, NY, 10466, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nelson</LastName>
                    <ForeName>Eric Andrew</ForeName>
                    <Initials>EA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3348-1499</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center, 111 E 210th Street, Bronx, NY, 10467, USA. nelson7@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swedish</LastName>
                    <ForeName>Kristin A</ForeName>
                    <Initials>KA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Montefiore Wakefield Campus, 600 East 233rd Street, Bronx, NY, 10466, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Neurovirol</MedlineTA>
            <NlmUniqueID>9508123</NlmUniqueID>
            <ISSNLinking>1355-0284</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Gabapentin</Keyword>
            <Keyword MajorTopicYN="N">Neuralgia</Keyword>
            <Keyword MajorTopicYN="N">Neuropathic pain</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32779108</ArticleId>
            <ArticleId IdType="doi">10.1007/s13365-020-00887-4</ArticleId>
            <ArticleId IdType="pii">10.1007/s13365-020-00887-4</ArticleId>
            <ArticleId IdType="pmc">PMC7416991</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pain Res Manag. 2009 Jul-Aug;14(4):275-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19714266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pain. 2017 Dec;158(12):2386-2395</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28832395</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32778730</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3998</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-17813-1</ELocationID>
            <Abstract>
                <AbstractText>Allergic asthma is a leading chronic disease associated with airway hyperreactivity (AHR). Type-2 innate lymphoid cells (ILC2s) are a potent source of T-helper 2 (Th2) cytokines that promote AHR and lung inflammation. As the programmed cell death protein-1 (PD-1) inhibitory axis regulates a variety of immune responses, here we investigate PD-1 function in pulmonary ILC2s during IL-33-induced airway inflammation. PD-1 limits the viability of ILC2s and downregulates their effector functions. Additionally, PD-1 deficiency shifts ILC2 metabolism toward glycolysis, glutaminolysis and methionine catabolism. PD-1 thus acts as a metabolic checkpoint in ILC2s, affecting cellular activation and proliferation. As the blockade of PD-1 exacerbates AHR, we also develop a human PD-1 agonist and show that it can ameliorate AHR and suppresses lung inflammation in a humanized mouse model. Together, these results highlight the importance of PD-1 agonistic treatment in allergic asthma and underscore its therapeutic potential.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Helou</LastName>
                    <ForeName>Doumet Georges</ForeName>
                    <Initials>DG</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5835-9214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shafiei-Jahani</LastName>
                    <ForeName>Pedram</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lo</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Howard</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hurrell</LastName>
                    <ForeName>Benjamin P</ForeName>
                    <Initials>BP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galle-Treger</LastName>
                    <ForeName>Lauriane</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Painter</LastName>
                    <ForeName>Jacob D</ForeName>
                    <Initials>JD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0273-8597</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lewis</LastName>
                    <ForeName>Gavin</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Research and Development, San Diego, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soroosh</LastName>
                    <ForeName>Pejman</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Janssen Research and Development, San Diego, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharpe</LastName>
                    <ForeName>Arlene H</ForeName>
                    <Initials>AH</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9736-2109</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, Harvard Medical School, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akbari</LastName>
                    <ForeName>Omid</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4359-9725</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. akbari@usc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 ES025786, R01 ES021801, R01 HL144790, R21 AI109059</GrantID>
                    <Agency>U.S. Department of Health &amp; Human Services | NIH | National Center for Research Resources (NCRR)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32778730</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-020-17813-1</ArticleId>
            <ArticleId IdType="pii">10.1038/s41467-020-17813-1</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32778700</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cross-talk between airway and gut microbiome links to IgE responses to house dust mites in childhood airway allergies.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13449</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-70528-7</ELocationID>
            <Abstract>
                <AbstractText>A connection between airway and gut microbiota related to allergen exposure in childhood allergies was not well addressed. We aimed to identify the microbiota alterations in the airway and gut related to mite-specific IgE responses in young children with airway allergies. This study enrolled 60 children, including 38 mite-sensitized children (20 rhinitis and 18 asthma), and 22 non-mite-sensitized healthy controls. Microbiome composition analysis of the throat swab and stool samples was performed using bacterial 16S rRNA sequencing. An integrative analysis of the airway and stool microbial profiling associated with IgE reactions in childhood allergic rhinitis and asthma was examined. The Chao1 and Shannon indices in the airway were significantly lower than those in the stool. Additionally, an inverse association of the airway microbial diversity with house dust mite (HDM) sensitization and allergic airway diseases was noted. Fecal IgE levels were positively correlated with the serum Dermatophagoides pteronyssinus- and Dermatophagoides farinae-specific IgE levels. Airway Leptotrichia spp. related to asthma were strongly correlated with fecal Dorea and Ruminococcus spp., which were inversely associated with fecal IgE levels and risk of allergic rhinitis. Moreover, four airway genera, Campylobacter, Selenomonas, Tannerella, and Atopobium, were negatively correlated with both serum mite-specific and fecal IgE levels. Among them, the airway Selenomonas and Atopobium spp. were positively correlated with stool Blautia and Dorea spp. related to asthma and allergic rhinitis, respectively. In conclusion, airway microbial dysbiosis in response to HDM and its cross-talk with the gut microbial community is related to allergic airway diseases in early childhood.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chiu</LastName>
                    <ForeName>Chih-Yung</ForeName>
                    <Initials>CY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, and Chang Gung University, Taoyuan, Taiwan. pedchestic@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Yi-Ling</ForeName>
                    <Initials>YL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Emergency Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinical Informatics and Medical Statistics Research Center, Chang Gung University, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsai</LastName>
                    <ForeName>Ming-Han</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Chang Gung Memorial Hospital at Keelung, and Chang Gung University, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Chia-Jung</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, and Chang Gung University, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiang</LastName>
                    <ForeName>Meng-Han</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Metabolomics Core Laboratory, Chang Gung Memorial Hospital at Linkou, College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chiu</LastName>
                    <ForeName>Chun-Che</ForeName>
                    <Initials>CC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Department of Pediatrics, Chang Gung Memorial Hospital at Linkou, and Chang Gung University, Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Shih-Chi</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung, Taiwan. zenith5862@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Central Research Laboratory, XiaMen Chang Gung Hospital, Xiamen, China. zenith5862@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>CMRPG2G0651-3 and CMRPG2E0301</GrantID>
                    <Agency>Chang Gung Memorial Hospital</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>MOST 108-2314-B-182A-087</GrantID>
                    <Agency>Ministry of Science and Technology, Taiwan</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32778700</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-020-70528-7</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-020-70528-7</ArticleId>
            <ArticleId IdType="pmc">PMC7417544</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Comput Biol. 2009 Apr;5(4):e1000352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19360128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2017 Apr;139(4):1099-1110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28257972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Immunopathol (Madr). 2019 Jul - Aug;47(4):365-371</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30765132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vet J. 2019 Jul;249:10-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31239159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Blood Marrow Transplant. 2015 Aug;21(8):1373-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25977230</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gut Microbes. 2016 May 3;7(3):189-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26963409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2019 Mar 25;12(3):100021</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30937143</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2018 Dec 30;20(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30598019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Board Fam Med. 2014 Jul-Aug;27(4):538-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25002008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2015 Jun;26(4):337-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25847488</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2018 Sep 19;9:2147</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30283410</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2012 May;129(5):1204-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22541361</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S150-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26595731</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2019 Aug;37(8):852-857</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31341288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Rev Immunol. 2011 Feb;30(1):16-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21235323</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiome. 2018 May 15;6(1):89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29764499</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2015 May 13;17(5):592-602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25974301</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ISME J. 2012 Aug;6(8):1621-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22402401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Microbiol. 2017 Aug 17;17(1):175</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28818050</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anaerobe. 2014 Aug;28:98-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24878320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ISME J. 2012 Mar;6(3):610-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22134646</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2017 May 12;7(1):1820</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28500319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Jul 17;9(7):e102809</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25033453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Immunopathol. 2020 Feb;42(1):75-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32072252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Res. 2019 Oct 3;2019:4735040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31687412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Oct 21;9(10):e111228</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25333938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2005 Feb;60(2):165-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15647036</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2012 Dec;30(4):294-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23393909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2015 Jul;136(1):38-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25457152</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32778497</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1995-9133</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>28</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi</Title>
                <ISOAbbreviation>J Microbiol Immunol Infect</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of biomarkers and effect of FIP-fve in acute and chronic animal asthma models.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1684-1182(20)30163-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jmii.2020.07.006</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma is a consequence of complex gene-environment interactions. Exploring the heterogeneity of asthma in different stages is contributing to our understanding of its pathogenesis and the development of new therapeutic strategies, especially in severe cases.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to further understand the relationship between manifestations of acute and chronic asthma and various endotypes, and explore the severity of lung inflammation, cell types, cytokine/chemokine differences, and the effects of FIP-fve.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Acute and chronic OVA-sensitization mouse asthma models, based on our previously published method, were used and FIP-fve was used to evaluate the effect on these two models. BALF cytokines/chemokines were detected according to the manufacturer's protocol.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventeen cytokine/chemokine secretions were higher in the chronic stage than in the acute stage. Whether in acute stage or chronic stage, the FIP-fve treatment groups had reduced airway hyperresponsiveness, infiltration of airway inflammatory cells, secretion of cytokines, chemokines by Th2 cells, and TNF-α, IL-8, IL-17, CXCL-1, CXCL-10, CCL-17, and CCL-22, and it was also found that the Treg cell cytokine IL-10 had increased significantly. PCA (Principal Component Analysis) was also used to compare statistics and laboratory data to find the important biomarkers in different stages and after treatment with FIP-fve.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There are many different immune responses in the different stages of the asthma process. Drug treatment at the appropriate times might help reduce the worsening of asthma.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Chia-Ta</ForeName>
                    <Initials>CT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Emergency Medicine, Changhua Christian Hospital, Changhua, Taiwan. Electronic address: allenpig1102@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Yu-Tzu</ForeName>
                    <Initials>YT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ku</LastName>
                    <ForeName>Min-Sho</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: cshy539@csh.org.tw.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lue</LastName>
                    <ForeName>Ko-Huang</ForeName>
                    <Initials>KH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan. Electronic address: cshy095@csh.org.tw.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Microbiol Immunol Infect</MedlineTA>
            <NlmUniqueID>100956211</NlmUniqueID>
            <ISSNLinking>1684-1182</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Acute</Keyword>
            <Keyword MajorTopicYN="N">Asthma cytokines</Keyword>
            <Keyword MajorTopicYN="N">Chemokines</Keyword>
            <Keyword MajorTopicYN="N">Chronic</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32778497</ArticleId>
            <ArticleId IdType="pii">S1684-1182(20)30163-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jmii.2020.07.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32778067</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2318</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC geriatrics</Title>
                <ISOAbbreviation>BMC Geriatr</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Agreement between self-reported morbidity and pharmacy claims data for prescribed medications in an older community based population.</ArticleTitle>
            <Pagination>
                <MedlinePgn>283</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12877-020-01684-8</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Studies have indicated variability around prevalence estimates of multimorbidity due to poor consensus regarding its definition and measurement. Medication-based measures of morbidity may be valuable resources in the primary-care setting where access to medical data can be limited. We compare the agreement between patient self-reported and medication-based morbidity; and examine potential patient-level predictors of discordance between these two measures of morbidity in an older (≥ 50 years) community-based population.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was performed using national pharmacy claims data linked to The Irish LongituDinal study on Ageing (TILDA). Morbidity was measured by patient self-report (TILDA) and two medication-based measures, the Rx-Risk (&lt; 65 years) and Rx-Risk-V (≥65 years), which classify drug claims into chronic disease classes. The kappa statistic measured agreement between self-reported and medication-based morbidity at the individual patient-level. Multivariate logistic regression was used to examine patient-level characteristics associated with discordance between measures of morbidity.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Two thousand nine hundred twenty-five patients were included (&lt; 65 years: N = 1095, 37.44%; and ≥ 65 years: N = 1830 62.56%). Hypertension and high cholesterol were the most prevalent self-reported morbidities in both age cohorts. Agreement was good or very good (κ = 0.61-0.81) for diabetes, osteoporosis and glaucoma; and moderate for high cholesterol, asthma, Parkinson's and angina (κ = 0.44-0.56). All other conditions had fair or poor agreement. Age, gender, marital status, education, poor-delayed recall, depression and polypharmacy were significantly associated with discordance between morbidity measures.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most conditions achieved only moderate or fair agreement between self-reported and medication-based morbidity. In order to improve the accuracy in prevalence estimates of multimorbidity, multiple measures of multimorbidity may be necessary. Future research should update the current Rx-Risk algorithms in-line with current treatment guidelines, and re-assess the feasibility of using these indices alone, or in combination with other methods, to yield more accurate estimates of multimorbidity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mannion</LastName>
                    <ForeName>Clionadh</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Therapeutics, University of Dublin, Trinity College Dublin, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hughes</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moriarty</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Research Board Centre for Primary Care Research, Royal College of Surgeons in Ireland, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Irish Longitudinal Study on Ageing, Trinity College Dublin, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bennett</LastName>
                    <ForeName>Kathleen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology and Therapeutics, University of Dublin, Trinity College Dublin, Dublin, Ireland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cahir</LastName>
                    <ForeName>Caitriona</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin 2, Ireland. caitrionacahir@rcsi.ie.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>RL-2015-1579</GrantID>
                    <Agency>Health Research Board Ireland</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Geriatr</MedlineTA>
            <NlmUniqueID>100968548</NlmUniqueID>
            <ISSNLinking>1471-2318</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Agreement</Keyword>
            <Keyword MajorTopicYN="N">Morbidity</Keyword>
            <Keyword MajorTopicYN="N">Older people</Keyword>
            <Keyword MajorTopicYN="N">Polypharmacy</Keyword>
            <Keyword MajorTopicYN="N">Rx-risk</Keyword>
            <Keyword MajorTopicYN="N">Rx-risk-V</Keyword>
            <Keyword MajorTopicYN="N">Self-report</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32778067</ArticleId>
            <ArticleId IdType="doi">10.1186/s12877-020-01684-8</ArticleId>
            <ArticleId IdType="pii">10.1186/s12877-020-01684-8</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777968</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-4954</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians</Title>
                <ISOAbbreviation>J. Matern. Fetal. Neonatal. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An assessment of baseline risk factors for peripartum maternal critical care interventions.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/14767058.2020.1803258</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Maternal morbidity presents a growing challenge to the American healthcare system and increasing numbers of patients are requiring higher levels of care in pregnancy. Identifying patients at high risk for critical care interventions, including intensive care unit admission, during delivery hospitalizations may facilitate appropriate multidisciplinary planning and lead to improved maternal safety. Baseline risk factors for critical care in pregnancy have not been well-described previously.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study assesses baseline factors associated with critical care interventions that were present at admission for delivery.</AbstractText>
                <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">This is a secondary analysis of a multicenter observational registry of pregnancy after prior uterine surgery and primary cesarean delivery. All women with known gestational age were included. The primary outcome measure was a composite of critical care interventions that included postpartum intensive care unit admission, mechanical ventilation, central intravenous access, and arterial line placement. Risk for this critical care outcome measure was compared by selected baseline and obstetric characteristics known at the time of hospital admission, including maternal age, pre-pregnancy BMI, race, maternal co-morbidities, parity, and plurality. We evaluated these potential predictors and fit a multivariable logistic regression model to ascertain the most significant risk factors for critical care during a delivery hospitalization.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">73,096 of 73,257 women in the parent trial met inclusion criteria, of whom 505 underwent a critical care intervention (0.7%). In the adjusted model, heart disease [aOR = 10.05, CI = 6.97 - 14.49], renal disease [aOR = 2.78, CI = 1.49 - 5.18], and connective tissue disease [aOR = 3.27, CI = 1.52 - 6.99], as well as hypertensive disorders of pregnancy [aOR = 2.04, CI = 1.31 - 3.17] were associated with the greatest odds of critical care intervention [<i>p</i> &lt; .01] (Table 2). Other predictors associated with increased risk included maternal age, African American race, smoking, diabetes, asthma, anemia, nulliparity, and twin pregnancy.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this cohort, women with cardiac disease, renal disease, connective tissue disease and preeclampsia spectrum disorders were at increased risk for critical care interventions. Obstetric providers should assess patient risk routinely, ensure appropriate maternal level of care, and create multidisciplinary plans to improve maternal safety and reduce risk.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kern-Goldberger</LastName>
                    <ForeName>Adina R</ForeName>
                    <Initials>AR</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7932-1987</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moroz</LastName>
                    <ForeName>Leslie</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Friedman</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Purisch</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>D'Alton</LastName>
                    <ForeName>Mary</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gyamfi-Bannerman</LastName>
                    <ForeName>Cynthia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, New York, NY, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Matern Fetal Neonatal Med</MedlineTA>
            <NlmUniqueID>101136916</NlmUniqueID>
            <ISSNLinking>1476-4954</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N"> co-morbidity</Keyword>
            <Keyword MajorTopicYN="N">Critical care</Keyword>
            <Keyword MajorTopicYN="N">intensive care unit</Keyword>
            <Keyword MajorTopicYN="N">levels of care</Keyword>
            <Keyword MajorTopicYN="N">maternal morbidity</Keyword>
            <Keyword MajorTopicYN="N">risk stratification</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>12</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777968</ArticleId>
            <ArticleId IdType="doi">10.1080/14767058.2020.1803258</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774095</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1302-7123</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>52</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2018</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Sisli Etfal Hastanesi tip bulteni</Title>
                <ISOAbbreviation>Sisli Etfal Hastan Tip Bul</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evaluation of Comorbidities in Patients with Autoimmune Bullous Diseases: A Retrospective Study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>302-306</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.14744/SEMB.2018.55376</ELocationID>
            <Abstract>
                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">The purpose of the present study was to define the accompanying diseases of patients with autoimmune bullous diseases (ABDs).</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">One hundred forty-two patients with ABD who were followed up in the dermatology and venereology inpatient clinic of Şişli Hamidiye Etfal Training and Research Hospital between January 1999 and December 2015 were enrolled in the study. Age, gender, and accompanying diseases of the participants were recorded and compared with the healthy subjects.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Eighty patients with pemphigus, 62 patients with pemphigoid, and 217 healthy subjects were included in the study. The pemphigoid group had a statistically significant higher prevalence of hypertension, diabetes mellitus, coronary artery diseases, cataract, malignancy, dementia, Alzheimer's disease, Parkinson's disease, and cerebrovascular events relative to the pemphigus and control groups (p&lt;0.01, p&lt;0.01, p=0.001, p&lt;0.01, p=0.02, p=0.008, p=0.001, p=0.001, and p&lt;0.01, respectively). The prevalence of asthma, benign prostatic hyperplasia, and cataract was higher in the pemphigus group than in the controls (p=0.02, p=0.04, and p=0.02, respectively).</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">To the best of our knowledge, this is the first study comparing accompanying diseases between controls and patients with pemphigus and pemphigoid. It is disputable whether the diseases mentioned occur due to some common pathophysiological pathways or coexist just coincidentally. We believe that it is important to evaluate accompanying diseases in patients with ABD.</AbstractText>
                <CopyrightInformation>Copyright: © 2018 by The Medical Bulletin of Sisli Etfal Hospital.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Karabay</LastName>
                    <ForeName>Ezgi Aktaş</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, Bahçeşehir University Faculty of Medicine, İstanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Çerman</LastName>
                    <ForeName>Aslı Aksu</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Altunay</LastName>
                    <ForeName>İlknur Kıvanç</ForeName>
                    <Initials>İK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, Şişli Hamidiye Etfal Training and Research Hospital, İstanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Turkey</Country>
            <MedlineTA>Sisli Etfal Hastan Tip Bul</MedlineTA>
            <NlmUniqueID>9424130</NlmUniqueID>
            <ISSNLinking>1302-7123</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Comorbidity</Keyword>
            <Keyword MajorTopicYN="N">diabetes mellitus</Keyword>
            <Keyword MajorTopicYN="N">hypertension</Keyword>
            <Keyword MajorTopicYN="N">pemfigoid</Keyword>
            <Keyword MajorTopicYN="N">pemfigus</Keyword>
            <Keyword MajorTopicYN="N">vesiculobullous skin diseases</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of Interest: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>12</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>02</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>28</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774095</ArticleId>
            <ArticleId IdType="doi">10.14744/SEMB.2018.55376</ArticleId>
            <ArticleId IdType="pii">MBSEH-52-302</ArticleId>
            <ArticleId IdType="pmc">PMC7406551</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Am Acad Dermatol. 1984 Dec;11(6):1099-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6392367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dermatol Res. 2015 May;307(4):291-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25589418</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Oncol (R Coll Radiol). 2003 Dec;15(8):505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14690009</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mult Scler. 2010 Jul;16(7):855-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20463037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Dermatol. 2010 Jan-Feb;20(1):96-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19797038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Dermatol Sci. 1995 Mar;9(2):136-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7772576</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dermatol. 2010 Nov;146(11):1251-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21079062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2007 Apr;46(4):356-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17442072</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>An Bras Dermatol. 2014 Mar-Apr;89(2):274-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24770504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Dermatol. 2001 May-Jun;11(3):230-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11358730</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dermatol. 1990 Jan;126(1):66-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2404464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2005 Mar;152(3):537-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15787824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Invest Dermatol. 2011 Mar;131(3):631-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21085189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Dermatol. 2015 Aug;40(6):593-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25786337</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2015 Nov;54(11):1246-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25783773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stroke. 2011 Feb;42(2):319-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21164122</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2012 Jan;51(1):35-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22182376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatology. 2007;215(3):187-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17823513</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Dermatol. 2006 Sep-Oct;16(5):581-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17101485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Ther. 2003;16(3):214-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14510878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2006 May;45(5):523-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16700784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2004 Dec;43(12):876-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15569006</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Dermatol. 2012 Jan-Feb;30(1):17-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22137223</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2011 Sep;165(3):593-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21517800</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32773430</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-1815</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Apr</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Pediatric emergency care</Title>
                <ISOAbbreviation>Pediatr Emerg Care</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Frequency of and Factors Associated With Prescription Medication Sharing Within Families.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/PEC.0000000000001804</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Limited literature has investigated caregiver sharing of prescription medications with children. Our primary aim was to determine the frequency of and factors associated with prescription medication sharing within families. Our secondary aim was to determine the source and type of medications shared.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a survey of a convenience sample of caregivers of children 1 to 17 years in a pediatric emergency department. The survey was developed through literature review, iterative feedback, and pilot testing on caregivers. We used logistic regression to identify factors associated with any history of medication sharing with a child in the home (primary outcome).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We enrolled 550 primary caregivers; 68 of the 535 analyzed (12.7%; 95% confidence interval [CI], 10.0-15.8) reported prescription medication sharing with their child/children. Of those who shared, 50 (73.5%) shared asthma medications and 14 (20.6%) shared antibiotics. Of the caregivers who shared prescription medications, 70.6% shared a medication for one child with another child, whereas 33.8% of caregivers shared their own or another adult's medication with their child. A child in the home with asthma (adjusted odds ratio [aOR], 3.35; CI, 1.82-6.17), a greater number of children in the household (aOR, 1.29; CI, 1.04-1.60), and a caregiver who previously shared medications with other family members and/or friends (aOR, 4.10; CI, 1.84-9.15) were factors independently associated with medication sharing.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Prescription medication sharing within families is common and most often involves asthma medications. We identified several factors associated with prescription medication sharing that could be used to target caregivers for preventative interventions.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Renny</LastName>
                    <ForeName>Madeline H</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>From the Department of Emergency Medicine, Division of Pediatric Emergency Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thaker</LastName>
                    <ForeName>Riddhi H</ForeName>
                    <Initials>RH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dayan</LastName>
                    <ForeName>Peter S</ForeName>
                    <Initials>PS</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Pediatr Emerg Care</MedlineTA>
            <NlmUniqueID>8507560</NlmUniqueID>
            <ISSNLinking>0749-5161</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>4</Month>
                <Day>30</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>4</Month>
                <Day>30</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32773430</ArticleId>
            <ArticleId IdType="doi">10.1097/PEC.0000000000001804</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777866</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2287-4208</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The world journal of men's health</Title>
                <ISOAbbreviation>World J Mens Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Estimating Maximal Oxygen Uptake from the Ratio of Heart Rate at Maximal Exercise to Heart Rate at Rest in Middle-Aged Men.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.5534/wjmh.200055</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To estimate the maximum mass-specific oxygen uptake (VO<sub>2max</sub>) from the ratio of the heart rate at maximal exercise (HR<sub>max</sub>) to heart rate at rest (HR<sub>rest</sub>) in middle-aged men. VO<sub>2max</sub> is an essential measure of cardiorespiratory fitness, but it is difficult to utilize in clinical practice. The proportionality factor HR<sub>max</sub> to HR<sub>rest</sub> is known to approximate 15 in young well-trained adults. Presumably, the same value is inaccurate for middle-aged men.</AbstractText>
                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Six-hundred thirty-four men belonging to the Kuopio Ischaemic Heart Disease Risk Factor Study. Their mean age, body mass index (BMI), the daily total physical activity (TPA), VO<sub>2max</sub>, HR<sub>max</sub>, and HR<sub>rest</sub> were: 49.4±6.4 years, 26.3±3.2 kg/m², 48.5±10.1 metabolic equivalent hours per day, 33.7±7.6 mL/min/kg, 170.1±15.4 beats/min, and 63.3±10.8 beats/min. They included never-smokers 38%, former smokers 29%, and current smokers 33%.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The proportionality factor HR<sub>max</sub> to HR<sub>rest</sub> in around 50-year-old men approximated 12. One year in age, one step change in BMI (normal weight, overweight, obese), smoking status (never, former, current), and TPA (moderately active, active, highly active) reduced the proportionality factor by 0.1, 0.6, 0.4, and 0.1, respectively. The proportionality factor in obese or current smoking middle-aged men was one point lower compared to normal weight or never-smoking peers. This corresponds to approximately 10 years in chronological age.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In around 50-year-old men with no cardiovascular diseases, bronchial asthma, or cancer, the HR<sub>max</sub> to HR<sub>rest</sub> ratio should be multiplied by approximately 12 to estimate VO<sub>2max</sub>. BMI and smoking status can be considered in calculations to improve accuracy.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Korean Society for Sexual Medicine and Andrology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Voutilainen</LastName>
                    <ForeName>Ari</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0664-2675</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland. ari.voutilainen@uef.fi.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Setti</LastName>
                    <ForeName>Mounir Ould</ForeName>
                    <Initials>MO</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8298-110X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tuomainen</LastName>
                    <ForeName>Tomi Pekka</ForeName>
                    <Initials>TP</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1949-3787</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Acronym>UEF</Acronym>
                    <Agency>University of Eastern Finland</Agency>
                    <Country>Finland</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Korea (South)</Country>
            <MedlineTA>World J Mens Health</MedlineTA>
            <NlmUniqueID>101596899</NlmUniqueID>
            <ISSNLinking>2287-4208</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Healthy lifestyle</Keyword>
            <Keyword MajorTopicYN="N">Heart rate</Keyword>
            <Keyword MajorTopicYN="N">Men's health</Keyword>
            <Keyword MajorTopicYN="N">Oxygen consumption</Keyword>
            <Keyword MajorTopicYN="N">Physical exertion</Keyword>
        </KeywordList>
        <CoiStatement>The authors have nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777866</ArticleId>
            <ArticleId IdType="pii">38.e39</ArticleId>
            <ArticleId IdType="doi">10.5534/wjmh.200055</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777786</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0097</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International archives of allergy and immunology</Title>
                <ISOAbbreviation>Int. Arch. Allergy Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Plasma P-Selectin Is Inversely Associated with Lung Function and Corticosteroid Responsiveness in Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000509600</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe asthma has multiple phenotypes for which biomarkers are still being defined. Plasma P-selectin reports endothelial and/or platelet activation.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine if P-selectin is associated with features of asthma in a longitudinal study.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Plasmas from 70 adult patients enrolled in the Severe Asthma Research Program (SARP) III at the University of Wisconsin-Madison were analyzed for concentration of P-selectin at several points over the course of 3 years, namely, at baseline (BPS), after intramuscular triamcinolone acetonide (TA) injection, and at 36 months after baseline. Thirty-four participants also came in during acute exacerbation and 6 weeks after exacerbation.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">BPS correlated inversely with forced expiratory volume in 1 s (FEV1) and with residual volume/total lung capacity, an indicator of air trapping. BPS was inversely associated with FEV1 change after TA, by regression analysis. FEV1 did not change significantly after TA if BPS was above the median, whereas patients with BPS below the median had significantly increased FEV1 after TA. BPS was higher in and predicted assignment to SARP phenotype cluster 5 (&quot;severe fixed-airflow asthma&quot;). P-selectin was modestly but significantly increased at exacerbation but returned to baseline within 3 years.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">High BPS is associated with airway obstruction, air trapping, the &quot;severe fixed-airflow&quot; cluster, and lack of FEV1 improvement in response to TA injection. P-selectin concentration, which is a stable trait with only modest elevation during exacerbation, may be a useful biomarker for a severe asthma pheno- or endotype characterized by low pulmonary function and lack of corticosteroid responsiveness.</AbstractText>
                <CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Mats W</ForeName>
                    <Initials>MW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA, mwjohansson@wisc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grill</LastName>
                    <ForeName>Brandon M</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barretto</LastName>
                    <ForeName>Karina T</ForeName>
                    <Initials>KT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Favour</LastName>
                    <ForeName>Molly C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schira</LastName>
                    <ForeName>Hazel M</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swanson</LastName>
                    <ForeName>Calvin M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Kristine E</ForeName>
                    <Initials>KE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sorkness</LastName>
                    <ForeName>Ronald L</ForeName>
                    <Initials>RL</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmacy, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mosher</LastName>
                    <ForeName>Deane F</ForeName>
                    <Initials>DF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Denlinger</LastName>
                    <ForeName>Loren C</ForeName>
                    <Initials>LC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jarjour</LastName>
                    <ForeName>Nizar N</ForeName>
                    <Initials>NN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int Arch Allergy Immunol</MedlineTA>
            <NlmUniqueID>9211652</NlmUniqueID>
            <ISSNLinking>1018-2438</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Corticosteroid</Keyword>
            <Keyword MajorTopicYN="N">Exacerbation</Keyword>
            <Keyword MajorTopicYN="N">Lung function</Keyword>
            <Keyword MajorTopicYN="N">P-selectin</Keyword>
            <Keyword MajorTopicYN="N">Phenotype</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777786</ArticleId>
            <ArticleId IdType="pii">000509600</ArticleId>
            <ArticleId IdType="doi">10.1159/000509600</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777782</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1423-0097</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International archives of allergy and immunology</Title>
                <ISOAbbreviation>Int. Arch. Allergy Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000508708</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">AERD (aspirin-exacerbated respiratory disease) is a severe form of an inflammatory disease of the upper airway system. Therapy remains challenging due to a complex underlying pathophysiology.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the efficacy of postoperative antileukotriene therapy concerning recurrence of nasal polyposis in patients with AERD and to compare it with AD (aspirin desensitization) over time.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this retrospective study we analyzed AERD patients (N = 61) after functional endoscopic sinus surgery (FESS). Patients were treated at our institution postoperatively with topical mometasone (control group, N = 22), leukotriene-receptor-antagonists (montelukast [MT], N = 18) or underwent an aspirin desensitization (N = 21). Subjective parameters as assessed by SNOT (sinonasal outcome test) questionnaire and endoscopic endonasal examination (polyposis grading) were evaluated throughout a follow-up period of 6-9 and &gt;12 (long-term) months after surgery.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Endoscopic endonasal examinations 6-9 months after sinus surgery showed a good disease control in all 3 groups with significant reduction in polyp grading in the AD group. After a follow-up period of more than 12 months, MT and AD patients had significantly less polyp recurrences as compared to the topical treatment group. Subjective sinonasal symptoms revealed that hyposmia and nasal obstruction were prominent factors in all 3 groups throughout the follow-up period. MT group showed significant improvement in sinonasal symptoms over time.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Postoperative treatment with leukotriene-receptor-antagonists and aspirin desensitization both significantly reduce nasal polyp recurrence. MT has a positive effect on subjective sinonasal outcomes and patients' quality of life over time.</AbstractText>
                <CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>San Nicoló</LastName>
                    <ForeName>Marion</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany, marion.sannicolo@med.uni-muenchen.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Habermann</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Havel</LastName>
                    <ForeName>Miriam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery, Ludwig-Maximilians-University of Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int Arch Allergy Immunol</MedlineTA>
            <NlmUniqueID>9211652</NlmUniqueID>
            <ISSNLinking>1018-2438</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antileukotriene therapy</Keyword>
            <Keyword MajorTopicYN="N">Aspirin desensitization</Keyword>
            <Keyword MajorTopicYN="N">Aspirin-exacerbated respiratory disease</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Nasal polyposis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777782</ArticleId>
            <ArticleId IdType="pii">000508708</ArticleId>
            <ArticleId IdType="doi">10.1159/000508708</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777762</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5967</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>130</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology</Title>
                <ISOAbbreviation>J. Clin. Virol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19.</ArticleTitle>
            <Pagination>
                <MedlinePgn>104577</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1386-6532(20)30319-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcv.2020.104577</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Molecular detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is key in the diagnosis of coronavirus disease 2019 (COVID-19) and has been widely used for followup of cases as a proxy for contagiousness. The persistence of SARS-CoV-2 RNA shedding in the context of clinical features and comorbidities is understudied.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We retrospectively reviewed laboratory-confirmed COVID-19 adult symptomatic cases at Mayo Clinic, eventually achieving cessation of viral RNA shedding (CVS), defined as two consecutive negative SARS-CoV-2 PCR results on nasopharyngeal swabs collected at least 24 h apart.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 251 patients were included, median age was 53 years and 59 % female. The most common symptoms at diagnosis were cough, myalgia, dyspnea, fever and chills. Myalgia, cough, anosmia, ageusia and sore throat were common at CVS, but fever and dyspnea were not observed. The median time from symptom onset to CVS was 23 days, and did not differ by symptoms. The weekly cumulative CVS rate was 2, 14, 44, 73, 91 and 95 % at 1-6 weeks from symptom onset, respectively. Cough and fever were associated with a positive PCR test if tested within 2 weeks of symptoms (P &lt; 0.05). Patients with asthma or immunosuppression were less likely to achieve CVS if tested 3 weeks into symptoms (P &lt; 0.04).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The cumulative CVS rate at 3 weeks from symptom-onset is 44 % in our entire cohort. The findings of our study highlight the low yield of repeating a SARS-CoV-2 NP PCR test within 21 days of a laboratoryconfirmed COVID-19 diagnosis.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Corsini Campioli</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Rochester, MN, USA. Electronic address: corsinicampioli.cristina@mayo.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cano Cevallos</LastName>
                    <ForeName>Edison</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Rochester, MN, USA; Infectious Diseases Research Laboratory, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Assi</LastName>
                    <ForeName>Mariam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Robin</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Rochester, MN, USA; Infectious Diseases Research Laboratory, Rochester, MN, USA; Division of Clinical Microbiology, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Binnicker</LastName>
                    <ForeName>Matthew J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Infectious Diseases Research Laboratory, Rochester, MN, USA; Division of Clinical Microbiology, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Horo</LastName>
                    <ForeName>John C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Infectious Diseases, Rochester, MN, USA; Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>J Clin Virol</MedlineTA>
            <NlmUniqueID>9815671</NlmUniqueID>
            <ISSNLinking>1386-6532</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">PCR testing</Keyword>
            <Keyword MajorTopicYN="N">SARSCo-V-2</Keyword>
            <Keyword MajorTopicYN="N">Viral RNA shedding</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest None.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777762</ArticleId>
            <ArticleId IdType="pii">S1386-6532(20)30319-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jcv.2020.104577</ArticleId>
            <ArticleId IdType="pmc">PMC7405830</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2020 May 6;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32374370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Jul 2;56(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32398298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Apr 27;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32337591</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 Jun;80(6):656-665</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Feb 7;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32031568</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2020 May;80(5):e1-e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171869</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Sci. 2020 Mar 15;16(10):1698-1707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32226287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2020 May;26(5):672-675</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32296168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neural Regen Res. 2015 Feb;10(2):203-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25883614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2006 Jan;129(1 Suppl):138S-146S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16428703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 21;369:m1443</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32317267</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Blood Marrow Transplant. 2011 Jan;17(1 Suppl):S2-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21195305</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 May 28;382(22):2158-2160</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32329972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2020 Apr 17;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302000</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Postgrad Med J. 1988 Jul;64(753):559-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3074289</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32293905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2020 Jul;96:531-537</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32425636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Aug;129:104477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32505778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2020 May 1;201(9):1150-1152</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32200654</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777705</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>130</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emerging role of non-coding RNAs in allergic disorders.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110615</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(20)30808-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2020.110615</ELocationID>
            <Abstract>
                <AbstractText>RNA transcripts that not undergo translation into polypeptides recently came into focus of research. Long non-coding RNAs (lncRNAs), microRNAs (miRNAs) and circular RNAs (circRNAs) comprise the most important groups of these transcripts. LncRNAs have a length over 200 nucleotides and like mRNAs, have regulated transcription in a tissue specific manner. Biogenesis and function of lncRNAs is related to cell differentiation, response to stimuli and regulation of immune responses. LncRNAs can interact with both miRNAs and mRNAs. MiRNAs are characterized by a length of 22-24 nucleotides. MiRNAs regulate expression of genes at the post-transcriptional level. LncRNAs together with miRNAs are considered as regulators of the immune system. Alterations in their biogenesis is an important mechanism in the development immune related disorders. CircRNAs are products of aberrant maturation of protein-coding transcripts in a process of back-splicing, in which a single strand RNA molecule attains a closed circle shape. Despite a low expression, some circRNA were found to titrate miRNAs and interfere with maturation of legitimate protein-coding transcripts. We summarize the current knowledge on the role of non-coding transcripts in allergic disorders: asthma, atopic dermatitis, allergic rhinitis and urticaria. The reviewed data suggest lncRNA and miRNAs as therapeutic targets and biomarkers of allergic disorders.</AbstractText>
                <CopyrightInformation>Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ghafouri-Fard</LastName>
                    <ForeName>Soudeh</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shoorei</LastName>
                    <ForeName>Hamed</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taheri</LastName>
                    <ForeName>Mohammad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: mohammad_823@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sanak</LastName>
                    <ForeName>Marek</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland. Electronic address: marek.sanak@uj.edu.pl.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">Non-coding RNA</Keyword>
            <Keyword MajorTopicYN="N">Urticaria</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777705</ArticleId>
            <ArticleId IdType="pii">S0753-3322(20)30808-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2020.110615</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777695</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-6232</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>149</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Early human development</Title>
                <ISOAbbreviation>Early Hum. Dev.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anatomical deadspace during resuscitation of infants with congenital diaphragmatic hernia.</ArticleTitle>
            <Pagination>
                <MedlinePgn>105150</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0378-3782(20)30313-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.earlhumdev.2020.105150</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Congenital diaphragmatic hernia (CDH) has a high mortality and morbidity related to pulmonary hypoplasia.</AbstractText>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To test the hypothesis that CDH infants who survived would have a greater anatomical deadspace reflecting less severe pulmonary hypoplasia. Furthermore, infants with CDH who had undergone feto-tracheal occlusion (FETO) would have a greater anatomical deadspace.</AbstractText>
                <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Infants were studied during resuscitation in the delivery suite. They were all intubated immediately at delivery, given a neuromuscular blocking agent and underwent respiratory monitoring. The anatomical deadspace was calculated from volumetric capnography measurements.</AbstractText>
                <AbstractText Label="SUBJECTS" NlmCategory="METHODS">Thirty infants born at 32 weeks of gestation or greater and diagnosed antenatally with a CDH were studied. Eleven had undergone FETO and overall five died.</AbstractText>
                <AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Anatomical deadspace (Vd<sub>ANA</sub>) and survival to discharge.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The median (IQR) gestational age of the infants was 38.1 (35.2-39.3) weeks and birthweight 2.8 (2.3-3.3) kg. The anatomical deadspace was higher in those infants who survived (2.9 (2.8-3.3) mls/kg) compared to those who died (2.2 (2.1-2.7) mls/kg; p = 0.003) and was higher in those who had undergone FETO (3.0 (2.8-3.8) mls/kg) compared to those who had not (2.8 (2.4-3.0) mls/kg; p = 0.032). In predicting survival to discharge, the anatomical deadspace had an AUC of 0.90 (p = 0.006).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CDH infants who survived had a larger anatomical deadspace than those who died suggesting they had less lung hypoplasia. In addition, infants who had undergone FETO had greater anatomical deadspace possibly reflecting distension of the conducting airways.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Emma E</ForeName>
                    <Initials>EE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Science and Medicine, King's College London, SE5 9RS, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dassios</LastName>
                    <ForeName>Theodore</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Science and Medicine, King's College London, SE5 9RS, United Kingdom; Neonatal Intensive Care Centre, King's College Hospital NHS Foundation Trust, London SE5 9RS, United Kingdom. Electronic address: Theodore.dassios@kcl.ac.uk.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murthy</LastName>
                    <ForeName>Vadivelam</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neonatal Intensive Care Centre, The Royal London Hospital-Barts Health NHS Foundation Trust, London E1 11B, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenough</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Science and Medicine, King's College London, SE5 9RS, United Kingdom; Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, SE1 9RT, United Kingdom; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust, King's College London, SE1 9RT, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Early Hum Dev</MedlineTA>
            <NlmUniqueID>7708381</NlmUniqueID>
            <ISSNLinking>0378-3782</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anatomical deadspace</Keyword>
            <Keyword MajorTopicYN="N">Congenital diaphragmatic hernia</Keyword>
            <Keyword MajorTopicYN="N">Feto-tracheal occlusion</Keyword>
            <Keyword MajorTopicYN="N">Resuscitation</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of competing interest The authors have no conflict of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777695</ArticleId>
            <ArticleId IdType="pii">S0378-3782(20)30313-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.earlhumdev.2020.105150</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777676</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-1705</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>88</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunopharmacology</Title>
                <ISOAbbreviation>Int. Immunopharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emodin ameliorates ovalbumin-induced airway remodeling in mice by suppressing airway smooth muscle cells proliferation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>106855</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1567-5769(20)31119-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.intimp.2020.106855</ELocationID>
            <Abstract>
                <AbstractText>Increased number of airway smooth muscle cells (ASMCs) is a characteristic of airway remodeling in asthma. In this study we investigated whether emodin alleviated airway remodeling in a murine asthma model and reduced the proliferation of ASMCs in vitro. We provided in vivo evidence suggesting that intraperitoneal injection of emodin (20 mg/kg) 1 h prior to OVA challenge apparently alleviated the thickness of airway smooth muscle, the mass of alpha-smooth muscle actin (α-SMA), collagen deposition, epithelial damage, goblet cell hyperplasia, airway inflammation and airway hyperresponsiveness (AHR) in lung tissue. Meanwhile, we found that emodin suppressed the activation of the Akt pathway in lungtissue of allergic mouse models. Additionally, we found that emodin inhibited cellular proliferation and Akt activation in a dose-dependent manner in vitro. Furthermore, LY294002, an inhibitor for PI3K, abrogated serum-induced phosphorylation of Akt, and decreased the proliferation of ASMCs. These findings indicated that emodin alleviated ASMCs proliferation by inhibiting PI3K/Akt pathway in vivo and in vitro, which may provide a potential therapeutic option for airway smooth muscle remodeling in asthma.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yuanyuan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China; Department of Respiratory Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Medicine, Weifang Medical University, Weifang, Shandong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Taian City Central Hospital, Taian, Shandong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Ran</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, The Second Affiliated Hospital of Shandong First Medical University, Taian, Shandong, China. Electronic address: mengling63055@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Caiqing</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China. Electronic address: zhangcaiqingqy@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int Immunopharmacol</MedlineTA>
            <NlmUniqueID>100965259</NlmUniqueID>
            <ISSNLinking>1567-5769</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway remodeling</Keyword>
            <Keyword MajorTopicYN="N">Airway smooth muscle cell</Keyword>
            <Keyword MajorTopicYN="N">Akt</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Emodin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777676</ArticleId>
            <ArticleId IdType="pii">S1567-5769(20)31119-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.intimp.2020.106855</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777445</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J. Allergy Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A model-based approach for assessing bronchodilator responsiveness in children: the conventional cut-off revisited.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0091-6749(20)31104-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2020.07.029</ELocationID>
            <Abstract>
                <AbstractText>A model-based approach is developed to establish clinically relevant cut-offs for bronchodilator response in children. A dynamic nomogram is proposed for predicting the probability of asthma in childhood clinical practice.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sottile</LastName>
                    <ForeName>Gianluca</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>the Department of Economics, Business and Statistics, University of Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferrante</LastName>
                    <ForeName>Giuliana</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>the Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialities, University of Palermo, Palermo, Italy. Electronic address: giuliana.ferrante@unipa.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cilluffo</LastName>
                    <ForeName>Giovanna</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>the National Research Council of Italy (CNR), Institute for Biomedical Research and Innovation (IRIB), (previously Institute of Biomedicine and Molecular Immunology &quot;Alberto Monroy&quot; - IBIM), Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fasola</LastName>
                    <ForeName>Salvatore</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>the National Research Council of Italy (CNR), Institute for Biomedical Research and Innovation (IRIB), (previously Institute of Biomedicine and Molecular Immunology &quot;Alberto Monroy&quot; - IBIM), Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Malizia</LastName>
                    <ForeName>Velia</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>the National Research Council of Italy (CNR), Institute for Biomedical Research and Innovation (IRIB), (previously Institute of Biomedicine and Molecular Immunology &quot;Alberto Monroy&quot; - IBIM), Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muggeo</LastName>
                    <ForeName>Vito Mr</ForeName>
                    <Initials>VM</Initials>
                    <AffiliationInfo>
                        <Affiliation>the Department of Economics, Business and Statistics, University of Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Viegi</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>the CNR Institute of Clinical Physiology, Pisa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>La Grutta</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>the National Research Council of Italy (CNR), Institute for Biomedical Research and Innovation (IRIB), (previously Institute of Biomedicine and Molecular Immunology &quot;Alberto Monroy&quot; - IBIM), Palermo, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ROC curve</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">bronchodilator response</Keyword>
            <Keyword MajorTopicYN="N">diagnosis</Keyword>
            <Keyword MajorTopicYN="N">dynamic nomogram</Keyword>
            <Keyword MajorTopicYN="N">segmented model</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777445</ArticleId>
            <ArticleId IdType="pii">S0091-6749(20)31104-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.07.029</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777433</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Desensitization for inhaled vancomycin.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30560-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.004</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Al-Kaabi</LastName>
                    <ForeName>Aba</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Rheumatology, Allergy and Immunology, Tufts Medical Center, Boston, MA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pandya</LastName>
                    <ForeName>Aarti</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Allergy, Asthma &amp; Immunology. Children's Mercy Hospital. Kansas City, MO. Electronic address: aartipandyamd@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martinez</LastName>
                    <ForeName>John</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, Kansas City, KS.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Love</LastName>
                    <ForeName>Marissa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Clinical Immunology and Rheumatology, University of Kansas Medical Center, Kansas City, KS.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anaphylaxis</Keyword>
            <Keyword MajorTopicYN="N">Cystic Fibrosis</Keyword>
            <Keyword MajorTopicYN="N">Desensitization</Keyword>
            <Keyword MajorTopicYN="N">Inhaled Vancomycin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777433</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30560-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777302</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0631</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Life sciences</Title>
                <ISOAbbreviation>Life Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Role of metalloproteinases and TNF-α in obesity-associated asthma in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>118191</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0024-3205(20)30943-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lfs.2020.118191</ELocationID>
            <Abstract>
                <AbstractText>Numerous population studies conducted worldwide indicate that the prevalence of asthma is higher in obese versus lean individuals. It has been reported that sensitized lean mice has a better recovery of lung inflammation in asthma. Extracellular matrix (ECM) plays an essential role in the structural support of the lungs regulating the airways diameter, thus preventing its collapse during expiration. ECM renewal by metalloproteinase (MMPs) enzymes is critical for pulmonary biology. There seems to be an imbalance of MMPs activity in asthma and obesity, which can impair the lung remodeling process. In this study, we characterized the pulmonary ECM of obese and lean mice, non-sensitized and sensitized with ovalbumin (OVA). Pharmacological intervention was performed by using anti-TNF-α, and MMP-8 and MMP-9 inhibitors in obese and lean sensitized mice. Activity of MMPs was assessed by gelatinase electrophorese, western blotting and zymogram in situ. Unbalance of MMP-2, MMP-8, MMP-9 and MMP-12 was detected in lung tissue of OVA-sensitized obese mice, which was accompanied by high degradation, corroborating an excessive deposition of types I and III collagen in pulmonary matrix of obese animals. Inhibitions of TNF-α and MMP-9 reduced this MMP imbalance, clearly suggesting a positive effect on pulmonary ECM. Obese and lean mice presented diverse phenotype of asthma regarding the ECM compounds and the inhibition of MMPs pathway could be a good alternative to regulate the activity in ECM lungs of asthmatic obese individuals.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vieira</LastName>
                    <ForeName>Cristiano Pedrozo</ForeName>
                    <Initials>CP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil. Electronic address: cristianobio@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Oliveira</LastName>
                    <ForeName>Leticia Prado</ForeName>
                    <Initials>LP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, 13083-863 CP 6109, Campinas, Sao Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bombardi</LastName>
                    <ForeName>Mariana</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, 13083-863 CP 6109, Campinas, Sao Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andre</LastName>
                    <ForeName>Diana M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bastos</LastName>
                    <ForeName>Edith G</ForeName>
                    <Initials>EG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pimentel</LastName>
                    <ForeName>Edson Rosa</ForeName>
                    <Initials>ER</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, 13083-863 CP 6109, Campinas, Sao Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antunes</LastName>
                    <ForeName>Edson</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), Campinas, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Life Sci</MedlineTA>
            <NlmUniqueID>0375521</NlmUniqueID>
            <ISSNLinking>0024-3205</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic inflammation</Keyword>
            <Keyword MajorTopicYN="N">Extracellular matrix</Keyword>
            <Keyword MajorTopicYN="N">Metalloproteinases</Keyword>
            <Keyword MajorTopicYN="N">Obesity</Keyword>
            <Keyword MajorTopicYN="N">Ovalbumin</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of competing interest No conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777302</ArticleId>
            <ArticleId IdType="pii">S0024-3205(20)30943-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2020.118191</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777237</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0333</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicology and applied pharmacology</Title>
                <ISOAbbreviation>Toxicol. Appl. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IL-33/ST2 signaling modulates Afghanistan particulate matter induced airway hyperresponsiveness in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115186</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-008X(20)30312-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.taap.2020.115186</ELocationID>
            <Abstract>
                <AbstractText>Increased symptoms of asthma-like respiratory illnesses have been reported in soldiers returning from tours of duty in Afghanistan. Inhalation of desert particulate matter (PM) may contribute to this deployment-related lung disease (DRLD), but little is known about disease mechanisms. The IL-33 signaling pathway, including its receptor ST2, has been implicated in the pathogenesis of lung diseases including asthma, but its role in PM-mediated airway dysfunction has not been studied. The goal of this study was to investigate whether IL-33/ST2 signaling contributes to airway dysfunction in preclinical models of lung exposure to Afghanistan PM (APM). Wild-type (WT) and ST2 knockout (KO) mice on the BALB/C background were oropharyngeally instilled with a single dose of saline or 50 μg of APM in saline. Airway hyperresponsiveness (AHR) and inflammation were assessed after 24 h. In WT mice, a single APM exposure induced AHR and neutrophilic inflammation. Unlike the WT mice, ST2 KO mice that lack the receptor for IL-33 did not demonstrate AHR although airway neutrophilic inflammation was comparable to the WT mice. Oropharyngeal delivery of a soluble ST2 decoy receptor in APM-exposed WT mice significantly blocked AHR. Additional data in mouse tracheal epithelial cell and lung macrophage cultures demonstrated a role of APM-induced IL-33/ST2 signaling in suppression of regulator of G protein signaling 2 (RGS2), a gene known to protect against bronchoconstriction. We present for the first time that APM may increase AHR, one of the features of asthma, in part through the IL-33/ST2/RGS2 pathway.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Berman</LastName>
                    <ForeName>Reena</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Basic Science Section, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kopf</LastName>
                    <ForeName>Katrina W</ForeName>
                    <Initials>KW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Resource Center, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Min</LastName>
                    <ForeName>Elysia</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Downey</LastName>
                    <ForeName>Gregory P</ForeName>
                    <Initials>GP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Pulmonary, Critical Care &amp; Sleep Medicine, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alam</LastName>
                    <ForeName>Rafeul</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Allergy &amp; Clinical Immunology, National Jewish Health, Denver, CO, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Hong Wei</ForeName>
                    <Initials>HW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Basic Science Section, National Jewish Health, Denver, CO, United States of America. Electronic address: ChuH@njhealth.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Day</LastName>
                    <ForeName>Brian J</ForeName>
                    <Initials>BJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Medicine Office of Research, National Jewish Health, Denver, CO, United States of America. Electronic address: DayB@njhealth.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Toxicol Appl Pharmacol</MedlineTA>
            <NlmUniqueID>0416575</NlmUniqueID>
            <ISSNLinking>0041-008X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway hyperresponsiveness</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">IL-33</Keyword>
            <Keyword MajorTopicYN="N">Particulate matter</Keyword>
            <Keyword MajorTopicYN="N">ST2</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777237</ArticleId>
            <ArticleId IdType="pii">S0041-008X(20)30312-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.taap.2020.115186</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777193</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-4303</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
                <ISOAbbreviation>J Asthma</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Intravenous Methylprednisolone versus Intravenous Methylprednisolone Combined with Inhaled Budesonide in Acute Severe Pediatric Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2020.1808988</ELocationID>
            <Abstract>
                <AbstractText><b>Introduction:</b> Corticosteroids are important part of acute severe asthma (ASA) management in pediatric intensive care units. Few studies look at the efficacy of inhaled corticosteroids (ICS) in critical care settings. We aimed to investigate the potential beneficial effects of ICS when added to intravenous corticosteroids in pediatric patients with ASA admitted to the pediatric intensive care unit (PICU)<b>Methods:</b> This was a randomized controlled trial involving pediatric patients aged 1-21 years admitted to PICU with ASA. Patients were randomized into 2 groups using block randomization. Patients in Group A received intravenous methylprednisolone (2mg/kg/day) alone and patients in Group B received intravenous methylprednisolone (2mg/kg/day) plus budesonide nebulization (0.5mg every 12 hours). Main outcomes were duration of continuous albuterol treatment, PICU and hospital length of stay (LOS), and need and duration of respiratory support. Kruskal-Wallis and Chi-square tests were used for statistical analysis, in which a p-value &lt;0.05 was considered statistically significant.<b>Results:</b> Duration of continuous albuterol treatment was not different between the 2 groups median/(QR), 30/(18-51) vs. 25/(14-49). (p = 0.38) PICU and hospital LOS between the 2 groups was similar, median/(QR), 44/(30-64) vs. 46/(30-62), (p = 0.75) and 78/(65-95) vs.72/(58-92), (p = 0.19). Number of patients requiring respiratory support was 22(58%) in Group A and 25(64%) in Group B. (p = 0.19)<b>Conclusions:</b> In critically ill children with ASA, intravenous methylprednisolone combined with inhaled budesonide did not shorten the duration of continuous albuterol inhalation treatment, the PICU and hospital LOS, and the need for respiratory support.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gummalla</LastName>
                    <ForeName>Prabha</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weaver</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmed</LastName>
                    <ForeName>Youssef</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shah</LastName>
                    <ForeName>Vikas</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Kings County Hospital Center, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keenaghan</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Kings County Hospital Center, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doymaz</LastName>
                    <ForeName>Sule</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, SUNY Downstate Health Sciences University, Brooklyn, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Asthma</MedlineTA>
            <NlmUniqueID>8106454</NlmUniqueID>
            <ISSNLinking>0277-0903</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Pediatrics</Keyword>
            <Keyword MajorTopicYN="N">Pharmacotherapy</Keyword>
            <Keyword MajorTopicYN="N">Treatment</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777193</ArticleId>
            <ArticleId IdType="doi">10.1080/02770903.2020.1808988</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777181</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-4303</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>
                <ISOAbbreviation>J Asthma</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Psychological Impairment on Quality of Life and Work Impairment in Severe Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-14</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/02770903.2020.1808989</ELocationID>
            <Abstract>
                <AbstractText><b>Background</b>: Psychological impairment, such as anxiety and depression, is common in severe asthma. However, the impact of psychological impairment on asthma-specific quality of life (ASQOL) and work impairment has not been assessed within Southeast-Asia. Furthermore, previous ASQOL questionnaires contained items overlapping with asthma control, making it challenging to isolate the relationship between psychological impairment with ASQOL and asthma control respectively.<b>Objective</b>: To evaluate the relationship between psychological impairment with ASQOL and work impairment in severe asthma.<b>Methods</b>: This is a cross-sectional study of severe asthma at Singapore General Hospital. We assessed ASQOL, psychological impairment, work impairment and asthma control using validated questionnaires. An ASQOL questionnaire not containing items evaluating asthma symptoms was selected to reduce overlap with asthma control. Medical records were used to obtain other asthma characteristics and healthcare utilization patterns.<b>Results</b>: Amongst 111 patients, 37% had psychological impairment based on Hospital Anxiety and Depression Scale. Poorer ASQOL was associated with anxiety (<i>p</i> = 0.013) after controlling for demographic characteristics, asthma control and comorbidities. Anxiety symptoms were associated with greater health concerns while depression symptoms were associated with sleep difficulty and physical limitations. Having depressive symptoms was associated with an additional 16% impairment of total work hours (<i>p</i> = 0.038). Psychological impairment was not associated with spirometry results or healthcare utilization. Ethnicity significantly predicted both ASQOL and work impairment.<b>Conclusions</b>: In severe asthma, patients with psychological impairment have poorer ASQOL and greater work impairment than those without psychological impairment. There is an urgent need to mitigate this problem.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ong</LastName>
                    <ForeName>Adriel Shao En</ForeName>
                    <Initials>ASE</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0463-6877</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Adrian Kwok Wai</ForeName>
                    <Initials>AKW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sultana</LastName>
                    <ForeName>Rehena</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koh</LastName>
                    <ForeName>Mariko Siyue</ForeName>
                    <Initials>MS</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1230-0129</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Duke-NUS Medical School, Singapore.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Asthma</MedlineTA>
            <NlmUniqueID>8106454</NlmUniqueID>
            <ISSNLinking>0277-0903</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anxiety</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Depression</Keyword>
            <Keyword MajorTopicYN="N">Presenteeism</Keyword>
            <Keyword MajorTopicYN="N">Quality of Life</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777181</ArticleId>
            <ArticleId IdType="doi">10.1080/02770903.2020.1808989</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32777108</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-8652</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of hematology</Title>
                <ISOAbbreviation>Am. J. Hematol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinically suspected cast nephropathy: a retrospective, national, real-world study.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ajh.25959</ELocationID>
            <Abstract>
                <AbstractText>Presentation with severe acute kidney injury due to cast nephropathy (CN) is a medical emergency in multiple myeloma (MM) with high risk of dialysis-dependent renal failure and death. Accrual of patients with CN into interventional studies is difficult, while phase III trials exclude patients with severe renal insufficiency. Real-world data are warranted. We assessed 2252 patients from the population-based Danish Multiple Myeloma Registry (DMMR), diagnosed 2013-2017. We identified 204 patients with clinically suspected CN, defined as serum creatinine concentration &gt;177 μmol/L and serum free light chain (sFLC) concentration &gt;1000 mg/L at the time of diagnosis. The median age was 72 years. Thirty-one percent of patients presented with dialysis-dependent renal failure. Kidney biopsies were performed in 19% of patients and showed CN in 74% of cases. Despite prompt initiation of bortezomib-based therapy in 94% of patients, 33% of patients died in the first year after diagnosis. Compared with the rest of the patients in the DMMR with symptomatic MM, patients with clinically suspected CN had worse overall survival (OS) irrespective of transplant eligibility. Achievement of renal recovery was associated with deep reductions of involved sFLC. Achievement of very good partial response or better in the first line of therapy and/or deep reduction of involved sFLC at three months after initiation of therapy were associated with superior OS. In conclusion, MM patients presenting with clinically suspected CN have an alarmingly high one-year mortality when treated with current standards of care. Early and deep hematologic response is crucial for survival. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Szabo</LastName>
                    <ForeName>Agoston Gyula</ForeName>
                    <Initials>AG</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-9943-7007</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Vejle Hospital, Vejle and University of Southern Denmark, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thorsen</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Vejle Hospital, Vejle and University of Southern Denmark, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iversen</LastName>
                    <ForeName>Katrine Fladeland</ForeName>
                    <Initials>KF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Vejle Hospital, Vejle and University of Southern Denmark, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hansen</LastName>
                    <ForeName>Charlotte Toftmann</ForeName>
                    <Initials>CT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Odense University Hospital, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teodorescu</LastName>
                    <ForeName>Elena Manuela</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pedersen</LastName>
                    <ForeName>Simon Bo</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Herlev University Hospital, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Flaeng</LastName>
                    <ForeName>Simon Bertram</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Regional Hospital West Jutland, Holstebro, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Strandholdt</LastName>
                    <ForeName>Casper</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Hospital of South West Jutland, Esbjerg, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frederiksen</LastName>
                    <ForeName>Mikael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Aabenraa Hospital, Aabenraa, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vase</LastName>
                    <ForeName>Maja Ølholm</ForeName>
                    <Initials>MØ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frølund</LastName>
                    <ForeName>Ulf Christian</ForeName>
                    <Initials>UC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Zealand University Hospital, Roskilde, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krustrup</LastName>
                    <ForeName>Dorrit</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Herlev University Hospital, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plesner</LastName>
                    <ForeName>Torben</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Vejle Hospital, Vejle and University of Southern Denmark, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Southern Denmark Faculty of Health Sciences, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vangsted</LastName>
                    <ForeName>Annette Juul</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2131-731X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Hematology, Rigshospitalet, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Hematol</MedlineTA>
            <NlmUniqueID>7610369</NlmUniqueID>
            <ISSNLinking>0361-8609</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32777108</ArticleId>
            <ArticleId IdType="doi">10.1002/ajh.25959</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32776985</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pulmonary function analysis in cotton rats after respiratory syncytial virus infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0237404</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0237404</ELocationID>
            <Abstract>
                <AbstractText>The cotton rat (Sigmodon hispidus) is an excellent small animal model for human respiratory viral infections such as human respiratory syncytial virus (RSV) and human metapneumovirus (HMPV). These respiratory viral infections, as well as other pulmonary inflammatory diseases such as asthma, are associated with lung mechanic disturbances. So far, the pathophysiological effects of viral infection and allergy on cotton rat lungs have not been measured, although this information might be an important tool to determine the efficacy of vaccine and drug candidates. To characterize pulmonary function in the cotton rat, we established forced oscillation technique in uninfected, RSV infected and HDM sensitized cotton rats, and characterized pulmonary inflammation, mucus production, pulmonary edema, and oxygenation. There was a gender difference after RSV infection, with females demonstrating airway hyper-responsiveness while males did not. Female cotton rats 2dpi had a mild increase in pulmonary edema (wet: dry weight ratios). At day 4 post infection, female cotton rats demonstrated mild pulmonary inflammation, no increase in mucus production or reduction in oxygenation. Pulmonary function was not significantly impaired after RSV infection. In contrast, cotton rats sensitized to HDM demonstrated airway hyper-responsiveness with a significant increase in pulmonary inflammation, increase in baseline tissue damping, and a decrease in baseline pulmonary compliance. In summary, we established baseline data for forced oscillation technique and other respiratory measures in the cotton rat and used it to analyze respiratory diseases in cotton rats.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Martinez</LastName>
                    <ForeName>Margaret E</ForeName>
                    <Initials>ME</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9637-7117</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harder</LastName>
                    <ForeName>Olivia E</ForeName>
                    <Initials>OE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosas</LastName>
                    <ForeName>Lucia E</ForeName>
                    <Initials>LE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joseph</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davis</LastName>
                    <ForeName>Ian C</ForeName>
                    <Initials>IC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niewiesk</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, Ohio, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>Genentech provided the corresponding author with a research fellowship that aided in the following research to be conducted. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32776985</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0237404</ArticleId>
            <ArticleId IdType="pii">PONE-D-20-10846</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32776586</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1529-8019</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Dermatologic therapy</Title>
                <ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Use of dupilumab in a patient with atopic dermatitis, severe asthma, and HIV infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e14159</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.14159</ELocationID>
            <Abstract>
                <AbstractText>Dupilumab is a monoclonal antibody against interleukin 4 (IL-4) receptor α that blocks signaling from IL-4 and IL-13, essential mediators of T helper 2 (Th2) pathway. To date, all clinical trials investigating the use of dupilumab excluded patients with human immunodeficiency virus. Herein, we describe the safe and successful use of dupilumab in a patient with atopic dermatitis, severe therapy resistant asthma, and HIV infection. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Petra</LastName>
                    <ForeName>Brodska</ForeName>
                    <Initials>B</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3321-7049</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, Charles University, Pilsen, Czech Republic.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petr</LastName>
                    <ForeName>Panzner</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1291-450X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Immunology and Allergology, Charles University, Pilsen, Czech Republic.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dalibor</LastName>
                    <ForeName>Sedlacek</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Charles University, Pilsen, Czech Republic.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milan</LastName>
                    <ForeName>Terl</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pneumology and Phthisiology, Charles University, Pilsen, Czech Republic.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Petra</LastName>
                    <ForeName>Cetkovska</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, Charles University, Pilsen, Czech Republic.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Dermatol Ther</MedlineTA>
            <NlmUniqueID>9700070</NlmUniqueID>
            <ISSNLinking>1396-0296</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HIV</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">dupilumab</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32776586</ArticleId>
            <ArticleId IdType="doi">10.1111/dth.14159</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32776473</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1610-0387</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG</Title>
                <ISOAbbreviation>J Dtsch Dermatol Ges</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mites, caterpillars and moths.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/ddg.14207</ELocationID>
            <Abstract>
                <AbstractText>Besides conditions such as scabies and hypersensitivity to house dust mites, other diseases caused by mites and caterpillars tend to be more uncommon in everyday practice. Nevertheless, there is a broad spectrum of medically relevant disorders associated with these arthropods. Mites may act as parasites that infect or colonize the skin (e.g., scabies, pseudoscabies, demodicosis) or they may pierce the host's skin and feed on tissue fluid and blood (trombiculosis). In the latter case, they also play a role as vectors transmitting Orientia tsutsugamushi, the pathogen that causes Tsutsugamushi fever. In addition to house dust mites, storage mites, too, are characterized by their allergenic potential. The terms erucism and lepidopterism are used for the various diseases caused by caterpillars and moths. Both terms are not used consistently. With respect to pathogenesis, various mechanisms have been described, including type I and type IV hypersensitivity as well as irritant and toxin-induced reactions. In Germany, skin reactions following exposure to the hairs of oak processionary caterpillars are particularly common. Extracutaneous manifestations including nausea, vomiting, hemorrhage, arthropathy or even life-threatening reactions have been reported in association with certain exotic species. Some species act as parasites by feeding on blood or tears. As natural silk can cause immediate and delayed-type hypersensitivity reactions, workers in the silk industry may develop allergic asthma, rhinitis, or conjunctivitis. Consumption of silkworm pupae is associated with the risk of food allergy.</AbstractText>
                <CopyrightInformation>© 2020 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Panzer</LastName>
                    <ForeName>Rüdiger</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, University Medical Center, Rostock, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krebs</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Venereology, University Medical Center, Rostock, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>J Dtsch Dermatol Ges</MedlineTA>
            <NlmUniqueID>101164708</NlmUniqueID>
            <ISSNLinking>1610-0379</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32776473</ArticleId>
            <ArticleId IdType="doi">10.1111/ddg.14207</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>References</Title>
            <Reference>
                <Citation>Sunderkötter C, Aebischer A, Neufeld M. Zunahme von Skabies in Deutschland und Entwicklung resistenter Krätzemilben? Evidenz und Konsequenz. J Dtsch Dermatol Ges 2019; 17(1): 15-24.</Citation>
            </Reference>
            <Reference>
                <Citation>Beck W, Pfister K. Mites as a cause of zoonoses in human beings. Wien Klin Wochenschr 2006; 118(Suppl 3): 27-32.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol 2014;170(6): 1219-25.</Citation>
            </Reference>
            <Reference>
                <Citation>Elston DM. What’s eating you? Chiggers. Cutis 2006; 77: 350-2.</Citation>
            </Reference>
            <Reference>
                <Citation>Grob, M, Dorn K, Lautenschlager S. Grain mites. A small epidemic caused by Pyemotes species. Hautarzt 1998; 49(11): 838-43.</Citation>
            </Reference>
            <Reference>
                <Citation>Lv Y, Guo X, Jin D. Research Progress on Leptotrombidium. Korean J Parasitol 2018; 56(4): 313-24.</Citation>
            </Reference>
            <Reference>
                <Citation>Calderón MA, Linneberg A, Kleine-Tebbe J et al. Respiratory allergy caused by house dust mites: What do we really know? J Allergy Clin Immunol 2015; 136(1): 38-48.</Citation>
            </Reference>
            <Reference>
                <Citation>Klimek L, Brehler R, Bergmann K. Mini-Review: Allergenspezifische Immuntherapie mit Vorratsmilben. Allergo J Int 2018; 27: 15-9.</Citation>
            </Reference>
            <Reference>
                <Citation>Hossler EW. Caterpillars and moths: Dermatologic manifestations of encounters with Lepidoptera. Part I. J Am Acad Dermatol 2010; 62(1): 1-10.</Citation>
            </Reference>
            <Reference>
                <Citation>Hossler EW. Caterpillars and moths: Dermatologic manifestations of encounters with Lepidoptera. Part II. J Am Acad Dermatol 2010; 62(1): 13-28.</Citation>
            </Reference>
            <Reference>
                <Citation>Diaz JH. The evolving global epidemiology, syndromic classification, management, and prevention of caterpillar envenoming. Am J Trop Med Hyg 2005; 72 (3): 347-57.</Citation>
            </Reference>
            <Reference>
                <Citation>Bänziger H. Skin-piercing blood-sucking moths I: ecological and ethological studies on Calpe eustrigata (Lepid., noctuidae). Acta Trop 1975; 32(2): 125-44.</Citation>
            </Reference>
            <Reference>
                <Citation>Makatsori M, Scadding GW, Skypala I et al. Silk contact anaphylaxis. Contact Dermatitis 2014; 71: 303-17.</Citation>
            </Reference>
            <Reference>
                <Citation>Liu Z, Xia L, Wu Y et al. Identification and characterization of an arginine kinase as a major allergen from silkworm (bombyx mori) larvae. Int Arch Allergy Immunol 2009; 150: 8-14.</Citation>
            </Reference>
            <Reference>
                <Citation>Cafiero MA, Barlaam A, Camarda A et al. Dermanysuss gallinae attacks humans. Mind the gap! Avian Pathol 2019; 48(sup1): S22-S34.</Citation>
            </Reference>
            <Reference>
                <Citation>Vargas-Arzola J, Reyes-Velasco L, Segura-Salvador A et al. Prevalence of demodex mites in eyelashes among people of Oaxaca, Mexico. Acta Microbiol Immunol Hung 2012; 59(2): 257-62.</Citation>
            </Reference>
            <Reference>
                <Citation>Litwin D, Chen W, Dzika E, Korycinska J. Human permanent ectoparasites; recent advances on biology and clinical significance of demodex mites: narrative review article. Iran J Parasitol 2017;12(1): 12-21.</Citation>
            </Reference>
            <Reference>
                <Citation>Moran EM, Foley R, Powell FC. Demodex and rosacea revisited. Clin Dermatol 2017; 35(2): 195-200.</Citation>
            </Reference>
            <Reference>
                <Citation>Forton FMN, De Maertelaer V. Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease? J Eur Acad Dermatol Venereol 2018; 32(6): 1011-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Forton F. Demodex-associated folliculitis. Am J Dermatopathol 1998; 20(5): 536-7.</Citation>
            </Reference>
            <Reference>
                <Citation>Yan S, Ci X, Chen N et al. Anti-inflammatory effects of ivermectin in mouse model of allergic asthma. Inflamm Res 2011; 60(6): 589-96.</Citation>
            </Reference>
            <Reference>
                <Citation>Pettengill MA, Lam VW, Ollawa I et al. Ivermectin inhibits growth of Chlamydia trachomatis in epithelial cells. PLoS One 2012; 7(10): e48456.</Citation>
            </Reference>
            <Reference>
                <Citation>Gao YY, Di Pascuale MA, Li W et al. In vitro and in vivo killing of ocular Demodex by tea tree oil. Br J Ophthalmol 2005; 89(11): 1468-73.</Citation>
            </Reference>
            <Reference>
                <Citation>Walton SF, McKinnon M, Pizzutto S et al. Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol 2004; 140(5): 563-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Hirsch-Hoffmann S, Kaufmann C, Bänninger PB. Treatment options for demodex blepharitis: patient choice and efficacy. Klin Monbl Augenheilkd 2015; 232(4): 384-7.</Citation>
            </Reference>
            <Reference>
                <Citation>di Meo N, Fadel M, Trevisan G. Pushing the edge of dermoscopy in new directions: entomodermoscopy of Trombicula autumnalis. Acta Dermatovenerol Alp Pannonica Adriat 2017; 26(2): 45-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Smith GA, Sharma V, Knapp JF et al. The summer penile syndrome: seasonal acute hypersensitivity reaction caused by chigger bites on the penis. Pediatr Emerg Care 1998; 14(2): 116-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Woloski JR, Burma D, Adebona O. Mite and bed bug infections. Prim Care Clin Office Pract 2018; 45: 409-21.</Citation>
            </Reference>
            <Reference>
                <Citation>Acevedo N, Zakzuk J, Caraballo L. House dust mite allergy under changing environments. Allergy Asthma Immunol Res 2019; 11(4): 450-69.</Citation>
            </Reference>
            <Reference>
                <Citation>Hilger C, Kuehn A, Raulf M, Jakob T. Cockroach, tick, storage mite and other arthropod allergies: Where do we stand with molecular allergy diagnostics?: Part 15 of the Series Molecular Allergology. Allergo J Int 2014; 23(6): 172-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Dietrich Mebs. Gifttiere - Ein Handbuch für Biologen, Toxikologen, Ärzte und Apotheker. 2. Auflage, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 2000.</Citation>
            </Reference>
            <Reference>
                <Citation>Maier H, Spiegel W, Kinaciyan T et al. Caterpillar dermatitis in two siblings due to the larvae of Thaumetopoea processionea L, the oak processionary caterpillar. Dermatology 2004; 208 (1), 70-3.</Citation>
            </Reference>
            <Reference>
                <Citation>Bonamonte D, Foti C, Vestita M et al. Skin reactions to pine processionary caterpillar, Thaumetopoea pityocampa Schiff. ScientificWorldJournal 2013; 27: 867431.</Citation>
            </Reference>
            <Reference>
                <Citation>Battisti A, Holm G, Fagrell B, et al. Urticating hairs in arthropods: their nature and medical significance. Annu Rev Entomol 2011; 56: 203-20.</Citation>
            </Reference>
            <Reference>
                <Citation>Vega JM, Moneo I, Armentia A et al. Allergy to the pine processionary caterpillar (Thaumetopoea pityocampa). Clin Exp Allergy 1999; 29(10): 1418-23.</Citation>
            </Reference>
            <Reference>
                <Citation>Rodriguez-Mahillo AI, Gonzalez-Muñoz M, Vega JM et al. Setae from the pine processionary moth (Thaumetopoea pityocampa) contain several relevant allergens. Contact Dermatitis 2012; 67(6): 367-74.</Citation>
            </Reference>
            <Reference>
                <Citation>Bänziger H. Skin-piercing blood-sucking moths III: feeding act and piercing mechanism of Calyptra eustrigata (Hmps.) (Lep., Noctuidae). Mitt Schweiz Entomol Ges Acta Trop 1980; 53: 127-42.</Citation>
            </Reference>
            <Reference>
                <Citation>Rahlenbeck S, Utikal J. The oak processionary moth: a new health hazard? Br J Gen Pract 2015; 65(637): 435-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Utikal J, Booken N, Peitsch WK et al. Caterpillar dermatitis. An increasing dermatologic problem in warmer regions of Germany. Hautarzt 2009; 60(1): 48-50.</Citation>
            </Reference>
            <Reference>
                <Citation>Maier H, Spiegel W, Kinaciyan T. The oak processionary caterpillar as the cause of an epidemic airborne disease: survey and analysis. Br J Dermatol 2003; 149(5): 990-7.</Citation>
            </Reference>
            <Reference>
                <Citation>Burgess NR, Chetwyn KN. The biology, medical significance and control of processionary caterpillars. J R Army Med Corps 1983; 129(3): 178-81.</Citation>
            </Reference>
            <Reference>
                <Citation>Umweltbundesamt. Leitfaden zur Eindämmung des Eichenprozessionsspinners Available from https://www.umweltbundesamt.de/sites/default/files/medien/417/dokumente/leitfaden_eps_nl_deutsch.pdf [Last accessed June 17, 2020].</Citation>
            </Reference>
            <Reference>
                <Citation>Chudzinski-Tavassi AM, Carrijo-Carvalho LC. Biochemical and biological properties of Lonomia obliqua bristle extract. J Venom Anim Toxins incl Trop Dis [online]. 2006; 12(2): 159-71.</Citation>
            </Reference>
            <Reference>
                <Citation>Verhulst L, Goossens A. Cosmetic components causing contact urticaria: a review and update. Contact Dermatitis 2016; 75: 333-44.</Citation>
            </Reference>
            <Reference>
                <Citation>Gowda G, Shivalingaiah AH, Vijayeendra AM. Sensitization to silk allergen among workers of silk filatures in India: a comparative study. Asia Pac Allergy 2016; 6: 90-3.</Citation>
            </Reference>
            <Reference>
                <Citation>Kurosaki S, Otsuka H, Kunitomo M. Fibroin allergy. IgE mediated hypersensitivity to silk suture materials. Nihon Ika Daigaku Zasshi 1999; 66(1): 41-4.</Citation>
            </Reference>
            <Reference>
                <Citation>Inoue A, lshido I, Shoji A. Textile dermatitis from silk. Contact Dermatitis 1997; 37: 185.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32776208</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1741-0444</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>10</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Medical &amp; biological engineering &amp; computing</Title>
                <ISOAbbreviation>Med Biol Eng Comput</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Differential diagnosis of asthma and restrictive respiratory diseases by combining forced oscillation measurements, machine learning and neuro-fuzzy classifiers.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11517-020-02240-7</ELocationID>
            <Abstract>
                <AbstractText>To design machine learning classifiers to facilitate the clinical use and increase the accuracy of the forced oscillation technique (FOT) in the differential diagnosis of patients with asthma and restrictive respiratory diseases. FOT and spirometric exams were performed in 97 individuals, including controls (n = 20), asthmatic patients (n = 38), and restrictive (n = 39) patients. The first experiment of this study showed that the best FOT parameter was the resonance frequency, providing moderate accuracy (AUC = 0.87). In the second experiment, a neuro-fuzzy classifier and different supervised machine learning techniques were investigated, including k-nearest neighbors, random forests, AdaBoost with decision trees, and support vector machines with a radial basis kernel. All classifiers achieved high accuracy (AUC ≥ 0.9) in the differentiation between patient groups. In the third and fourth experiments, the use of different feature selection techniques allowed us to achieve high accuracy with only three FOT parameters. In addition, the neuro-fuzzy classifier also provided rules to explain the classification. Neuro-fuzzy and machine learning classifiers can aid in the differential diagnosis of patients with asthma and restrictive respiratory diseases. They can assist clinicians as a support system providing accurate diagnostic options.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Amaral</LastName>
                    <ForeName>Jorge L M</ForeName>
                    <Initials>JLM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Electronics and Telecommunications Engineering, State University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sancho</LastName>
                    <ForeName>Alexandre G</ForeName>
                    <Initials>AG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Instrumentation Laboratory, Institute of Biology Roberto Alcantara Gomes and Laboratory of Clinical and Experimental Research in Vascular Biology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Faria</LastName>
                    <ForeName>Alvaro C D</ForeName>
                    <Initials>ACD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Instrumentation Laboratory, Institute of Biology Roberto Alcantara Gomes and Laboratory of Clinical and Experimental Research in Vascular Biology, State University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopes</LastName>
                    <ForeName>Agnaldo J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary Function Laboratory, Pedro Ernesto University Hospital, State University of Rio de Janeiro, Rio de Janeiro, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melo</LastName>
                    <ForeName>Pedro L</ForeName>
                    <Initials>PL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2081-6619</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Instrumentation Laboratory, Institute of Biology Roberto Alcantara Gomes and Laboratory of Clinical and Experimental Research in Vascular Biology, State University of Rio de Janeiro, Rio de Janeiro, Brazil. plopes@uerj.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Med Biol Eng Comput</MedlineTA>
            <NlmUniqueID>7704869</NlmUniqueID>
            <ISSNLinking>0140-0118</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Clinical decision support system</Keyword>
            <Keyword MajorTopicYN="N">Diagnostic of respiratory diseases</Keyword>
            <Keyword MajorTopicYN="N">Differential diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Forced oscillation technique</Keyword>
            <Keyword MajorTopicYN="N">Respiratory oscillometry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32776208</ArticleId>
            <ArticleId IdType="doi">10.1007/s11517-020-02240-7</ArticleId>
            <ArticleId IdType="pii">10.1007/s11517-020-02240-7</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32775397</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2312-0541</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>6</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Apr</Month>
                    </PubDate>
                </JournalIssue>
                <Title>ERJ open research</Title>
                <ISOAbbreviation>ERJ Open Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The impact of a heat and moisture exchange mask on respiratory symptoms and airway response to exercise in asthma.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">00271-2019</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1183/23120541.00271-2019</ELocationID>
            <Abstract>
                <AbstractText>Respiratory symptoms, including cough, are prevalent in individuals with asthma when exercising. This study investigates whether a heat and moisture exchanger (HME) face mask is effective in modulating exercise-induced bronchoconstriction (EIB) and post-exercise cough in a cold, dry environment in individuals with asthma. Twenty-six participants diagnosed with asthma (20 males, 6 females) completed three cycling exercise challenges at 8°C and 24% relative humidity in a randomised order. Participants wore either an HME mask (MASK), sham mask (SHAM), or no mask (CONT). Following a 3-min warm-up, participants completed 6-min cycling at 80% peak power output. Before and after exercise, maximal flow-volume loops were recorded. Post-exercise cough was monitored with a Leicester Cough Monitor (LCM) for 24 h. Results were analysed using repeated-measures ANOVA and Friedman's tests and data were presented as the mean±sd or median (interquartile range (IQR)). Eleven participants failed to demonstrate EIB (<i>i.e.</i> &gt;10% fall in forced expiratory volume in 1 s after exercise) and were removed from analysis. The percentage fall in forced expiratory volume in 1 s following exercise in CONT was greater than MASK (MASK: -6% (7%), SHAM: -11% (11%), CONT: -13% (9%); p&lt;0.01). No difference was found between exercise in cough count per hour over the 24-h monitoring period or the number of coughs in the first hour after exercise. HME masks can attenuate EIB when exercising in cold, dry environments. The SHAM mask may not have been entirely inert, demonstrating the challenges of running randomised control trials utilising control and sham conditions.</AbstractText>
                <CopyrightInformation>Copyright ©ERS 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jackson</LastName>
                    <ForeName>Anna R</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Sport and Exercise Sciences, University of Kent, Chatham, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>English Institute of Sport, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hull</LastName>
                    <ForeName>J H</ForeName>
                    <Initials>JH</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4697-1526</Identifier>
                    <AffiliationInfo>
                        <Affiliation>English Institute of Sport, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Dept of Respiratory Medicine, Royal Brompton Hospital, London, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Heart and Lung Institute, Imperial College, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hopker</LastName>
                    <ForeName>James G</ForeName>
                    <Initials>JG</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Sport and Exercise Sciences, University of Kent, Chatham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fletcher</LastName>
                    <ForeName>Hannah</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>King's College Hospital NHS Foundation Trust, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gowers</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Sport and Exercise Sciences, University of Kent, Chatham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Birring</LastName>
                    <ForeName>Surinder S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>King's College Hospital NHS Foundation Trust, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dickinson</LastName>
                    <ForeName>John W</ForeName>
                    <Initials>JW</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Sport and Exercise Sciences, University of Kent, Chatham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>Dryad</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>10.5061/dryad.gf1vhhmkm</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>ERJ Open Res</MedlineTA>
            <NlmUniqueID>101671641</NlmUniqueID>
            <ISSNLinking>2312-0541</ISSNLinking>
        </MedlineJournalInfo>
        <CoiStatement>Conflict of interest: A.R. Jackson has nothing to disclose. Conflict of interest: J.H. Hull has nothing to disclose. Conflict of interest: J.G. Hopker has nothing to disclose. Conflict of interest: H. Fletcher has nothing to disclose. Conflict of interest: W. Gowers has nothing to disclose. Conflict of interest: S.S. Birring reports grants and personal fees from Merck, and personal fees from Bayer, NeRRe and Sanofi, outside the submitted work. Conflict of interest: J.W. Dickinson has nothing to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32775397</ArticleId>
            <ArticleId IdType="doi">10.1183/23120541.00271-2019</ArticleId>
            <ArticleId IdType="pii">00271-2019</ArticleId>
            <ArticleId IdType="pmc">PMC7401317</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Allergy. 1995 Mar;50(3):221-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7677238</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2008 May;31(5):1013-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18184683</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2000 Jan;161(1):309-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10619836</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 1992 Feb 22;304(6825):479-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1547419</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Med Sci Sports. 2016 Jul;26(7):835-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26283581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Appl Physiol (1985). 2011 Oct;111(4):1059-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21799131</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Aug;26(2):319-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16055882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Allergy Clin North Am. 2013 Aug;33(3):363-80, viii</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23830130</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2011 Sep 1;184(5):602-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21885636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1984 Oct 4;311(14):883-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6472400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cough. 2012 Mar 26;8(1):2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22449054</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Allergy Clin North Am. 2013 Aug;33(3):299-312, vii</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23830126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2015 Oct 16;17(10):e234</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26475634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thorac Dis. 2014 Oct;6(Suppl 7):S728-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25383207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 1980 Nov 14;244(19):2196-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7420725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):163-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17085791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1992 Jun;47(6):446-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1496504</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Med Sci Sports. 2020 Mar;30(3):591-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31755166</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2003 Apr;58(4):339-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12668799</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2000 Jun;161(6):2086-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10852791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2017 Jan 17;317(3):269-279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28114551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2017 Dec;47:49-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28412479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2006 May;129(5):1188-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16685008</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2000 Jul;55(7):672-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10921469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1979 Sep 22;2(8143):629</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">90283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2006 Jun;100(6):1105-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16266801</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2013 May 1;187(9):1016-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23634861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Mal Respir. 1994;11 Suppl 3:5-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7973051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2008 Aug;122(2):225-35; quiz 236-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18554705</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32775214</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2214-7500</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicology reports</Title>
                <ISOAbbreviation>Toxicol Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of a system for the detection of the inflammatory response induced by airborne fine particulate matter in rat tracheal epithelial cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>900-908</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.toxrep.2020.06.011</ELocationID>
            <Abstract>
                <AbstractText>Exposure to airborne particulate matter (PM) is related to the increased risk of several diseases, including chronic and allergic rhinitis. We have previously shown that atmospheric endotoxin level was positively associated with the number of emergency department visits for asthma even after adjusting for meteorological factors, suggestive of the significant association between atmospheric endotoxin level and asthma exacerbation. Whether atmospheric endotoxin level is related to inflammatory response induction is, however, unclear. Here, we established stable cell lines to determine the promoter activity of the genes encoding pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin 6 (IL6), and IL33 by transfection of each reporter plasmid into rat tracheal epithelial EGV-4 T cells. These cells could measure the inflammatory response induced by endotoxin treatment more easily, rapidly, and sensitively than the conventional system using immunodetection assays. Furthermore, we revealed a relationship between atmospheric endotoxin level and inflammatory response induction. Thus, the system established herein may serve as a promising tool to monitor inflammatory response induced upon PM exposure.</AbstractText>
                <CopyrightInformation>© 2020 Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yamagishi</LastName>
                    <ForeName>Nobuyuki</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Analytics for Biomolecules, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamaguchi</LastName>
                    <ForeName>Tomoki</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Analytics for Biomolecules, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuga</LastName>
                    <ForeName>Takahisa</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Analytics for Biomolecules, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taniguchi</LastName>
                    <ForeName>Masanari</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Analytics for Biomolecules, Faculty of Pharmaceutical Sciences, Setsunan University, 45-1 Nagaotoge-cho, Hirakata, Osaka 573-0101, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khan</LastName>
                    <ForeName>Mohammad Shahriar</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health, Kyoto Pharmaceutical University, 1 Misasagishichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsumoto</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health, Kyoto Pharmaceutical University, 1 Misasagishichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deguchi</LastName>
                    <ForeName>Yuya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagaoka</LastName>
                    <ForeName>Hiroaki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wakabayashi</LastName>
                    <ForeName>Keiji</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health, Kyoto Pharmaceutical University, 1 Misasagishichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Graduate Division of Nutritional and Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Watanabe</LastName>
                    <ForeName>Tetsushi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health, Kyoto Pharmaceutical University, 1 Misasagishichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Toxicol Rep</MedlineTA>
            <NlmUniqueID>101630272</NlmUniqueID>
            <ISSNLinking>2214-7500</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airborne particulate matter</Keyword>
            <Keyword MajorTopicYN="N">Coarse particle</Keyword>
            <Keyword MajorTopicYN="N">Endotoxin</Keyword>
            <Keyword MajorTopicYN="N">Fine particle</Keyword>
            <Keyword MajorTopicYN="N">Pro-inflammatory cytokines</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32775214</ArticleId>
            <ArticleId IdType="doi">10.1016/j.toxrep.2020.06.011</ArticleId>
            <ArticleId IdType="pii">S2214-7500(20)30346-2</ArticleId>
            <ArticleId IdType="pmc">PMC7394921</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2014 Oct 07;5:491</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25339958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e34664</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22529923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tohoku J Exp Med. 2016;239(2):117-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27246665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Perspect. 1997 Sep;105 Suppl 5:1053-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9400700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Perspect. 2001 Jun;109 Suppl 3:395-403</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11427389</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Perspect. 2005 Aug;113(8):934-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16079061</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Feb 1;174(3):1638-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15661927</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol. 1999 Apr;276(4):L604-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10198358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Feb 07;9(2):e88578</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24516670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Rep. 2014 May 16;1:145-156</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28962235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Epidemiol. 2016 Nov 5;26(11):593-601</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27180931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2002 Oct 15;169(8):4531-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12370390</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Toxicol. 2014 Jun;29(6):642-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22778050</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Epidemiol. 2017 Jan 1;185(1):30-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27927620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2000 Apr 17;249(1-3):85-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10813449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Sep 18;10(9):e0138146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26382947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Pharm Bull. 2018;41(1):115-122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29311473</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol In Vitro. 2013 Sep;27(6):1762-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23685237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2015 Dec 1;192(11):1287-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26258643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Sci. 1998 Jun;43(2):204-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9710962</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Toxicol. 2012 Jun;8(2):166-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22194192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Prev Med. 2018 Aug 28;23(1):41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30153806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2017 Jul;57(1):59-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28245149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicology. 2000 Nov 2;152(1-3):13-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11090935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Rep. 2016 Sep 23;3:785-795</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28959605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Perspect. 2015 Jan;123(1):6-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25303775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Prev Med. 2010 Nov;15(6):350-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21432566</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2010 Aug 1;182(3):307-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20378732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2001 Aug 15;164(4):704-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11520740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Toxicol Pharmacol. 2015 Sep;40(2):375-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26245811</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2010 Dec 15;182(12):1475-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20656941</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32775193</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2213-0071</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>31</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Respiratory medicine case reports</Title>
                <ISOAbbreviation>Respir Med Case Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Marked hypereosinophilia secondary to endometrioid ovarian cancer presenting with asthma symptoms, a case report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>101178</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rmcr.2020.101178</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Hypereosinophilia (HE) is defined by the presence of &gt;1.5 × 10<sup>9</sup>/L eosinophils in the peripheral blood. Paraneoplastic HE has been reported in a number of solid and hematologic malignancies including ovarian cancer. We present a case with paraneoplastic HE in the setting of underlying endometrioid ovarian carcinoma.</AbstractText>
                <AbstractText Label="Case presentation" NlmCategory="UNASSIGNED">An 88-year-old woman presented with cough, dyspnea and 20-pound unintentional weight loss of one month duration. Evaluation revealed peripheral hypereosinophilia (HE) with absolute eosinophil count of 15.38 × 10<sup>9</sup>/L (53.8%) and an elevated exhaled nitric oxide at 172 parts per billion (normal &lt; 39 PPB). Given the HE and unintentional weight loss, computed tomography (CT) scan was obtained and showed a pelvic mass. The patient underwent bilateral salpingo-ophorectomy with pathology consistent with endometrioid ovarian carcinoma. The patient experienced complete resolution of her cough, dyspnea, and peripheral eosinophilia following surgical resection.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">This case highlights that solid malignancy should be considered in patients with marked HE.</AbstractText>
                <CopyrightInformation>© 2020 The Authors. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hasan Albitar</LastName>
                    <ForeName>Hasan Ahmad</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Egan</LastName>
                    <ForeName>Ashley M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alkhateeb</LastName>
                    <ForeName>Hassan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Almodallal</LastName>
                    <ForeName>Yahya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iyer</LastName>
                    <ForeName>Vivek N</ForeName>
                    <Initials>VN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Respir Med Case Rep</MedlineTA>
            <NlmUniqueID>101604463</NlmUniqueID>
            <ISSNLinking>2213-0071</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Eosinophilia</Keyword>
            <Keyword MajorTopicYN="N">Hypereosinophilia</Keyword>
            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
            <Keyword MajorTopicYN="N">Paraneoplastic</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no competing or conflicting interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32775193</ArticleId>
            <ArticleId IdType="doi">10.1016/j.rmcr.2020.101178</ArticleId>
            <ArticleId IdType="pii">S2213-0071(20)30392-0</ArticleId>
            <ArticleId IdType="pii">101178</ArticleId>
            <ArticleId IdType="pmc">PMC7404536</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Jpn J Clin Oncol. 1998 Sep;28(9):559-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9793030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Harefuah. 1976 Mar 1;90(5):213-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1270013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2011 Jan;105(1):114-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21036585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Oncol. 2005 Mar 15;89(4):273-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15726608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Lab Hematol. 2019 Apr;41(2):153-161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30499630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med Sci. 2003 Aug;326(2):98-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12920442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2006 Jun;133(5):468-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16681635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 1982 Nov;37(8):539-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6758627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Chem. 2016;23(7):650-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26785997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2012 Sep;130(3):607-612.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22460074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2001 Feb;34(2):355-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11281573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Q J Med. 1983 Winter;52(205):1-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6878618</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Haematol. 2007 Feb;78(2):169-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17328718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19910029</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32775066</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Print">2168-8184</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cureus</Title>
                <ISOAbbreviation>Cureus</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss Syndrome) Mimicking a Stroke and Acute Coronary Syndrome: A Case Report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e8984</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.8984</ELocationID>
            <Abstract>
                <AbstractText>Churg-Strauss syndrome (CSS) is a rare disease of multiple organ involvement attributed to asthma, eosinophilia, and vasculitis as a diagnostic criterion. Here we report a case of CSS presenting with left leg weakness and chest pain with a diagnosis of myocarditis and neuropathy. Eosinophilia, history of asthma, peripheral neurological damage led to the diagnosis of CSS. Transthoracic echo showed a full-sized segmental wall motion abnormality with normal CT angiography. He responded well to steroid therapy.</AbstractText>
                <CopyrightInformation>Copyright © 2020, Ishaq et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ishaq</LastName>
                    <ForeName>Uzma</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hematology and Medical Oncology, Fauji Foundation Hospital, Rawalpindi, PAK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Malik</LastName>
                    <ForeName>Jahanzeb</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baig</LastName>
                    <ForeName>Adnan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Javaid</LastName>
                    <ForeName>Muhammad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ikram</LastName>
                    <ForeName>Umar</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cardiology, Rawalpindi Institute of Cardiology, Rawalpindi, PAK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cureus</MedlineTA>
            <NlmUniqueID>101596737</NlmUniqueID>
            <ISSNLinking>2168-8184</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">acute coronary syndrome</Keyword>
            <Keyword MajorTopicYN="N">churg-strauss syndrome</Keyword>
            <Keyword MajorTopicYN="N">eosinophilia</Keyword>
            <Keyword MajorTopicYN="N">eosinophilic granulomatosis with polyangiitis</Keyword>
            <Keyword MajorTopicYN="N">hypereosinophilia</Keyword>
            <Keyword MajorTopicYN="N">hypereosinophilia syndrome</Keyword>
            <Keyword MajorTopicYN="N">myocarditis</Keyword>
            <Keyword MajorTopicYN="N">rituximab</Keyword>
        </KeywordList>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32775066</ArticleId>
            <ArticleId IdType="doi">10.7759/cureus.8984</ArticleId>
            <ArticleId IdType="pmc">PMC7402424</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ Case Rep. 2017 Nov 23;2017:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29170172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rheumatology (Oxford). 2020 May 1;59(Supplement_3):iii42-iii50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32348522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2019 Apr;7(4):1347-1351.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30317003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Nephrol. 2018 Jan;33(1):25-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28062909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 2013 Jan;65(1):270-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23044708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Hypertens Rev. 2019;15(1):8-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30179138</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Clin Immunol. 2016 Oct;12(10):1059-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27191665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cardiol. 2018 May 1;258:321-324</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29459042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2016 Nov;48(5):1429-1441</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27587545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1951 Mar-Apr;27(2):277-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14819261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med Case Rep. 2017 Mar 08;21:1-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28337408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Neurol. 2017 Jan;13(1):77-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28079316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1556-1563</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28916432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2013 Mar;68(3):261-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23330816</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med (Lond). 2020 Mar;20(Suppl 2):s51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32409371</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Care Res (Hoboken). 2016 Mar;68(3):374-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26315340</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774780</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1949-8462</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jun</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of cardiology</Title>
                <ISOAbbreviation>World J Cardiol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tale of fat and fib - cardiac lipoma managed with radiofrequency ablation: A case report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>285-290</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.4330/wjc.v12.i6.285</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Cardiac lipoma and lipomatous hypertrophy of interatrial septum (LHIS) are very rare disorders with distinct pathological features. While cardiac lipoma is a well-circumscribed encapsulated tumor of mature adipocytes, LHIS is due to entrapment of fat cells in the interatrial septum during embryogenesis. Although a biopsy is the definitive diagnostic test, these disorders can be differentiated by a cardiac magnetic resonance imaging (MRI). Treatment of LHIS is not warranted in asymptomatic patients. In symptomatic patients, surgical resection is the only recommended treatment, which has shown to improve good long-term prognosis.</AbstractText>
                <AbstractText Label="CASE SUMMARY" NlmCategory="METHODS">A 63-year-old Caucasian woman with past medical history significant for hypertension, hypothyroidism, right breast ductal cell carcinoma treated with mastectomy and breast implant, platelet granule disorder, asthma requiring chronic intermittent prednisone use, presented to the outpatient cardiology office with recent onset exertional dyspnea, palpitations, weight gain and weakness. Initial workup with electrocardiogram and holter monitor did not reveal significant findings. During the subsequent hospitalization for community acquired pneumonia, the patient developed symptomatic paroxysmal atrial fibrillation. Transthoracic echocardiogram showed a right ventricular mass. A biopsy was not pursued given the high risk of bleeding due to platelet granule disorder. Cardiac MRI showed characteristic features consistent with cardiac lipoma and LHIS. Prednisone was discontinued. Genetic testing for arrhythmogenic right ventricular dysplasia and 24-h urine cortisol test was negative. As multiple attempts at rhythm control failed with sotalol and flecainide, pulmonary vein isolation and right atrial isthmus radiofrequency ablation were done. She is in follow-up with symptomatic relief and no recurrence of atrial fibrillation for 10 mo.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Benign fatty lesions in heart include solitary lipoma, lipomatous infiltration and lipomatous hypertrophy of interatrial septum. Although transvenous biopsy provides a definitive diagnosis, Cardiac MRI is superior to computed tomography and aids in differentiating benign from malignant lesions. Surgical excision of cardiac lipoma along with capsule and pedicle removal generally prevents recurrence, but with our patient's unusual tumor features and comorbidities proscribed a surgical approach. Symptom management with antiarrhythmics and ablation techniques were successfully utilized.</AbstractText>
                <CopyrightInformation>©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nalluru</LastName>
                    <ForeName>Swarna Sri</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01604, United States. swarna.nalluru@stvincenthospital.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nadadur</LastName>
                    <ForeName>Srinivas</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01604, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trivedi</LastName>
                    <ForeName>Nitin</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01604, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trivedi</LastName>
                    <ForeName>Sunita</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA 01604, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goyal</LastName>
                    <ForeName>Sanjeev</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology, Saint Vincent Hospital, Worcester, MA 01604, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Cardiol</MedlineTA>
            <NlmUniqueID>101537090</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Atrial fibrillation</Keyword>
            <Keyword MajorTopicYN="N">Cardiac lipoma</Keyword>
            <Keyword MajorTopicYN="N">Case report</Keyword>
            <Keyword MajorTopicYN="N">Lipomatous hypertrophy of interatrial septum</Keyword>
            <Keyword MajorTopicYN="N">Radiofrequency ablation</Keyword>
        </KeywordList>
        <CoiStatement>Conflict-of-interest statement: The authors have no conflicts of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774780</ArticleId>
            <ArticleId IdType="doi">10.4330/wjc.v12.i6.285</ArticleId>
            <ArticleId IdType="pmc">PMC7383356</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>South Med J. 1998 Dec;91(12):1169-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9853734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes Chromosomes Cancer. 2008 Nov;47(11):971-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18663748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cardiothorac Surg. 1997 Apr;11(4):785-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9151056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 1986;4(4):337-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3513985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2001 Jul;120(1):311-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11451858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Skeletal Radiol. 2012 Apr;41(4):465-6, 489-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22075714</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pathol Lab Med. 1993 Oct;117(10):1027-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8215825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2013 Jul;268(1):26-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23793590</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Surg Case Rep. 2015;9:105-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25746952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Sci Monit. 2017 Dec 31;23:6201-6209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29289957</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Magn Reson Imaging. 1990;8(6):825-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2266812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Cardiovasc Imaging Rep. 2014;7:9281</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25018846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2003 Dec;124(6):2068-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14665481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1996 Sep;110(3):852-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8797442</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Sci Monit. 2017 May 3;23:2111-2117</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28469127</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ISRN Cardiol. 2011;2011:243637</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22347636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 2016 Jan;95(3):e2561</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26817909</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774762</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1943-8141</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of translational research</Title>
                <ISOAbbreviation>Am J Transl Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of catalpol on asthma by airway remodeling via inhibiting TGF-β1 and EGF in ovalbumin-induced asthmatic mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4084-4093</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Airway remodeling represents the healing and alteration in the airway that occur as a consequence of chronic inflammation. Extracellular matrix synthesis regulated by transforming growth factor (TGF-β1) and vascular remodeling regulated by epidermal growth factor (EGF) are important factors for the airway remodeling. This study aimed to probe the effect of catalpol, a major component of <i>Radix Rehmanniae Preparata</i> (Shudihuang), on airway remodeling and expression of TGF-β1 and EGF in asthmatic mice. A mice model of asthma was induced by ovalbumin (OVA) treatment. BALB/c mice were randomly divided into blank control group, asthma model group, dexamethasone (DEX) group (positive control), high, medium and low dose of catalpol intervention group. Changes in lung histology were observed using hematoxylin and eosin staining. The levels of TGF-β1 and EGF in mouse sera and bronchoalveolar lavage fluid (BALF) were examined by ELISA. The EGF mRNA and protein levels in mice tissues were determined. The results indicated that catalpol improved general conditions and reduced the damage of lung tissues in asthmatic mice. Moreover, results of ELISA revealed that catalpol significantly reduced the OVA-induced levels of TGF-β1 and EGF in sera and in bronchoalveolar lavage fluid (BALF). Additionally, results indicated that catalpol decreased the OVA-induced EGF mRNA and protein expression in lung tissues in asthmatic mice. Catalpol at a high dose was more efficient in decreasing the level of TGF-β1 in mice sera and BALF comparing the DEX group. Current study has demonstrated that catalpol might effectively prevent airway remodeling in asthma via inhibiting TGF-β1 and EGF.</AbstractText>
                <CopyrightInformation>AJTR Copyright © 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Xujun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Department, First People's Hospital of Jiujiang Jiujiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yikun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Thoracic Surgery Department, National Cancer Center/Cancer Hospital &amp; Shenzhen Hospital, Chinese Academy of Medicine Sciences and Peking Union Medical College Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Yawei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Experimental Hematology, Institute of Hematology &amp; Blood Diseases Hospital China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Macromolecular Platforms for Translational Medicine and Bio-Manufacturing Laboratory, Precision Medicine and Healthcare Research Center, Tsinghua-Berkeley Shenzhen Institute Shenzhen, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Yanxia</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Department, First People's Hospital of Jiujiang Jiujiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanchang University Nanchang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Transl Res</MedlineTA>
            <NlmUniqueID>101493030</NlmUniqueID>
            <ISSNLinking>1943-8141</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway remodeling</Keyword>
            <Keyword MajorTopicYN="N">EGF</Keyword>
            <Keyword MajorTopicYN="N">TGF-β1</Keyword>
            <Keyword MajorTopicYN="N">catalpol</Keyword>
        </KeywordList>
        <CoiStatement>None.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774762</ArticleId>
            <ArticleId IdType="pmc">PMC7407718</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2004 Sep 17;305(5691):1776-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15375268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Biochem Biophys. 2015 Apr;71(3):1349-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25388838</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biochem. 2019 Jun;120(6):8992-8998</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30536454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dev Neurosci. 2008 May-Jun;26(3-4):309-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18337048</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transl Res. 2019 Oct 15;11(10):6413-6421</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31737193</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Transl Res. 2019 Apr 15;11(4):2463-2469</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31105853</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Clin Exp Med. 2015 Feb 15;8(2):2038-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25932134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Med Bull. 2000;56(4):985-1003</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11359633</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nat Med. 2016 Jul;70(3):620-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27007911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>South Med J. 2003 Nov;96(11):1049-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14632350</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Biochem Behav. 2007 Nov;88(1):64-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17698178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2008 May 8;117(2):199-214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18407446</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2014 Dec;23(2):400-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25063711</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Invest. 2010;39(4-5):526-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20450290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2014 Nov;18(11):1269-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25299857</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 1997 Mar;16(3):220-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9070605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mediators Inflamm. 2009;2009:413270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19657453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Immunopharmacol. 2017 Feb;43:140-146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27992791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2015 Apr 22;164:368-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25625352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2006 Jul;130(1 Suppl):4S-12S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16840363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Sci (Lond). 2002 Aug;103(2):201-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12149112</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 1995 Sep 29;764:123-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7486511</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir Rev. 2013 Sep 1;22(129):251-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23997052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2009 Oct;158(1):10-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19737225</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pharm Res. 2009 Apr;32(4):559-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19407974</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 1999 Oct;104(8):985-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10525032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol In Vitro. 2013 Mar;27(2):543-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23164921</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 2008 Jan 10;1188:139-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18022141</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Food Chem Toxicol. 2013 Aug;58:50-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23612000</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2003 May;33(5):550-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12752581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Res. 2001;2(2):64-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11686866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2011 Oct;45(4):667-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21474432</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Life Sci. 2006 Dec 23;80(3):193-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17049947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Fitoterapia. 2013 Apr;86:19-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23376161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2015 Nov 27;467(4):853-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26474703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurosci Lett. 2008 Sep 19;442(3):224-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18652878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2014 Oct 24;15(11):19394-405</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25347277</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy (Cairo). 2012;2012:157047</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23118774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Evid Based Complement Alternat Med. 2012;2012:910520</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23049614</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Biochim Biophys Sin (Shanghai). 2014 Sep;46(9):738-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25178463</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774761</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1943-8141</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of translational research</Title>
                <ISOAbbreviation>Am J Transl Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Blocking pannexin1 reduces airway inflammation in a murine model of asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4074-4083</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>Stressed or injured cells release ATP into the extracellular milieu via the pannexin1 (Panx1) channels, which is the basis of inflammation in a variety of conditions, including allergic lung inflammation. Although the role of Panx1 in mediating inflammation has been well established, the role of its mimetic peptide, <sup>10</sup>Panx1, which inhibits ATP release from Panx1 channels, in allergic asthma remains understudied. The aim of this study was to evaluate the effects of using <sup>10</sup>Panx1 to inhibit Panx1 channel in a murine model of ovalbumin (OVA)-induced asthma. We demonstrate that blockade of Panx1 significantly attenuated goblet cell hyperplasia and inflammatory cell infiltration into the lungs of OVA-sensitized mice. Inhibition of Panx1 also reduced the total and eosinophil cell numbers in the bronchoalveolar lavage fluid (BALF) and reduced expression of CCL11 and CCL2 in lung tissues from mice. Moreover, we detected lower levels of IL-5 and IL-13 in the culture supernatant of OVA-restimulated splenocytes from <sup>10</sup>Panx1-treated mice. Collectively, our findings suggest that Panx1 inhibition of allergen-mediated lung inflammation has the potential to suppress allergic responses in asthma.</AbstractText>
                <CopyrightInformation>AJTR Copyright © 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Khan</LastName>
                    <ForeName>Matarr</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Current address: Division of Immunobiology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Yung-An</ForeName>
                    <Initials>YA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuo</LastName>
                    <ForeName>Chieh-Ying</ForeName>
                    <Initials>CY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Tong</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lu</LastName>
                    <ForeName>Chun-Hao</ForeName>
                    <Initials>CH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Fundamental Oncology, University of Lausanne Lausanne, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Ludwig Institute for Cancer Research, University of Lausanne Épalinges, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Li-Chen</ForeName>
                    <Initials>LC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuo</LastName>
                    <ForeName>Ming-Ling</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Microbiology and Immunology, Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Memorial Hospital Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Research Center for Chinese Herbal Medicine, College of Human Ecology, Chang Gung University of Science and Technology Taoyuan, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Transl Res</MedlineTA>
            <NlmUniqueID>101493030</NlmUniqueID>
            <ISSNLinking>1943-8141</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">10Panx1</Keyword>
            <Keyword MajorTopicYN="N">EXtracellular ATP</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">chemokine</Keyword>
            <Keyword MajorTopicYN="N">lung inflammation</Keyword>
            <Keyword MajorTopicYN="N">pannexin1</Keyword>
        </KeywordList>
        <CoiStatement>None.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774761</ArticleId>
            <ArticleId IdType="pmc">PMC7407700</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2010 Sep 15;182(6):774-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20522787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JCI Insight. 2018 Mar 22;3(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29563335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Soc Nephrol. 2018 Jul;29(7):1887-1899</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29866797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2004 Aug 13;572(1-3):65-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15304325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Physiol. 2014 Mar 14;5:96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24672487</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mediators Inflamm. 2015;2015:427125</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25944982</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2015 Aug 05;6:7965</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26242575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2008 Nov;118(11):3546-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18982161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Signal. 2017 Nov 21;10(506):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29162744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2015 Jan;15(1):57-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25534623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2010 Dec;65(12):1545-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20880147</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2014 Apr 17;588(8):1416-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24642372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2010 Nov 4;116(18):3475-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20660288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2007 Aug;13(8):913-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17632526</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2017 Mar;23(3):355-360</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28134928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2011 Apr;44(4):456-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20508067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2011 Apr 1;186(7):4375-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21357533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Physiol. 2014 Feb 25;5:63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24616702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2012 Sep 1;189(5):2545-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22851704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Signal. 2008 Sep 30;1(39):ra6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18827222</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancers (Basel). 2019 Jan 16;11(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30654593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 Sep;134(3):499-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25171864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2019 Apr 16;50(4):975-991</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30995510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurochem Res. 2014 Jan;39(1):216-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24317635</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2016 Mar;16(3):177-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26922909</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2018 Aug 1;128(8):3583-3594</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29894310</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2012 Jul 19;120(3):511-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22661701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2015 Jan;16(1):45-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25521684</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed J. 2016 Aug;39(4):229-233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27793264</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2013 Feb 1;304(3):L162-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23204071</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pharmacol. 2018 Aug 06;9:865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30127744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Res. 2017;2017:5358647</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28626774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2014 Jun;69(6):763-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24758146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2018 Apr 18;19(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29669994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Rev. 2019 Jul;71(3):345-382</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31235653</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Cell Res. 2017 Jan;1864(1):51-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27741412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2015 Jun;52(6):772-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25360868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Physiol. 2018 Mar;233(3):2075-2090</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28295275</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2014 Sep;69(9):1189-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24931417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Toxicol. 2017 May;91(5):2245-2261</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27826632</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774662</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1939-4551</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>13</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The World Allergy Organization journal</Title>
                <ISOAbbreviation>World Allergy Organ J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An appraisal of allergic disorders in India and an urgent call for action.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100446</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.waojou.2020.100446</ELocationID>
            <Abstract>
                <AbstractText>India is the second most populous country in the world with a population of nearly 1.3 billion, comprising 20% of the global population. There are an estimated 37.5 million cases of asthma in India, and recent studies have reported a rise in prevalence of allergic rhinitis and asthma. Overall, 40-50% of paediatric asthma cases in India are uncontrolled or severe. Treatment of allergic rhinitis and asthma is sub-optimal in a significant proportion of cases due to multiple factors relating to unaffordability to buy medications, low national gross domestic product, religious beliefs, myths and stigma regarding chronic ailment, illiteracy, lack of allergy specialists, and lack of access to allergen-specific immunotherapy for allergic rhinitis and biologics for severe asthma. High quality allergen extracts for skin tests and adrenaline auto-injectors are currently not available in India. Higher postgraduate specialist training programmes in Allergy and Immunology are also not available. Another major challenge for the vast majority of the Indian population is an unacceptably high level of exposure to particulate matter (PM)<sub>2.5</sub> generated from traffic pollution and use of fossil fuel and biomass fuel and burning of incense sticks and mosquito coils. This review provides an overview of the burden of allergic disorders in India. It appraises current evidence and justifies an urgent need for a strategic multipronged approach to enhance quality of care for allergic disorders. This may include creating an infrastructure for education and training of healthcare professionals and patients and involving regulatory authorities for making essential treatments accessible at subsidised prices. It calls for research into better phenotypic characterisation of allergic disorders, as evidence generated from high income western countries are not directly applicable to India, due to important confounders such as ethnicity, air pollution, high rates of parasitic infestation, and other infections.</AbstractText>
                <CopyrightInformation>© 2020 Published by Elsevier Inc. on behalf of World Allergy Organization.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Krishna</LastName>
                    <ForeName>Mamidipudi Thirumala</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Allergy and Immunology, University Hospitals Birmingham NHS Foundation Trust and Institute of Immunology &amp; Immunotherapy &amp; Institute of Clinical Sciences, University of Birmingham, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mahesh</LastName>
                    <ForeName>Padukudru Anand</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department and Respiratory Medicine, JSS Medical College, JSSAHER, Mysore, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vedanthan</LastName>
                    <ForeName>Pudupakkam</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Allergy and Immunology, The University of Colorado, Aurora, CO, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moitra</LastName>
                    <ForeName>Saibal</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Allergy and Immunology, Apollo Gleneagles Hospital, Kolkota, West Bengal, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mehta</LastName>
                    <ForeName>Vinay</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy, Asthma and Immunology Associates, Lincoln, NE, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Christopher</LastName>
                    <ForeName>Devasahayam Jesudas</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Medicine, Christian Medical College, Vellore, Tamilnadu and Indian Chest Society, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World Allergy Organ J</MedlineTA>
            <NlmUniqueID>101481283</NlmUniqueID>
            <ISSNLinking>1939-4551</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">A&amp;I, Allergy and Immunology</Keyword>
            <Keyword MajorTopicYN="N">AB-NHPS, Ayushman Bharath National Health Protection Scheme</Keyword>
            <Keyword MajorTopicYN="N">ABPA, Allergic Bronchopulmonary Aspergillosis</Keyword>
            <Keyword MajorTopicYN="N">AD, Atopic Dermatitis</Keyword>
            <Keyword MajorTopicYN="N">BTS, British Thoracic Society</Keyword>
            <Keyword MajorTopicYN="N">CME, Continuing Medical Education</Keyword>
            <Keyword MajorTopicYN="N">COPD, Chronic Obstructive Pulmonary Disease</Keyword>
            <Keyword MajorTopicYN="N">DALY, Disability Associated Life Years</Keyword>
            <Keyword MajorTopicYN="N">DBPCFC, Double Blind Placebo Controlled Food Challenge</Keyword>
            <Keyword MajorTopicYN="N">ELISA, Enzyme Linked Immunosorbent Assay</Keyword>
            <Keyword MajorTopicYN="N">ETS, Environmental Tobacco Smoke</Keyword>
            <Keyword MajorTopicYN="N">GDP, Gross Domestic Product</Keyword>
            <Keyword MajorTopicYN="N">GINA, Global Initiative for Asthma</Keyword>
            <Keyword MajorTopicYN="N">ICAAI, Indian College of Allergy Asthma and Applied Immunology</Keyword>
            <Keyword MajorTopicYN="N">IHDS, Indian Human Development Survey</Keyword>
            <Keyword MajorTopicYN="N">INR, Indian Rupees</Keyword>
            <Keyword MajorTopicYN="N">ISAAC, International Study of Asthma and Allergies in Childhood</Keyword>
            <Keyword MajorTopicYN="N">NMBA, Neuromuscular blocking agents</Keyword>
            <Keyword MajorTopicYN="N">PAFs, Population Attributable Factors</Keyword>
            <Keyword MajorTopicYN="N">SAFS, Severe Asthma and Fungal Sensitisation</Keyword>
            <Keyword MajorTopicYN="N">SCIT, Subcutaneous Injection Immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">SLIT, Sublingual Immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">SPT, Skin Prick Test</Keyword>
            <Keyword MajorTopicYN="N">USA, United States of America</Keyword>
            <Keyword MajorTopicYN="N">USD, United States Dollars</Keyword>
            <Keyword MajorTopicYN="N">WHO, World Health Organization</Keyword>
        </KeywordList>
        <CoiStatement>MTKs department received educational grant from ALK Abello, MEDA, Thermo Fisher and other companies for annual PracticAllergy course in recent years. MTK received funds from ALK Abello to attend EAACI conference. Other authors have no conflict of interest to declare.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774662</ArticleId>
            <ArticleId IdType="doi">10.1016/j.waojou.2020.100446</ArticleId>
            <ArticleId IdType="pii">S1939-4551(20)30349-5</ArticleId>
            <ArticleId IdType="pii">100446</ArticleId>
            <ArticleId IdType="pmc">PMC7398972</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Indian Pediatr. 2013 Dec;50(12):1113-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23999673</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2016;53(3):238-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26365004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Anaesth. 2017 May;61(5):387-392</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28584347</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2000 Oct;122(1):13-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11012611</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1998 Apr 25;351(9111):1225-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9643741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Dermatol Venereol Leprol. 1999 Jan-Feb;65(1):14-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20885028</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gastroenterol Hepatol. 2012 Aug;27(8):1266-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22497584</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 Sep 19;347(12):911-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12239261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2006 Dec;24(4):191-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17348241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Trop Parasitol. 2011 Jul;1(2):104-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23508675</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Med Res. 2013 Jan;137(1):87-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23481056</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2019;178(1):60-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30257248</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Agric Environ Med. 2003;10(2):131-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14677902</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Planet Health. 2019 Jan;3(1):e26-e39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30528905</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Rhinol (Providence). 2018 Sep 25;9:2152656718796746</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30263870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2020 Apr;8(4):1349-1358.e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31857266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2009 Jan;2(1):9-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23282888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2015 Dec;3(12):e776-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26566749</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tubercle. 1989 Dec;70(4):273-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2516671</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mycoses. 2010 Mar 1;53(2):138-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19207831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nat Sci Biol Med. 2013 Jan;4(1):191-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23633861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2014 Nov;178(2):399-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25070464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Pediatr. 2016 May;83(5):386-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26666904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Agric Environ Med. 2015;22(2):236-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26094515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2001 Aug;87(2):140-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11527247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Nov 14;10:2639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31798582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Assoc Physicians India. 2015 Sep;63(9):36-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27608865</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunobiology. 2007;212(2):141-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17336834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Crit Care Med. 2015 Jul;19(7):412-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26180434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Dermatol Venereol Leprol. 2004 Jan-Feb;70(1):20-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17642552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2008 Nov;38(11):1795-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18681854</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2009 Jun;64(6):476-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19237391</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2018 Dec;6(12):e1363-e1374</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30219316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Rhinol Allergy. 2010 Sep-Oct;24(5):e98-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21244724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Chest Dis Allied Sci. 2010 Oct-Dec;52(4):217-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21302599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Dermatol Venereol Leprol. 1999 Nov-Dec;65(6):253-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20921678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2018 Oct;48(10):1317-1324</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30025179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2014;164(3):218-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25138428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Natl Med J India. 2000 Jan-Feb;13(1):16-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10743370</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2001 Sep;38(6):501-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11642417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy. 1993 Apr;70(4):305-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7682041</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Oct 26;12(10):e0185938</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29073132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Crit Care Med. 2014 Dec;18(12):796-806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25538414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2008 Mar;19(2):110-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17651373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asian Pac J Allergy Immunol. 2009 Mar;27(1):71-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19548632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Pediatr. 2002 Apr;69(4):309-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12019551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Saf. 2012 Dec 1;35(12):1171-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23072620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2019 May;122(5):449-455</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30465859</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2006 Jan;61(1):104-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16364164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2009 Jan;39(1):43-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19128352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2011 Jul;128(1):e9-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21690110</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2016 Jul;71(7):1010-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27297800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asia Pac Allergy. 2012 Jul;2(3):210-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22872824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2014 Dec;69(12):1639-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25041549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2015 Dec;70(12):1580-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26214068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Pharmacol. 2015 Jan-Feb;47(1):65-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25821314</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunopharmacol Immunotoxicol. 2008;30(3):529-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18618316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2002 Nov;110(5):784-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12417889</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2008 Apr;121(4):947-54.e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18155278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Agric Environ Med. 2008;15(1):105-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18581987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2009 Dec;124(6):1251-8.e23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20004783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indian J Chest Dis Allied Sci. 2006 Jan-Mar;48(1):13-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16482947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Dec 05;9(12):e114745</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25478929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mycoses. 2018 Mar;61(3):195-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29110335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Allergy Clin Immunol. 2001 Aug;1(4):305-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11964705</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Clin Nutr. 2001 Apr;55(4):298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11360135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Diagn Res. 2017 Aug;11(8):OC01-OC04</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28969175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Respir J. 2018 Feb;12(2):547-556</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27663282</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2009 Sep;124(3):447-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19647861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Anesthesiology. 2003 Sep;99(3):536-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12960536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 Dec;144(6):1727-1729.e6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31449913</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung India. 2018 Jul-Aug;35(4):281-283</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29970764</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774661</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1939-4551</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>13</Volume>
                    <Issue>7</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The World Allergy Organization journal</Title>
                <ISOAbbreviation>World Allergy Organ J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Beliefs and preferences regarding biological treatments for severe asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100441</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.waojou.2020.100441</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Severe asthma is a serious condition with a significant burden on patients' morbidity, mortality, and quality of life. Some biological therapies targeting the IgE and interleukin-5 (IL5) mediated pathways are now available. Due to the lack of direct comparison studies, the choice of which medication to use varies. We aimed to explore the beliefs and practices in the use of biological therapies in severe asthma, hypothesizing that differences will occur depending on the prescribers' specialty and experience.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We conducted an online survey composed of 35 questions in English. The survey was circulated via the INterasma Scientific Network (INESNET) platform as well as through social media. Responses from allergists and pulmonologists, both those with experience of prescribing omalizumab with (OMA/IL5) and without (OMA) experience with anti-IL5 drugs, were compared.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">Two hundred eighty-five (285) valid questionnaires from 37 countries were analyzed. Seventy-on percent (71%) of respondents prescribed biologics instead of oral glucocorticoids and believed that their side effects are inferior to those of Prednisone 5 mg daily. Agreement with ATS/ERS guidelines for identifying severe asthma patients was less than 50%. Specifically, significant differences were found comparing responses between allergists and pulmonologists (Chi-square test, p &lt; 0.05) and between OMA/IL5 and OMA groups (p &lt; 0.05).</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">Uncertainties and inconsistencies regarding the use of biological medications have been shown. The accuracy of prescribers to correctly identify asthma severity, according to guidelines criteria, is quite poor. Although a substantial majority of prescribers believe that biological drugs are safer than low dose long-term treatment with oral steroids, and that they must be used instead of oral steroids, every effort should be made to further increase awareness. Efficacy as disease modifiers, biomarkers for selecting responsive patients, timing for outcomes evaluation, and checks need to be addressed by further research. Practices and beliefs regarding the use of asthma biologics differ between the prescriber's specialty and experience; however, the latter seems more significant in determining beliefs and behavior. Tailored educational measures are needed to ensure research results are better integrated in daily practice.</AbstractText>
                <CopyrightInformation>© 2020 Published by Elsevier Inc. on behalf of World Allergy Organization.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bikov</LastName>
                    <ForeName>Andras</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Manchester University NHS Foundation Trust, Manchester, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oğuzülgen</LastName>
                    <ForeName>Ipek Kivilcim</ForeName>
                    <Initials>IK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Medicine, Gazi University School of Medicine, Ankara, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baiardini</LastName>
                    <ForeName>Ilaria</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, Humanitas University, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Contoli</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences, University of Ferrara, Ferrara, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Emelyanov</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, North-Western Medical University Named After I.I.Mechnikov, St-Petersburg, Russia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fassio</LastName>
                    <ForeName>Omar</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Associazione di Ricerca Malattie Immunologiche e Allergiche (ARMIA), Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ivancevich</LastName>
                    <ForeName>Juan Carlos</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology Department, Faculty of Medicine, del Salvador University, Buenos Aires, Argentina.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaidashev</LastName>
                    <ForeName>Igor</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Ukrainian Medical Stomatological Academy, Poltava, Ukraine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kowal</LastName>
                    <ForeName>Krzysztof</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Białymstoku Klinika Alergologii.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Labor</LastName>
                    <ForeName>Marina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonology, University Hospital Centre Osijek, Osijek, Croatia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lahousse</LastName>
                    <ForeName>Lies</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mihaicuta</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonology Department, CardioPrevent Foundation, University of Medicine and Pharmacy &quot;Dr Victor Babes&quot;, Timisoara, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Novakova</LastName>
                    <ForeName>Silviya</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy Unit of Internal Consulting Department, University Hospital &quot;St. George&quot;, Plovdiv, Bulgaria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Padilla Galo</LastName>
                    <ForeName>Alicia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unidad de Neumología, Agencia Sanitaria Costa del Sol, Marbella, Málaga, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simidchiev</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Hospital Lorenetz, MedUNI, Sofia, Bulgaria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tiotiu</LastName>
                    <ForeName>Angelica</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonology, University Hospital of Nancy, Nancy, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Development, Adaptation and Disadvantage, Cardiorespiratory Regulations and Motor Control (EA 3450 DevAH), University of Lorraine, Nancy, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ansotegui</LastName>
                    <ForeName>Ignacio J</ForeName>
                    <Initials>IJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hospital Quirónsalud Bizkaia, Bilbao, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bernstein</LastName>
                    <ForeName>Jonathan A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Division of Immunology, Allergy Section University of Cincinnati Cincinnati, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boulet</LastName>
                    <ForeName>Louis Philippe</ForeName>
                    <Initials>LP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Québec Heart and Lung Institute- Laval University, Québec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Canonica</LastName>
                    <ForeName>Giorgio Walter</ForeName>
                    <Initials>GW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Personalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Rozzano, MI, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, MI, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dubuske</LastName>
                    <ForeName>Lawrence</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy and Immunology, Department of Internal Medicine, George Washington University School of Medicine and Health Sciences, George Washington University Medical Faculty Associates, Washington, DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosario</LastName>
                    <ForeName>Nelson</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Federal University of Paraná (UFPR), Curitiba, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santus</LastName>
                    <ForeName>Pierachille</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical and Clinical Sciences, University of Milan, Division of Respiratory Diseases &quot;L. Sacco&quot; Hospital, ASST Fatebenefratelli Sacco, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Braido</LastName>
                    <ForeName>Fulvio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Università di Genova, Dipartimento di Medicina Interna (DiMI), Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Unit for Continuity of Care - University Hospital IRCCS San Martino di Genoa, Department of Internal Medicine, University of Genoa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Interasma Scientific Network (INES)</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World Allergy Organ J</MedlineTA>
            <NlmUniqueID>101481283</NlmUniqueID>
            <ISSNLinking>1939-4551</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Behavior</Keyword>
            <Keyword MajorTopicYN="N">Belief</Keyword>
            <Keyword MajorTopicYN="N">Biological drug</Keyword>
            <Keyword MajorTopicYN="N">Eos: Eosinophil, IL5</Keyword>
            <Keyword MajorTopicYN="N">ICS, inhaled corticosteroids</Keyword>
            <Keyword MajorTopicYN="N">INterasma Scientific Network, LABA</Keyword>
            <Keyword MajorTopicYN="N">Immunoglobulin E, INESNET</Keyword>
            <Keyword MajorTopicYN="N">Omalizumab. OMA/IL5, Omalizumab plus anti-IL5 molecule</Keyword>
            <Keyword MajorTopicYN="N">Severe asthma</Keyword>
            <Keyword MajorTopicYN="N">interleukine 5, IgE</Keyword>
            <Keyword MajorTopicYN="N">long-acting beta2-agonist, OMA</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no competing interest.</CoiStatement>
        <InvestigatorList>
            <Investigator ValidYN="Y">
                <LastName>Ardelean</LastName>
                <ForeName>Carmen</ForeName>
                <Initials>C</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Badellino</LastName>
                <ForeName>Hector</ForeName>
                <Initials>H</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Blua</LastName>
                <ForeName>Ariel</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Castillo</LastName>
                <ForeName>Antonio</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Carpagnano Giovanna</LastName>
                <ForeName>E</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Chong-Neto Herberto</LastName>
                <ForeName>J</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Colodenco</LastName>
                <ForeName>F Daniel</ForeName>
                <Initials>FD</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Md Colombaro</LastName>
                <ForeName>Dario</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Correia-De-Sousa</LastName>
                <ForeName>Jaime</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Di Marco</LastName>
                <ForeName>Fabiano</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Dobashi</LastName>
                <ForeName>Kunio</ForeName>
                <Initials>K</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Garcia</LastName>
                <ForeName>Rocio</ForeName>
                <Initials>R</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gomez</LastName>
                <ForeName>René Maximiliano</ForeName>
                <Initials>RM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Gopko</LastName>
                <ForeName>Olecsandr</ForeName>
                <Initials>O</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Guidos</LastName>
                <ForeName>Guillermo</ForeName>
                <Initials>G</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hajduk</LastName>
                <ForeName>Martina</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Hermanowicz-Salamon</LastName>
                <ForeName>Joanna</ForeName>
                <Initials>J</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Heffler</LastName>
                <ForeName>Enrico</ForeName>
                <Initials>E</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Karadag</LastName>
                <ForeName>Bulent</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kalyoncu</LastName>
                <ForeName>Ali F</ForeName>
                <Initials>AF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Keren</LastName>
                <ForeName>Metin</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kolilekas</LastName>
                <ForeName>Lykorguos</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Kocwin</LastName>
                <ForeName>Marcelina</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Krusheva</LastName>
                <ForeName>Borislava</ForeName>
                <Initials>B</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Larenas Linnemann</LastName>
                <ForeName>Désirée</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Litovchenko</LastName>
                <ForeName>Irine</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Marcipar</LastName>
                <ForeName>A</ForeName>
                <Initials>A</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Meza</LastName>
                <ForeName>L E</ForeName>
                <Initials>LE</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Nedeva</LastName>
                <ForeName>D</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Novakova</LastName>
                <ForeName>P</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Plavec</LastName>
                <ForeName>D</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Popović-Grle</LastName>
                <ForeName>S</ForeName>
                <Initials>S</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Puggioni</LastName>
                <ForeName>F</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Pur Oziygit</LastName>
                <ForeName>L</ForeName>
                <Initials>L</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Rodrigez</LastName>
                <ForeName>N</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ryan</LastName>
                <ForeName>D</ForeName>
                <Initials>D</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Ruzsics</LastName>
                <ForeName>I</ForeName>
                <Initials>I</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Scichilone</LastName>
                <ForeName>N</ForeName>
                <Initials>N</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Serpa</LastName>
                <ForeName>F</ForeName>
                <Initials>F</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Steiropoulos</LastName>
                <ForeName>P</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Solidoro</LastName>
                <ForeName>P</ForeName>
                <Initials>P</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Turkalj</LastName>
                <ForeName>M</ForeName>
                <Initials>M</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Umanets</LastName>
                <ForeName>T</ForeName>
                <Initials>T</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Victorio</LastName>
                <ForeName>C F</ForeName>
                <Initials>CF</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zubeldia</LastName>
                <ForeName>J M</ForeName>
                <Initials>JM</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Yachnyk</LastName>
                <ForeName>V</ForeName>
                <Initials>V</Initials>
            </Investigator>
            <Investigator ValidYN="Y">
                <LastName>Zitt</LastName>
                <ForeName>M</ForeName>
                <Initials>M</Initials>
            </Investigator>
        </InvestigatorList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774661</ArticleId>
            <ArticleId IdType="doi">10.1016/j.waojou.2020.100441</ArticleId>
            <ArticleId IdType="pii">S1939-4551(20)30344-6</ArticleId>
            <ArticleId IdType="pii">100441</ArticleId>
            <ArticleId IdType="pmc">PMC7396819</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ. 1999 Jul 24;319(7204):224-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10417084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma Allergy. 2016 Apr 04;9:71-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27110133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2017 May;5(5):390-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28395936</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2020 Feb;8(2):507-515.e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31336178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Biol Ther. 2018 Jul;18(7):747-754</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29938543</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung. 2018 Oct;196(5):517-530</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30167841</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Clin Pharmacol. 2009 Jul;68(1):61-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19660004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2001 Apr;56(4):279-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11254818</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2018 Jan 1;197(1):38-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28915080</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Rhinol Allergy. 2019 Mar;33(2):203-211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30587005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2017 Sep;130:55-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29206634</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2017 Nov 30;50(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29191955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2017 Jun 22;376(25):2448-2458</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28530840</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 Jan;143(1):190-200.e20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30205189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2014 Sep 25;371(13):1198-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25199059</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2018 Jan;55(1):89-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28459601</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2014 Sep 25;371(13):1189-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25199060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2015 Feb 03;5:8191</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25645133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Technol Assess. 2009 Sep;13 Suppl 2:31-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19804687</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2012 Aug 18;380(9842):651-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22901886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2015 May;3(5):355-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25736990</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Med Res Opin. 2011 Nov;27(11):2223-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21933100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2017 Dec 7;50(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29217605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2014 Feb;43(2):343-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24337046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2020 Jul;75(7):1555-1563</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32124991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs Context. 2018 Dec 05;7:212561</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30534175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2018 Aug;141:56-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30053973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32774640</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1937-8688</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>36</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>The Pan African medical journal</Title>
                <ISOAbbreviation>Pan Afr Med J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Implications of COVID-19 infections in sickle cell disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>81</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2020.36.81.23776</ELocationID>
            <Abstract>
                <AbstractText>Sickle cell disease is a major concern of public health significance in Africa. Nearly 2/3<sup>rd</sup> of the global burden of sickle cell disease (SCD) is found to be in sub-Saharan Africa. There is increased mortality risk in sickle cell disease patients in Africa due to associated complications such as acute chest syndrome, asthma, pulmonary emboli and sepsis. Sickle cell disease management is the major contributor of financial burden on the government. Moreover, there is a shortage of medical specialists in Africa. COVID-19 pandemic has further led to devastating impact on economy and health globally. The chances of SCD patient contracting COVID-19 infections are higher as these patients are immunocompromised and may be at a higher risk of mortality. Practicing preventive measures including isolation and social distancing by these patients will prevent mortality rates as well as economic burden on government in the present unprecedented COVID-19 pandemic.</AbstractText>
                <CopyrightInformation>© Nitin Ashok John et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>John</LastName>
                    <ForeName>Nitin Ashok</ForeName>
                    <Initials>NA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiology, Dr Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>John</LastName>
                    <ForeName>Jyoti Elgiva</ForeName>
                    <Initials>JE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry, All India Institute of Medical Sciences, Nagpur, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Uganda</Country>
            <MedlineTA>Pan Afr Med J</MedlineTA>
            <NlmUniqueID>101517926</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Africa</Keyword>
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Sickle cell disease</Keyword>
            <Keyword MajorTopicYN="N">advisory</Keyword>
            <Keyword MajorTopicYN="N">global</Keyword>
            <Keyword MajorTopicYN="N">mortality</Keyword>
            <Keyword MajorTopicYN="N">pulmonary</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774640</ArticleId>
            <ArticleId IdType="doi">10.11604/pamj.2020.36.81.23776</ArticleId>
            <ArticleId IdType="pii">PAMJ-36-81</ArticleId>
            <ArticleId IdType="pmc">PMC7386278</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Haematol. 2020 Jun;7(6):e430-e432</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32334676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Surg. 2020 Jun;78:185-193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32305533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Lett. 1993 Jul;37(1):77-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7901154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Haematol. 2020 Jun;189(5):851-852</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32314798</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Glob Health. 2019 Oct;7(10):e1458-e1466</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31451441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Med. 2013 Oct 01;3(10):a011783</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23813607</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Prev Med. 2011 Dec;41(6 Suppl 4):S398-405</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22099364</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32774625</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1937-8688</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>36</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>The Pan African medical journal</Title>
                <ISOAbbreviation>Pan Afr Med J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Asthma and obesity: relationship and therapeutic implications in patients with asthma at the Department of Pneumology in Monastir, Tunisia].</ArticleTitle>
            <Pagination>
                <MedlinePgn>49</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2020.36.49.21098</ELocationID>
            <Abstract>
                <AbstractText Label="Introduction" NlmCategory="UNASSIGNED">Obesity and asthma are two chronic diseases affecting millions of people around the world. A causal relationship has been suggested. The purpose of our study is to examine the profile in obese people with asthma and to determine the relationship between the different severity parameters in asthma and the degree of obesity.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">We conducted a retrospective, monocentric, analytical study involving 450 asthmatics with a body mass index (BMI) ≥ 30 kg/m<sup>2</sup> having follow up visit at less than 6 months. The study was conducted in the Department of Pneumology and Allergology at the Fattouma Bourguiba Hospital in Monastir.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The average age at diagnosis was 45±12.8 years. Mean BMI was 34.8±4.2 kg/m<sup>2</sup>. Asthma was well-controlled in 55.3% of patients. Severity criteria were reported in 37.4% of cases. According to GINA 2016, 24.2% of patients received treatment at step 4. Two asthma phenotypes associated with obesity were reported. The first phenotype (52.4%) was characterized by early-onset asthma associated with a higher incidence of allergic disease and manifestations of atopy. The second phenotype (47.6%) was characterized by late onset asthma, commonly occurring in female sex as well as a higher rate of comorbidities and hospitalizations. Patients with class II and III obesity had significant ventilatory deficiency (CVF: p = 0.002 and FEV1: p = 0.007).</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">Obesity is one of the key factors involved in poor asthma control. Its management, which has not yet been codified, should be multidisciplinary.</AbstractText>
                <CopyrightInformation>© Saousen Cheikh Mhamed et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mhamed</LastName>
                    <ForeName>Saousen Cheikh</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saad</LastName>
                    <ForeName>Ahmed Ben</ForeName>
                    <Initials>AB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Migaou</LastName>
                    <ForeName>Asma</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fahem</LastName>
                    <ForeName>Nesrine</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rouatbi</LastName>
                    <ForeName>Naceur</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joobeur</LastName>
                    <ForeName>Samah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>fre</Language>
            <PublicationTypeList>
                <PublicationType UI="D004740">English Abstract</PublicationType>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Asthme et obésité: relation et implications thérapeutiques auprès des patients asthmatiques du Service de Pneumologie de Monastir, Tunisie.</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Uganda</Country>
            <MedlineTA>Pan Afr Med J</MedlineTA>
            <NlmUniqueID>101517926</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthme</Keyword>
            <Keyword MajorTopicYN="N">contrôle</Keyword>
            <Keyword MajorTopicYN="N">exploration fonctionnelle respiratoire</Keyword>
            <Keyword MajorTopicYN="N">obésité</Keyword>
            <Keyword MajorTopicYN="N">traitement</Keyword>
        </KeywordList>
        <CoiStatement>Les auteurs ne déclarent aucun conflit d’intérêts.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774625</ArticleId>
            <ArticleId IdType="doi">10.11604/pamj.2020.36.49.21098</ArticleId>
            <ArticleId IdType="pii">PAMJ-36-49</ArticleId>
            <ArticleId IdType="pmc">PMC7388602</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Thorax. 2008 Jan;63(1):14-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18156567</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Glob Health. 2019 Jan 22;85(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30741512</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2013 Jan;43(1):8-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23278876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Postepy Dermatol Alergol. 2018 Dec;35(6):563-571</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30618522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Pharmacol. 2006 Jun;6(3):230-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16530012</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Pulm Med. 2019 Jan;25(1):44-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30394901</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2006 Oct;28(4):763-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16870655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2011 Jan;106(1):30-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21195942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Jpn Dent Sci Rev. 2019 Nov;55(1):103-107</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31516639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2010 Feb 15;181(4):315-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19892860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Biol Med (Maywood). 2014 Nov;239(11):1531-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24719380</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Allergy Asthma Rep. 2019 Sep 10;19(10):49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31506820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung India. 2019 Sep-Oct;36(5):404-410</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31464212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2008 Aug 1;178(3):218-224</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18480428</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Pathol. 1997 Jun;150(6):2223-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9176411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Feb;25(2):282-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15684292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2013 Feb 1;143(2):406-414</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23064546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biochem. 2014 Mar;115(3):421-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24115053</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2007 Nov;101(11):2240-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17686624</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tanaffos. 2012;11(1):38-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25191399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2009 Jun;123(6):1328-34.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19501235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2006 Apr;100(4):648-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16159709</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Allergy Clin North Am. 2014 Nov;34(4):739-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25282287</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2009 Dec;103 Suppl 2:S38-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20122628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Otolaryngol Suppl. 1998;537:27-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9870645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Allergy Clin Immunol. 2012 Feb;12(1):76-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22157152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2003 Feb;111(2):263-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12589343</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respirology. 2012 Apr;17(3):412-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21992497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Appl Physiol (1985). 2010 Jan;108(1):197-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19875706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Endocrinol Metab. 1996 Sep;81(9):3424-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8784109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genet Epidemiol. 2001;21 Suppl 1:S154-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11793659</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Pulm Med. 2010 Jan;16(1):64-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19844182</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2012 Mar;166(3):498-504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21999468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2014 Apr;1311:31-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24517401</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Int. 2019 Apr;68(2):135-142</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30509734</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2001 Jan;56(1):4-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11120896</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32774614</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1937-8688</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>36</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>The Pan African medical journal</Title>
                <ISOAbbreviation>Pan Afr Med J</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Can inhaled foreign body mimic asthma in an adolescent?</ArticleTitle>
            <Pagination>
                <MedlinePgn>38</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2020.36.38.20037</ELocationID>
            <Abstract>
                <AbstractText>A 14 year old male was diagnosed with asthma but didn't improve with appropriate inhalation therapy. Rigid bronchoscopy revealed a food fragment, almost completely occluding the lower-left bronchus lumen. Based on the reported history, it had been likely there for several years.</AbstractText>
                <CopyrightInformation>© Alessandro Bodini et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bodini</LastName>
                    <ForeName>Alessandro</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pecoraro</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Catalano</LastName>
                    <ForeName>Filippo</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emergency Endoscopy Unit, Borgo Trento Hospital, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aricò</LastName>
                    <ForeName>Melodie Olivia</ForeName>
                    <Initials>MO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tenero</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Piazza</LastName>
                    <ForeName>Michele</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Piacentini</LastName>
                    <ForeName>Giorgio</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>27</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Uganda</Country>
            <MedlineTA>Pan Afr Med J</MedlineTA>
            <NlmUniqueID>101517926</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Foreign body aspiration</Keyword>
            <Keyword MajorTopicYN="N">adolescent</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">bronchoscopy</Keyword>
            <Keyword MajorTopicYN="N">cough</Keyword>
            <Keyword MajorTopicYN="N">differential diagnosis</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774614</ArticleId>
            <ArticleId IdType="doi">10.11604/pamj.2020.36.38.20037</ArticleId>
            <ArticleId IdType="pii">PAMJ-36-38</ArticleId>
            <ArticleId IdType="pmc">PMC7388604</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Exp Otorhinolaryngol. 2015 Jun;8(2):161-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26045916</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2010 Aug 18;341:c3924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20719826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Nov;26(5):948-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16264058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child Educ Pract Ed. 2015 Feb;100(1):18, 55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24821991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Jan 2;55(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31515408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Harefuah. 2015 Mar;154(3):175-7, 211</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25962247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr Surg. 2013 Sep;48(9):1867-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24074659</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32774291</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1663-2699</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <MedlineDate>2020 May-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Case reports in ophthalmology</Title>
                <ISOAbbreviation>Case Rep Ophthalmol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting Remission.</ArticleTitle>
            <Pagination>
                <MedlinePgn>268-275</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1159/000508031</ELocationID>
            <Abstract>
                <AbstractText>Vernal keratoconjunctivitis (VKC) is a persistent, severe allergic eye disease, mainly occurring in children, that can lead to severe ocular complications including visual loss. The underlying etiology and pathophysiology of VKC remain unclear. Common therapies include topical antihistamines and mast cell stabilizers that are effective in mild-to-moderate forms of VKC but are often ineffective in severe forms that require topical or systemic corticosteroids. Dependence on steroids is common with potential adverse effects both local, as increased intraocular pressure, glaucoma, infection and cataract, as well as systemic ones, as reduction in child growth velocity. Alternative therapies are immunosuppressive drugs, like cyclosporine A and tacrolimus, that usually are effective but may also cause adverse effects. A promising therapeutic option is omalizumab, a recombinant anti-IgE humanized monoclonal antibody, currently used as add-on therapy for moderate to severe uncontrolled allergic asthma and chronic spontaneous urticaria. Here, we report the short-time duration of effective relief of symptoms after the prolonged use of omalizumab in a patient affected by refractory VKC. However, in our case any apparent beneficial effect was short lasting, and we propose that the duration of the disease and the concomitant long-term use of steroids leads to iatrogenic damage; thus, the disease becomes refractory to anti-IgE treatment.</AbstractText>
                <CopyrightInformation>Copyright © 2020 by S. Karger AG, Basel.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gatta</LastName>
                    <ForeName>Alessia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Della Valle</LastName>
                    <ForeName>Loredana</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Farinelli</LastName>
                    <ForeName>Anila</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scarano</LastName>
                    <ForeName>Gilda</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lumaca</LastName>
                    <ForeName>Arianna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cavallucci</LastName>
                    <ForeName>Enrico</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Gioacchino</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paganelli</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine and Science of Ageing, and School of Specialization in Allergy and Clinical Immunology, G. d'Annunzio University, Chieti, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Case Rep Ophthalmol</MedlineTA>
            <NlmUniqueID>101532006</NlmUniqueID>
            <ISSNLinking>1663-2699</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Corneal ulcer</Keyword>
            <Keyword MajorTopicYN="N">Giant papillae</Keyword>
            <Keyword MajorTopicYN="N">IgE</Keyword>
            <Keyword MajorTopicYN="N">Omalizumab</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare that they have no conflict of interest in relation to the content of this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32774291</ArticleId>
            <ArticleId IdType="doi">10.1159/000508031</ArticleId>
            <ArticleId IdType="pii">cop-0011-0268</ArticleId>
            <ArticleId IdType="pmc">PMC7383183</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Ophthalmol Ther. 2017 Jun;6(1):195-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27909980</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2000 Dec;106(6):1019-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11112882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Allergy Asthma Rep. 2013 Jun;13(3):308-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23625179</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Alerg Mex. 2018 Apr-Jun;65(2):192-196</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29983017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J AAPOS. 2013 Jun;17(3):305-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23607979</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rev Allergy Immunol. 2016 Feb;50(1):84-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26048266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2017 Aug;28(5):503-505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28543949</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2012 Nov;67(11):1327-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22947083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Immunopathol (Madr). 2012 Sep-Oct;40(5):319-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21975146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Ophthalmol. 2013 Jan;97(1):9-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23038763</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2015 May;26(3):289-291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25692810</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Opin Biol Ther. 2005 Dec;5(12):1603-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16318424</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ophthalmol. 2012;6:1253-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22927736</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2014 Jun;25(4):314-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24438133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Ophthalmol. 2016 Apr;134(4):461-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26795360</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32773940</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0377-1237</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>76</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Medical journal, Armed Forces India</Title>
                <ISOAbbreviation>Med J Armed Forces India</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Reactive airway dysfunction syndrome: Are we missing these patients?</ArticleTitle>
            <Pagination>
                <MedlinePgn>342-344</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.mjafi.2018.06.013</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tyagi</LastName>
                    <ForeName>Rahul</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Graded Specialist (Pulmonary Medicine) INHS Asvini, Colaba, Mumbai 400005, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohanty</LastName>
                    <ForeName>C S</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Senior Advisor (Marine Medicine), INHS Asvini, Colaba, Mumbai 400005, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hande</LastName>
                    <ForeName>Vivek</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Senior Advisor and Head of Department (Medicine and Gastroenterology), INHS Asvini, Colaba, Mumbai 400005, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>Med J Armed Forces India</MedlineTA>
            <NlmUniqueID>7602492</NlmUniqueID>
            <ISSNLinking>0377-1237</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Bronchial hyperresponsiveness (BHR)</Keyword>
            <Keyword MajorTopicYN="N">Diving</Keyword>
            <Keyword MajorTopicYN="N">Reactive airway dysfunction syndrome (RADS)</Keyword>
            <Keyword MajorTopicYN="N">Spirometry</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>03</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2018</Year>
                <Month>06</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2021</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32773940</ArticleId>
            <ArticleId IdType="doi">10.1016/j.mjafi.2018.06.013</ArticleId>
            <ArticleId IdType="pii">S0377-1237(18)30087-X</ArticleId>
            <ArticleId IdType="pmc">PMC7399555</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Allergy Clin Immunol. 1994 Jan;93(1 Pt 1):12-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8308178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma Allergy. 2011;4:87-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22034572</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2008 Sep;134(3 Suppl):1S-41S</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18779187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1985 Sep;88(3):376-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4028848</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med J Armed Forces India. 2015 Dec;71(Suppl 2):S538-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26858490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1994 Jun;105(6):1895-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8205904</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mil Med. 2012 Jan;177(1):108-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22338991</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Pulm Med. 1996 Mar;2(2):104-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9363124</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32773365</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of Aerobic Training versus Breathing Exercises on Asthma Control: A Randomized Trial.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30682-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.06.042</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Aerobic training and breathing exercises are interventions that improve asthma control. However, the outcomes of these 2 interventions have not been compared.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the effects of aerobic training versus breathing exercises on clinical control (primary outcome), quality of life, exercise capacity, and airway inflammation in outpatients with moderate-to-severe asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Fifty-four asthmatics were randomized into either the aerobic training group (AG, n = 29) or the breathing exercise group (BG, n = 25). Both interventions lasted for 24 sessions (2/week, 40 minutes/session). Asthma clinical control (Asthma Control Questionnaire [ACQ]), quality of life (Asthma Quality of Life Questionnaire), asthma symptom-free days (ASFD), airway inflammation, exercise capacity, psychological distress (Hospital Anxiety and Depression Scale), daily-life physical activity (DLPA), and pulmonary function were evaluated before, immediately after, and 3 months after the intervention.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Both interventions presented similar results regarding the ACQ score, psychological distress, ASFD, DLPA, and airway inflammation (P &gt; .05). However, participants in the AG were 2.6 times more likely to experience clinical improvement at the 3-month follow-up than participants in the BG (P = .02). A greater proportion of participants in the AG also presented a reduction in the number of days without rescue medication use compared with BG (34% vs 8%; P = .04).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Outpatients with moderate-to-severe asthma who participated in aerobic training or breathing exercise programs presented similar results in asthma control, quality of life, asthma symptoms, psychological distress, physical activity, and airway inflammation. However, a greater proportion of participants in the AG presented improvement in asthma control and reduced use of rescue medication.</AbstractText>
                <CopyrightInformation>Copyright © 2020 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Evaristo</LastName>
                    <ForeName>Karen B</ForeName>
                    <Initials>KB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mendes</LastName>
                    <ForeName>Felipe Augusto Rodrigues</ForeName>
                    <Initials>FAR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil; Department of Physical Therapy, Universidade Ibirapuera, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saccomani</LastName>
                    <ForeName>Milene G</ForeName>
                    <Initials>MG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cukier</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Division (InCor), School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho-Pinto</LastName>
                    <ForeName>Regina M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Division (InCor), School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodrigues</LastName>
                    <ForeName>Marcos R</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Sports, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Santaella</LastName>
                    <ForeName>Danilo F</ForeName>
                    <Initials>DF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Sports, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saraiva-Romanholo</LastName>
                    <ForeName>Beatriz M</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, School of Medicine, University of São Paulo, São Paulo, Brazil; Department of Physical Therapy, University City of Sao Paulo (UNICID), São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martins</LastName>
                    <ForeName>Milton A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Sports, School of Medicine, University of São Paulo, São Paulo, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho</LastName>
                    <ForeName>Celso R F</ForeName>
                    <Initials>CRF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physical Therapy, School of Medicine, University of São Paulo, São Paulo, Brazil. Electronic address: cscarval@usp.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway inflammation</Keyword>
            <Keyword MajorTopicYN="N">Asthma guidelines</Keyword>
            <Keyword MajorTopicYN="N">Clinical control</Keyword>
            <Keyword MajorTopicYN="N">Persistent asthma</Keyword>
            <Keyword MajorTopicYN="N">Pulmonary rehabilitation</Keyword>
            <Keyword MajorTopicYN="N">Quality of life</Keyword>
            <Keyword MajorTopicYN="N">Symptoms</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32773365</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30682-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.06.042</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32773326</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2212-5353</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Respiratory investigation</Title>
                <ISOAbbreviation>Respir Investig</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An official JRS statement: The principles of fractional exhaled nitric oxide (FeNO) measurement and interpretation of the results in clinical practice.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2212-5345(20)30091-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resinv.2020.05.006</ELocationID>
            <Abstract>
                <AbstractText>Nitric oxide (NO) is produced in the body and has been shown to have diverse actions in the abundance of research that has been performed on it since the 1970s, leading to Furchgott, Murad, and Ignarro receiving the Nobel Prize in Physiology or Medicine in 1998. NO is produced by nitric oxide synthase (NOS). NOS is broadly distributed, being found in the nerves, blood vessels, airway epithelium, and inflammatory cells. In asthma, inflammatory cytokines induce NOS activity in the airway epithelium and inflammatory cells, producing large amounts of NO. Measurement of fractional exhaled nitric oxide (FeNO) is a simple, safe, and quantitative method of assessing airway inflammation. The FeNO measurement method has been standardized and, in recent years, this noninvasive test has been broadly used to support the diagnosis of asthma, monitor airway inflammation, and detect asthma overlap in chronic obstructive pulmonary disease (COPD) patients. Since the normal upper limit of FeNO for healthy Japanese adults is 37 ppb, values of 35 ppb or more are likely to be interpreted as a signature of inflammatory condition presenting features with asthma, and this value is used in clinical practice. Research is also underway for clinical application of these measurements in other respiratory diseases such as COPD and interstitial lung disease. Currently, there remains some confusion regarding the significance of these measurements and the interpretation of the results. This statement is designed to provide a simple explanation including the principles of FeNO measurements, the measurement methods, and the interpretation of the measurement results.</AbstractText>
                <CopyrightInformation>Copyright © 2020 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Matsunaga</LastName>
                    <ForeName>Kazuto</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine and Infectious Disease, Yamaguchi University, Ube, Japan. Electronic address: kazmatsu@yamaguchi-u.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuwahira</LastName>
                    <ForeName>Ichiro</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Medicine, Tokai University Tokyo Hospital, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hanaoka</LastName>
                    <ForeName>Masayuki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>First Department of Internal Medicine, Shinshu University, Matsumoto, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saito</LastName>
                    <ForeName>Junpei</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonary Medicine, Fukushima Medical University, Fukushima, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsuburai</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Respiratory Diseases, Saint Marianna University Yokohama City Seibu Hospital, Yokohama, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fukunaga</LastName>
                    <ForeName>Koichi</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary Medicine, Department of Medicine, Keio University, Tokyo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsumoto</LastName>
                    <ForeName>Hisako</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Kyoto University, Kyoto, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugiura</LastName>
                    <ForeName>Hisatoshi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Tohoku University, Sendai, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ichinose</LastName>
                    <ForeName>Masakazu</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Tohoku University, Sendai, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>Japanese Respiratory Society Assembly on Pulmonary Physiology</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Respir Investig</MedlineTA>
            <NlmUniqueID>101581124</NlmUniqueID>
            <ISSNLinking>2212-5345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway disease</Keyword>
            <Keyword MajorTopicYN="N">Airway inflammation</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Asthma-COPD overlap</Keyword>
            <Keyword MajorTopicYN="N">Biomarker</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest Kazuto Matsunaga received consulting fees and lecture fees from Astra-Zeneca, Nippon Boehringer Ingelheim, Novartis Pharma, Kyorin Pharma, Meiji-Seika Pharma, Sanofi, GlaxoSmithKline, and Kyorin Pharma, and research grant from Nippon Boehringer Ingelheim and Novartis Pharma. Junpei Saito received consulting fees and lecture fees from AstraZeneca and GlaxoSmithKline, and research grant from AstraZeneca, Novartis Pharma, and Shionogi &amp; Co.,Ltd. Koichi Fukunaga received consulting fees and lectures fee from Astra-Zeneca and Nippon Boehringer Ingelheim. Ichiro Kuwahira, Masayuki Hanaoka, Takahiro Tsuburai, Hisako Matsumoto, Hisatoshi Sugiura, and Masakazu Ichinose have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32773326</ArticleId>
            <ArticleId IdType="pii">S2212-5345(20)30091-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.resinv.2020.05.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32772428</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1651-2227</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta paediatrica (Oslo, Norway : 1992)</Title>
                <ISOAbbreviation>Acta Paediatr.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>YKL-40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/apa.15525</ELocationID>
            <Abstract>
                <AbstractText>YKL-40 is a chitinase-like, secreted glycoprotein associated with several respiratory disorders, including asthma and oxidant-induced lung injuries. Its biological role remains unclear, but it correlates with markers of airway fibrosis and remodelling in asthma, where it has emerged as a candidate biomarker for non-type 2 inflammation. Bronchopulmonary dysplasia (BPD) is a chronic disorder, characterised by underdeveloped, damaged lungs following premature birth and mechanical ventilation, whereas asthma is a chronic inflammatory disease, often associated with atopy and reversibility in children (3). BPD has been associated with more airway fibrosis and non-reversible lung function impairment than asthma. Although airway obstruction is generally fixed in BPD, and variable in asthma, bronchial hyperresponsiveness may be present in both. Children with both diseases may experience wheeze and obstruction and receive similar treatment.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>James</LastName>
                    <ForeName>Anna J</ForeName>
                    <Initials>AJ</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2698-8419</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nordlund</LastName>
                    <ForeName>Björn</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Konradsen</LastName>
                    <ForeName>Jon R</ForeName>
                    <Initials>JR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ebersjö</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7578-8555</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dahlén</LastName>
                    <ForeName>Sven-Erik</ForeName>
                    <Initials>SE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Experimental Asthma and Allergy Research, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berggren Broström</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sach's Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hedlin</LastName>
                    <ForeName>Gunilla</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Astrid Lindgren Children's Hospital, Lung and Allergy Unit, Karolinska University Hospital, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Norway</Country>
            <MedlineTA>Acta Paediatr</MedlineTA>
            <NlmUniqueID>9205968</NlmUniqueID>
            <ISSNLinking>0803-5253</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32772428</ArticleId>
            <ArticleId IdType="doi">10.1111/apa.15525</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32772357</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-8785</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>09</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of perinatology</Title>
                <ISOAbbreviation>Am J Perinatol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evidence on the Link between Respiratory Syncytial Virus Infection in Early Life and Chronic Obstructive Lung Diseases.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0040-1714345</ELocationID>
            <Abstract>
                <AbstractText>There is growing evidence in medical literature to support an association between early-life respiratory syncytial virus lower respiratory tract-lower respiratory tract infection (RSV-LRTI) and recurrent wheezing/asthma-like symptoms. It has been estimated that children with a history of RSV-LRTI have a 2- to 12-fold higher risk of developing asthma. The connection between RSV infection and a developmental trajectory of reduced lung function remains throughout adolescence and early adulthood, suggesting a possible role for RSV even in the inception of chronic obstructive pulmonary disease. That is why the postnatal period appears to offer a specific window of opportunity for early intervention to prevent chronic obstructive lung diseases. The mechanisms by which RSV contributes to the onset of wheezing/asthma and lung function impairment are not fully understood but appear to relate to injury caused directly by the virus and/or to pre-existing predisposing factors. While awaiting a deeper understanding of the association between RSV and chronic lung diseases, the crucial role of pediatricians and physicians is to develop strategies to prevent RSV infections to try and protect children's lifelong respiratory health. KEY POINTS: · Several evidence suggest a link between RSV infection in early life and wheezing/asthma development.. · RSV infection appears to have long term respiratory effects.. · The prevention of RSV infections could reduce the incidence of chronic obstructive respiratory diseases..</AbstractText>
                <CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Baraldi</LastName>
                    <ForeName>Eugenio</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neonatal Intensive Care Unit, Department of Women's and Children's Health, University of Padova, Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Bonadies</LastName>
                    <ForeName>Luca</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neonatal Intensive Care Unit, Department of Women's and Children's Health, University of Padova, Padova, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y" EqualContrib="N">
                    <LastName>Manzoni</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Maternal-Infant Medicine, University Hospital &quot;Degli Infermi,&quot; Ponderano, Biella, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>09</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Am J Perinatol</MedlineTA>
            <NlmUniqueID>8405212</NlmUniqueID>
            <ISSNLinking>0735-1631</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32772357</ArticleId>
            <ArticleId IdType="doi">10.1055/s-0040-1714345</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32772062</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2391-5854</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>54</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Apr</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Psychiatria polska</Title>
                <ISOAbbreviation>Psychiatr. Pol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Correlates of respiratory admissions frequency in patients with obstructive lung diseases: coping styles, personality and anxiety.</ArticleTitle>
            <Pagination>
                <MedlinePgn>303-316</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">109823</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.12740/PP/OnlineFirst/109823</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Asthma and chronic obstructive pulmonary disease (COPD) are associated with a huge financial burden on the budget and healthcare in the world. Personality traits, ways of coping with stress and anxiety levels affect the functioning of sick people. Objective of the study was to evaluate correlation between those features and the frequency of hospital and outpatient clinic admissions among people with chronic pulmonary diseases.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Participants (n=100) with asthma and COPD were subjected to: a sociodemographic urvey, NEO-FFI Personality Inventory, State-Trait Anxiety Inventory (STAI) and Brief COPE Inventory.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There was a relationship between the hospital admission frequency and neuroticism (positive correlation). The frequency of visits to the outpatient clinic was positively correlated with the level of conscientiousness, use of emotional support and negatively with cessation of action.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The obtained results may indicate the need to offer patients with respiratory diseases psychotherapeutic activities aimed at building a more constructive functioning, reducing anxiety, increasing the sense of control.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tabała</LastName>
                    <ForeName>Klaudia</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Łodzi, Zakład Rehabilitacji Psychospołecznej.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wrzesińska</LastName>
                    <ForeName>Magdalena Agnieszka</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Łodzi, Zakład Rehabilitacji Psychospołecznej.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stecz</LastName>
                    <ForeName>Patryk</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Łódzki, Wydział Nauk o Wychowaniu, Instytut Psychologii, Zakład Psychoprofilaktyki i Psychologii Uzależnień.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mąkosa</LastName>
                    <ForeName>Grzegorz</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wojewódzki Zakład Opieki Zdrowotnej Centrum Leczenia Chorób Płuc i Rehabilitacji w Łodzi, Oddział Rehabilitacji Ogólnoustrojowej w Tuszynie.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kocur</LastName>
                    <ForeName>Józef</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wyższa Szkoła Informatyki i Umiejętności w Łodzi.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <Language>pol</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Profil osobowości, poziom lęku i style radzenia sobie ze stresem a liczba hospitalizacji i konsultacji specjalistycznych u osób z chorobami obturacyjnymi płuc.</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Poland</Country>
            <MedlineTA>Psychiatr Pol</MedlineTA>
            <NlmUniqueID>0103314</NlmUniqueID>
            <ISSNLinking>0033-2674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">mental functioning</Keyword>
            <Keyword MajorTopicYN="N">obstructive lung diseases</Keyword>
            <Keyword MajorTopicYN="N">respiratory admissions frequency</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32772062</ArticleId>
            <ArticleId IdType="pii">109823</ArticleId>
            <ArticleId IdType="doi">10.12740/PP/OnlineFirst/109823</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32772056</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2391-5854</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>54</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Apr</Month>
                        <Day>30</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Psychiatria polska</Title>
                <ISOAbbreviation>Psychiatr. Pol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A multi-perspective analysis of dissemination, etiology, clinical view and therapeutic approach for binge eating disorder (BED).</ArticleTitle>
            <Pagination>
                <MedlinePgn>223-238</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">105502</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.12740/PP/105502</ELocationID>
            <Abstract>
                <AbstractText>Eating disorders (ED) constitute the third most common group of chronic diseases among people aged 14-19 years after asthma and obesity, and one of their forms is binge eating disorder (BED). The purpose of the present review was to summarize new research findings on BED and overview the epidemiology, characteristics, criteria, etiopathogenesis, and treatment. Etiopathogenesis of BED is still poorly understood, and the current state of knowledge leads to the conclusion that the pathomechanism of the development and persistence of the symptoms of that disorder is very complicated - factors influencing these symptoms have a genetic, neurobiological, biochemical, cognitive, and emotional background. Treatment targeted at selected pathogenetic mechanisms - i.a., disturbance in the corticostriatal circuit, neurohormonal dysregulation or incorrect regulation of emotions - may be of help for people with binge eating disorder. Often comorbid mental, e.g., mood, anxiety and personality disorders, psychoactive substance abuse, suicidal ideation and suicide attempts, and somatic problems are particularly crucial in the context of primary care physicians and psychiatrists work and should encourage the expanding knowledge about BED and the creation of interdisciplinary therapeutic teams.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jowik</LastName>
                    <ForeName>Katarzyna</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Poznaniu, Klinika Psychiatrii Dzieci i Młodzieży, SKN Psychiatrii Dzieci i Młodzieży.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dutkiewicz</LastName>
                    <ForeName>Agata</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Poznaniu, Klinika Psychiatrii Dzieci i Młodzieży.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Słopień</LastName>
                    <ForeName>Agnieszka</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Poznaniu, Klinika Psychiatrii Dzieci i Młodzieży.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tyszkiewicz-Nwafor</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Uniwersytet Medyczny w Poznaniu, Klinika Psychiatrii Dzieci i Młodzieży.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <Language>pol</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <VernacularTitle>Wieloaspektowa analiza rozpowszechnienia, czynników etiologicznych, obrazu klinicznego i postępowania terapeutycznego zaburzeń z napadami objadania (Binge Eating Disorder, BED).</VernacularTitle>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Poland</Country>
            <MedlineTA>Psychiatr Pol</MedlineTA>
            <NlmUniqueID>0103314</NlmUniqueID>
            <ISSNLinking>0033-2674</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">BED</Keyword>
            <Keyword MajorTopicYN="N">binge eating disorder</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32772056</ArticleId>
            <ArticleId IdType="pii">105502</ArticleId>
            <ArticleId IdType="doi">10.12740/PP/105502</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771949</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-1705</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>88</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunopharmacology</Title>
                <ISOAbbreviation>Int. Immunopharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Panax notoginseng saponin R1 modulates TNF-α/NF-κB signaling and attenuates allergic airway inflammation in asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>106860</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1567-5769(19)32858-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.intimp.2020.106860</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUD" NlmCategory="UNASSIGNED">Panax notoginseng saponin R1 (PNS-R1) is one of the most important chemical monomers derived from the panax notoginseng, and our previous study found that PNS-R1 reduced glucocorticoid-induced apoptosis in asthmatic airway epithelial cells. Thus, in this study, we explored the effects of the PNS-R1 on inflammation of allergic asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The asthmatic mice were administered 15 mg/kg PNS-R1 by intraperitoneal injection three days before sensitized to OVA. The effects of PNS-R1 on asthmatic mice were detected by airway hyperresponsiveness, inflammation, mucus hypersecretion and inflammatory cytokines such as interleukin (IL)-13, IL-4, IL-5, IL-8 and tumor necrosis factor (TNF)-α were studied. We also treated human bronchial epithelial cells (16HBE) with house dust mites (HDM) and then detected the secretion of cellular inflammatory factors (IL-13 and TNF-α). Western blot and immunofluorescence were used to examine the effect of PNS-R1 on TNF-α/NF-κB pathway. TNF-α/NF-κB/IKK signal pathway activator was used in PNS-R1-treated asthmatic mice.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">PNS-R1 significantly reduced the airway inflammatory, mucus secretion and hyperresponsiveness in asthma model. It also reduced the levels of IL-13, IL-4, IL-5 and IL-8 in bronchoalveolar lavage fluid (BALF) and IgE and OVA-specific IgE in serum for asthma mice. PNS-R1 reduced IL-13 and TNF-α secretion in HDM-treated 16HBE cells. In addition, PNS-R1 suppressed TNF-α/NF-κB pathway in both asthmatic mice and 16HBE. Activation of NF-kB pathway reversed the therapeutic effect of PNS-R1 on asthmatic mice.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results indicated that PNS-R1 effectively suppresses allergic airway inflammation of asthma partly through TNF-α/NF-κB pathway. PNS-R1 may play a potential role in allergic asthma treatment in the future.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xue</LastName>
                    <ForeName>Kunjiao</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, PR China; Chongqing Key Laboratory of Pediatrics, Chongqing, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ruan</LastName>
                    <ForeName>Lingying</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, PR China; Chongqing Key Laboratory of Pediatrics, Chongqing, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, PR China; Chongqing Key Laboratory of Pediatrics, Chongqing, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fu</LastName>
                    <ForeName>Zhou</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Daiyin</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chongqing Key Laboratory of Pediatrics, Chongqing, PR China. Electronic address: t_dy@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zou</LastName>
                    <ForeName>Wenjing</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respiratory Medicine, Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Children's Hospital of Chongqing Medical University, Chongqing, PR China; Chongqing Key Laboratory of Pediatrics, Chongqing, PR China. Electronic address: lucky_121212@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int Immunopharmacol</MedlineTA>
            <NlmUniqueID>100965259</NlmUniqueID>
            <ISSNLinking>1567-5769</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">NF-κB</Keyword>
            <Keyword MajorTopicYN="N">Panax notoginseng saponin R1</Keyword>
            <Keyword MajorTopicYN="N">TNF-α</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771949</ArticleId>
            <ArticleId IdType="pii">S1567-5769(19)32858-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.intimp.2020.106860</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771720</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-264X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>189</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of pharmaceutical and biomedical analysis</Title>
                <ISOAbbreviation>J Pharm Biomed Anal</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Microbiota-derived metabolites as diagnostic markers for respiratory fungal infections.</ArticleTitle>
            <Pagination>
                <MedlinePgn>113473</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0731-7085(20)31359-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpba.2020.113473</ELocationID>
            <Abstract>
                <AbstractText>An emerging body of evidence has highlighted the significant role of the pulmonary microbiota during respiratory infections. The individual microbiome is nowadays recognized to supervise the outcome of the host-pathogen interaction by orchestrating mechanisms of immune regulation, inflammation, metabolism, and other physiological processes. A shift in the normal flora of the respiratory tract is associated with several lung inflammatory disorders including asthma, chronic obstructive pulmonary disease, or cystic fibrosis. These diseases are characterized by a lung microenvironment that becomes permissive to infections caused by the opportunistic fungal pathogen Aspergillus fumigatus. Although the role of the lung microbiota in the pathophysiology of respiratory fungal diseases remains elusive, microbiota-derived components have been proposed as important biomarkers to be considered in the diagnosis of these severe infections. Here, we review this emerging area of research and discuss the potential of microbiota-derived products in the diagnosis of respiratory fungal diseases.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hérivaux</LastName>
                    <ForeName>Anaїs</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Guimarães, Braga, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gonçalves</LastName>
                    <ForeName>Samuel M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Guimarães, Braga, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho</LastName>
                    <ForeName>Agostinho</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Guimarães, Braga, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cunha</LastName>
                    <ForeName>Cristina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's - PT Government Associate Laboratory, Guimarães, Braga, Portugal. Electronic address: cristinacunha@med.uminho.pt.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Pharm Biomed Anal</MedlineTA>
            <NlmUniqueID>8309336</NlmUniqueID>
            <ISSNLinking>0731-7085</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aspergillus</Keyword>
            <Keyword MajorTopicYN="N">Biomarkers</Keyword>
            <Keyword MajorTopicYN="N">Diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Fungal infection</Keyword>
            <Keyword MajorTopicYN="N">Microbiota</Keyword>
            <Keyword MajorTopicYN="N">VOCs</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771720</ArticleId>
            <ArticleId IdType="pii">S0731-7085(20)31359-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jpba.2020.113473</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771687</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antineutrophil cytoplasmic antibodies and organ-specific manifestations in eosinophilic granulomatosis with polyangiitis: A systematic review and meta-analysis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30796-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.07.038</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Eosinophilic granulomatosis with polyangiitis (EGPA), also known as Churg-Strauss syndrome, is a rare and often severe systemic vasculitis associated with antineutrophil cytoplasmic antibodies (ANCAs). EGPA can affect multiple organ systems, but the relationships between ANCA status and the organ-specific manifestations of EGPA in previous reports were inconsistent.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the association of the ANCA status with organ-specific manifestations in EGPA.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We performed a systematic review of studies published before March 16, 2020 in the Pubmed, Embase, Web of Science, and Cochrane Library databases. The primary outcome was the association of ANCA status with organ-specific involvements of EGPA. Odds ratios (ORs) and 95% confidence intervals were calculated using a random-effects model.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 24 cross-sectional studies with 2527 patients with EGPA, including 921 ANCA-positive patients and 1606 ANCA-negative patients, were included in the meta-analysis. The significant results of pooled analyses revealed that compared with patients with negative ANCA status, patients with EGPA with positive ANCA status had higher risks of peripheral neuropathy (OR: 1.701), renal involvement (OR: 5.097), and cutaneous purpura (OR: 1.746) and lower risks of pulmonary infiltrates (OR: 0.589) and cardiac involvement (OR: 0.427). The pooled analysis also revealed no significant association of ANCA status with asthma and involvements of the central nervous system, gastrointestinal tract, or skin.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study provides more evidence that patients with EGPA may exhibit different features of disease based on their ANCA status.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>Hua-Ching</ForeName>
                    <Initials>HC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan; Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chou</LastName>
                    <ForeName>Pai-Chien</ForeName>
                    <Initials>PC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan; Division of Thoracic Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lai</LastName>
                    <ForeName>Chun-Yu</ForeName>
                    <Initials>CY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsai</LastName>
                    <ForeName>Hsiou-Hsin</ForeName>
                    <Initials>HH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Dermatology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan. Electronic address: tsaihh2000@yahoo.com.tw.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Churg–Strauss syndrome</Keyword>
            <Keyword MajorTopicYN="N">antineutrophil cytoplasmic antibodies</Keyword>
            <Keyword MajorTopicYN="N">eosinophilic granulomatosis with polyangiitis</Keyword>
            <Keyword MajorTopicYN="N">meta-analysis</Keyword>
            <Keyword MajorTopicYN="N">systematic review</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771687</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30796-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.07.038</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771685</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2201</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of allergy and clinical immunology. In practice</Title>
                <ISOAbbreviation>J Allergy Clin Immunol Pract</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Psychometric properties of the Asthma Control Test in two randomized clinical trials.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2198(20)30798-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaip.2020.07.040</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kosinski</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Optum, Johnston, RI, USA. Electronic address: mkosinski@qualitymetric.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nelsen</LastName>
                    <ForeName>Linda</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Value Evidence and Outcomes, GlaxoSmithKline plc., Collegeville, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizio</LastName>
                    <ForeName>Avery A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Optum, Johnston, RI, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lay-Flurrie</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Statistics, GlaxoSmithKline plc., Uxbridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>von Maltzahn</LastName>
                    <ForeName>Robyn</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Value Evidence and Outcomes, GlaxoSmithKline plc., London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacques</LastName>
                    <ForeName>Loretta</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Sciences, GlaxoSmithKline plc., Uxbridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schatz</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Kaiser Permanente, San Diego, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stanford</LastName>
                    <ForeName>Richard H</ForeName>
                    <Initials>RH</Initials>
                    <AffiliationInfo>
                        <Affiliation>AESARA Inc, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Svedsater</LastName>
                    <ForeName>Henrik</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Value Evidence and Outcomes, GlaxoSmithKline plc., London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol Pract</MedlineTA>
            <NlmUniqueID>101597220</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>12</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771685</ArticleId>
            <ArticleId IdType="pii">S2213-2198(20)30798-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaip.2020.07.040</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771571</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1876-7591</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JACC. Cardiovascular imaging</Title>
                <ISOAbbreviation>JACC Cardiovasc Imaging</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Myocardial Native T<sub>1</sub> Predicts Load-Independent Left Ventricular Chamber Stiffness In Patients With HFpEF.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1936-878X(20)30518-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcmg.2020.05.030</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study sought to evaluate the potential of cardiac magnetic resonance T<sub>1</sub> mapping to detect load-independent left ventricular (LV) chamber stiffness by histological confirmation.</AbstractText>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accurate noninvasive diagnosis of LV diastolic dysfunction in heart failure with preserved ejection fraction (HFpEF) remains challenging.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Nineteen HFpEF patients (14 female, 65 ± 16 years of age) without primary cardiomyopathy were prospectively enrolled. Cine, late gadolinium enhancement cardiac magnetic resonance, and triple-slice T<sub>1</sub> mapping using a modified Look-Locker inversion recovery sequence were performed at 3-T. Extracellular volume (ECV) was quantified from pre- and post-contrast T<sub>1</sub> values of the blood and myocardium with hematocrit correction. LV stiffness constant (beta) was assessed by calculating the slope of the end-diastolic pressure-volume relationship curve during vena cava occlusion. Biopsy samples were used for quantification of collagen volume fraction (CVF) and myocardial cell size.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Six patients showed focal scar on late gadolinium enhancement. There was no significant difference in histological CVF between patients with and without focal myocardial scarring (p = 0.2). Septal ECV rather than native T<sub>1</sub> was a better surrogate marker for detecting histological CVF (r = 0.54; p = 0.02, and r = 0.44; p = 0.06, respectively). Global native T<sub>1</sub> and ECV, but not native T<sub>1</sub> and ECV in the septal myocardium, correlated well with the beta of passive LV stiffness, and had similar ability for predicting LV stiffness to histological CVF (r = 0.54, 0.50, 0.53, all p &lt; 0.05, respectively). When the beta ≥0.054 was considered as moderately increased LV stiffness, global native T<sub>1</sub> ≥1,362 ms provided 88% sensitivity and 64% specificity with the C-statistic of 0.81 (95% confidence interval: 0.56 to 0.95).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Myocardial native T<sub>1</sub> provides comparable ability in predicting LV stiffness to ECV and histological CVF and may be useful for monitoring patients with HFpEF who have renal dysfunction, allergy to gadolinium, or wheezing that can simulate asthma. Our feasibility study shows the potential of native T<sub>1</sub> to allow for insight of heterogeneous pathophysiology and better risk stratification of HFpEF.</AbstractText>
                <CopyrightInformation>Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Omori</LastName>
                    <ForeName>Taku</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakamori</LastName>
                    <ForeName>Shiro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan. Electronic address: n-shiro@clin.medic.mie-u.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fujimoto</LastName>
                    <ForeName>Naoki</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ishida</LastName>
                    <ForeName>Masaki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kitagawa</LastName>
                    <ForeName>Kakuya</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ichikawa</LastName>
                    <ForeName>Yasutaka</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumagai</LastName>
                    <ForeName>Naoto</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kurita</LastName>
                    <ForeName>Tairo</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imanaka-Yoshida</LastName>
                    <ForeName>Kyoko</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center for Matrix Biology, Mie University, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hiroe</LastName>
                    <ForeName>Michiaki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Center for Matrix Biology, Mie University, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sakuma</LastName>
                    <ForeName>Hajime</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Masaaki</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dohi</LastName>
                    <ForeName>Kaoru</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>JACC Cardiovasc Imaging</MedlineTA>
            <NlmUniqueID>101467978</NlmUniqueID>
            <ISSNLinking>1876-7591</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cardiovascular magnetic resonance</Keyword>
            <Keyword MajorTopicYN="N">heart failure with preserved ejection fraction</Keyword>
            <Keyword MajorTopicYN="N">histological collagen volume fraction</Keyword>
            <Keyword MajorTopicYN="N">left ventricular stiffness</Keyword>
            <Keyword MajorTopicYN="N">native T(1)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771571</ArticleId>
            <ArticleId IdType="pii">S1936-878X(20)30518-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jcmg.2020.05.030</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771560</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J. Allergy Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asthma Among Hospitalized Patients with COVID-19 and Related Outcomes.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0091-6749(20)31100-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaci.2020.07.026</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several underlying conditions have been associated with severe SARS-CoV2 illness, it remains unclear if underlying asthma is associated with worse COVID-19 outcomes.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Given the high prevalence of asthma in the New York City area, our objective was to determine if underlying asthma was associated with poor outcomes among hospitalized patients with severe COVID-19 disease compared to patients without asthma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Electronic heath records were reviewed for 1,298 sequential patients age &lt;65 years without chronic obstructive pulmonary disease (COPD) who were admitted to our hospital system with a confirmed positive SARS-CoV-2 test.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall prevalence of asthma among all hospitalized patients with COVID-19 was 12.6%, yet a higher prevalence (23.6%) was observed in the subset 55 patients &lt;21 years of age. There was no significant difference in hospital length of stay, need for intubation, length of intubation, tracheostomy tube placement, hospital readmission or mortality between asthmatic vs. non-asthmatic patients. Observations between asthmatic and non-asthmatic patients were similar when stratified by obesity, other comorbid conditions (i.e. hypertension, hyperlipidemia, and diabetes), use of controller asthma medication and absolute eosinophil count.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among hospitalized patients &lt;65 years with severe COVID-19, asthma diagnosis was not associated with worse outcomes, regardless of age, obesity, or other high-risk comorbidities. Future population based studies are needed to investigate the risk of developing COVID-19 among patients with asthma once universal testing becomes readily available.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lovinsky-Desir</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY. Electronic address: sl3230@cumc.columbia.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deshpande</LastName>
                    <ForeName>Deepti R</ForeName>
                    <Initials>DR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Immunology and Rheumatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De</LastName>
                    <ForeName>Aliva</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>Laurie</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, New York Presbyterian - Morgan Stanley Children's Hospital of New York, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stingone</LastName>
                    <ForeName>Jeanette A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Immunology and Rheumatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Neha</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rai</LastName>
                    <ForeName>Nooralam</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>DiMango</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milner</LastName>
                    <ForeName>Joshua</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Immunology and Rheumatology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kattan</LastName>
                    <ForeName>Meyer</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">New York City</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV2</Keyword>
            <Keyword MajorTopicYN="N">coronavirus</Keyword>
            <Keyword MajorTopicYN="N">respiratory disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771560</ArticleId>
            <ArticleId IdType="pii">S0091-6749(20)31100-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2020.07.026</ArticleId>
            <ArticleId IdType="pmc">PMC7409831</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771356</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibited IL-35 expression and IL-35-induced regulatory T cells promote type II innate lymphoid cells response in allergic rhinitis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30562-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.005</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">IL-35 and IL-35-producing regulatory T cells (iTr35) have been reported to inhibit Th2 response in allergic rhinitis (AR). However, its effects on type II innate lymphoid cells (ILC2) are not well characterized.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the effect of IL-35 on type II innate lymphoid cells (ILC2) in AR.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-five AR patients and 20 controls were recruited. The expression and regulation of IL-35 receptor in ILC2 were analyzed by real-time PCR. The effect of IL35 on ILC2 differentiation and cytokine production was analyzed by real-time PCR and enzyme-linked immunosorbnent assay (ELISA). The iTr35 were cocultured with ILC2 to explore the effect of the iTr35 on ILC2. AR mice models were also established to confirm the role of IL-35 in vivo .</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">AR patients had decreased IL-35 expression and iTr35 proportion and increased ILC2 and type II cytokines compared with controls. The IL-35 inhibited ILC2 differentiation and type II cytokine production by regulation of IL-12Rβ2 and gp130. IL35 promoted the inducible costimulatory molecule (ICOS) expression by iTr35 and ICOS ligand (ICOSL) expression by ILC2. IL-35 treated AR mice presented as decreased frequency and function of nasal ILC2.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">IL-35 inhibited ILC2 responses directly or through mutual contact between iTr35 and ILC2 in AR, suggesting that IL-35 may be used as potential treatment target in AR.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Wenlong</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China. Electronic address: lwl20103@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Qingxiang</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wen</LastName>
                    <ForeName>Yanhui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, The third people's hospital of Dongguan, Dongguan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Yiquan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Shengbao</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Lifeng</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luo</LastName>
                    <ForeName>Renzhong</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IL-35</Keyword>
            <Keyword MajorTopicYN="N">ILC2,iTr35</Keyword>
            <Keyword MajorTopicYN="N">allergic rhinitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771356</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30562-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771355</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The relationship of race and aeroallergen sensitization in a pediatric urban allergy clinic.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30565-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.007</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tuong</LastName>
                    <ForeName>Linh-An C</ForeName>
                    <Initials>LC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rutgers University. Electronic address: Linh-An.Tuong@rochesterregional.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trivedi</LastName>
                    <ForeName>Radhika</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rutgers University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenberg</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rutgers University.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Narisety</LastName>
                    <ForeName>Satya D</ForeName>
                    <Initials>SD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Rutgers University.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Black/African-American</Keyword>
            <Keyword MajorTopicYN="N">Newark</Keyword>
            <Keyword MajorTopicYN="N">Urban</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771355</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30565-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.007</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771354</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Infectious Complications of Atopic Dermatitis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30558-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.002</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Atopic dermatitis (AD) is a chronic inflammatory skin disease that is complicated by an increased risk for skin and systemic infections. Preventive therapy for AD is based on skin barrier improvement and anti-inflammatory treatments, whereas overt skin and systemic infections require antibiotics or anti-viral treatments. This review updates the pathophysiology, diagnosis, management, controversy of antibiotic use, and potential treatments of AD infectious complications.</AbstractText>
                <AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Published literature obtained through PubMed searches and clinical pictures.</AbstractText>
                <AbstractText Label="STUDY SELECTIONS" NlmCategory="METHODS">Studies relevant to the mechanisms, diagnosis, management and potential therapy of AD infectious complications.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Skin barrier defects, type 2 inflammation, S. aureus colonization and cutaneous dysbiosis are the major predisposing factors for the increased infections in AD. While overt infections require antibiotics, the use of antibiotics in AD exacerbation remains controversial.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Infectious complications are a co-morbidity of AD. Although not common, systemic bacterial infections and eczema herpeticum can be life-threatening. Preventive therapy of infections in AD emphasizes skin barrier improvement and anti- inflammatory therapy. The use of antibiotics in AD exacerbation requires further studies.</AbstractText>
                <CopyrightInformation>Copyright © 2020. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Vivian</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, California.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boguniewicz</LastName>
                    <ForeName>Juri</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Infectious Diseases, Children's Hospital Colorado; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boguniewicz</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy-Immunology, Department of Pediatrics, National Jewish Health, Denver, Colorado; Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ong</LastName>
                    <ForeName>Peck Y</ForeName>
                    <Initials>PY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical Immunology and Allergy, Children's Hospital Los Angeles; Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California. Electronic address: pyong@chla.usc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">S. aureus colonization</Keyword>
            <Keyword MajorTopicYN="N">bacteremia</Keyword>
            <Keyword MajorTopicYN="N">bacterial resistance</Keyword>
            <Keyword MajorTopicYN="N">eczema flare</Keyword>
            <Keyword MajorTopicYN="N">osteomyelitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771354</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30558-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.002</ArticleId>
            <ArticleId IdType="pmc">PMC7411503</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2019 Oct 16;10(1):4703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31619666</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Dermatol. 2019 Jan;36(1):115-120</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30303549</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2018 Jan;120(1):10-22.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29273118</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Invest Dermatol. 2019 Oct;139(10):2077-2079</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31543211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2020 Feb 17;10(1):2721</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32066784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2018 Apr 27;8(1):6665</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29703987</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatol Ther. 2013 Nov-Dec;26(6):445-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24552407</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Dermatol. 2019 Sep;36(5):634-639</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31328306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2020 Jun;145(6):1606-1614.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32179159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Acad Dermatol. 2019 Jan;80(1):89-98.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30554600</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEMS Microbiol Rev. 2020 Jan 1;44(1):123-153</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31841134</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Infect Dis Rep. 2019 Mar 11;21(4):12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30859379</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Dermatol. 2004;5(4):217-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15301569</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Dermatol. 2019 Jul;36(4):540-541</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30838689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 21;395(10228):923-924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32087123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Rev Allergy Immunol. 2016 Dec;51(3):329-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27377298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 2020 Apr;80(6):609-615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32166597</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2020 Jul 1;130(7):3750-3760</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32271718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Invest Dermatol. 2020 Feb;140(2):415-424.e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31344386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2018 Aug;57(8):1001-1006</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29904968</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2020 Jan;124(1):28-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31622669</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Sep 11;9(1):13082</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31511620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Dermatol. 2011 Jan-Feb;28(1):46-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21261703</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2018 Nov;73(11):2205-2213</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29672867</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 Oct 10;347(15):1151-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12374875</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Apr;137(4):1091-1102.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26431582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2019 May;180(5):1030-1038</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30623408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2017 Dec;119(6):480-488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29223298</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771353</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30566-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.008</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Laidlaw</LastName>
                    <ForeName>Tanya M</ForeName>
                    <Initials>TM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: tlaidlaw@bwh.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771353</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30566-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.008</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771274</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1166</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Human immunology</Title>
                <ISOAbbreviation>Hum. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A profile of TNFR2<sup>+</sup> regulatory T cells and CD103<sup>+</sup> dendritic cells in the peripheral blood of patients with asthma.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0198-8859(20)30359-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.humimm.2020.07.006</ELocationID>
            <Abstract>
                <AbstractText>The interaction of tolerogenic CD103<sup>+</sup> dendritic cells (DCs) with regulatory T (Tregs) cells modulates immune responses by inducing immune tolerance. Hence, we determined the proportion of these cells in the peripheral blood mononuclear cells (PBMC) of asthmatic patients. We observed lower trends of CD11b<sup>-</sup>CD103<sup>+</sup> DCs and CD86 within CD11b<sup>-</sup>CD103<sup>+</sup> DCs, while increased levels of Foxp3 expressing CD25<sup>+/-</sup>TNFR2<sup>+</sup> cells in asthmatics. There was a positive correlation in the expression of Foxp3 within CD3<sup>+</sup>CD4<sup>+</sup>CD25<sup>+</sup>TNFR2<sup>+</sup> Tregs and CD11b<sup>-</sup>CD103<sup>+</sup> as well as the expression of CD86 within HLA-DR<sup>+</sup>CD11c<sup>+</sup>CD11b<sup>-</sup>CD103<sup>+</sup> DCs. In conclusion, we suggest that the increased levels of Tregs in blood could continuously suppress the T helper 2 (Th2) cells activation in the circulation which is also supported by the increase of anti-inflammatory cytokines IL-10 and TNF. Overall, functional immunoregulation of the regulatory cells, particularly Tregs, exhibit immune suppression and induce immune tolerance linked with the immune activation by the antigen presenting cells (APC).</AbstractText>
                <CopyrightInformation>Copyright © 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Azid</LastName>
                    <ForeName>Nor Azrini</ForeName>
                    <Initials>NA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmad</LastName>
                    <ForeName>Suhana</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boer</LastName>
                    <ForeName>Jennifer C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Immunology and Nanotechnology Unit, School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia. Electronic address: jennifer.boer@rmit.edu.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Hatamleh</LastName>
                    <ForeName>Mohammad A I</ForeName>
                    <Initials>MAI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohammad</LastName>
                    <ForeName>Nurashikin</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kelantan, Malaysia. Electronic address: nurashikinm@usm.my.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohd Ashari</LastName>
                    <ForeName>Noor Suryani</ForeName>
                    <Initials>NS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kelantan, Malaysia. Electronic address: suryani@usm.my.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Hern Tze</ForeName>
                    <Initials>HT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kelantan, Malaysia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, China. Electronic address: xchen@umac.mo.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plebanski</LastName>
                    <ForeName>Magdalena</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Immunology and Nanotechnology Unit, School of Health and Biomedical Sciences, RMIT University, Bundoora 3083, Australia. Electronic address: magdalena.plebanski@rmit.edu.au.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohamud</LastName>
                    <ForeName>Rohimah</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia; Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Kelantan, Malaysia. Electronic address: rohimahm@usm.my.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Hum Immunol</MedlineTA>
            <NlmUniqueID>8010936</NlmUniqueID>
            <ISSNLinking>0198-8859</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">CD103</Keyword>
            <Keyword MajorTopicYN="N">Dendritic cells</Keyword>
            <Keyword MajorTopicYN="N">Tregs</Keyword>
            <Keyword MajorTopicYN="N">Tumor necrosis factor receptor 2 (TNFR2)</Keyword>
        </KeywordList>
        <CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771274</ArticleId>
            <ArticleId IdType="pii">S0198-8859(20)30359-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.humimm.2020.07.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32771080</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2213-2619</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Lancet. Respiratory medicine</Title>
                <ISOAbbreviation>Lancet Respir Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>COVID-19, asthma, and return to school.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S2213-2600(20)30353-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(20)30353-2</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Abrams</LastName>
                    <ForeName>Elissa M</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Section of Allergy and Clinical Immunology, University of Manitoba, Winnipeg, MB R2A 5L9, Canada; Department of Pediatrics, Division of Allergy and Immunology, University of British Columbia, Vancouver, BC, Canada. Electronic address: eabram10@jhu.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGill</LastName>
                    <ForeName>Gráinne</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Architecture, Faculty of Engineering, University of Strathclyde, Glasgow, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhopal</LastName>
                    <ForeName>Sunil S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle, UK; Northumbria Healthcare NHS Foundation Trust, Newcastle, UK; Maternal and Child Health Intervention Research Group, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sinha</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Alder Hey Children's Hospital, Liverpool, UK; Division of Child Health, University of Liverpool, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fernandes</LastName>
                    <ForeName>Ricardo M</ForeName>
                    <Initials>RM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Pharmacology Unit, Faculty of Medicine and Instituto de Medicina Molecular, University of Lisbon, Lisbon, Portugal; Department of Pediatrics, Santa Maria Hospital, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Lancet Respir Med</MedlineTA>
            <NlmUniqueID>101605555</NlmUniqueID>
            <ISSNLinking>2213-2600</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32771080</ArticleId>
            <ArticleId IdType="pii">S2213-2600(20)30353-2</ArticleId>
            <ArticleId IdType="doi">10.1016/S2213-2600(20)30353-2</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32770990</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2458</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC public health</Title>
                <ISOAbbreviation>BMC Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exposure to environmental tobacco smoke and prevalence of asthma among adolescents in a middle eastern country.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1210</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-020-09245-9</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is increasing evidence linking environmental tobacco smoke (ETS) exposure at homes to the development of asthma among adolescents. Few studies have addressed this issue in the Middle Eastern countries including Kuwait. Therefore, this cross-sectional study assessed the prevalence of ETS exposure at home, prevalence of asthma and other respiratory conditions and examined the ETS exposure at home and personal tobacco smoking as risk factors for self-reported asthma among high-school students in Kuwait.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this cross-sectional study, we enrolled participants from nine high-schools of Hawally Governorate of Kuwait during October 2015. We adapted a previously validated self-administered questionnaire for data collection. Prevalence of self-reported asthma and ETS exposure (≥ 1 smoker at home vs. none) were computed. The association between exposures of interest and self-reported asthma status was examined using a multivariable log-binomial regression model.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 800 enrolled participants, 746 (92.2%) consented and completed the questionnaire. The participants with mean (SD) age of 16.8 (0.68) years were predominantly Kuwaiti (74.8%) and female (50.1%). The prevalence of ETS exposure at home and personal current smoking was 54 and 12.4% respectively. Self-reported asthma prevalence was 20.5%. Furthermore, the prevalence of physician-diagnosed asthma, wheezing during the last 12 months and wheezing 'ever' was 16.4, 20.1 and 26.2%, respectively. Fitted multivariable log-binomial regression model revealed that compared with the non-asthmatic, participants with self-reported asthma tended to be current smokers (adjusted prevalence ratio (adjusted PR) = 1.82; 95% CI: 1.30-2.56; p = 0.001) or have had ETS exposure at home (adjusted PR = 1.64; 95% CI: 1.21-2.23; p = 0.002).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We recorded a high prevalence of ETS exposure at home, high prevalence of self-reported asthma and identified ETS exposure at home and being a current smoker as strong risk factors for self-reported asthma among adolescents. Voluntary household smoking bans may substantially minimize the ETS exposure among adolescents. Additionally, such restriction may inculcate an antismoking attitude and prevent smoking initiation among adolescents. Such efforts may bring about reduction in ETS exposure and associated asthma risk and other smoking-related morbidities in this and other similar settings.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Booalayan</LastName>
                    <ForeName>Hussain</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abdualrasool</LastName>
                    <ForeName>Mosa</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Shanfari</LastName>
                    <ForeName>Saad</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boujarwa</LastName>
                    <ForeName>Abdulwahab</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Mukaimi</LastName>
                    <ForeName>Abdullah</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alkandery</LastName>
                    <ForeName>Omar</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akhtar</LastName>
                    <ForeName>Saeed</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1261-788X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine and Behavioral Sciences, Faculty of Medicine, Kuwait University, PO Box 24923, 13110, Safat, Kuwait. saeed.akhtar@hsc.edu.kw.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Public Health</MedlineTA>
            <NlmUniqueID>100968562</NlmUniqueID>
            <ISSNLinking>1471-2458</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adolescents</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Environmental tobacco smoke</Keyword>
            <Keyword MajorTopicYN="N">Log-binomial model</Keyword>
            <Keyword MajorTopicYN="N">Prevalence ratio</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770990</ArticleId>
            <ArticleId IdType="doi">10.1186/s12889-020-09245-9</ArticleId>
            <ArticleId IdType="pii">10.1186/s12889-020-09245-9</ArticleId>
            <ArticleId IdType="pmc">PMC7414674</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Med Princ Pract. 2013;22:576-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24021780</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Health Perspect. 2006 Apr;114(4):627-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16581557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr (Rio J). 2013 May-Jun;89(3):294-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23684453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 1983 Oct;58(10):777-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6639124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Epidemiol. 2007 Dec;17(12):1004-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17855117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1989 Aug;44(8):614-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2799740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1998 Mar;53(3):204-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9659358</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1999 Jan;54(1):27-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10343627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 1997 Nov;8(4):161-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9553981</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2009 Oct;44(10):954-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19728392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2006 Aug 26;368(9537):733-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16935684</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2009 Jan;64(1):5-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19076533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2016 Sep 01;16(1):913</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27586515</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2009 Aug;13(8):1023-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19723384</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Public Health. 2012 Mar 26;12:239</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22443305</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1201-1205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29037303</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 1998 Apr 25;351(9111):1225-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9643741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dermatology. 2018;234(5-6):186-191</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30286465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Tuberc Lung Dis. 2017 Nov 1;21(11):1093</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29037288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 1998 Aug;12(2):315-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9727780</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2012 Nov;67(11):941-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22693180</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2000 Jul;85(1):58-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10923606</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 1995 Mar;8(3):483-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7789502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Springer Semin Immunopathol. 2004 Feb;25(3-4):257-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15007630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Epidemiol Community Health. 1986 Jun;40(2):121-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3746173</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tob Induc Dis. 2020 Apr 07;18:32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32336970</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 1970 Dec;45(244):789-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5491883</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Prim Prev. 2017 Aug;38(4):385-402</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28343288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2007 Sep;62(9):758-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17504817</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2017 May 13;389(10082):1885-1906</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28390697</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Bronconeumol. 2006 Dec;42(12):621-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17178065</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Immunopathol (Madr). 2013 Mar-Apr;41(2):73-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22771150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Res Int. 2017;2017:2184193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28951868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nicotine Tob Res. 2004 Apr;6 Suppl 2:S239-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15203824</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2014 Sep;134(3):428-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25136039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bull World Health Organ. 2000;78(11):1306-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11143190</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Occup Med Environ Health. 2015;28(1):147-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26159955</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Sch Health. 2008 Jun;78(6):337-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18489467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Public Health. 2008 Feb;18(1):55-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17569700</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Princ Pract. 2008;17(4):284-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18523395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Public Health. 2008 Oct;98(10):1886-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18703438</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32770967</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-2458</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>BMC public health</Title>
                <ISOAbbreviation>BMC Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1211</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-020-09259-3</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma control is influenced by multiple factors. These factors must be considered when appraising asthma interventions and their effectiveness in the Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates [UAE]). Based on published studies, the most prevalent asthma treatment in these countries are fixed dose combinations (FDC) of inhaled corticosteroid and long-acting beta-agonist (ICS/LABA). This study is a rapid review of the literature on: (a) factors associated with asthma control in the GCC countries and (b) generalisability of ICS/LABA FDC effectiveness studies.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">To review local factors associated with asthma control and, generalisability of published ICS/LABA FDC studies, two rapid reviews were conducted. Review 1 targeted literature pertaining to asthma control factors in GCC countries. Eligible studies were appraised, and clustering methodology used to summarise factors. Review 2 assessed ICS/LABA FDC studies in conditions close to actual clinical practice (i.e. effectiveness studies). Eligibility was determined by reviewing study characteristics. Evaluation of studies focused on randomised controlled trials (RCTs). In both reviews, initial (January 2018) and updated (November 2019) searches were conducted in EMBASE and PubMed databases. Eligible studies were appraised using the Critical Appraisal Skills Program (CASP) checklists.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 51 publications reporting factors associated with asthma control. These publications reported studies conducted in Saudi Arabia (35), Qatar (5), Kuwait (5), UAE (3), Oman (1) and multiple countries (2). The most common factors associated with asthma control were: asthma-related education (13 articles), demographics (11articles), comorbidities (11 articles) and environmental exposures (11 articles). Review 2 identified 61 articles reporting ICS/LABA FDC effectiveness studies from countries outside of the GCC. Of these, six RCTs were critically appraised. The adequacy of RCTs in informing clinical practice varied when appraised against previously published criteria.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asthma-related education was the most recurring factor associated with asthma control in the GCC countries. Moreover, the generalisability of ICS/LABA FDC studies to this region is variable. Hence, asthma patients in the region, particularly those on ICS/LABA FDC, will continue to require physician review and oversight. While our findings provide evidence for local treatment guidelines, further research is required in GCC countries to establish the causal pathways through which asthma-related education influence asthma control for patients on ICS/LABA FDC therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Noibi</LastName>
                    <ForeName>Saeed</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs Department, GSK Saudi Arabia, 22nd Floor Head Quarters Business Park, Jeddah, Kingdom of Saudi Arabia. saeed.o.noibi@gsk.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohy</LastName>
                    <ForeName>Ahmed</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs Department, GSK Saudi Arabia, 22nd Floor Head Quarters Business Park, Jeddah, Kingdom of Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gouhar</LastName>
                    <ForeName>Raef</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs Department, GSK Gulf Countries, Arenco Towers, Dubai Medial City, Dubai, United Arab Emirates.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shaker</LastName>
                    <ForeName>Fadel</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs Department, GSK Saudi Arabia, 22nd Floor Head Quarters Business Park, Jeddah, Kingdom of Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lukic</LastName>
                    <ForeName>Tamara</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Affairs Department, GSK Gulf Countries, Arenco Towers, Dubai Medial City, Dubai, United Arab Emirates.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Jahdali</LastName>
                    <ForeName>Hamdan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>King Saud bin Abdulaziz University for Health Sciences I KSAU-HS, College of Medicine, Riyadh, Kingdom of Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>HO-18-19414</GrantID>
                    <Agency>GlaxoSmithKline</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>BMC Public Health</MedlineTA>
            <NlmUniqueID>100968562</NlmUniqueID>
            <ISSNLinking>1471-2458</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma control factors</Keyword>
            <Keyword MajorTopicYN="N">Clinical practice</Keyword>
            <Keyword MajorTopicYN="N">Effectiveness studies</Keyword>
            <Keyword MajorTopicYN="N">Evidence-informed policy-making</Keyword>
            <Keyword MajorTopicYN="N">Gulf cooperation council (GCC) countries</Keyword>
            <Keyword MajorTopicYN="N">ICS/LABA FDC</Keyword>
            <Keyword MajorTopicYN="N">Rapid review</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>11</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770967</ArticleId>
            <ArticleId IdType="doi">10.1186/s12889-020-09259-3</ArticleId>
            <ArticleId IdType="pii">10.1186/s12889-020-09259-3</ArticleId>
            <ArticleId IdType="pmc">PMC7414753</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Respir Med. 2005 Jan;99(1):11-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15672843</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1378-1387.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28351782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Mar 9;13(3):e0192269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29522542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Syst Rev. 2020 Jan 16;9(1):14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31948468</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drugs. 2019 Nov;79(16):1729-1737</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31584145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2014 Apr;27(2):190-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24388868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2018 May;138:64-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29724395</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2019 Sep 14;394(10202):919-928</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31451207</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pragmat Obs Res. 2017 Sep 20;8:175-181</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29033625</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Technol Assess. 2005 Jun;9(23):iii-iv, 1-167</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15929858</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>East Mediterr Health J. 2011 Aug;17(8):703-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21977574</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Risk Manag Healthc Policy. 2010;3:61-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22312219</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pol Arch Intern Med. 2017 Jan 18;127(2):100-106</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28220767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Syst Rev. 2012 Feb 10;1:10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22587960</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Chron Obstruct Pulmon Dis. 2017 Oct 09;12:2869-2890</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29070946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2018 Oct;102:1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29864540</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epidemiology. 1999 Jan;10(1):37-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9888278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2017 Nov 18;390(10109):2247-2255</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28903864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Pulm Med. 2018 Apr 24;18(1):61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29699541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Infect Dis. 2016 May;46:116-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26996460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2012 Jul;42(7):1006-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22251011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Health Serv Res. 2014 Nov 21;14:579</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25413154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Health Technol Assess. 2008 May;12(19):iii-iv, 1-360</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18485271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Pediatr Adolesc Med. 2019 Jun;6(2):74-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31388551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Pulm Med. 2018 May 11;18(1):68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29751756</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Thorac Med. 2019 Jan-Mar;14(1):3-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30745934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>NPJ Prim Care Respir Med. 2014 Jun 12;24:14009</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24921985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2006 Jun;117(6):1249-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16750983</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2013 Mar 06;9(1):8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23510684</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2019 Apr 29;15:29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31168304</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2000 Jun 22;342(25):1887-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10861325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2017 Sep;5(9):691-706</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28822787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2013 Nov;66(11):1209-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23953085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Thorac Med. 2019 Apr-Jun;14(2):148-154</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31007767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2019 May 23;380(21):2020-2030</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31112386</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2009 Oct 27;181(9):E181-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19752106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2010 Sep;36(3):524-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20595145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Multidiscip Respir Med. 2015 Apr 15;10(1):15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25905019</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2010 Aug;65(8):747-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20581409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Family Community Med. 2015 Jan-Apr;22(1):25-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25657608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Ther. 2016;2:19-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27512723</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2017 Aug;88:7-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28549929</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Saudi Dent J. 2018 Jul;30(3):175-182</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29942100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2016 Aug;53(6):644-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27058241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Res Int. 2018 May 23;2018:8102527</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29951546</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2009 Oct;62(10):1006-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19631508</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32770850</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1326-5377</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Medical journal of Australia</Title>
                <ISOAbbreviation>Med. J. Aust.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Respiratory and atopic conditions in children two to four years after the 2014 Hazelwood coalmine fire.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.5694/mja2.50719</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate associations between exposure during early life to mine fire smoke and parent-reported indicators of respiratory and atopic illness 2-4 years later.</AbstractText>
                <AbstractText Label="DESIGN, SETTING" NlmCategory="UNASSIGNED">The Hazelwood coalmine fire exposed a regional Australian community to markedly increased air pollution during February - March 2014. During June 2016 - October 2018 we conducted a prospective cohort study of children from the Latrobe Valley.</AbstractText>
                <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Seventy-nine children exposed to smoke in utero, 81 exposed during early childhood (0-2 years of age), and 129 children conceived after the fire (ie, unexposed).</AbstractText>
                <AbstractText Label="EXPOSURE" NlmCategory="METHODS">Individualised mean daily and peak 24-hour fire-attributable fine particulate matter (PM<sub>2.5</sub> ) exposure during the fire period, based on modelled air quality and time-activity data.</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Parent-reported symptoms, medications use, and contacts with medical professionals, collected in monthly online diaries for 29 months, 2-4 years after the fire.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the in utero exposure analysis (2678 monthly diaries for 160 children exposed in utero or unexposed), each 10 μg/m<sup>3</sup> increase in mean daily PM<sub>2.5</sub> exposure was associated with increased reports of runny nose/cough (relative risk [RR], 1.09; 95% CI, 1.02-1.17), wheeze (RR, 1.56; 95% CI, 1.18-2.07), seeking health professional advice (RR, 1.17; 95% CI 1.06-1.29), and doctor diagnoses of upper respiratory tract infections, cold or flu (RR, 1.35; 95% CI, 1.14-1.60). Associations with peak 24-hour PM<sub>2.5</sub> exposure were similar. In the early childhood exposure analysis (3290 diaries for 210 children exposed during early childhood, or unexposed), each 100 μg/m<sup>3</sup> increase in peak 24-hour PM<sub>2.5</sub> exposure was associated with increased use of asthma inhalers (RR, 1.26; 95% CI, 1.01-1.58).</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Exposure to mine fire smoke in utero was associated with increased reports by parents of respiratory infections and wheeze in their children 2-4 years later.</AbstractText>
                <CopyrightInformation>© 2020 AMPCo Pty Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Willis</LastName>
                    <ForeName>Gabriela A</ForeName>
                    <Initials>GA</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2508-412X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chappell</LastName>
                    <ForeName>Kate</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Williams</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Epidemiology and Population Health, Australian National University, Canberra, ACT.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melody</LastName>
                    <ForeName>Shannon M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wheeler</LastName>
                    <ForeName>Amanda</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, VIC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dalton</LastName>
                    <ForeName>Marita</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dharmage</LastName>
                    <ForeName>Shyamali C</ForeName>
                    <Initials>SC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zosky</LastName>
                    <ForeName>Graeme R</ForeName>
                    <Initials>GR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johnston</LastName>
                    <ForeName>Fay H</ForeName>
                    <Initials>FH</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-5150-8678</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Med J Aust</MedlineTA>
            <NlmUniqueID>0400714</NlmUniqueID>
            <ISSNLinking>0025-729X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Air pollutants</Keyword>
            <Keyword MajorTopicYN="N">Atopy</Keyword>
            <Keyword MajorTopicYN="N">Child health</Keyword>
            <Keyword MajorTopicYN="N">Emergencies</Keyword>
            <Keyword MajorTopicYN="N">Population health</Keyword>
            <Keyword MajorTopicYN="N">Respiratory tract infections</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770850</ArticleId>
            <ArticleId IdType="doi">10.5694/mja2.50719</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Teague B, Catford J, Petering S. Hazelwood mine fire inquiry report (Victorian Government: PP no 342, session 2010-2014). Aug 2014. http://report.hazelwoodinquiry.vic.gov.au (viewed Dec 2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Luhar AK, Emmerson KM, Reisen F, et al. Modelling smoke distribution in the vicinity of a large and prolonged fire from an open-cut coal mine. Atmos Environ 2020; 229: 117471.</Citation>
            </Reference>
            <Reference>
                <Citation>Korten I, Ramsey K, Latzin P. Air pollution during pregnancy and lung development in the child. Paediatr Respir Rev 2017; 21: 38-46.</Citation>
            </Reference>
            <Reference>
                <Citation>Hehua Z, Qing C, Shanyan G, et al. The impact of prenatal exposure to air pollution on childhood wheezing and asthma: a systematic review. Environ Res 2017; 159: 519-530.</Citation>
            </Reference>
            <Reference>
                <Citation>Jedrychowski WA, Perera FP, Spengler JD, et al. Intrauterine exposure to fine particulate matter as a risk factor for increased susceptibility to acute broncho-pulmonary infections in early childhood. Int J Hyg Environ Health 2013; 216: 395-401.</Citation>
            </Reference>
            <Reference>
                <Citation>Jedrychowski WA, Perera FP, Maugeri U, et al. Effect of prenatal exposure to fine particulate matter on ventilatory lung function of preschool children of non-smoking mothers. Paediatr Perinat Epidemiol 2010; 24: 492-501.</Citation>
            </Reference>
            <Reference>
                <Citation>Latzin P, Röösli M, Huss A, et al. Air pollution during pregnancy and lung function in newborns: a birth cohort study. Eur Respir J 2009; 33: 594-603.</Citation>
            </Reference>
            <Reference>
                <Citation>Gouveia N, Junger WL; ESCALA investigators. Effects of air pollution on infant and children respiratory mortality in four large Latin-American cities. Environ Pollut 2018; 232: 385-391.</Citation>
            </Reference>
            <Reference>
                <Citation>Morgenstern V, Zutavern A, Cyrys J, et al; GINI Study Group; LISA Study Group. Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med 2008; 177: 1331-1337.</Citation>
            </Reference>
            <Reference>
                <Citation>Ahn K. The role of air pollutants in atopic dermatitis. J Allergy Clin Immunol 2014; 134: 993-999.</Citation>
            </Reference>
            <Reference>
                <Citation>Kim J, Kim EH, Oh I, et al. Symptoms of atopic dermatitis are influenced by outdoor air pollution. J Allergy Clin Immunol 2013; 132: 495-498.e1.</Citation>
            </Reference>
            <Reference>
                <Citation>Reid CE, Brauer M, Johnston FH, et al. Critical review of health impacts of wildfire smoke exposure. Environ Health Perspect 2016; 124: 1334-1343.</Citation>
            </Reference>
            <Reference>
                <Citation>Melody S, Dalton M, Dennekamp M, et al. Hazelwood health study: the Latrobe Early Life Follow-up (ELF) cohort study. Volume 1, version 1.2. Nov 2017. https://hazelwoodhealthstudy.org.au/__data/assets/pdf_file/0009/1636452/elf-vol-1_-cohortdesciption_parentreportedoutcomes-v1.2.pdf (viewed Dec 2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Melody SM, Ford JB, Wills K, et al. Maternal exposure to fine particulate matter from a large coal mine fire is associated with gestational diabetes mellitus: a prospective cohort study. Environ Res 2019; 183: 108956.</Citation>
            </Reference>
            <Reference>
                <Citation>Australian Bureau of Statistics. 1270.0.55.001. Australian Statistical Geography Standard (ASGS): volume 1 - main structure and greater capital city statistical areas, July 2016. July 2016. http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/1270.0.55.001~July%202016~Main%20Features~Mesh%20Blocks%20(MB)~10012 (viewed Dec 2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Knibbs LD, Hewson MG, Bechle MJ, et al. A national satellite-based land-use regression model for air pollution exposure assessment in Australia. Environ Res 2014; 135: 204-211.</Citation>
            </Reference>
            <Reference>
                <Citation>Australian Bureau of Statistics. Census of population and housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2011. Mar 2013. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/2033.0.55.0012011?OpenDocument (viewed Dec 2019).</Citation>
            </Reference>
            <Reference>
                <Citation>Cakmak S, Hebbern C, Cakmak JD, Vanos J. The modifying effect of socioeconomic status on the relationship between traffic, air pollution and respiratory health in elementary schoolchildren. J Environ Manage 2016; 177: 1-8.</Citation>
            </Reference>
            <Reference>
                <Citation>Uphoff E, Cabieses B, Pinart M, et al. A systematic review of socioeconomic position in relation to asthma and allergic diseases. Eur Respir J 2015; 46: 364e374.</Citation>
            </Reference>
            <Reference>
                <Citation>Golenko XA, Shibl R, Scuffham PA, Cameron CM. Relationship between socioeconomic status and general practitioner visits for children in the first 12 months of life: an Australian study. Aust Health Rev 2015; 39: 136e145.</Citation>
            </Reference>
            <Reference>
                <Citation>Vanker A, Gie RP, Zar HJ. The association between environmental tobacco smoke exposure and childhood respiratory disease: a review. Expert Rev Respir Med 2017; 11: 661e673.</Citation>
            </Reference>
            <Reference>
                <Citation>Lee A, Leon Hsu HH, Mathilda Chiu YH, et al. Prenatal fine particulate exposure and early childhood asthma: effect of maternal stress and fetal sex. J Allergy Clin Immunol 2018; 141: 1880e1886.</Citation>
            </Reference>
            <Reference>
                <Citation>Pereira G, Cook A, De Vos AJ, Holman CD. A case-crossover analysis of traffic-related air pollution and emergency department presentations for asthma in Perth, Western Australia. Med J Aust 2010; 193: 511-514. https://www.mja.com.au/journal/2010/193/9/case-crossover-analysis-traffic-related-air-pollution-and-emergency-department.</Citation>
            </Reference>
            <Reference>
                <Citation>Knibbs LD, Woldeyohannes S, Marks GB, Cowie CT. Damp housing, gas stoves, and the burden of childhood asthma in Australia. Med J Aust 2018; 208: 299-302. https://www.mja.com.au/journal/2018/208/7/damp-housing-gas-stoves-and-burden-childhood-asthma-australia.</Citation>
            </Reference>
            <Reference>
                <Citation>Textor J, van der Zander B, Gilthorpe MS, et al. Robust causal inference using directed acyclic graphs: the R package “dagitty”. Int J Epidemiol 2016; 45: 1887-1894.</Citation>
            </Reference>
            <Reference>
                <Citation>Brauer M, Hoek G, Smit HA, et al. Air pollution and development of asthma, allergy and infections in a birth cohort. Eur Respir J 2007; 29: 879-888.</Citation>
            </Reference>
            <Reference>
                <Citation>Dherani M, Pope D, Mascarenhas M, et al. Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis. Bull World Health Organ 2008; 86: 390-398C.</Citation>
            </Reference>
            <Reference>
                <Citation>Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol 2005; 115: 689-699.</Citation>
            </Reference>
            <Reference>
                <Citation>Leibel S, Post M. Endogenous and exogenous stem/progenitor cells in the lung and their role in the pathogenesis and treatment of pediatric lung disease. Front Pediatr 2016; 4: 36.</Citation>
            </Reference>
            <Reference>
                <Citation>Holstius DM, Reid CE, Jesdale BM, et al. Birth weight following pregnancy during the 2003 Southern California wildfires. Environ Health Perspect 2012; 120: 1340-1345.</Citation>
            </Reference>
            <Reference>
                <Citation>Clark NA, Demers PA, Karr CJ, et al. Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect 2010; 118: 284-290.</Citation>
            </Reference>
            <Reference>
                <Citation>Ford B, Val Martin M, Zelasky SE, et al. Future fire impacts on smoke concentrations, visibility, and health in the contiguous United States. GeoHealth 2018; 2: 229-247.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32770542</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1749-6632</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of the New York Academy of Sciences</Title>
                <ISOAbbreviation>Ann. N. Y. Acad. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Reconsidering the &quot;protective&quot; hypothesis of Helicobacter pylori infection in eosinophilic esophagitis.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/nyas.14449</ELocationID>
            <Abstract>
                <AbstractText>Since its discovery, Helicobacter pylori (H. pylori) has attracted attention in the biomedical world with its numerous pathophysiologic implications, both gastrointestinal and systemic. Beyond its well-established carcinogenic properties, emerging evidence also supports &quot;harmful&quot; proinflammatory and neurodegenerative roles of H. pylori. On the other hand, H. pylori infection has been proposed to be &quot;protective&quot; against several diseases, such as asthma and gastroesophageal reflux disease. Eosinophilic esophagitis (EoE) is a relatively new, allergen/immune-mediated disease, which has also been linked to these considerations. Main arguments are a postulated shift of immune responses by H. pylori from T helper 2 (T<sub>H</sub> 2) to T<sub>H</sub> 1 polarization, as well as a potential decline of the H. pylori burden with the dramatic parallel rise of ΕοΕ: a series of observational studies reported an inverse association. In this review, we counter these arguments by providing further epidemiological data, which point out that this generalization might be rather incomplete. We also discuss the limitations of the existing studies evaluating a possible association. Furthermore, we provide current evidence on common pathogenetic components, which share both entities. In summary, the claim that H. pylori is protective against EoE is rather incomplete, and further mechanistic studies are necessary to elucidate a possible association.</AbstractText>
                <CopyrightInformation>© 2020 New York Academy of Sciences.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Doulberis</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-0396-5081</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Second Medical Clinic, Faculty of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kountouras</LastName>
                    <ForeName>Jannis</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Second Medical Clinic, Faculty of Medicine, Ippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Macedonia, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rogler</LastName>
                    <ForeName>Gerhard</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann N Y Acad Sci</MedlineTA>
            <NlmUniqueID>7506858</NlmUniqueID>
            <ISSNLinking>0077-8923</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Helicobacter pylori</Keyword>
            <Keyword MajorTopicYN="N">eosinophilic esophagitis</Keyword>
            <Keyword MajorTopicYN="N">epidemiology</Keyword>
            <Keyword MajorTopicYN="N">inflammation</Keyword>
            <Keyword MajorTopicYN="N">microbiome</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770542</ArticleId>
            <ArticleId IdType="doi">10.1111/nyas.14449</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>References</Title>
            <Reference>
                <Citation>Crowe, S.E. 2019. Helicobacter pylori infection. N. Engl. J. Med. 380: 1158-1165.</Citation>
            </Reference>
            <Reference>
                <Citation>Mentis, A.-F.A., M. Boziki, N. Grigoriadis &amp; A.G. Papavassiliou. 2019. Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword. Cell. Mol. Life Sci. 76: 2477-2486.</Citation>
            </Reference>
            <Reference>
                <Citation>Kuo, S.-H. &amp; A.-L. Cheng. 2013. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new. Hematol. Am. Soc. Hematol. Educ. Progr. 2013: 109-117.</Citation>
            </Reference>
            <Reference>
                <Citation>D'Elios, M.M., A. Amedei, M. Benagiano, et al. 2005. Helicobacter pylori, T cells and cytokines: the “dangerous liaisons”. FEMS Immunol. Med. Microbiol. 44: 113-119.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., A. Papaefthymiou, M. Doulberis &amp; S.A. Polyzos. 2020. Influence of Helicobacter pylori-connected metabolic syndrome on non-alcoholic fatty liver disease and its related colorectal neoplasm high risk. Liver Int. 40: 475-476.</Citation>
            </Reference>
            <Reference>
                <Citation>Kapetanakis, N., J. Kountouras, C. Zavos, et al. 2012. Helicobacter pylori infection and colorectal carcinoma: pathologic aspects. J. Gastrointest. Oncol. 3: 377-379.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., M. Doulberis, A. Papaefthymiou, et al. 2019. A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection. Ann. N.Y. Acad. Sci. 1452: 12-17.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., M. Doulberis, S.A. Polyzos, et al. 2018. Helicobacter pylori infection and gastroesophageal reflux disease-Barrett's esophagus-esophageal adenocarcinoma sequence. Am. J. Gastroenterol. 113: 1723-1724.</Citation>
            </Reference>
            <Reference>
                <Citation>Cellini, L., R. Grande, L. Artese &amp; L. Marzio. 2010. Detection of Helicobacter pylori in saliva and esophagus. New Microbiol. 33: 351-357.</Citation>
            </Reference>
            <Reference>
                <Citation>Ackermark, P., E.J. Kuipers, C. Wolf, et al. 2003. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction. Am. J. Gastroenterol. 98: 1719-1724.</Citation>
            </Reference>
            <Reference>
                <Citation>Contreras, M., V. Salazar, M.A. García-Amado, et al. 2012. High frequency of Helicobacter pylori in the esophageal mucosa of dyspeptic patients and its possible association with histopathological alterations. Int. J. Infect. Dis. 16: e364-e370.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang, X.M., K.C. Yee, N. Hazeki-Taylor, et al. 2014. Oral Helicobacter pylori, its relationship to successful eradication of gastric H. pylori and saliva culture confirmation. J. Physiol. Pharmacol. 65: 559-566.</Citation>
            </Reference>
            <Reference>
                <Citation>Yee, J.K.C. 2016. Helicobacter pylori colonization of the oral cavity: a milestone discovery. World J. Gastroenterol. 22: 641-648.</Citation>
            </Reference>
            <Reference>
                <Citation>Siupsinskiene, N., I. Katutiene, V. Jonikiene, et al. 2018. Intranasal Helicobacter pylori infection in patients with chronic rhinosinusitis with polyposis. J. Laryngol. Otol. 132: 816-821.</Citation>
            </Reference>
            <Reference>
                <Citation>Butt, J. &amp; M. Epplein. 2019. Helicobacter pylori and colorectal cancer-a bacterium going abroad? PLoS Pathog. 15: e1007861.</Citation>
            </Reference>
            <Reference>
                <Citation>Franceschi, F., A. Gasbarrini, S.A. Polyzos &amp; J. Kountouras. 2015. Extragastric diseases and Helicobacter pylori. Helicobacter 20(Suppl. 1): 40-46.</Citation>
            </Reference>
            <Reference>
                <Citation>Polyzos, S.A. &amp; J. Kountouras. 2019. Helicobacter pylori infection and nonalcoholic fatty liver disease: time for large clinical trials evaluating eradication therapy. Helicobacter 24: e12588.</Citation>
            </Reference>
            <Reference>
                <Citation>Polyzos, S.A., J. Kountouras &amp; C.S. Mantzoros. 2019. Helicobacter pylori infection and nonalcoholic fatty liver disease: are the four meta-analyses favoring an intriguing association pointing to the right direction? Metabolism 96: iii-v.</Citation>
            </Reference>
            <Reference>
                <Citation>Doulberis, M., S. Srivastava, S.A. Polyzos, et al. 2020. Active Helicobacter pylori infection is independently associated with nonalcoholic steatohepatitis in morbidly obese patients. J. Clin. Med. 9: 215.</Citation>
            </Reference>
            <Reference>
                <Citation>Xu, M.-Y., J.-H. Ma, J. Du, et al. 2020. Nonalcoholic fatty liver disease is associated with Helicobacter pylori infection in North Urban Chinese: a retrospective study. Gastroenterol. Res. Pract. 2020: 9797841.</Citation>
            </Reference>
            <Reference>
                <Citation>Abo-Amer, Y.E.-E., A. Sabal, R. Ahmed, et al. 2020. Relationship between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing country: a cross-sectional study. Diabetes Metab. Syndr. Obes. 13: 619-625.</Citation>
            </Reference>
            <Reference>
                <Citation>Chen, C., C. Zhang, X. Wang, et al. 2020. Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome. Eur. J. Gastroenterol. Hepatol. 32: 857-866.</Citation>
            </Reference>
            <Reference>
                <Citation>Fouad, Y., I. Waked, S. Bollipo, et al. 2020. What's in a name? Renaming ‘NAFLD’ to ‘MAFLD.’ Liver Int. 40: 1254-1261.</Citation>
            </Reference>
            <Reference>
                <Citation>Roubaud Baudron, C., F. Franceschi, N. Salles &amp; A. Gasbarrini. 2013. Extragastric diseases and Helicobacter pylori. Helicobacter 18: 44-51.</Citation>
            </Reference>
            <Reference>
                <Citation>Gravina, A.G., R.M. Zagari, C. De Musis, et al. 2018. Helicobacter pylori and extragastric diseases: a review. World J. Gastroenterol. 24: 3204-3221.</Citation>
            </Reference>
            <Reference>
                <Citation>Franceschi, F., A. Tortora, G. Gasbarrini &amp; A. Gasbarrini. 2014. Helicobacter pylori and extragastric diseases. Helicobacter 19: 52-58.</Citation>
            </Reference>
            <Reference>
                <Citation>Doulberis, M., G. Kotronis, R. Thomann, et al. 2017. Impact of Helicobacter pylori on Alzheimer's disease: what do we know so far? Helicobacter 23: e12454.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., M. Tsolaki, E. Gavalas, et al. 2006. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 66: 938-940.</Citation>
            </Reference>
            <Reference>
                <Citation>Deretzi, G., E. Gavalas, M. Boziki, et al. 2016. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurol. Scand. 133: 268-275.</Citation>
            </Reference>
            <Reference>
                <Citation>Gavalas, E., J. Kountouras, M. Boziki, et al. 2015. Relationship between Helicobacter pylori infection and multiple sclerosis. Ann. Gastroenterol. 28: 353-356.</Citation>
            </Reference>
            <Reference>
                <Citation>Rustagi, S., D. Mullins &amp; E. Yanney. 2020. Current updates in diagnosis and management of eosinophilic esophagitis. Curr. Probl. Pediatr. Adolesc. Health Care 50. https://doi.org/10.1016/j.cppeds.2020.100783.</Citation>
            </Reference>
            <Reference>
                <Citation>Attwood, S.E., T.C. Smyrk, T.R. Demeester &amp; J.B. Jones. 1993. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig. Dis. Sci. 38: 109-116.</Citation>
            </Reference>
            <Reference>
                <Citation>Straumann, A., H.P. Spichtin, R. Bernoulli, et al. 1994. [Idiopathic eosinophilic esophagitis: a frequently overlooked disease with typical clinical aspects and discrete endoscopic findings]. Schweiz. Med. Wochenschr. 124: 1419-1429.</Citation>
            </Reference>
            <Reference>
                <Citation>Lucendo, A.J., J. Molina-Infante, Á. Arias, et al. 2017. Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults. United Eur. Gastroenterol. J. 5: 335-358.</Citation>
            </Reference>
            <Reference>
                <Citation>Reed, C.C. &amp; E.S. Dellon. 2019. Eosinophilic esophagitis. Med. Clin. North Am. 103: 29-42.</Citation>
            </Reference>
            <Reference>
                <Citation>Ekre, M., J. Tytor, M. Bove, et al. 2020. Retrospective chart review: seasonal variation in incidence of bolus impaction is maintained and statistically significant in subgroups with atopy and eosinophilic esophagitis. Dis. Esophagus 33. https://doi.org/10.1093/dote/doaa013.</Citation>
            </Reference>
            <Reference>
                <Citation>Dellon, E.S. &amp; I. Hirano. 2018. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology 154: 319-332.e3.</Citation>
            </Reference>
            <Reference>
                <Citation>O'Shea, K.M., S.S. Aceves, E.S. Dellon, et al. 2018. Pathophysiology of eosinophilic esophagitis. Gastroenterology 154: 333-345.</Citation>
            </Reference>
            <Reference>
                <Citation>Straumann, A. &amp; D.A. Katzka. 2018. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology 154: 346-359.</Citation>
            </Reference>
            <Reference>
                <Citation>World Health Organization/International Agency for Research on Cancer. 1994. IARC monographs on the evaluation of carcinogenic risks to humans. Vol. 61. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon: International Agency for Research on Cancer.</Citation>
            </Reference>
            <Reference>
                <Citation>IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 2012. Helicobacter pylori. Biologic agents: a review of human carcinogens. Vol. 100B. Lyon: International Agency for Research on Cancer.</Citation>
            </Reference>
            <Reference>
                <Citation>Brzozowski, T., P.C. Konturek, Z. Sliwowski, et al. 1997. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide. J. Physiol. Pharmacol. 48: 699-717.</Citation>
            </Reference>
            <Reference>
                <Citation>Labenz, J. &amp; P. Malfertheiner. 1997. Helicobacter pylori in gastro-oesophageal reflux disease: causal agent, independent or protective factor? Gut 41: 277-280.</Citation>
            </Reference>
            <Reference>
                <Citation>El-Serag, H.B., A. Sonnenberg, M.M. Jamal, et al. 1999. Corpus gastritis is protective against reflux oesophagitis. Gut 45: 181-185.</Citation>
            </Reference>
            <Reference>
                <Citation>Santolaria, S., A. Lanas, R. Benito, et al. 1999. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment. Pharmacol. Ther. 13: 1511-1518.</Citation>
            </Reference>
            <Reference>
                <Citation>Rokkas, T., J. Gisbert, Y. Niv &amp; C. O'Morain. 2015. The association between Helicobacter pylori infection and inflammatory bowel disease based on meta-analysis. United Eur. Gastroenterol. J. 3: 539-550.</Citation>
            </Reference>
            <Reference>
                <Citation>Zavos, C., J. Kountouras, D. Vini, et al. 2007. A critique on the possible protective role of Helicobacter pylori infection in childhood asthma. Hippokratia 11: 221.</Citation>
            </Reference>
            <Reference>
                <Citation>Blaser, M.J., Y. Chen &amp; J. Reibman. 2008. Does Helicobacter pylori protect against asthma and allergy? Gut 57: 561-567.</Citation>
            </Reference>
            <Reference>
                <Citation>Garrido Serrano, A., J.A. Lepe Jiménez, F.J. Guerrero Igea &amp; C. Perianes Hernández. 2003. Helicobacter pylori and gastroesophageal reflux disease. Rev. Esp. Enferm. Dig. 95: 788-790, 785-7.</Citation>
            </Reference>
            <Reference>
                <Citation>Ashktorab, H., O. Entezari, M. Nouraie, et al. 2012. Helicobacter pylori protection against reflux esophagitis. Dig. Dis. Sci. 57: 2924-2928.</Citation>
            </Reference>
            <Reference>
                <Citation>Wang, W.-L. &amp; X.-J. Xu. 2019. Correlation between Helicobacter pylori infection and Crohn's disease: a meta-analysis. Eur. Rev. Med. Pharmacol. Sci. 23: 10509-10516.</Citation>
            </Reference>
            <Reference>
                <Citation>Sayar, R., J. Shokri Shirvani, K. Hajian-Tilaki, et al. 2019. The negative association between inflammatory bowel disease and Helicobacter pylori seropositivity. Casp. J. Intern. Med. 10: 217-222.</Citation>
            </Reference>
            <Reference>
                <Citation>Cheung, K.M., M.R. Oliver, D.J.S. Cameron, et al. 2003. Esophageal eosinophilia in children with dysphagia. J. Pediatr. Gastroenterol. Nutr. 37: 498-503.</Citation>
            </Reference>
            <Reference>
                <Citation>Ronkainen, J., N.J. Talley, P. Aro, et al. 2007. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 56: 615-620.</Citation>
            </Reference>
            <Reference>
                <Citation>Furuta, K., K. Adachi, M. Aimi, et al. 2013. Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J. Clin. Biochem. Nutr. 53: 60-62.</Citation>
            </Reference>
            <Reference>
                <Citation>von Arnim, U., T. Wex, A. Link, et al. 2016. Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment. Pharmacol. Ther. 43: 825-830.</Citation>
            </Reference>
            <Reference>
                <Citation>Sonnenberg, A., E.S. Dellon, K.O. Turner &amp; R.M. Genta. 2017. The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia. Helicobacter 22: e12370.</Citation>
            </Reference>
            <Reference>
                <Citation>Elitsur, Y., B.A. Alrazzak, D. Preston &amp; Y. Demetieva. 2014. Does Helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter 19: 367-371.</Citation>
            </Reference>
            <Reference>
                <Citation>Dellon, E.S., A.F. Peery, N.J. Shaheen, et al. 2011. Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology 141: 1586-1592.</Citation>
            </Reference>
            <Reference>
                <Citation>Norder Grusell, E., G. Dahlén, M. Ruth, et al. 2018. The cultivable bacterial flora of the esophagus in subjects with esophagitis. Scand. J. Gastroenterol. 53: 650-656.</Citation>
            </Reference>
            <Reference>
                <Citation>Ness-Jensen, E., A. Langhammer, K. Hveem &amp; Y. Lu. 2019. Helicobacter pylori in relation to asthma and allergy modified by abdominal obesity: the HUNT study in Norway. World Allergy Organ. J. 12: 100035.</Citation>
            </Reference>
            <Reference>
                <Citation>Fouda, E.M., T.B. Kamel, E.S. Nabih &amp; A.A. Abdelazem. 2018. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity. Allergol. Immunopathol. (Madr.) 46: 76-81.</Citation>
            </Reference>
            <Reference>
                <Citation>Lee, Y.Y., S. Mahendra Raj &amp; D.Y. Graham. 2013. Helicobacter pylori infection-a boon or a bane: lessons from studies in a low-prevalence population. Helicobacter 18: 338-346.</Citation>
            </Reference>
            <Reference>
                <Citation>van Wijck, Y., G. John-Schuster, A. van Schadewijk, et al. 2019. Extract of Helicobacter pylori ameliorates parameters of airway inflammation and goblet cell hyperplasia following repeated allergen exposure. Int. Arch. Allergy Immunol. 180: 1-9.</Citation>
            </Reference>
            <Reference>
                <Citation>Polyzos, S.A., C. Zeglinas, F. Artemaki, et al. 2018. Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view. Ann. Gastroenterol. 31: 8-13.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., S.A. Polyzos, M. Doulberis, et al. 2018. Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. Metabolism 87: 18-24.</Citation>
            </Reference>
            <Reference>
                <Citation>Wun, J.C., J. Ching, F. Lai, et al. 2005. Time trends of Helicobacter pylori (Hp) related diseases and reflux esophagitis (RE) in Chinese population: a retrospective cohort study of 20,918 cases. Gastroenterology 128: S966.</Citation>
            </Reference>
            <Reference>
                <Citation>Bahmanyar, S., K. Zendehdel, O. Nyrén &amp; W. Ye. 2007. Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers. Gut 56: 464-468.</Citation>
            </Reference>
            <Reference>
                <Citation>Graham, D.Y. 2003. Helicobacter pylori is not and never was “protective” against anything, including GERD. Dig. Dis. Sci. 48: 629-630.</Citation>
            </Reference>
            <Reference>
                <Citation>Hait, E.J. &amp; D.R. McDonald. 2019. Impact of gastroesophageal reflux disease on mucosal immunity and atopic disorders. Clin. Rev. Allergy Immunol. 57: 213-225.</Citation>
            </Reference>
            <Reference>
                <Citation>Anderson, J., S. Moonie, M.B. Hogan, et al. 2020. Eosinophilic esophagitis: comorbidities and atopic disease in Nevada. Dis. Esophagus 33. https://doi.org/10.1093/dote/doz105.</Citation>
            </Reference>
            <Reference>
                <Citation>Okimoto, K., M. Arai, H. Ishigami, et al. 2018. A prospective study of eosinophilic esophagitis and the expression of tight junction proteins in patients with gastroesophageal reflux disease symptoms. Gut Liver 12: 30-37.</Citation>
            </Reference>
            <Reference>
                <Citation>Gerges, S.E., T.K. Alosh, S.H. Khalil &amp; M.M.W. El Din. 2018. Relevance of Helicobacter pylori infection in Egyptian multiple sclerosis patients. Egypt. J. Neurol. Psychiatry Neurosurg. 54: 41.</Citation>
            </Reference>
            <Reference>
                <Citation>Olar, L., P. MitruŢ, C. Florou, et al. 2017. Evaluation of Helicobacter pylori infection in patients with eso-gastro-duodenal pathology. Rom. J. Morphol. Embryol. 58: 809-815.</Citation>
            </Reference>
            <Reference>
                <Citation>Chapelle, N., M. Péron, J.-F. Mosnier, et al. 2020. Prevalence, characteristics and endoscopic management of gastric premalignant lesions in France. Dig. Dis. 38: 286-292.</Citation>
            </Reference>
            <Reference>
                <Citation>Hooi, J.K.Y., W.Y. Lai, W.K. Ng, et al. 2017. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology 153: 420-429.</Citation>
            </Reference>
            <Reference>
                <Citation>De Vries, A.C., H.F. Van Driel, J.H. Richardus, et al. 2008. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries. Scand. J. Gastroenterol. 43: 403-409.</Citation>
            </Reference>
            <Reference>
                <Citation>Cherian, S., D. Forbes, F. Sanfilippo, et al. 2008. The epidemiology of Helicobacter pylori infection in African refugee children resettled in Australia. Med. J. Aust. 189: 438-441.</Citation>
            </Reference>
            <Reference>
                <Citation>Shavalipour, A., H. Malekpour, H. Dabiri, et al. 2017. Prevalence of cytotoxin-associated genes of Helicobacter pylori among Iranian GERD patients. Gastroenterol. Hepatol. Bed Bench 10: 178-183.</Citation>
            </Reference>
            <Reference>
                <Citation>Tan, L.N.M., S. Srivastava, M. Teh, et al. 2017. Eosinophilic oesophagitis in children: an uncommon occurrence in a predominantly Chinese population in Singapore. Singapore Med. J. 58: 218-222.</Citation>
            </Reference>
            <Reference>
                <Citation>Baruah, B., T. Kumar, P. Das, et al. 2017. Prevalence of eosinophilic esophagitis in patients with gastroesophageal reflux symptoms: a cross-sectional study from a tertiary care hospital in North India. Indian J. Gastroenterol. 36: 353-360.</Citation>
            </Reference>
            <Reference>
                <Citation>Saeed, A., A.M. Assiri, M. Al Asmi &amp; A. Ullah. 2018. Trend, clinical presentations and diagnosis of eosinophilic esophagitis in Saudi children. Saudi Med. J. 39: 668-673.</Citation>
            </Reference>
            <Reference>
                <Citation>Jensen, E.T. &amp; E.S. Dellon. 2018. Environmental factors and eosinophilic esophagitis. J. Allergy Clin. Immunol. 142: 32-40.</Citation>
            </Reference>
            <Reference>
                <Citation>Rothenberg, M.E. 2015. Molecular, genetic, and cellular bases for treating eosinophilic esophagitis. Gastroenterology 148: 1143-1157.</Citation>
            </Reference>
            <Reference>
                <Citation>Gómez-Aldana, A., M. Jaramillo-Santos, A. Delgado, et al. 2019. Eosinophilic esophagitis: current concepts in diagnosis and treatment. World J. Gastroenterol. 25: 4598-4613.</Citation>
            </Reference>
            <Reference>
                <Citation>Dowling, P.J., H. Neuhaus &amp; B.I. Polk. 2019. The role of the environment in eosinophilic esophagitis. Clin. Rev. Allergy Immunol. 57: 330-339.</Citation>
            </Reference>
            <Reference>
                <Citation>Kashyap, P.C., S. Johnson, D.M. Geno, et al. 2019. A decreased abundance of clostridia characterizes the gut microbiota in eosinophilic esophagitis. Physiol. Rep. 7: e14261.</Citation>
            </Reference>
            <Reference>
                <Citation>Corning, B., A.P. Copland &amp; J.W. Frye. 2018. The esophageal microbiome in health and disease. Curr. Gastroenterol. Rep. 20: 39.</Citation>
            </Reference>
            <Reference>
                <Citation>Ma, X., Q. Xu, Y. Zheng, et al. 2015. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China. Dig. Dis. Sci. 60: 1716-1723.</Citation>
            </Reference>
            <Reference>
                <Citation>Sealock, R.J., J.R. Kramer, G. Verstovsek, et al. 2013. The prevalence of oesophageal eosinophilia and eosinophilic oesophagitis: a prospective study in unselected patients presenting to endoscopy. Aliment. Pharmacol. Ther. 37: 825-832.</Citation>
            </Reference>
            <Reference>
                <Citation>Molina-Infante, J., C. Gutierrez-Junquera, E. Savarino, et al. 2018. Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study. Am. J. Gastroenterol. 113: 972-979.</Citation>
            </Reference>
            <Reference>
                <Citation>Molina-Infante, J., A.J. Lucendo &amp; J.P. Gisbert. 2016. Letter: Helicobacter pylori infection and eosinophilic oesophagitis - causal or casual inverse association? Aliment. Pharmacol. Ther. 43: 1244.</Citation>
            </Reference>
            <Reference>
                <Citation>Talley, N.J. &amp; M.M. Walker. 2018. The rise and rise of eosinophilic gut diseases including eosinophilic esophagitis is probably not explained by the disappearance of Helicobacter pylori, so who or what’ s to blame? Am. J. Gastroenterol. 113: 941-944.</Citation>
            </Reference>
            <Reference>
                <Citation>Inage, E., G.T. Furuta, C. Menard-Katcher &amp; J.C. Masterson. 2018. Eosinophilic esophagitis: pathophysiology and its clinical implications. Am. J. Physiol. Gastrointest. Liver Physiol. 315: G879-G886.</Citation>
            </Reference>
            <Reference>
                <Citation>Sjomina, O., F. Heluwaert, D. Moussata &amp; M. Leja. 2017. Helicobacter pylori infection and nonmalignant diseases. Helicobacter 22: 1-5.</Citation>
            </Reference>
            <Reference>
                <Citation>Shah, S.C., A. Tepler, R.M. Peek, et al. 2019. Systematic reviews and meta-analyses association between Helicobacter pylori exposure and decreased odds of eosinophilic esophagitis - a systematic review and meta-analysis. Clin. Gastroenterol. Hepatol. 17: 2185-2198.e3.</Citation>
            </Reference>
            <Reference>
                <Citation>Seiskari, T., H. Viskari, M. Kaila, et al. 2009. Time trends in allergic sensitisation and Helicobacter pylori prevalence in Finnish pregnant women. Int. Arch. Allergy Immunol. 150: 83-88.</Citation>
            </Reference>
            <Reference>
                <Citation>den Hollander, W.J., A.M.M. Sonnenschein-van der Voort, I.L. Holster, et al. 2016. Helicobacter pylori in children with asthmatic conditions at school age, and their mothers. Aliment. Pharmacol. Ther. 43: 933-943.</Citation>
            </Reference>
            <Reference>
                <Citation>Shi, Y., X.-F. Liu, Y. Zhuang, et al. 2010. Helicobacter pylori-induced TH17 responses modulate TH1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol. 184: 5121-5129.</Citation>
            </Reference>
            <Reference>
                <Citation>Johnson, K.S. &amp; K.M. Ottemann. 2018. Colonization, localization, and inflammation: the roles of H. pylori chemotaxis in vivo. Curr. Opin. Microbiol. 41: 51-57.</Citation>
            </Reference>
            <Reference>
                <Citation>Lianto, P., Y. Zhang &amp; H. Che. 2019. Signals from the various immune cells in promoting food allergy-induced eosinophilic esophagitis like disease. Asia Pac. Allergy 9: 1-20.</Citation>
            </Reference>
            <Reference>
                <Citation>Sindher, S.B., L. Monaco-Shawver, A. Berry, et al. 2016. Differences in CD4IL-17+ in children and adults with eosinophilic esophagitis. J. Allergy Clin. Immunol. 137: AB230.</Citation>
            </Reference>
            <Reference>
                <Citation>Weerasekera, K., D. Sim, F. Coughlan &amp; S. Inns. 2019. Eosinophilic esophagitis incidence in New Zealand: high but not increasing. Clin. Exp. Gastroenterol. 12: 367-374.</Citation>
            </Reference>
            <Reference>
                <Citation>García-Compeán, D., J.A. González-González, J.J. Duran-Castro, et al. 2018. Low prevalence of biopsy-proven eosinophilic esophagitis in patients with esophageal food impaction in Mexican population. Dig. Dis. Sci. 63: 1506-1512.</Citation>
            </Reference>
            <Reference>
                <Citation>Boziki, M., S.A. Polyzos, G. Deretzi, et al. 2018. A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration. Neurochem. Int. 113: 137-151.</Citation>
            </Reference>
            <Reference>
                <Citation>Park, A.-M., S. Hagiwara, D.K. Hsu, et al. 2016. Galectin-3 plays an important role in innate immunity to gastric infection by Helicobacter pylori. Infect. Immun. 84: 1184-1193.</Citation>
            </Reference>
            <Reference>
                <Citation>Boziki, M., N. Grigoriadis, M. Doulberis, et al. 2020. Potential impact of Helicobacter pylori-related galectin-3 on chronic kidney, cardiovascular and brain disorders in decompensated cirrhosis. Dig. Liver Dis. 52: 121-123.</Citation>
            </Reference>
            <Reference>
                <Citation>Rao, S.P., X.N. Ge &amp; P. Sriramarao. 2017. Regulation of eosinophil recruitment and activation by galectins in allergic asthma. Front. Med. 4. https://doi.org/10.3389/fmed.2017.00068.</Citation>
            </Reference>
            <Reference>
                <Citation>Saegusa, J., D.K. Hsu, H.-Y. Chen, et al. 2009. Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am. J. Pathol. 174: 922-931.</Citation>
            </Reference>
            <Reference>
                <Citation>Schroeder, J.T., A.A. Adeosun, D. Do &amp; A.P. Bieneman. 2019. Galectin-3 is essential for IgE-dependent activation of human basophils by A549 lung epithelial cells. J. Allergy Clin. Immunol. 144: 312-315.e1.</Citation>
            </Reference>
            <Reference>
                <Citation>de Paulis, A., N. Prevete, I. Fiorentino, et al. 2004. Basophils infiltrate human gastric mucosa at sites of Helicobacter pylori infection, and exhibit chemotaxis in response to H. pylori-derived peptide Hp(2-20). J. Immunol. 172: 7734-7743.</Citation>
            </Reference>
            <Reference>
                <Citation>Davis, C.M., G. Hiremath, J.E. Wiktorowicz, et al. 2016. Proteomic analysis in esophageal eosinophilia reveals differential galectin-3 expression and S-nitrosylation. Digestion 93: 288-299.</Citation>
            </Reference>
            <Reference>
                <Citation>Youngblood, B.A., E.C. Brock, J. Leung, et al. 2019. Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis. JCI Insight 4: e126219.</Citation>
            </Reference>
            <Reference>
                <Citation>Wershil, B.K. 2009. Exploring the role of mast cells in eosinophilic esophagitis. Immunol. Allergy Clin. North Am. 29: 189-195, xiii.</Citation>
            </Reference>
            <Reference>
                <Citation>Cianferoni, A., J.M. Spergel &amp; A. Muir. 2015. Recent advances in the pathological understanding of eosinophilic esophagitis. Expert Rev. Gastroenterol. Hepatol. 9: 1501-1510.</Citation>
            </Reference>
            <Reference>
                <Citation>Li, N., C. Xie &amp; N.-H. Lu. 2015. Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis. Front. Cell. Infect. Microbiol. 5. https://doi.org/10.3389/fcimb.2015.00077.</Citation>
            </Reference>
            <Reference>
                <Citation>Wu, M.-S., J.-T. Lin, P.-N. Hsu, et al. 2007. Preferential induction of transforming growth factor-beta production in gastric epithelial cells and monocytes by Helicobacter pylori soluble proteins. J. Infect. Dis. 196: 1386-1393.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J. 2009. Helicobacter pylori: an intruder involved in conspiring glaucomatous neuropathy. Br. J. Ophthalmol. 93: 1413-1415.</Citation>
            </Reference>
            <Reference>
                <Citation>Ko, E. &amp; M. Chehade. 2018. Biological therapies for eosinophilic esophagitis: where do we stand? Clin. Rev. Allergy Immunol. 55: 205-216.</Citation>
            </Reference>
            <Reference>
                <Citation>Gao, Y., B. Xu, P. Zhang, et al. 2017. TNF-α regulates mast cell functions by inhibiting cell degranulation. Cell. Physiol. Biochem. 44: 751-762.</Citation>
            </Reference>
            <Reference>
                <Citation>Gu, Y., D.K. Yang, E. Spinas, et al. 2015. Role of TNF in mast cell neuroinflammation and pain. J. Biol. Regul. Homeost. Agents 29: 787-791.</Citation>
            </Reference>
            <Reference>
                <Citation>Lv, Y., Y. Teng, F. Mao, et al. 2018. Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis. Cell Death Dis. 9: 457.</Citation>
            </Reference>
            <Reference>
                <Citation>Iwakura, N., Y. Fujiwara, F. Tanaka, et al. 2015. Basophil infiltration in eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia. Aliment. Pharmacol. Ther. 41: 776-784.</Citation>
            </Reference>
            <Reference>
                <Citation>Venturelli, N., W.S. Lexmond, A. Ohsaki, et al. 2016. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice. J. Allergy Clin. Immunol. 138: 1367-1380.e5.</Citation>
            </Reference>
            <Reference>
                <Citation>Jafarzadeh, A., T. Larussa, M. Nemati &amp; S. Jalapour. 2018. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection. Microb. Pathog. 116: 227-236.</Citation>
            </Reference>
            <Reference>
                <Citation>Fuentebella, J., A. Patel, T. Nguyen, et al. 2010. Increased number of regulatory T cells in children with eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 51: 283-289.</Citation>
            </Reference>
            <Reference>
                <Citation>Jang, T.J. 2010. The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol. Res. Pract. 206: 34-38.</Citation>
            </Reference>
            <Reference>
                <Citation>Niyonsaba, F., C. Kiatsurayanon &amp; H. Ogawa. 2016. The role of human β-defensins in allergic diseases. Clin. Exp. Allergy 46: 1522-1530.</Citation>
            </Reference>
            <Reference>
                <Citation>Schroeder, S., Z.D. Robinson, J.C. Masterson, et al. 2013. Esophageal human β-defensin expression in eosinophilic esophagitis. Pediatr. Res. 73: 647-654.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., G. Deretzi, E. Gavalas, et al. 2014. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med. Hypotheses 82: 368-373.</Citation>
            </Reference>
            <Reference>
                <Citation>Kazakos, E.I., N. Dorrell, S.A. Polyzos, et al. 2017. Comment on “Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics”. World J. Gastroenterol. 23: 6194-6196.</Citation>
            </Reference>
            <Reference>
                <Citation>Schnoll-Sussman, F. &amp; P.O. Katz. 2016. Managing esophageal dysphagia in the elderly. Curr. Treat. Options Gastroenterol. 14: 315-326.</Citation>
            </Reference>
            <Reference>
                <Citation>Kountouras, J., F. Tsolaki, M. Tsolaki, et al. 2016. Helicobacter pylori-related ApoE 4 polymorphism may be associated with dysphagic symptoms in older adults. Dis. Esophagus 29: 842.</Citation>
            </Reference>
            <Reference>
                <Citation>Schwimmer, M.H., M.C. Sawh, K.M. Heskett, et al. 2018. A bibliometric analysis of clinical and translational research in pediatric gastroenterology from 1970 to 2017. J. Pediatr. Gastroenterol. Nutr. 67: 564-569.</Citation>
            </Reference>
            <Reference>
                <Citation>Arias, Á., M. Vicario, D. Bernardo, et al. 2018. Toll-like receptors-mediated pathways activate inflammatory responses in the esophageal mucosa of adult eosinophilic esophagitis. Clin. Transl. Gastroenterol. 9: 147.</Citation>
            </Reference>
            <Reference>
                <Citation>O'Connor, P.M., T.K. Lapointe, S. Jackson, et al. 2011. Helicobacter pylori activates calpain via toll-like receptor 2 to disrupt adherens junctions in human gastric epithelial cells. Infect. Immun. 79: 3887-3894.</Citation>
            </Reference>
            <Reference>
                <Citation>Barooei, R., R.A. Mahmoudian, M.R. Abbaszadegan, et al. 2015. Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer. Med. Oncol. 32: 217.</Citation>
            </Reference>
            <Reference>
                <Citation>Jones, N. &amp; E. Galindo-Mata. 2001. Susceptibility to Helicobacter pylori infection in mice is regulated by STAT6. Gastroenterology 120: A68.</Citation>
            </Reference>
            <Reference>
                <Citation>Hofman, V.J., C. Moreilhon, P.D. Brest, et al. 2007. Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod. Pathol. 20: 974-989.</Citation>
            </Reference>
            <Reference>
                <Citation>Lario, S., M.J. Ramírez-Lázaro, A.M. Aransay, et al. 2012. microRNA profiling in duodenal ulcer disease caused by Helicobacter pylori infection in a Western population. Clin. Microbiol. Infect. 18: E273-E282.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32770299</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-6315</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current allergy and asthma reports</Title>
                <ISOAbbreviation>Curr Allergy Asthma Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Current E-Cigarette Research in the Context of Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>62</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11882-020-00952-2</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">The purpose of this review is to integrate recent research on the respiratory immune effects of e-cigarettes with the pathogenesis of asthma to better understand how e-cigarettes may affect asthmatics and to note critical knowledge gaps regarding the effects of e-cigarettes on asthmatics.</AbstractText>
                <AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">Human, rodent, and cell culture studies show that key cellular functions of epithelial cells, macrophages, and neutrophils are altered by e-cigarette exposure. Because respiratory immunity is already dysregulated in asthma, further alteration of cellular function by e-cigarettes could impact asthma development, severity, and/or exacerbations. Future research is needed to more directly investigate this relationship using controlled human exposure studies and exposure of cell culture or animal models of asthma to e-cigarettes.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hickman</LastName>
                    <ForeName>Elise</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Curriculum in Toxicology &amp; Environmental Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Environmental Medicine, Asthma, and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaspers</LastName>
                    <ForeName>Ilona</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8728-0305</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Curriculum in Toxicology &amp; Environmental Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Ilona_jaspers@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Environmental Medicine, Asthma, and Lung Biology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Ilona_jaspers@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Ilona_jaspers@med.unc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R01 HL139369</GrantID>
                    <Acronym>HL</Acronym>
                    <Agency>NHLBI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 ES007126</GrantID>
                    <Acronym>ES</Acronym>
                    <Agency>NIEHS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Curr Allergy Asthma Rep</MedlineTA>
            <NlmUniqueID>101096440</NlmUniqueID>
            <ISSNLinking>1529-7322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">E-cigarettes</Keyword>
            <Keyword MajorTopicYN="N">Environmental exposure</Keyword>
            <Keyword MajorTopicYN="N">Immune</Keyword>
            <Keyword MajorTopicYN="N">Vaping</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770299</ArticleId>
            <ArticleId IdType="doi">10.1007/s11882-020-00952-2</ArticleId>
            <ArticleId IdType="pii">10.1007/s11882-020-00952-2</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32770271</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1437-160X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Rheumatology international</Title>
                <ISOAbbreviation>Rheumatol. Int.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Presence of purpura is related to active inflammation in association with IL-5 in eosinophilic granulomatosis with polyangiitis.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00296-020-04672-8</ELocationID>
            <Abstract>
                <AbstractText>Eosinophilic granulomatosis with polyangiitis (EGPA) is a relatively rare necrotizing vasculitis that causes asthma, nasal involvement, peripheral nerve disturbance, renal disorder, and cutaneous lesions like purpura and is characterized by eosinophil infiltration into the damaged tissue. Purpura is the most common cutaneous lesion, but it remains unknown whether this skin lesion is associated with disease activity of EGPA and laboratory data including interleukin (IL)-5, a target cytokine of this disease. We conducted a search of our hospital electronic records for cases of EGPA from the last 10 years. Symptoms related to EGPA (fever, asthma, nasal and cutaneous manifestations, neuropathy), the Birmingham Vasculitis Activity Score (BVAS), and laboratory parameters, such as eosinophil count, urinalysis, antineutrophil cytoplasmic antibody (ANCA), CRP, IgE and IL-5, before and during treatment were compared among the eligible cases. A total of 28 EGPA patients (21 females and 7 males) were selected. Almost all developed peripheral neuropathy. Fever occurred in 25%, nasal symptoms in 38.1% and purpura in 44%. Glomerulonephritis developed in 7.7%. One patient had cardiac involvement (3.6%). The laboratory data showed a marked increase in peripheral eosinophil count, CRP, serum IgE and serum IL-5. ANCA was positive in 15.4%. In the univariate analysis, presence of purpura was associated with increased CRP and IL-5, and high BVAS score. Multivariate analysis revealed a robust relationship between purpura and CRP. Our findings showed that presence of purpura was associated with increased CRP and IL-5, and high disease activity in EGPA.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kataoka</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2502-8304</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan. hiroshi.kataoka@doc.city.sapporo.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomita</LastName>
                    <ForeName>Tomoko</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kondo</LastName>
                    <ForeName>Makoto</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukai</LastName>
                    <ForeName>Masaya</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Sapporo, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Germany</Country>
            <MedlineTA>Rheumatol Int</MedlineTA>
            <NlmUniqueID>8206885</NlmUniqueID>
            <ISSNLinking>0172-8172</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antineutrophil cytoplasmic antibody</Keyword>
            <Keyword MajorTopicYN="N">Churg–Strauss syndrome</Keyword>
            <Keyword MajorTopicYN="N">Eosinophils</Keyword>
            <Keyword MajorTopicYN="N">Interleukin-5</Keyword>
            <Keyword MajorTopicYN="N">Purpura</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770271</ArticleId>
            <ArticleId IdType="doi">10.1007/s00296-020-04672-8</ArticleId>
            <ArticleId IdType="pii">10.1007/s00296-020-04672-8</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32770056</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transcriptomic analysis delineates potential signature genes and miRNAs associated with the pathogenesis of asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13354</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-70368-5</ELocationID>
            <Abstract>
                <AbstractText>Asthma is a multifarious disease affecting several million people around the world. It has a heterogeneous risk architecture inclusive of both genetic and environmental factors. This heterogeneity can be utilised to identify differentially expressed biomarkers of the disease, which may ultimately aid in the development of more localized and molecularly targeted therapies. In this respect, our study complies with meta-analysis of microarray datasets containing mRNA expression profiles of both asthmatic and control patients, to identify the critical Differentially Expressed Genes (DEGs) involved in the pathogenesis of asthma. We found a total of 30 DEGs out of which 13 were involved in the pathway and functional enrichment analysis. Moreover, 5 DEGs were identified as the hub genes by network centrality-based analysis. Most hub genes were involved in protease/antiprotease pathways. Also, 26 miRNAs and 20 TFs having an association with these hub genes were found to be intricated in a 3-node miRNA Feed-Forward Loop. Out of these, miR-34b and miR-449c were identified as the key miRNAs regulating the expression of SERPINB2 gene and SMAD4 transcription factor. Thus, our study is suggestive of certain miRNAs and unexplored pathways which may pave a way to unravel critical therapeutic targets in asthma.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Prithvi</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sharma</LastName>
                    <ForeName>Archana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Research Lab, Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, 110025, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jha</LastName>
                    <ForeName>Rishabh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arora</LastName>
                    <ForeName>Shweta</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Research Lab, Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, 110025, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmad</LastName>
                    <ForeName>Rafiq</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Nanoscience and Nanotechnology, Jamia Millia Islamia, New Delhi, 110025, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rahmani</LastName>
                    <ForeName>Arshad Husain</ForeName>
                    <Initials>AH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, 51452, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Almatroodi</LastName>
                    <ForeName>Saleh A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, 51452, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dohare</LastName>
                    <ForeName>Ravins</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India. ravinsdohare@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Syed</LastName>
                    <ForeName>Mansoor Ali</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Research Lab, Department of Biotechnology, Faculty of Natural Sciences, Jamia Millia Islamia, New Delhi, 110025, India. smansoor@jmi.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32770056</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-020-70368-5</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-020-70368-5</ArticleId>
            <ArticleId IdType="pmc">PMC7414199</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2019 Aug;61(2):134-135</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30768914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Genomics. 2016 Feb 03;10:6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26842383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 1996 Apr;14(4):319-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8600935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Autom Exp. 2010 Feb 15;2(1):2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20334628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Mar 21;9(1):4980</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30899073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2019 Aug 19;20(16):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31430856</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1992 Jan 30;326(5):298-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1530827</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2012;8(7):e1002488</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22829753</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2013 Nov 15;191(10):4908-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24108699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2005 Mar 18;280(11):9761-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15677460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging (Albany NY). 2009 Sep 08;1(9):762-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20157565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2012 Nov 15;186(10):965-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22955319</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2015 Jan 15;308(2):L130-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25326577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2009 Oct 15;25(20):2692-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19628502</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Cell Biol. 2011 Jun;13(6):693-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21602795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Bioinformatics. 2013 Apr 15;14:128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23586463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 1997 Nov;156(5):1421-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9372655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Biol Macromol. 2019 Feb 1;122:1080-1089</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30218739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2016 Aug;39:14-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27246785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunology. 2006 Oct;119(2):159-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16800860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2003 Feb 15;31(4):e15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12582260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2002 Aug;8(8):885-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12091879</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 Mar;133(3):670-8.e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24495433</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2012 May 04;18(5):716-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22561835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Heliyon. 2019 Jun 14;5(6):e01707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31338439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2006 Aug 26;368(9537):804-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16935691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Apr 20;43(7):e47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25605792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Int. 2006 Sep;55(3):235-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17075263</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2017 Nov 29;6(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29186064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2009 Sep 1;180(5):388-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19483109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2016;1418:93-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27008011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2006 Jan 1;173(1):32-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16179645</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24297251</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir Rev. 2013 Mar 1;22(127):44-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23457164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Dis. 2017 Aug 10;8(8):e2998</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28796252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D408-D414</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27794551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Toxicol Pathol. 2006;34(3):252-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16698724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Oct 18;13(10):e0206239</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30335862</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14597658</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 May 30;346(22):1699-705</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12037149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2017 Jan 4;45(D1):D43-D50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27924033</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biosystems. 2015 Aug;134:71-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26116091</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Chem Hoppe Seyler. 1996 Feb;377(2):71-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8868064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2008 Oct 15;24(20):2416-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18713790</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2008 Jun;38(6):872-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18498538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2019 Jan 8;47(D1):D529-D541</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30476227</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2007 Jul 15;23(14):1846-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17496320</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Rep. 2015 Sep;3(5):611-616</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26405533</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS Comput Biol. 2007 Jul;3(7):e131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17630826</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proteomics. 2006 Jan;6(1):35-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16281187</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2009 Jul 21;339:b2535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19622551</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2018 Feb;58(2):261-270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28933920</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2018 Aug;142(2):569-581.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29106998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27141961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Invest Dermatol. 2015 Jan;135(1):160-169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25111616</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 2017 Dec;92:38-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29031950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2001 May 3;411(6833):41-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11333967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Ther Med. 2016 Oct;12(4):2109-2119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27703495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Oct 21;10(10):e0141278</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26488881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes (Basel). 2019 Dec 04;10(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31817302</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2019 Mar 29;9(1):5372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30926874</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2012 May 15;185(10):1058-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22403800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Redox Biol. 2018 Sep;18:104-113</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30007886</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thromb Res. 2003;112(1-2):1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15013265</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32769801</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1536-5948</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of occupational and environmental medicine</Title>
                <ISOAbbreviation>J. Occup. Environ. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Impact of an Urban Scrapyard Fire on Respiratory-related Pediatric Emergency Department Visits.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/JOM.0000000000001972</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">In Philadelphia, a scrapyard fire generated PM2.5 concentrations &gt;1000 μg/m. We assessed whether this was associated with pediatric emergency department visits for respiratory diagnoses.</AbstractText>
                <AbstractText Label="DESIGN/METHODS" NlmCategory="METHODS">Retrospective observational study using electronic health record data from a local, academic pediatric hospital.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared to the two-week prior before the fire, patients living directly north of the fire (downwind) had a significant difference in all asthma diagnoses (OR = 3.02, p = 0.03); asthma &amp; upper respiratory infection (OR = 17.3, p = 0.01); overall admissions (OR = 3.04, p = 01); asthma admissions (OR = 4.45, p = .01); and asthma &amp; upper respiratory infection admissions (OR = 15.0, p = 0.01). We did not observe any significant differences among visits or admissions from patients residing in other adjacent zip codes.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A localized, transient increase in PM2.5 was associated with increased pediatric ED visits for asthma among patients living downwind of the fire.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jonathan C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA (Dr Li, Danielle); Combined Internal Medicine-Pediatrics Residency Program, ChristianaCare/Nemours A.I. duPont, Newark, DE (Dr Li) and Pediatric Emergency Medicine, St. Christopher's Hospital for Children, Philadelphia, PA (Dr Casher).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Casher</LastName>
                    <ForeName>Danielle</ForeName>
                    <Initials>D</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Occup Environ Med</MedlineTA>
            <NlmUniqueID>9504688</NlmUniqueID>
            <ISSNLinking>1076-2752</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32769801</ArticleId>
            <ArticleId IdType="doi">10.1097/JOM.0000000000001972</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32769782</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1536-5948</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of occupational and environmental medicine</Title>
                <ISOAbbreviation>J. Occup. Environ. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Respiratory Health and Inflammatory Markers - Exposure to Cobalt in the Swedish Hard Metal Industry.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/JOM.0000000000001952</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To study the relationship between inhalable dust and cobalt and respiratory symptoms, lung function, exhaled nitric oxide in expired air and CC16 in the Swedish hard metal industry.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Personal sampling of inhalable dust and cobalt, medical examination including blood sampling was performed for 72 workers. Exposure-response relationships was determined using logistic, linear and mixed model analysis.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The average inhalable dust and cobalt concentrations were 0.079 and 0.0017 mg/m, respectively. Statistically significant increased serum levels of CC16 were determined when the high and low cumulative exposures for cobalt were compared. Non-significant exposure-response relationships was observed between cross-shift inhalable dust or cobalt exposures and asthma, nose dripping and bronchitis.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings suggest an exposure-response relationship between inhalable cumulative cobalt exposure and CC16 levels in blood, which may reflect an injury or a reparation process in the lungs.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Andersson</LastName>
                    <ForeName>Lena</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Medicine, Faculty of Medicine and Health, Örebro University, SE 701 82 Örebro, Sweden (Lena Andersson, Ing-Liss Bryngelsson, Anders Johansson, Annette Ericsson, Per Vihlborg, Håkan Westberg); School of Medical Sciences, Faculty of Medicine and Health, Örebro University, SE-701 82 Örebro, Sweden (Lena Andersson, Alexander Hedbrant, Alexander Persson, Eva Särndahl, Håkan Westberg); Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, SE-701 82 Örebro, Sweden (Lena Andersson, Alexander Hedbrant, Alexander Persson, Eva Särndahl, Håkan Westberg); Integrative Toxicology, Institute of Environmental Medicine, Karolinska Institute, SE-171 77 Stockholm, Sweden (Bengt Sjögren); Unit of Occupational and Environmental Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg and Sahlgrenska University Hospital, PB 414, SE-405 30 Gothenburg, Sweden (Leo Stockfelt).</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hedbrant</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bryngelsson</LastName>
                    <ForeName>Ing-Liss</ForeName>
                    <Initials>IL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Persson</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Anders</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ericsson</LastName>
                    <ForeName>Annette</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vihlborg</LastName>
                    <ForeName>Per</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sjögren</LastName>
                    <ForeName>Bengt</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Särndahl</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stockfelt</LastName>
                    <ForeName>Leo</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Westberg</LastName>
                    <ForeName>Håkan</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Occup Environ Med</MedlineTA>
            <NlmUniqueID>9504688</NlmUniqueID>
            <ISSNLinking>1076-2752</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32769782</ArticleId>
            <ArticleId IdType="doi">10.1097/JOM.0000000000001952</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32769712</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1473-6322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current opinion in allergy and clinical immunology</Title>
                <ISOAbbreviation>Curr Opin Allergy Clin Immunol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Advances in allergen immunotherapy for asthma.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1097/ACI.0000000000000686</ELocationID>
            <Abstract>
                <AbstractText Label="PURPOSE OF REVIEW" NlmCategory="OBJECTIVE">Allergen immunotherapy (AIT) is a well-known disease-modifying intervention for allergic diseases. Its benefit in allergic asthma, ranging from prevention to facilitating asthma control, is yet to be clarified.</AbstractText>
                <AbstractText Label="RECENT FINDINGS" NlmCategory="RESULTS">In 2017, following several well-designed randomised controlled trials (RCTs) with house-dust mites (HDM) sublingual (SLIT) tablets in asthma, global initiative for asthma (GINA) guidelines highlighted the need to treat the allergic component of asthma. In 2019, the European Academy of Allergy and Clinical Immunology published the first comprehensive guidelines for HDM AIT in allergic asthma, formulating separate recommendations for subcutaneous, SLIT drops, and SLIT tablets. Significant steps were undertaken in understanding the mechanisms of allergic asthma, facilitating the stratified approach for selecting responders and in translating the immune-modulation effect in achieving long-term control of the chronic inflammation in asthma.</AbstractText>
                <AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Currently existing guidelines recommend AIT as a therapeutic option in controlled or partially controlled HDM allergic asthma. Limited data are available for pollen, molds and pets, as well as for the severe allergic asthma population. The challenge for the future research will be to clarify the subendotypes of allergic asthma responding to AIT, the mechanisms facilitating its' preventive and disease-modifying effect, the optimal duration of the treatment, and route of administration.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Agache</LastName>
                    <ForeName>Ioana</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Theramed Healthcare, Brasov, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Laculiceanu</LastName>
                    <ForeName>Alexandru</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cojanu</LastName>
                    <ForeName>Catalina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Theramed Healthcare, Brasov, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spanu</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rogozea</LastName>
                    <ForeName>Liliana</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Curr Opin Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>100936359</NlmUniqueID>
            <ISSNLinking>1473-6322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32769712</ArticleId>
            <ArticleId IdType="doi">10.1097/ACI.0000000000000686</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32769140</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1470-7926</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Occupational and environmental medicine</Title>
                <ISOAbbreviation>Occup Environ Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Airborne occupational exposures and inflammatory biomarkers in the Lifelines cohort study.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">oemed-2020-106493</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1136/oemed-2020-106493</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Inflammatory biomarkers are associated with negative health outcomes. In this study, we investigated the associations between airborne occupational exposures and levels and changes in inflammatory biomarkers.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We included 79 604 adults at baseline from the Lifelines cohort of which 48 403 (60.8%) subjects were followed for a median of 4.5 years. Airborne occupational exposures at the current or last-held job at baseline were estimated with the occupational asthma-specific job-exposure matrix. Both in cross-sectional and longitudinal analyses, we used linear regression models (adjusted for age, sex, education, monthly income, body mass index, smoking, pack-years, asthma and anti-inflammatory medication) to investigate the associations between airborne occupational exposures (allergens, reactive chemicals, pesticides and micro-organisms) and inflammatory biomarkers (C reactive protein (CRP), eosinophils and neutrophils).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the cross-sectional analyses, exposure to allergens, reactive chemicals and micro-organisms was associated with a lower (Log) CRP level (B(95% CI)=-0.05 (-0.08 to -0.02),-0.05(-0.08 to -0.02) and -0.09(-0.16 to -0.02), respectively). Likewise, exposure to allergens, reactive chemicals, pesticides and micro-organisms was associated with a lower (log) neutrophils count (-0.01 (-0.02 to -0.01), -0.01 (-0.02 to -0.01),-0.02 (-0.04 to -0.01) and -0.02(-0.03 to -0.01), respectively). No association between airborne occupational exposures and eosinophils count was found. In the longitudinal analyses, no association between airborne occupational exposures and changes in inflammatory biomarkers was found.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">At baseline, airborne occupational exposures are inversely associated with inflammation; no effect of occupational exposures on inflammation was found at follow-up. In the future studies, details of occupational exposures, such as duration of exposures and cumulative exposures, need to be included to investigate the airborne occupational exposures and inflammatory biomarkers.</AbstractText>
                <CopyrightInformation>© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Faruque</LastName>
                    <ForeName>Md Omar</ForeName>
                    <Initials>MO</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3806-6606</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Department of Epidemiology, University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vonk</LastName>
                    <ForeName>Judith M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Department of Epidemiology, University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bültmann</LastName>
                    <ForeName>Ute</ForeName>
                    <Initials>U</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9589-9220</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Sciences, Community and Occupational Medicine, University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boezen</LastName>
                    <ForeName>H Marike</ForeName>
                    <Initials>HM</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Department of Epidemiology, University of Groningen, Groningen, The Netherlands h.m.boezen@umcg.nl.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Occup Environ Med</MedlineTA>
            <NlmUniqueID>9422759</NlmUniqueID>
            <ISSNLinking>1351-0711</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">epidemiology</Keyword>
            <Keyword MajorTopicYN="N">international occupational health</Keyword>
            <Keyword MajorTopicYN="N">occupational health practice</Keyword>
        </KeywordList>
        <CoiStatement>Competing interests: None declared.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32769140</ArticleId>
            <ArticleId IdType="pii">oemed-2020-106493</ArticleId>
            <ArticleId IdType="doi">10.1136/oemed-2020-106493</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32768634</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1534-4436</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of allergy, asthma &amp; immunology : official publication of the American College of Allergy, Asthma, &amp; Immunology</Title>
                <ISOAbbreviation>Ann. Allergy Asthma Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Economic Implications of Penicillin Allergy.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1081-1206(20)30559-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.anai.2020.08.003</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Parikh</LastName>
                    <ForeName>Purvi</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University School of Medicine. Electronic address: purviparikh7@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patel</LastName>
                    <ForeName>Niraj C</ForeName>
                    <Initials>NC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Atrium Health, Levine's Children's Hospital.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trogen</LastName>
                    <ForeName>Brit</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University School of Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Feldman</LastName>
                    <ForeName>Eleanor</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University School of Medicine/ Winthrop Hospital.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meadows</LastName>
                    <ForeName>J Allen</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Alabama College of Osteopathic Medicine.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Ann Allergy Asthma Immunol</MedlineTA>
            <NlmUniqueID>9503580</NlmUniqueID>
            <ISSNLinking>1081-1206</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">: Penicillin</Keyword>
            <Keyword MajorTopicYN="N">allergy</Keyword>
            <Keyword MajorTopicYN="N">antibiotic stewardship</Keyword>
            <Keyword MajorTopicYN="N">cost</Keyword>
            <Keyword MajorTopicYN="N">reimbursement</Keyword>
            <Keyword MajorTopicYN="N">testing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32768634</ArticleId>
            <ArticleId IdType="pii">S1081-1206(20)30559-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.anai.2020.08.003</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32768137</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-491X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of nursing studies</Title>
                <ISOAbbreviation>Int J Nurs Stud</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characteristics of self-care interventions for patients with a chronic condition: A scoping review.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103713</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0020-7489(20)30199-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijnurstu.2020.103713</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Self-care is a fundamental element of treatment for patients with a chronic condition and a major focus of many interventions. A large body of research exists describing different types of self-care interventions, but these studies have never been compared across conditions. Examination of heterogeneous interventions could provide insights into effective approaches that should be used in diverse patient populations.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To provide a comprehensive and standardized cross-condition overview of interventions to enhance self-care in patients with a chronic condition. Specific aims were to: 1) identify what self-care concepts and behaviors are evaluated in self-care interventions; 2) classify and quantify heterogeneity in mode and type of delivery; 3) quantify the behavior change techniques used to enhance self-care behavior; and 4) assess the dose of self-care interventions delivered.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">Scoping review DATA SOURCES: Four electronic databases - PubMed, EMBASE, PsychINFO and CINAHL - were searched from January 2008 through January 2019.</AbstractText>
                <AbstractText Label="ELIGIBILITY CRITERIA FOR STUDY SELECTION" NlmCategory="UNASSIGNED">Randomized controlled trials (RCTs) with concealed allocation to the intervention were included if they compared a behavioral or educational self- care intervention to usual care or another self-care intervention and were conducted in adults. Nine common chronic conditions were included: hypertension, coronary artery disease, arthritis, chronic kidney disease, heart failure, stroke, asthma, chronic obstructive lung disease, and type 2 diabetes mellitus. Diagnoses that are psychiatric (e.g. schizophrenia), acute rather than chronic, or benefitting little from self-care (e.g. dementia) were excluded. Studies had to be reported in English with full-text available.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">9309 citations were considered and 233 studies were included in the final review. Most studies addressed type 2 diabetes mellitus (n = 85; 36%), hypertension (n = 32; 14%) or heart failure (n = 27; 12%). The majority (97%) focused on healthy behaviors like physical activity (70%), dietary intake (59%), and medication management (52%). Major deficits found in self-care interventions included a lack of attention to the psychological consequences of chronic illness, technology and behavior change techniques were rarely used, few studies focused on helping patients manage signs and symptoms, and the interventions were rarely innovative. Research reporting was generally poor.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Major gaps in targeted areas of self-care were identified. Opportunities exist to improve the quality and reporting of future self-care intervention research. Registration: The study was registered in the PROSPERO database (#123,719).</AbstractText>
                <CopyrightInformation>Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Riegel</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Edith Clemmer Steinbright Professor of Gerontology School of Nursing, University of Pennsylvania, 418 Curie Boulevard, Philadelphia, PA 19104-4217, United States; Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, Australia. Electronic address: briegel@nursing.upenn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Westland</LastName>
                    <ForeName>Heleen</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. Electronic address: H.Westland@umcutrecht.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iovino</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Rome Tor Vergata, Rome, Italy; Australian Catholic University, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barelds</LastName>
                    <ForeName>Ingrid</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. Electronic address: i.barelds@pl.hanze.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bruins Slot</LastName>
                    <ForeName>Joyce</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division Heart and Lungs, University Medical Center Utrecht, The Netherlands. Electronic address: J.C.BruinsSlot@umcutrecht.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stawnychy</LastName>
                    <ForeName>Michael A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Nursing, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: mstawn@nursing.upenn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Osokpo</LastName>
                    <ForeName>Onome</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Nursing, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: onome@nursing.upenn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tarbi</LastName>
                    <ForeName>Elise</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Nursing, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: etarbi@nursing.upenn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trappenburg</LastName>
                    <ForeName>Jaap C A</ForeName>
                    <Initials>JCA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. Electronic address: jtrappen@umcutrecht.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vellone</LastName>
                    <ForeName>Ercole</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Rome Tor Vergata, Rome, Italy. Electronic address: ercole.vellone@uniroma2.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Strömberg</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health, Medicine and Caring Sciences and Department of Cardiology, Linköping University, Linköping, Sweden. Electronic address: anna.stromberg@liu.se.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaarsma</LastName>
                    <ForeName>Tiny</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Mary Mackillop Institute for Health Research, Australian Catholic University, Melbourne, Australia; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands; Department of Health, Medicine and Caring Sciences and Department of Cardiology, Linköping University, Linköping, Sweden. Electronic address: tiny.jaarsma@liu.se.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Int J Nurs Stud</MedlineTA>
            <NlmUniqueID>0400675</NlmUniqueID>
            <ISSNLinking>0020-7489</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CitationSubset>N</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Randomized controlled trials</Keyword>
            <Keyword MajorTopicYN="N">Scoping review</Keyword>
            <Keyword MajorTopicYN="N">Self-care</Keyword>
            <Keyword MajorTopicYN="N">Self-management</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32768137</ArticleId>
            <ArticleId IdType="pii">S0020-7489(20)30199-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijnurstu.2020.103713</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32768065</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1931-3543</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>158</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Chest</Title>
                <ISOAbbreviation>Chest</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The First Description of Asthma Due to Heart Conditions in the History of Medicine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>461-463</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0012-3692(20)30121-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2020.01.011</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Taghizadieh</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Tuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Internal Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mohammadinasab</LastName>
                    <ForeName>Reza</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of History of Medicine, School of Traditional Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghazi-Sha'rbaf</LastName>
                    <ForeName>Javad</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Islamic History and Civilization, Faculty of Theology, Azarbaijan Shahid Madani University, Tabriz, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Safiri</LastName>
                    <ForeName>Saeid</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Community Medicine, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran; Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: saeidsafiri@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Chest</MedlineTA>
            <NlmUniqueID>0231335</NlmUniqueID>
            <ISSNLinking>0012-3692</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">cardiology</Keyword>
            <Keyword MajorTopicYN="N">heart conditions</Keyword>
            <Keyword MajorTopicYN="N">history</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32768065</ArticleId>
            <ArticleId IdType="pii">S0012-3692(20)30121-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.chest.2020.01.011</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32768054</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1931-3543</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>158</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Chest</Title>
                <ISOAbbreviation>Chest</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Methacholine Challenge Testing in the Diagnosis of Asthma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>433-434</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0012-3692(20)30780-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2020.04.034</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cockcroft</LastName>
                    <ForeName>Donald W</ForeName>
                    <Initials>DW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Respirology, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, Canada. Electronic address: don.cockcroft@usask.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016421">Editorial</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Chest</MedlineTA>
            <NlmUniqueID>0231335</NlmUniqueID>
            <ISSNLinking>0012-3692</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>AIM</CitationSubset>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>04</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32768054</ArticleId>
            <ArticleId IdType="pii">S0012-3692(20)30780-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.chest.2020.04.034</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32767985</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>12</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2049-2618</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Microbiome</Title>
                <ISOAbbreviation>Microbiome</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Environmental shaping of the bacterial and fungal community in infant bed dust and correlations with the airway microbiota.</ArticleTitle>
            <Pagination>
                <MedlinePgn>115</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s40168-020-00895-w</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">From early life, children are exposed to a multitude of environmental exposures, which may be of crucial importance for healthy development. Here, the environmental microbiota may be of particular interest as it represents the interface between environmental factors and the child. As infants in modern societies spend a considerable amount of time indoors, we hypothesize that the indoor bed dust microbiota might be an important factor for the child and for the early colonization of the airway microbiome. To explore this hypothesis, we analyzed the influence of environmental exposures on 577 dust samples from the beds of infants together with 542 airway samples from the Copenhagen Prospective Studies on Asthma in Childhood<sub>2010</sub> cohort.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Both bacterial and fungal community was profiled from the bed dust. Bacterial and fungal diversity in the bed dust was positively correlated with each other. Bacterial bed dust microbiota was influenced by multiple environmental factors, such as type of home (house or apartment), living environment (rural or urban), sex of siblings, and presence of pets (cat and/or dog), whereas fungal bed dust microbiota was majorly influenced by the type of home (house or apartment) and sampling season. We further observed minor correlation between bed dust and airway microbiota compositions among infants. We also analyzed the transfer of microbiota from bed dust to the airway, but we did not find evidence of transfer of individual taxa.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Current study explores the influence of environmental factors on bed dust microbiota (both bacterial and fungal) and its correlation with airway microbiota (bacterial) in early life using high-throughput sequencing. Our findings demonstrate that bed dust microbiota is influenced by multiple environmental exposures and could represent an interface between environment and child. Video Abstract.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Shashank</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hjelmsø</LastName>
                    <ForeName>Mathis H</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health Sciences, Copenhagen University Hospital Gentofte, University of Copenhagen, Gentofte, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lehtimäki</LastName>
                    <ForeName>Jenni</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health Sciences, Copenhagen University Hospital Gentofte, University of Copenhagen, Gentofte, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xuanji</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mortensen</LastName>
                    <ForeName>Martin S</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Host-Microbiota Interactions Laboratory, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Russel</LastName>
                    <ForeName>Jakob</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trivedi</LastName>
                    <ForeName>Urvish</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasmussen</LastName>
                    <ForeName>Morten A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health Sciences, Copenhagen University Hospital Gentofte, University of Copenhagen, Gentofte, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Section of Chemometrics and Analytical Technologies, Department of Food Science, University of Copenhagen, Rolighedsvej 30, 1958 Frederiksberg C, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stokholm</LastName>
                    <ForeName>Jakob</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health Sciences, Copenhagen University Hospital Gentofte, University of Copenhagen, Gentofte, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bisgaard</LastName>
                    <ForeName>Hans</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen Prospective Studies on Asthma in Childhood, Faculty of Health Sciences, Copenhagen University Hospital Gentofte, University of Copenhagen, Gentofte, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sørensen</LastName>
                    <ForeName>Søren J</ForeName>
                    <Initials>SJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6227-9906</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Microbiology, Department of Biology, University of Copenhagen, Universitetsparken 15, bldg. 1, DK2100, Copenhagen, Denmark. sjs@bio.ku.dk.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>903516</GrantID>
                    <Agency>Ministeriet Sundhed Forebyggelse</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>0603-00280B</GrantID>
                    <Agency>Strategiske Forskningsråd</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R16-A1694</GrantID>
                    <Agency>Lundbeckfonden</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Microbiome</MedlineTA>
            <NlmUniqueID>101615147</NlmUniqueID>
            <ISSNLinking>2049-2618</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Airway microbiome</Keyword>
            <Keyword MajorTopicYN="N">Bacterial microbiome</Keyword>
            <Keyword MajorTopicYN="N">Fungal microbiome</Keyword>
            <Keyword MajorTopicYN="N">House dust</Keyword>
            <Keyword MajorTopicYN="N">Infant microbiome</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>10</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767985</ArticleId>
            <ArticleId IdType="doi">10.1186/s40168-020-00895-w</ArticleId>
            <ArticleId IdType="pii">10.1186/s40168-020-00895-w</ArticleId>
            <ArticleId IdType="pmc">PMC7414761</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2015 May 5;112(18):5756-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25902536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indoor Air. 2018 Jul;28(4):539-547</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29468742</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indoor Air. 2016 Apr;26(2):179-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25833176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Microbiol. 2017 May;15(5):259-270</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28316330</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Nat. 2017 Sep;28(3):255-273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28639123</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Res. 2015 Apr;138:130-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25707017</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2019 Nov 1;10(1):5001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31676759</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2013 Sep;132(3):616-622.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23711545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(8):e43214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22952649</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Biol. 2011 Jun 24;12(6):R60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21702898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Microbiol. 2013 Feb;15(2):588-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23171378</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2018 Dec 5;11(1):37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30534340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiome. 2018 Sep 15;6(1):159</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30219104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2015 May;26(3):247-255</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25735463</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2018 May 8;115(19):4897-4902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29686089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2008 Mar;158(3):442-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18275522</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Commun Biol. 2019 Aug 5;2:291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31396571</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2014 Aug 29;345(6200):1048-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25170151</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(5):e37849</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22666400</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Total Environ. 2018 Jan 1;610-611:212-218</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28803198</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 Dec;134(6):1301-1309.e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25262465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Expo Anal Environ Epidemiol. 2001 May-Jun;11(3):231-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11477521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Oct 11;357(15):1487-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17928596</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2015 May;45(5):953-963</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25523199</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Methods. 2016 Jul;13(7):581-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27214047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2010 Mar;125(3):545-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20226291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Apr 22;8(4):e61217</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23630581</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2018 Jan 24;553(7689):427-436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29364286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indoor Air. 2017 Mar;27(2):338-344</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27018492</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2017 Aug 24;8:1595</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28883812</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Appl Environ Microbiol. 2002 Apr;68(4):1743-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11916692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiome. 2018 Dec 17;6(1):226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30558668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2015 May 13;17(5):704-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25865368</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Indoor Air. 2014 Feb;24(1):41-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23621155</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23193283</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2017 May 24;9(391):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28539477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Apr 21;11(4):e0154131</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27100967</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEMS Microbiol Ecol. 2007 May;60(2):341-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17343679</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2019 Apr 10;10:767</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31024514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiome. 2015 Oct 13;3:49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26459172</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Elife. 2019 Sep 10;8:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31502536</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Environ Sci Process Impacts. 2016 Jun 15;18(6):713-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27213188</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2013 Dec;43(12):1384-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24118234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>New Phytol. 2005 Jun;166(3):1063-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15869663</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(4):e34867</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22529946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Biol Sci. 2015 Sep 7;282(1814):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26311665</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2011 Feb 24;364(8):701-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21345099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Microbiol. 2018 Feb 05;9:84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29467728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Microbiome. 2016 Dec 30;4(1):70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28038686</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2012 May 22;109(21):8334-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22566627</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2019 Aug;37(8):852-857</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31341288</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2000 Aug 24;343(8):538-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10954761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32767573</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria - a systematic review for the EAACI Biologicals Guidelines.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14547</ELocationID>
            <Abstract>
                <AbstractText>This systematic review evaluates the efficacy and safety of omalizumab for chronic spontaneous urticaria (CSU). Pubmed, EMBASE and Cochrane Library were searched for RCTs. Critical and important CSU-related outcomes were considered. The risk of bias and the certainty of the evidence were assessed using GRADE. Ten RCTs including 1620 subjects aged 12 to 75 years old treated with omalizumab for 16 to 40 weeks were evaluated. Omalizumab 150 mg: does not result in clinically meaningful improvement (high certainty) of the urticaria activity score (UAS)7 (mean difference (MD) -5; 95%CI -7.75 to -2.25) and the itch severity score (ISS)7 (MD -2.15; 95% CI -3.2 to -1.1); does not increase (moderate certainty) quality of life (QoL) (Dermatology Life Quality Index (DLQI); MD -2.01; 95%CI -3.22 to -0.81); decreases (moderate certainty) rescue medication use (MD -1.68; 95%CI -2.95 to -0.4). Omalizumab 300 mg: results in clinically meaningful improvements (moderate certainty) of the UAS7 (MD -11.05; 95%CI -12.87 to -9.24), the ISS7 (MD -4.45; 95%CI -5.39 to -3.51), and QoL (high certainty) (DLQI; MD -4.03; 95% CI -5.56 to -2.5); decreases (moderate certainty) rescue medication use (MD -2.04; 95%CI -3.19 to -0.88) and drug-related serious AEs (RR 0.77; 95%CI 0.20 to 2.91).</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Agache</LastName>
                    <ForeName>Ioana</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7994-364X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Transylvania University, Faculty of Medicine, Brasov, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rocha</LastName>
                    <ForeName>Claudio</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alonso-Coello</LastName>
                    <ForeName>Pablo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Solà</LastName>
                    <ForeName>Ivan</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beltran</LastName>
                    <ForeName>Jessica</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Iberoamerican Cochrane Centre, Department of Clinical Epidemiology and Public Health, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Posso</LastName>
                    <ForeName>Margarita</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akdis</LastName>
                    <ForeName>Cezmi</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8020-019X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akdis</LastName>
                    <ForeName>Mubeccel</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0554-9943</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Christine Kühne-Center for Allergy Research and Education, Davos, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brockow</LastName>
                    <ForeName>Knut</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2775-3681</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Allergology Biederstein, Technical University of Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chivato</LastName>
                    <ForeName>Tomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, University CEU San Pablo, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Del Giacco</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4517-1749</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eiwegger</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2914-7829</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Translational Medicine Program, Research Institute, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Immunology, University of Toronto, Toronto, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunology and Allergy, Food Allergy and Anaphylaxis Program, The Hospital for Sick Children, Departments of Paediatrics and Immunology, University of Toronto, Toronto, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eyerich</LastName>
                    <ForeName>Kilian</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0094-2674</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Allergy Biederstein, Technical University of Munich, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giménez-Arnau</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-9548-5423</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Hospital del Mar- Institut Mar d'Investigacions Mèdiques, Universitat Autònoma de Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gutermuth</LastName>
                    <ForeName>Jan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guttman-Yassky</LastName>
                    <ForeName>Emma</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9363-324X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maurer</LastName>
                    <ForeName>Marcus</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4121-481X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Dermatological Allergology, Allergie-Centrum-Charité, Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ogg</LastName>
                    <ForeName>Graham</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, Department of Medicine, University of Oxford, Radcliffe, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ong</LastName>
                    <ForeName>Peck</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Keck School of Medicine, University of Southern California, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Mahony</LastName>
                    <ForeName>Liam</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4705-3583</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Departments of Medicine and Microbiology, APC Microbiome Ireland, University College Cork, Cork, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schwarze</LastName>
                    <ForeName>Jürgen</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Inflammation Research, Child Life and Health, The University of Edinburgh, Edinburgh, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Werfel</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Immunodermatology and Allergy Research, Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Canelo-Aybar</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CIBER de Epidemiología y Salud Pública (CIBERESP), Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Palomares</LastName>
                    <ForeName>Oscar</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-4516-0369</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry and Molecular Biology, Chemistry School, Complutense University of Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jutel</LastName>
                    <ForeName>Marek</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Wroclaw, Department of Clinical Immunology, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>ALL-MED&quot; Medical Research Institute, Wroclaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chronic idiopathic urticaria</Keyword>
            <Keyword MajorTopicYN="N">chronic spontaneous urticaria</Keyword>
            <Keyword MajorTopicYN="N">itch severity score</Keyword>
            <Keyword MajorTopicYN="N">omalizumab</Keyword>
            <Keyword MajorTopicYN="N">urticaria activity score</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767573</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14547</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32767571</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1469-493X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Cochrane database of systematic reviews</Title>
                <ISOAbbreviation>Cochrane Database Syst Rev</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.</ArticleTitle>
            <Pagination>
                <MedlinePgn>CD012977</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/14651858.CD012977.pub2</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Asthma is an illness that commonly affects adults and children, and it serves as a common reason for children to attend emergency departments. An asthma exacerbation is characterised by acute or subacute worsening of shortness of breath, cough, wheezing, and chest tightness and may be triggered by viral respiratory infection, poor compliance with usual medication, a change in the weather, or exposure to allergens or irritants. Most children with asthma have mild or moderate exacerbations and respond well to first-line therapy (inhaled short-acting beta-agonists and systemic corticosteroids). However, the best treatment for the small proportion of seriously ill children who do not respond to first-line therapy is not well understood. Currently, a large number of treatment options are available and there is wide variation in management.</AbstractText>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Main objective - To summarise Cochrane Reviews with or without meta-analyses of randomised controlled trials on the efficacy and safety of second-line treatment for children with acute exacerbations of asthma (i.e. after first-line treatments, titrated oxygen delivery, and administration of intermittent inhaled short-acting beta<sub>2</sub>-agonists and oral corticosteroids have been tried and have failed) Secondary objectives - To identify gaps in the current evidence base that will inform recommendations for future research and subsequent Cochrane Reviews - To categorise information on reported outcome measures used in trials of escalation of treatment for acute exacerbations of asthma in children, and to make recommendations for development and reporting of standard outcomes in future trials and reviews - To identify relevant randomised controlled trials that have been published since the date of publication of each included review METHODS: We included Cochrane Reviews assessing interventions for children with acute exacerbations of asthma. We searched the Cochrane Database of Systematic Reviews. The search is current to 28 December 2019. We also identified trials that were potentially eligible for, but were not currently included in, published reviews. We assessed the quality of included reviews using the ROBIS criteria (tool used to assess risk of bias in systematic reviews). We presented an evidence synthesis of data from reviews alongside an evidence map of clinical trials. Primary outcomes were length of stay, hospital admission, intensive care unit admission, and adverse effects. We summarised all findings in the text and reported data for each outcome in 'Additional tables'.</AbstractText>
                <AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">We identified 17 potentially eligible Cochrane Reviews but extracted data from, and rated the quality of, 13 reviews that reported results for children alone. We excluded four reviews as one did not include any randomised controlled trials (RCTs), one did not provide subgroup data for children, and the last two had been updated and replaced by subsequent reviews. The 13 reviews included 67 trials; the number of trials in each review ranged from a single trial up to 27 trials. The vast majority of comparisons included between one and three trials, involving fewer than 100 participants. The total number of participants included in reviews ranged from 40 to 2630. All studies included children; 16 (24%) included children younger than two years of age. Most of the reviews reported search dates older than four years. We have summarised the published evidence as outlined in Cochrane Reviews. Key findings, in terms of our primary outcomes, are that (1) intravenous magnesium sulfate was the only intervention shown to reduce hospital length of stay (high-certainty evidence); (2) no evidence suggested that any intervention reduced the risk of intensive care admission (low- to very low-certainty evidence); (3) the risk of hospital admission was reduced by the addition of inhaled anticholinergic agents to inhaled beta<sub>2</sub>-agonists (moderate-certainty evidence), the use of intravenous magnesium sulfate (high-certainty evidence), and the use of inhaled heliox (low-certainty evidence); (4) the addition of inhaled magnesium sulfate to usual bronchodilator therapy appears to reduce serious adverse events during hospital admission (moderate-certainty evidence); (5) aminophylline increased vomiting compared to placebo (moderate-certainty evidence) and increased nausea and nausea/vomiting compared to intravenous beta<sub>2</sub>-agonists (low-certainty evidence); and (6) the addition of anticholinergic therapy to short-acting beta<sub>2</sub>-agonists appeared to reduce the risk of nausea (high-certainty evidence) and tremor (moderate-certainty evidence) but not vomiting (low-certainty evidence). We considered 4 of the 13 reviews to be at high risk of bias based on the ROBIS framework. In all cases, this was due to concerns regarding identification and selection of studies. The certainty of evidence varied widely (by review and also by outcome) and ranged from very low to high.</AbstractText>
                <AbstractText Label="AUTHORS' CONCLUSIONS" NlmCategory="CONCLUSIONS">This overview provides the most up-to-date evidence on interventions for escalation of therapy for acute exacerbations of asthma in children from Cochrane Reviews of randomised controlled trials. A vast majority of comparisons involved between one and three trials and fewer than 100 participants, making it difficult to assess the balance between benefits and potential harms. Due to the lack of comparative studies between various treatment options, we are unable to make firm practice recommendations. Intravenous magnesium sulfate appears to reduce both hospital length of stay and the risk of hospital admission. Hospital admission is also reduced with the addition of inhaled anticholinergic agents to inhaled beta<sub>2</sub>-agonists. However, further research is required to determine which patients are most likely to benefit from these therapies. Due to the relatively rare incidence of acute severe paediatric asthma, multi-centre research will be required to generate high-quality evidence. A number of existing Cochrane Reviews should be updated, and we recommend that a new review be conducted on the use of high-flow nasal oxygen therapy. Important priorities include development of an internationally agreed core outcome set for future trials in acute severe asthma exacerbations and determination of clinically important differences in these outcomes, which can then inform adequately powered future trials.</AbstractText>
                <CopyrightInformation>Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Craig</LastName>
                    <ForeName>Simon S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics, School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Emergency Research, Murdoch Children's Research Institute, Parkville, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Emergency Department, Monash Medical Centre, Monash Emergency Service, Monash Health, Clayton, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Research in Emergency Departments International Collaborative (PREDICT), Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dalziel</LastName>
                    <ForeName>Stuart R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departments of Surgery and Paediatrics: Child and Youth Health, The University of Auckland, Auckland, New Zealand.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Research in Emergency Departments International Collaborative (PREDICT), Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Children's Emergency Department, Starship Children's Hospital, Auckland, New Zealand.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Powell</LastName>
                    <ForeName>Colin Ve</ForeName>
                    <Initials>CV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Emergency Medicine, Sidra Medciine, Doha, Qatar.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Cardiff University, Cardiff, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Graudins</LastName>
                    <ForeName>Andis</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Research in Emergency Departments International Collaborative (PREDICT), Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Monash Emergency Service, Monash Health, Dandenong Hospital, Dandenong, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Babl</LastName>
                    <ForeName>Franz E</ForeName>
                    <Initials>FE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emergency Research, Murdoch Children's Research Institute, Parkville, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Paediatric Research in Emergency Departments International Collaborative (PREDICT), Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Emergency Department, Royal Children's Hospital, Parkville, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Paediatrics and Centre for Integrated Critical Care, University of Melbourne, Parkville, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lunny</LastName>
                    <ForeName>Carole</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cochrane Hypertension Group, Faculty of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cochrane Database Syst Rev</MedlineTA>
            <NlmUniqueID>100909747</NlmUniqueID>
            <ISSNLinking>1361-6137</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767571</ArticleId>
            <ArticleId IdType="doi">10.1002/14651858.CD012977.pub2</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>References</Title>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32767484</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Asthma exacerbations on benralizumab are largely non-eosinophilic.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14514</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Poznanski</LastName>
                    <ForeName>Sophie M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukherjee</LastName>
                    <ForeName>Manali</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7924-7211</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Respirology, Department of Medicine, McMaster University, Hamilton &amp; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Nan</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Respirology, Department of Medicine, McMaster University, Hamilton &amp; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Chynna</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Respirology, Department of Medicine, McMaster University, Hamilton &amp; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radford</LastName>
                    <ForeName>Katherine</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Respirology, Department of Medicine, McMaster University, Hamilton &amp; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ashkar</LastName>
                    <ForeName>Ali A</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Molecular Medicine, McMaster Immunology Research Centre, McMaster University, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nair</LastName>
                    <ForeName>Parameswaran</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1041-9492</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Respirology, Department of Medicine, McMaster University, Hamilton &amp; Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">airway infections</Keyword>
            <Keyword MajorTopicYN="N">benralizumab</Keyword>
            <Keyword MajorTopicYN="N">eosinophils</Keyword>
            <Keyword MajorTopicYN="N">natural killer cells</Keyword>
            <Keyword MajorTopicYN="N">severe asthma</Keyword>
            <Keyword MajorTopicYN="N">sputum</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767484</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14514</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32767473</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1440-1843</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Respirology (Carlton, Vic.)</Title>
                <ISOAbbreviation>Respirology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Predictors of response to anti-IL-5 biologics.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/resp.13926</ELocationID>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nair</LastName>
                    <ForeName>Parameswaran</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1041-9492</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare, Hamilton, ON, L8N4A6, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>Respirology</MedlineTA>
            <NlmUniqueID>9616368</NlmUniqueID>
            <ISSNLinking>1323-7799</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-IL5 biologicals</Keyword>
            <Keyword MajorTopicYN="N">eosinophils</Keyword>
            <Keyword MajorTopicYN="N">severe asthma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767473</ArticleId>
            <ArticleId IdType="doi">10.1111/resp.13926</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Title>REFERENCES</Title>
            <Reference>
                <Citation>McGregor MC, Krings JG, Nair P, Castro M. Role of biologics in asthma. Am. J. Respir. Crit. Care Med. 2019; 199: 433-45.</Citation>
            </Reference>
            <Reference>
                <Citation>Mukherjee M, Nair P. Blood or sputum eosinophils to guide asthma therapy? Lancet Respir. Med. 2015; 3: 824-5.</Citation>
            </Reference>
            <Reference>
                <Citation>Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O'Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin J et al. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J. Allergy Clin. Immunol. 2016; 137: 75-86.e8.</Citation>
            </Reference>
            <Reference>
                <Citation>Katz LE, Gleich GJ, Hartley BF, Yancey SW, Ortega HG. Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma. Ann. Am. Thorac. Soc. 2014; 11: 531-6.</Citation>
            </Reference>
            <Reference>
                <Citation>Mukherjee M, Aleman Paramo F, Kjarsgaard M, Salter B, Nair G, LaVigne N, Radford K, Sehmi R, Nair P. Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab. Am. J. Respir. Crit. Care Med. 2018; 197: 38-46.</Citation>
            </Reference>
            <Reference>
                <Citation>Mukherjee M, Forero DF, Tran S, Boulay ME, Bertrand M, Bhalla A, Cherukat J, al-Hayyan H, Ayoub A, Revill SD et al. Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena. Eur. Respir. J. 2020: 2000117. https://doi.org/10.1183/13993003.00117-2020.</Citation>
            </Reference>
            <Reference>
                <Citation>Kuo CS, Pavlidis S, Loza M, Baribaud F, Rowe A, Pandis I, Sousa A, Corfield J, Djukanovic R, Lutter R et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur. Respir. J. 2017; 49: 1602135.</Citation>
            </Reference>
            <Reference>
                <Citation>Persson EK, Verstraete K, Heyndrickx I. Protein crystallization promotes type 2 immunity and is reversible by antibody treatment. Science 2019; 364: eaaw4295.</Citation>
            </Reference>
            <Reference>
                <Citation>Machida K, Aw M, Salter BM, Ju X, Mukherjee M, Gauvreau GM, O'Byrne PM, Nair P, Sehmi R. Role of TL1A/DR3 axis in the activation of ILC2s in eosinophilic asthmatics. Am. J. Respir. Crit. Care Med. 2020. https://doi.org/10.1164/rccm.201909-1722OC.</Citation>
            </Reference>
            <Reference>
                <Citation>Mukherjee M, Bulir DC, Radford K, Kjarsgaard M, Huang CM, Jacobsen EA, Ochkur SI, Catuneanu A, Lamothe-Kipnes H, Mahony J et al. Sputum autoantibodies in patients with severe eosinophilic asthma. J. Allergy Clin. Immunol. 2018; 141: 1269-79.</Citation>
            </Reference>
            <Reference>
                <Citation>Sehmi R, Lim HF, Mukherjee M, Huang C, Radford K, Newbold P, Boulet LP, Dorscheid D, Martin JG, Nair P. Benralizumab attenuates airway eosinophilia in prednisone-dependent asthma. J. Allergy Clin. Immunol. 2018; 141: 1529-32.e8.</Citation>
            </Reference>
            <Reference>
                <Citation>Poznanski SM, Mukherjee M, Zhao N, Huang C, Radford K, Ashkar AA, Nair P. Asthma exacerbations onbenralizumab are largely non-eosinophilic. Allergy 2020. http://dx.doi.org/10.1111/all.14514.</Citation>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32767400</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1398-9995</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Allergy</Title>
                <ISOAbbreviation>Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dupilumab, Severe Asthma Airway Responses, and SARS-CoV2 Serology.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/all.14534</ELocationID>
            <Abstract>
                <AbstractText>There is paucity of evidence assessing immune responses to COVID-19 in severe asthmatics treated with biologics. Recent guidelines recommend continuing these agents (as clinically indicated) to maintaining asthma control. Supporting this claim, Lommatzsch demonstrated that omalizumab could safely be continued during active COVID-19 infection in a patient with allergic asthma.<sup>1</sup> There are other emerging reports that show that treatment with benralizumab<sup>2</sup> and dupilumab<sup>3</sup> is not associated with significant negative impact. We had similar experience in a young patient with severe asthma treated with dupilumab.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bhalla</LastName>
                    <ForeName>Anurag</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0613-0546</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare &amp; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukherjee</LastName>
                    <ForeName>Manali</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7924-7211</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare &amp; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radford</LastName>
                    <ForeName>Katherine</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare &amp; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nazy</LastName>
                    <ForeName>Ishac</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kjarsgaard</LastName>
                    <ForeName>Melanie</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare &amp; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bowdish</LastName>
                    <ForeName>Dawn M E</ForeName>
                    <Initials>DME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Michael G. DeGroote Institute for Infectious Disease Research, McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nair</LastName>
                    <ForeName>Parameswaran</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1041-9492</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Firestone Institute for Respiratory Health, St Joseph's Healthcare &amp; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Allergy</MedlineTA>
            <NlmUniqueID>7804028</NlmUniqueID>
            <ISSNLinking>0105-4538</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32767400</ArticleId>
            <ArticleId IdType="doi">10.1111/all.14534</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32766998</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2509-2723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>GeroScience</Title>
                <ISOAbbreviation>Geroscience</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Companion animals likely do not spread COVID-19 but may get infected themselves.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-020-00248-3</ELocationID>
            <Abstract>
                <AbstractText>Coronavirus disease 2019 (COVID-19) is a highly contagious infectious disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). From the epidemiological data, the picture emerges that the more severe etiopathologies among COVID-19 patients are found in elderly people. The risk of death due to COVID-19 increases exponentially with age. Eight out of 10 COVID-19 related deaths occur in people older than 65 years of age. Older patients with comorbid conditions such as hypertension, heart failure, diabetes mellitus, asthma, chronic obstructive pulmonary disease, and cancer have a much higher case fatality rate. Governments and public health authorities all over the world have realized that protections of vulnerable older adults should be a priority during the COVID-19 pandemic. COVID-19 is a zoonotic disease. The SARS-CoV-2 virus was originally transmitted likely from a bat or a pangolin to humans. Recent evidence suggests that SARS-CoV-2, similar to other coronaviruses, can infect several species of animals, including companion animals such as dogs, cats, and ferrets although their viral loads remain low. While the main source of infection transmission therefore is human to human, there are a few rare cases of pets contracting the infection from a SARS-CoV-2-infected human. Although there is no evidence that pets actively transmit SARS-CoV-2 via animal-to-human transmission, senior pet ownership potentially may pose a small risk to older adults by (1) potentially enabling animal-to-human transmission of SARS-CoV-2 in the most vulnerable population and (2) by increasing the exposition risk for the elderly due to the necessity to care for the pet and, in the case of dogs, to take them outside the house several times per day. In this overview, the available evidence on SARS-CoV-2 infection in pets is considered and the potential for spread of COVID-19 from companion animals to older individuals and the importance of prevention are discussed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Csiszar</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vascular Cognitive Impairment and Neurodegeneration Program, Reynolds Oklahoma Center on Aging/Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1311, Oklahoma City, OK, 73104, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Theoretical Medicine Doctoral School/Department of Cell Biology and Molecular Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jakab</LastName>
                    <ForeName>Ferenc</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Szentágothai Research Center, Virological Research Group, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Sciences, Institute of Biology, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Coronavirus Research Center, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valencak</LastName>
                    <ForeName>Teresa G</ForeName>
                    <Initials>TG</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Animal Sciences, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lanszki</LastName>
                    <ForeName>Zsófia</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Szentágothai Research Center, Virological Research Group, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Sciences, Institute of Biology, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Coronavirus Research Center, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tóth</LastName>
                    <ForeName>Gábor Endre</ForeName>
                    <Initials>GE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Szentágothai Research Center, Virological Research Group, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Sciences, Institute of Biology, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Coronavirus Research Center, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kemenesi</LastName>
                    <ForeName>Gábor</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Szentágothai Research Center, Virological Research Group, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Sciences, Institute of Biology, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>National Coronavirus Research Center, University of Pécs, Pécs, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tarantini</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vascular Cognitive Impairment and Neurodegeneration Program, Reynolds Oklahoma Center on Aging/Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1311, Oklahoma City, OK, 73104, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Theoretical Medicine Doctoral School/Department of Cell Biology and Molecular Medicine, University of Szeged, Szeged, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fazekas-Pongor</LastName>
                    <ForeName>Vince</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ungvari</LastName>
                    <ForeName>Zoltan</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6035-6039</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Vascular Cognitive Impairment and Neurodegeneration Program, Reynolds Oklahoma Center on Aging/Center for Geroscience and Healthy Brain Aging, Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC 1311, Oklahoma City, OK, 73104, USA. zoltan-ungvari@ouhsc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Theoretical Medicine Doctoral School/Department of Cell Biology and Molecular Medicine, University of Szeged, Szeged, Hungary. zoltan-ungvari@ouhsc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary. zoltan-ungvari@ouhsc.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. zoltan-ungvari@ouhsc.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>T32AG052363</GrantID>
                    <Agency>National Institute on Aging (US)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>1P20GM125528</GrantID>
                    <Agency>National Institute on Aging (US)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Geroscience</MedlineTA>
            <NlmUniqueID>101686284</NlmUniqueID>
            <ISSNLinking>2509-2723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aging</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
            <Keyword MajorTopicYN="N">Senescence</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766998</ArticleId>
            <ArticleId IdType="doi">10.1007/s11357-020-00248-3</ArticleId>
            <ArticleId IdType="pii">10.1007/s11357-020-00248-3</ArticleId>
            <ArticleId IdType="pmc">PMC7410515</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Respir Med. 2020 May;8(5):430-432</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32272081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hosp Infect. 2020 Mar;104(3):246-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32035997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Autoimmun. 2020 May;109:102433</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32113704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 May 29;368(6494):1016-1020</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32269068</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vet Radiol Ultrasound. 2013 Jan-Feb;54(1):3-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22994206</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 16;382(16):1564-1567</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32182409</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Vet Med A Physiol Pathol Clin Med. 2007 Nov;54(9):504-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17931226</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2020 Jun 12;368(6496):1169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32527808</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Feb 22;395(10224):e39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32035510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2020 May 5;172(9):577-582</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32150748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Jul;583(7815):282-285</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32218527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Host Microbe. 2020 May 13;27(5):704-709.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32259477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Xenotransplantation. 2020 Mar;27(2):e12591</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32222047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vet Res Commun. 2007 Aug;31 Suppl 1:35-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17682844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nature. 2020 Mar;579(7798):265-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32015508</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32766984</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1940-6029</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2163</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Methods in molecular biology (Clifton, N.J.)</Title>
                <ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Detection of Basophils and Other Granulocytes in Induced Sputum by Flow Cytometry.</ArticleTitle>
            <Pagination>
                <MedlinePgn>281-291</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-0696-4_23</ELocationID>
            <Abstract>
                <AbstractText>Flow cytometry is one of the most widely used techniques for the detection of surface markers on various cells, particularly the cells of the immune system, at a single-cell resolution. Modern flow cytometers can identify rare cell population in highly heterogeneous samples. Here we present a protocol that allows a precise detection of basophils as well as eosinophils and neutrophils in induced sputum samples. The identification of sputum basophils and other granulocytes contributes to a better understanding of the cellular network that promotes and regulates inflammation of the lower respiratory tract.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rohner</LastName>
                    <ForeName>Lionel</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Institute of Clinical Chemistry, University Hospital Bern, Inselspital, Bern, Switzerland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fux</LastName>
                    <ForeName>Michaela</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>University Institute of Clinical Chemistry, University Hospital Bern, Inselspital, Bern, Switzerland. michaela.fux@insel.ch.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Methods Mol Biol</MedlineTA>
            <NlmUniqueID>9214969</NlmUniqueID>
            <ISSNLinking>1064-3745</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Airway inflammation</Keyword>
            <Keyword MajorTopicYN="Y">Allergy</Keyword>
            <Keyword MajorTopicYN="Y">Asthma</Keyword>
            <Keyword MajorTopicYN="Y">Basophils</Keyword>
            <Keyword MajorTopicYN="Y">Eosinophils</Keyword>
            <Keyword MajorTopicYN="Y">Flow cytometry</Keyword>
            <Keyword MajorTopicYN="Y">Induced sputum</Keyword>
            <Keyword MajorTopicYN="Y">Neutrophils</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766984</ArticleId>
            <ArticleId IdType="doi">10.1007/978-1-0716-0696-4_23</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">32766967</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1940-6029</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2163</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Methods in molecular biology (Clifton, N.J.)</Title>
                <ISOAbbreviation>Methods Mol. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Modulating the Human Basophil Phenotype During Its Development and Maturation: Basophils Derived from In Vitro Cultures of CD34<sup>+</sup> Progenitor Cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>69-83</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1007/978-1-0716-0696-4_6</ELocationID>
            <Abstract>
                <AbstractText>Historically, the human basophil that is studied experimentally comes from peripheral blood. But there is evidence that only a short portion of the basophil life cycle related to IgE-mediated function occurs in the blood. The same evidence suggests that IgE-mediated functionality is present for 5-7 days in the bone marrow (or other tissues) during which the cell modulates its phenotype according to local conditions. It is suggested that to properly understand the nature of basophil behavior, a better understanding of its biology during maturation would be helpful. For example, one highly suggestive line of evidence for the relevance of understanding the maturation period is related to the change in basophil phenotype that occurs during treatment of patients with omalizumab. During this treatment, the intrinsic reactivity or sensitivity of the basophils is significantly increased despite, or perhaps because of, the dramatic reduction in FcεRI expression that accompanies this treatment. One of the critical signaling enzymes to increase expression selectively in basophils during treatment is SYK, which is one of the earliest signaling tyrosine kinases involved in translating the aggregation of FcεRI into secretion from the cell. Treatment with omalizumab increases SYK expression, and this observation focuses some attention of how SYK expression is regulated. It is possible that the key regulation occurs during maturation of the basophil. Regardless of the mechanisms operative in this particular treatment, understanding the process of maturation and the extrinsic factors that influence it may lead to better understanding of disease processes. Therefore, this chapter will discuss and present techniques to work with maturing human basophils.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>MacGlashan</LastName>
                    <ForeName>Donald</ForeName>
                    <Initials>D</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Asthma and Allergy Center, Johns Hopkins University, Baltimore, MD, USA. dmacglas@jhmi.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Methods Mol Biol</MedlineTA>
            <NlmUniqueID>9214969</NlmUniqueID>
            <ISSNLinking>1064-3745</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="Y">Basophils</Keyword>
            <Keyword MajorTopicYN="Y">CD34</Keyword>
            <Keyword MajorTopicYN="Y">Culture</Keyword>
            <Keyword MajorTopicYN="Y">FcεRI</Keyword>
            <Keyword MajorTopicYN="Y">Histamine</Keyword>
            <Keyword MajorTopicYN="Y">IgE</Keyword>
            <Keyword MajorTopicYN="Y">Stem cells</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766967</ArticleId>
            <ArticleId IdType="doi">10.1007/978-1-0716-0696-4_6</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32766546</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2589-5370</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>24</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>EClinicalMedicine</Title>
                <ISOAbbreviation>EClinicalMedicine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characteristics, risk factors and outcomes among the first consecutive 1096 patients diagnosed with COVID-19 in Kuwait.</ArticleTitle>
            <Pagination>
                <MedlinePgn>100448</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2020.100448</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">In Kuwait, prior to the first case of COVID-19 being reported in the country, mass screening of incoming travelers from countries with known outbreaks was performed and resulted in the first identified cases in the country. All COVID-19 cases at the time and subsequently after, were transferred to a single center, Jaber Al-Ahmad Al-Sabah Hospital, where the patients received standardized investigations and treatments. The objective of this study was to characterize the demographics, clinical manifestations, and outcomes in this unique patient population.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">This retrospective cohort study was conducted between 24th February 2020 and 20th April 2020. All consecutive patients in the entire State of Kuwait diagnosed with COVID-19 according to WHO guidelines and admitted to Jaber Al-Ahmad Al-Sabah Hospital were included. Patients received standardized investigations and treatments. Multivariable analysis was used to determine the associations between risk factors and outcomes (admission to intensive care and/or mortality).</AbstractText>
                <AbstractText Label="Findings" NlmCategory="UNASSIGNED">Of 1096 patients, the median age was 41 years and 81% of patients were male. Most patients were asymptomatic on admission (46.3%), of whom 35 later developed symptoms, and 59.7% had no signs of infection. Only 3.6% of patients required an ICU admission and 1.7% were dead at the study's cutoff date. On multivariable analysis, the risk factors found to be significantly associated with admission to intensive care were age above 50 years old, a qSOFA score above 0, smoking, elevated CRP and elevated procalcitonin levels. Asthma, smoking and elevated procalcitonin levels correlated significantly with mortality in our cohort.</AbstractText>
                <CopyrightInformation>© 2020 The Author(s).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Almazeedi</LastName>
                    <ForeName>Sulaiman</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Youha</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jamal</LastName>
                    <ForeName>Mohammad H</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Haddad</LastName>
                    <ForeName>Mohannad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Muhaini</LastName>
                    <ForeName>Ali</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Ghimlas</LastName>
                    <ForeName>Fahad</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Director of the Public Health Administration, Ministry of Health, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Sabah</LastName>
                    <ForeName>Salman</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>COVID-19 Research Group, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>EClinicalMedicine</MedlineTA>
            <NlmUniqueID>101733727</NlmUniqueID>
            <ISSNLinking>2589-5370</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">COVID-19</Keyword>
            <Keyword MajorTopicYN="N">Clinical outcomes</Keyword>
            <Keyword MajorTopicYN="N">Risk factors</Keyword>
            <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766546</ArticleId>
            <ArticleId IdType="doi">10.1016/j.eclinm.2020.100448</ArticleId>
            <ArticleId IdType="pii">S2589-5370(20)30192-9</ArticleId>
            <ArticleId IdType="pii">100448</ArticleId>
            <ArticleId IdType="pmc">PMC7335246</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Intern Emerg Med. 2020 May 9;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32385628</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infection. 2020 Aug;48(4):543-551</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32342479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Radiology. 2020 Aug;296(2):E72-E78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32216717</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109013</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32171076</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thromb Haemost. 2020 Jul;18(7):1747-1751</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32302448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 6;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32250385</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Virol. 2020 Jun;127:104364</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32311650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Intern Med. 2020 Mar 13;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32167524</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Med. 2020 Mar 20;9(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32244852</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Apr 3;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32242950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Med Mal Infect. 2020 Jun;50(4):332-334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32243911</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Virol. 2020 Jun;92(6):577-583</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32162702</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2020 Apr 20;369:m1548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32312785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tob Induc Dis. 2020 Mar 20;18:20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32206052</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2020 Jun;20(6):352</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32346090</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes Metab Syndr. 2020 Jul - Aug;14(4):283-287</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32283499</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Endocrinol (Lausanne). 2019 Jul 09;10:449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31338067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Jun 4;55(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32350106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2020 Apr 22;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32320003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2016 Feb 23;315(8):762-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26903335</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Aging (Albany NY). 2020 Jun 25;12(12):11287-11295</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32589164</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32766376</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2327-2236</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>7</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of health economics and outcomes research</Title>
                <ISOAbbreviation>J Health Econ Outcomes Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Patient-Centric Structural Determinants of Adherence Rates Among Asthma Populations: Exploring the Potential of Patient Activation and Encouragement Tool TRUSTR to Improve Adherence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111-122</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.36469/jheor.2020.13607</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Lack of adherence with prescribed medications among the asthma populations exacerbates health outcomes and increases social and economic costs.</AbstractText>
                <AbstractText Label="Objectives" NlmCategory="UNASSIGNED">The proposed study aims to model patient-centric structural determinants of adherence rates among asthma patients and explore the potential of mobile health apps such as the TRUSTR platform to improve adherence using its power of monetary and non-monetary chatbotting and non-non-monetary nudges. Following specific hypotheses are tested: (1) Patient attributes, such as their age and monetary medical condition, have significant effect on their adherence with the prescribed treatment plans. (2) Behavioral nudging with rewards and engagement via mobile health apps will increase adherence rates.</AbstractText>
                <AbstractText Label="Methods" NlmCategory="UNASSIGNED">The patient population (N = 37 359) consists of commercially insured patients with asthma who have been identified from administrative claims in the HealthCore Integrated Research Database (HIRD) between April 1, 2018 and March 31, 2019. Two Structural Equation Models (SEMs) are estimated to quantify direct, indirect, and total effect sizes of age and medical condition on proportion of days covered (PDC) and medical possession ratio (MPR), mediated by patient medical and pharmacy visits. Fourteen additional SEMs were estimated to lateralize TRUSTR findings and conduct sensitivity analysis.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">HIRD data reveal mean adherence rate of 59% (standard deviation (SD) 29%) for PDC and 58% for MPR (SD 36%). Key structural findings from SEMs derived from the HIRD dataset indicate that each additional year in the age of the patient has a positive total effect on the adherence rate. Patients with poor medical condition are likely to have lower adherence rate, but this direct effect is countered by mediating variables. Further, each additional reward and higher engagement with a mobile app is likely to have a positive total effect on increasing the adherence rate.</AbstractText>
                <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">HIRD data reveal mean adherence rate of 59% (SD 29%), providing the evidence for the opportunity to increase adherence rate by around 40%. Statistical modeling results reveal structural determinants, such as the opportunity to nudge, are higher among younger patients, as they have higher probability of being non-adherent. Methodologically, lateralization approach demonstrates the potential to capture real-world evidence beyond clinical data and merge it with clinical data.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zia</LastName>
                    <ForeName>Asim</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Community Development and Applied Economics &amp; Computer Science, University of Vermont, Burlington, VT, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>trUSX, Inc., South Burlington, VT, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brassart</LastName>
                    <ForeName>Arthur</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>trUSX, Inc., South Burlington, VT, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thomas</LastName>
                    <ForeName>Sheila</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi, Inc., Bridgewater, NJ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Fen</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sanofi, Inc., Bridgewater, NJ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stephenson</LastName>
                    <ForeName>Judith J</ForeName>
                    <Initials>JJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>HealthCore Inc., Wilmington, DE, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mullins</LastName>
                    <ForeName>C Daniel</ForeName>
                    <Initials>CD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy Baltimore, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jones</LastName>
                    <ForeName>Christopher A</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>trUSX, Inc., South Burlington, VT, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Pharmaceutical Health Services Research Department, University of Maryland School of Pharmacy Baltimore, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Health Econ Outcomes Res</MedlineTA>
            <NlmUniqueID>101648581</NlmUniqueID>
            <ISSNLinking>2326-697X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">adherence rates</Keyword>
            <Keyword MajorTopicYN="N">behavioral nudging</Keyword>
            <Keyword MajorTopicYN="N">mobile health apps</Keyword>
            <Keyword MajorTopicYN="N">respiratory diseases</Keyword>
            <Keyword MajorTopicYN="N">rewards</Keyword>
            <Keyword MajorTopicYN="N">structural models</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766376</ArticleId>
            <ArticleId IdType="doi">10.36469/jheor.2020.13607</ArticleId>
            <ArticleId IdType="pii">jheor-7-2-13607</ArticleId>
            <ArticleId IdType="pmc">PMC7398613</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Patient Prefer Adherence. 2014 Jan 13;8:83-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24470757</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Gen Pract. 2014 Jul;64(624):e384-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24982490</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Patient Prefer Adherence. 2017 Aug 30;11:1469-1478</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28919719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA Psychiatry. 2014 May;71(5):566-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24671165</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2010 Feb;104(2):166-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19854632</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Coll Health. 2015;63(3):204-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25338175</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutrition. 2017 Jan;33:343-347</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27742102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2004 Dec;114(6):1288-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15577825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open. 2020 Jan 30;10(1):e032045</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32005778</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>AIDS Patient Care STDS. 2014 Nov;28(11):579-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25290556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2014 Jun;51(5):536-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24506699</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2012 Mar;106(3):338-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22188844</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Health Psychol. 2012 Feb;17(1):74-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22107110</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Patient Prefer Adherence. 2016 Nov 04;10:2271-2275</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27853357</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Manag Care Spec Pharm. 2014 May;20(5):477-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24761819</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Adv Nurs. 2014 Sep;70(9):1932-1953</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24689978</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Am Med Inform Assoc. 2016 May;23(3):449-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26661717</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2015 Apr;45(4):994-1018</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25504997</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Manag Care Spec Pharm. 2017 May;23(5):549-560</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28448784</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2015 Oct 22;17(10):e238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26494159</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Healthc Inform Res. 2018 Jul;24(3):207-226</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30109154</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2011 Oct;26(10):1175-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21533823</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Care. 2015 Mar;60(3):455-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25118311</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Top Stroke Rehabil. 2016 Jun;23(3):170-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27077973</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pharm Ther. 2015 Oct;40(5):590-593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26291693</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2015 Feb;45(2):396-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25323234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2015 Feb;12(2):161-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25569765</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2008 May;23(5):611-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18288541</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2014 Nov 18;161(10 Suppl):S5-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25402403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Med Internet Res. 2013 Apr 15;15(4):e32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23587561</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32766182</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">2296-2360</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>8</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Frontiers in pediatrics</Title>
                <ISOAbbreviation>Front Pediatr</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Pediatric Dysfunctional Breathing: Proposed Components, Mechanisms, Diagnosis, and Management.</ArticleTitle>
            <Pagination>
                <MedlinePgn>379</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2020.00379</ELocationID>
            <Abstract>
                <AbstractText>Dysfunctional breathing (DB) is an overarching term describing deviations in the normal biomechanical patterns of breathing which have a significant impact on quality of life, performance and functioning. Whilst it occurs in both children and adults, this article focuses specifically on children. DB can be viewed as having two components; breathing pattern disorder (BPD) and inducible laryngeal obstruction (ILO). They can be considered in isolation, however, are intricately related and often co-exist. When both are suspected, we propose both BPD and ILO be investigated within an all-encompassing multi-disciplinary dysfunctional breathing clinic. The MDT clinic can diagnose DB through expert history taking and a choice of appropriate tests/examinations which may include spirometry, breathing pattern analysis, exercise testing and laryngoscopic examination. Use of the proposed algorithm presented in this article will aid decision making regarding choosing the most appropriate tests and understanding the diagnostic implications of these tests. The most common symptoms of DB are shortness of breath and chest discomfort, often during exercise. Patients with DB typically present with normal spirometry and an altered breathing pattern at rest which is amplified during exercise. In pediatric ILO, abnormalities of the upper airway such as cobblestoning are commonly seen followed by abnormal activity of the upper airway structures provoked by exercise. This may be associated with a varying degree of stridor. The symptoms, however, are often misdiagnosed as asthma and the picture can be further complicated by the common co-presentation of DB and asthma. Associated conditions such as asthma, extra-esophageal reflux, rhinitis, and allergy must be treated appropriately and well controlled before any directed therapy for DB can be started if therapy is to be successful. DB in pediatrics is commonly treated with a course of non-pharmaceutical therapy. The therapy is provided by an experienced physiotherapist, speech and language therapist or psychologist depending on the dominant features of the DB presentation (i.e., BPD or ILO in combination or in isolation) and some patients will benefit from input from more than one of these disciplines. An individualized treatment program based on expert assessment and personalized goals will result in a return to normal function with reoccurrence being rare.</AbstractText>
                <CopyrightInformation>Copyright © 2020 Barker, Thevasagayam, Ugonna and Kirkby.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Barker</LastName>
                    <ForeName>Nicki</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thevasagayam</LastName>
                    <ForeName>Ravi</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ugonna</LastName>
                    <ForeName>Kelechi</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kirkby</LastName>
                    <ForeName>Jane</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Front Pediatr</MedlineTA>
            <NlmUniqueID>101615492</NlmUniqueID>
            <ISSNLinking>2296-2360</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">breathing pattern disorders</Keyword>
            <Keyword MajorTopicYN="N">dysfunctional breathing</Keyword>
            <Keyword MajorTopicYN="N">exercise induced dyspnoea</Keyword>
            <Keyword MajorTopicYN="N">inducible laryngeal obstruction</Keyword>
            <Keyword MajorTopicYN="N">pediatrics</Keyword>
            <Keyword MajorTopicYN="N">vocal cord dysfunction</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32766182</ArticleId>
            <ArticleId IdType="doi">10.3389/fped.2020.00379</ArticleId>
            <ArticleId IdType="pmc">PMC7378385</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Acta Paediatr. 2019 Aug;108(8):1398-1405</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30825228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med Insights Circ Respir Pulm Med. 2015 Oct 11;9(Suppl 1):57-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26512209</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 1950 Jun;8(6):691-700</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15419184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2016 Apr 26;4:CD011995</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27115216</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Arch Otorhinolaryngol. 2011 Sep;268(9):1313-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21528411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2016 Nov 1;194(9):1062-1072</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27575803</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pediatr. 2018 Dec 20;6:406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30627527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir Rev. 2016 Sep;25(141):287-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27581828</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Otolaryngol Head Neck Surg. 2001 Apr;127(4):369-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11296043</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1485-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21643933</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2007 Dec;62(12):1039-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17573445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Voice. 2017 Jul;31(4):518.e1-518.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28148461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Respir J. 2008 Apr;2(2):86-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20298312</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2017 Sep 9;50(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28889105</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2015 Jan;70(1):57-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25380758</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1990 Apr;45(4):287-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2278552</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2015 Jan;16(1):53-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25499573</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2020 Jun;130(6):E400-E406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31498449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Care. 2009 Apr;54(4):467-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19327181</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2004 Feb;125(2):459-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14769725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2019 Jun;54(6):706-712</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30938089</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2019 Jun;56:108-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31004747</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2011 Mar;12(1):83-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21172680</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2020 Apr;145(4):1165-1173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31940470</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2011 Jan;37(1):194-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21205712</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ERJ Open Res. 2015 May 15;1(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27730128</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2006 Jan;116(1):52-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16481809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pediatr. 2019 Mar 01;7:52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30881950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breathe (Sheff). 2016 Jun;12(2):120-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27408630</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2017 Sep;24:29-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28433261</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Clin North Am. 2010 Feb;43(1):43-66, viii</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20172256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2014 Mar;108(3):517-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24269004</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Surg. 2019 Jul 31;6:44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31417908</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychosom Res. 1985;29(2):199-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4009520</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope Investig Otolaryngol. 2019 Mar 06;4(2):227-233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31024992</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2014 Jan-Feb;2(1):65-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24565771</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open Sport Exerc Med. 2019 Jan 23;5(1):e000487</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30740235</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Voice. 1993 Dec;7(4):319-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8293064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2017 Oct;127(10):2298-2301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28236311</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rev Mal Respir. 2008 Sep;25(7):829-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18946408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pediatr. 2018 Oct 03;6:276</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30338252</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pediatr. 2009 Aug;16(8):1118-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19497716</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 1994 Feb;104(2):209-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8302126</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2017 Jun;52(6):813-819</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27797458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Pediatr. 2019 Dec;178(12):1801-1812</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31414212</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Psychosom Res. 1975;19(5-6):375-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1214233</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ Open Sport Exerc Med. 2019 Jan 18;5(1):e000436</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30792880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2020 Jan 8;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31913523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2015 Sep;45(9):1406-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25867098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respirology. 2018 Mar;23(3):284-290</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28905471</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2017 Jan;21:86-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27492717</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2014 Oct;124(10):2363-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24781959</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>ERJ Open Res. 2016 Sep 26;2(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27957485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Ann. 2019 Mar 1;48(3):e121-e127</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30874820</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2013 May 1;187(9):1016-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23634861</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Md Med J. 1998 Jan;47(1):23-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9448412</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Prim Care Respir J. 2005 Apr;14(2):78-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16701702</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32765833</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">2046-1402</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>F1000Research</Title>
                <ISOAbbreviation>F1000Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diagnosis and management of chronic cough: similarities and differences between children and adults.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">F1000 Faculty Rev-757</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.25468.1</ELocationID>
            <Abstract>
                <AbstractText>Cough is a natural process that protects the airway. Cough can occur spontaneously or voluntarily. It is considered chronic when it is present for longer than 4 weeks in children or 8 weeks in adults. In both, chronic cough causes patient distress and increased healthcare utilization. Etiologies of pediatric chronic cough include asthma, protracted bacterial bronchitis, tracheomalacia, habit cough, and various systemic disorders. While some diagnoses are identifiable by careful history alone, others require testing guided by specific pointers. Flexible fiberoptic bronchoscopy has been an important tool to identify etiologies of chronic cough that were not otherwise apparent. In adults, asthma and bronchitis are well-defined etiologies of chronic cough, but much chronic cough in adults is largely a conundrum. Reviews of adult chronic cough report that at least 40% of adults with chronic cough have no medical explanation. Gastroesophageal reflux and upper airway cough syndrome (a.k.a. post-nasal drip) have been common diagnoses of chronic cough, but those diagnoses have no support from controlled clinical trials and have been subjected to multiple published critiques. Cough hypersensitivity is considered to be an explanation for chronic cough in adults who have no other confirmed diagnosis. Gabapentin, a neuromodulator, has been associated with a modest effect in adults, as has speech pathology. While habit cough has not generally been a diagnosis in adults, there is evidence for a behavioral component in adults with chronic cough. Treatment for a specific diagnosis provides a better outcome than trials of cough suppression in the absence of a specific diagnosis. More data are needed for chronic cough in adults to examine the hypothesized cough hypersensitivity and behavioral management. This article reviews etiologies and the treatment of chronic cough in children and the conundrum of diagnosing and treating chronic cough in adults.</AbstractText>
                <CopyrightInformation>Copyright: © 2020 Weinberger M and Hurvitz M.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Weinberger</LastName>
                    <ForeName>Miles</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-2341-2094</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Rady Children's Hospital, University of California San Diego, San Diego, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hurvitz</LastName>
                    <ForeName>Manju</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-2353-5687</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Rady Children's Hospital, University of California San Diego, San Diego, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>F1000Res</MedlineTA>
            <NlmUniqueID>101594320</NlmUniqueID>
            <ISSNLinking>2046-1402</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Chronic cough</Keyword>
            <Keyword MajorTopicYN="N">bronchoscopy</Keyword>
            <Keyword MajorTopicYN="N">habit cough</Keyword>
            <Keyword MajorTopicYN="N">tracheomalacia</Keyword>
        </KeywordList>
        <CoiStatement>No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765833</ArticleId>
            <ArticleId IdType="doi">10.12688/f1000research.25468.1</ArticleId>
            <ArticleId IdType="pmc">PMC7385707</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Pulm Pharmacol Ther. 2004;17(6):343-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15564073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2008 Nov;43(11):1147-1149</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18846560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Pediatr. 2017 Sep 05;5:196</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28929095</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1997 Jul;112(1):129-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9228368</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2016 Mar;51(3):286-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26099051</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1981 Feb;98(2):320-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6906363</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Breathe (Sheff). 2017 Mar;13(1):22-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28289448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):e123-e125</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28637326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2018 Feb;153(2):467-497</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29196066</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Chest Med. 2016 Mar;37(1):47-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26857767</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1990 Jan;97(1):199-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2403897</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2012 Oct;142(4):943-950</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22459773</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Transl Sci Rare Dis. 2019;4(1-2):51-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31572664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2018 Oct 25;379(17):1612-1620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30334692</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2008 Apr 19;371(9621):1375-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18424326</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Intern Med. 2006 Feb;21(2):C1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16606374</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Mar;137(3):930-1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26483178</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2006 Jun;96(6):794-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16802766</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2014 Nov;44(5):1132-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25142479</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rhinology. 2015 Jun;53(2):195-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26030035</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2020 Aug;8(8):775-785</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32109425</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2018 Mar;141(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29449341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br Med J. 1949 Dec 3;2(4639):1269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15394636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2017 Aug 24;50(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28838975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2018 Mar;103(3):292-296</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28882881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2018 Oct;121(4):387-388</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30290892</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child Educ Pract Ed. 2019 Oct 29;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31662313</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2005 Mar;127(3):984-1005</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15764786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 1990 Mar;116(3):404-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2308032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2018 Jan;153(1):196-209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29080708</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>West J Med. 1986 Feb;144(2):229</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3953093</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2006 Sep;61 Suppl 1:i1-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16936230</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMJ. 2006 Jul 22;333(7560):174-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16829538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2017 Apr;151(4):875-883</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28104362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2017 Feb;72(2):129-136</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27682331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2012 Nov 3;380(9853):1583-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22951084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 1984 Jul;74(1):11-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6739203</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2015 Jul;148(1):24-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25856777</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2020 Jan 2;55(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31515408</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 1979 Mar 22;300(12):633-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">763286</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2016 Oct 20;375(16):1544-1551</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27797316</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2018 May;53(5):535-537</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29484846</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2018 Apr;53(4):512-516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29363880</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2015 Jul 2;373(1):8-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26132938</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Cardiothorac Surg. 2018 Sep 1;54(3):585-592</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29514258</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J La State Med Soc. 1963 Jan;115:17-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13989411</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rhinology. 2006 Dec;44(4):270-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17216744</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2009 May 30;373(9678):1891-904</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19403164</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2019 Sep 28;54(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31320455</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy. 1991 Dec;67(6):579-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1750719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy. 1992 Dec;69(6):505-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1471782</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Proc. 2014 Mar-Apr;35(2):95-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24717785</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2002 Aug;34(2):144-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12112783</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Pediatr. 2020 Feb;27 Suppl 1:eS19-eS24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32172931</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2019 Nov;123(5):515-516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31446133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1724-1729</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31279460</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Pediatr (Phila). 1969 Oct;8(10):580-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5344422</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Paediatr Respir Rev. 2006 Mar;7(1):31-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16473814</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2018 Sep 8;392(10150):866-879</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30215382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Head Neck Surg. 1993 Nov;109(5):954-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8247580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2019 Nov;156(5):820-821</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31699228</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ups J Med Sci. 2006;111(1):155-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16553254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 2007 Dec;92(12):1136-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17634184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2004 Feb;23(2):199-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14979491</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pediatr. 2012 Jan;160(1):88-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21868031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>S Afr Med J. 1980 Feb 9;57(6):198-200</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7361211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 2017 Apr;130(4):e143-e144</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28159186</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterol Clin North Am. 2014 Mar;43(1):105-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24503362</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy. 1966 Jan;24(1):43-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5902120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Am Thorac Soc. 2020 Feb;17(2):e1-e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31770003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2017 May;127(5):1007-1008</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27861928</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Ther Bull. 2019 May;57(5):74-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30904833</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765714</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1792-0981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>20</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental and therapeutic medicine</Title>
                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review).</ArticleTitle>
            <Pagination>
                <MedlinePgn>2352-2360</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2020.8961</ELocationID>
            <Abstract>
                <AbstractText>Allergic diseases have been classified in the last decades using various theories. The main classes of the newest classification in allergic respiratory diseases focus on the characterization of the endotype (which takes into account biomarkers related to determinant pathophysiological mechanisms) and of the phenotype (based on the description of the disease). Th2, Th1 and Th17 lymphocytes and the type of inflammatory response mediated by them represent the basis for Th2 and non-Th2 endotype classification. In addition, new lymphocytes were also used to characterize allergic diseases: Th9 lymphocytes, Th22 lymphocytes, T follicular helper cells (T<sub>FH</sub>) lymphocytes and invariant natural killer T (iNKT) lymphocytes. In the last decade, a growing body of evidence focused on chemokines, chemoattractant cytokines, which seems to have an important contribution to the pathogenesis of this pathology. This review presents the interactions between chemokines and Th lymphocytes in the context of Th2/non-Th2 endotype classification of respiratory allergies.</AbstractText>
                <CopyrightInformation>Copyright: © Berghi et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Berghi</LastName>
                    <ForeName>Nicolae Ovidiu</ForeName>
                    <Initials>NO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncologic Dermatology, 'Elias' Emergency University Hospital, 'Carol Davila' University of Medicine and Pharmacy, 011461 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dumitru</LastName>
                    <ForeName>Mihai</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Anatomy Department, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vrinceanu</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>ENT Department, 'Carol Davila' University of Medicine and Pharmacy, 010271 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ciuluvica</LastName>
                    <ForeName>Radu Constantin</ForeName>
                    <Initials>RC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Anatomy Department, 'Carol Davila' University of Medicine and Pharmacy, 050474 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simioniuc-Petrescu</LastName>
                    <ForeName>Anca</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>ENT Department, 'Carol Davila' University of Medicine and Pharmacy, 010271 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caragheorgheopol</LastName>
                    <ForeName>Ramona</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology Laboratory, 'Cantacuzino' National Military-Medical Institute for Research and Development, 050096 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tucureanu</LastName>
                    <ForeName>Catalin</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology Laboratory, 'Cantacuzino' National Military-Medical Institute for Research and Development, 050096 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cornateanu</LastName>
                    <ForeName>Roxana Sfrent</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physiopathology and Immunology, 'Carol Davila' University of Medicine and Pharmacy, 041914 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giurcaneanu</LastName>
                    <ForeName>Calin</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncologic Dermatology, 'Elias' Emergency University Hospital, 'Carol Davila' University of Medicine and Pharmacy, 011461 Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Exp Ther Med</MedlineTA>
            <NlmUniqueID>101531947</NlmUniqueID>
            <ISSNLinking>1792-0981</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">chemokines</Keyword>
            <Keyword MajorTopicYN="N">endotypes</Keyword>
            <Keyword MajorTopicYN="N">lymphocytes</Keyword>
            <Keyword MajorTopicYN="N">respiratory allergies</Keyword>
            <Keyword MajorTopicYN="N">rhinitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765714</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2020.8961</ArticleId>
            <ArticleId IdType="pii">ETM-0-0-8961</ArticleId>
            <ArticleId IdType="pmc">PMC7401840</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Adv Biomed Res. 2014 May 28;3:127</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24949298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Rep. 2017 Dec 09;13:27-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29264403</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2008 Dec;9(12):1341-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18931678</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lung. 2017 Dec;195(6):749-757</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28993876</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2018 Dec;142(6):1781-1792.e12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29474842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2012 Apr;108(4):243-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22469443</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Diagn Ther. 2014 Oct;18(5):523-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25004906</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Immunol. 2007 Mar;147(3):526-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17302903</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Eye Res. 2014 Feb;39(2):120-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24144346</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2004 Feb;41(1):27-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15046375</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Immunol. 2006 Mar;26(2):145-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16602032</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Feb 16;354(7):697-708</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16481637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2007 Dec;125(3):291-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17911044</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2010 Jan 29;32(1):116-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20079668</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2012 Jul 10;3:188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22787461</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Rhinol Allergy. 2014 Nov-Dec;28(6):197-201</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25514475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunity. 2009 Sep 18;31(3):362-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19766079</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2018 Oct;73(10):1964-1978</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29869791</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Sci (Lond). 2017 Oct 12;131(20):2533-2548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29026003</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2003 Dec;112(6):1139-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14657873</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Int. 2020 Jan;69(1):66-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31648923</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 May;137(5):1449-1456.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26949058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ophthalmic Res. 2014;52(1):32-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24903557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2017 Feb;139(2):696-699.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27639935</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2013 Sep 1;191(5):2731-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23904157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2017 Jun 15;198(12):4868-4878</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28476932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Microbiol Immunol Infect. 2018 Feb;51(1):18-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27325144</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 Nov;134(5):1175-1186.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25042748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jan 3;12(1):e0169353</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28046055</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Int. 2008 Feb;50(1):99-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18279215</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2014 Jan 07;9(1):e84449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24409298</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2005 Dec;116(6):1372-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16337473</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2018 Sep;109:52-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29402725</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 1999 Mar;54(3):212-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10321556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Nov;138(5):1344-1353</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27544740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2012 May 04;18(5):705-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22561834</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2014 Jul;113(1):108-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24745701</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e697-704</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20444156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2015 Sep;136(3):628-637.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25772594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Scand J Immunol. 2019 Sep;90(3):e12794</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31141185</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Forum Allergy Rhinol. 2016 Aug;6(8):862-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27012942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Investig Allergol Clin Immunol. 2005;15(3):172-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16261952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Proc. 2011 May-Jun;32(3):230-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21703102</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2011 May 1;183(9):1153-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21297073</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Aug 1;179(3):1740-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17641040</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Otolaryngol Head Neck Surg. 2015 Feb;152(2):233-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25505260</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Lung Cell Mol Physiol. 2002 Jul;283(1):L198-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12060577</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2019 Dec 13;10:2918</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31921177</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2007;143 Suppl 1:84-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17541284</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2011 Dec 14;7:22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22168152</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Exp Med Biol. 2018;1040:101-112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27739024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2001 Apr;124(4):423-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11340325</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2011 Apr 1;183(7):865-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20971830</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Lett. 2018 May;197:9-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29518454</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Lett. 2003 Dec 15;90(2-3):71-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14687706</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Opin Pulm Med. 2016 Jan;22(1):1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26574722</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2006 Jul;28(1):59-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16540498</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 May;137(5):1347-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27155030</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2003 Aug;22(2):310-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12952266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Rhinol Allergy. 2013 Mar-Apr;27(2):e58-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23562192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunogenetics. 2005 Jan;56(10):760-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15580493</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2016 May;71(5):629-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26752101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2007;144(2):123-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17536220</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2004 May 15;169(10):1118-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15001464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Signal. 2014 May;26(5):1105-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24509414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2012 Jan;129(1):119-27.e1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21943944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2017 Jan 1;198(1):461-471</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27895167</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2015 Jan;45(1):238-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25048800</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2012 Dec;130(6):1404-12.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22981793</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ter. 2017 Mar-Apr;168(2):e151-e157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28383629</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Med Res. 2012 Jan;43(1):36-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22300682</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2006;140 Suppl 1:55-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16772728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2018 Jul;48(7):787-797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29520864</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2004 Feb;34(2):345-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14768039</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Proc. 2016 Jan-Feb;37(1):35-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26831845</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2006 Aug;118(2):511-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16890779</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Med Sci. 2013 Oct 31;9(5):849-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24273568</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2018 Mar;188:7-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29196148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2013 Feb;43(2):187-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23331560</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2018 Apr 23;9(1):1603</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29686383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Proc. 2016 Nov;37(6):154-161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27931292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Immunol. 2017 Feb;82:34-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28011367</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Oct 1;179(7):4840-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17878383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Ther Nucleic Acids. 2016 May 03;5:e316</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27138176</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2015 Jun 12;10(6):e0129446</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26067998</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2016 May;116(5):394-401</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27153739</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2012 Nov;109(5):303-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23062383</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Med. 2010 Nov;16(11):1305-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21037587</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Rep. 2016 Sep 14;6:33123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27625115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2019 Mar 11;129(4):1493-1503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30855278</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2017 Aug 30;8:1031</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28912775</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2016 Jun 13;11(6):e0157058</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27295300</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2009 Feb;135(2):295-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19017877</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2010 Aug;40(8):1175-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20455898</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Rhinol Allergy. 2013 Jul-Aug;27(4):266-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23883806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2003 Jun;97(6):726-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12814161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunol Cell Biol. 2006 Feb;84(1):44-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16277637</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Transl Med. 2017 Aug 2;9(401):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28768806</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2017 Oct;119(4):310-316.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28870448</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Transl Allergy. 2012 Aug 01;2(1):13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22853438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 Feb 1;176(3):1860-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16424217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Front Immunol. 2018 Jul 30;9:1766</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30105031</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2015 Jan;15(1):57-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25534623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2003 Jun;111(6):1293-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12789232</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Apr 1;178(7):4080-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17371962</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Otol Rhinol Laryngol. 2017 Aug;126(8):573-580</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28587510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2006 May 15;176(10):6286-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16670340</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10139-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27551096</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Res. 2008 Jan 30;9:15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18234086</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Immunol. 2013 Apr;147(1):50-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23518598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2014 Oct;51(8):847-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24796647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergol Immunopathol (Madr). 2017 Sep - Oct;45(5):473-481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28259510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2011 Jul;128(1):239-242.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21388664</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2007 Jun;37(6):901-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17517104</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2005 Jun 15;174(12):8183-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15944327</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2008 Feb;324(2):769-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18029547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2014 Sep;69(9):1189-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24931417</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2012 Jan 15;188(2):615-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22156341</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Pulm Med. 2019 Jan 7;19(1):5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30616547</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2011 Feb;127(2):355-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21281866</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chin Med J (Engl). 2017 Sep 5;130(17):2033-2040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28836545</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Parasitol. 2014 Nov;146:71-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25300761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765690</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1792-0981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>20</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental and therapeutic medicine</Title>
                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>IL-22/IL-22R1 promotes proliferation and collagen synthesis of MRC-5 cells via the JAK/STAT3 signaling pathway and regulates airway subepithelial fibrosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2148-2156</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2020.8931</ELocationID>
            <Abstract>
                <AbstractText>Asthma in children poses a threat to their health, but the mechanism remains to be elucidated. The present study investigated the mechanism by which the interleukin (IL)-22/IL-22 receptor 1 (IL-22R1) signaling pathway regulates subepithelial fibrosis in children with asthma. A total of 41 children with asthma and 12 healthy children were included in the present study. ELISA was performed to measure the content of IL-22 in peripheral blood. Serum from children with asthma was used to incubate MRC-5 cells and IL-22 antibody rescued the effect of IL-22 on the biological functions of MRC-5 cells. Reverse transcription-quantitative PCR was performed to determine IL-22R1 mRNA expression levels and western blotting was performed to measure IL-22R1 protein expression. The Cell Counting Kit-8 assay was used to analyze cell proliferation and flow cytometry was performed to assess the cell cycle distribution of MRC-5 cells. The expression of IL-22 was elevated in peripheral blood from children with asthma, which promoted the proliferation of MRC-5 cells, possibly via the upregulation of collagen type I α1 chain (COL1α1) and collagen type I α2 chain (COL1α2). IL-22 exerted its biological functions via IL-22R1. The IL-22/IL-22R1 signaling pathway regulated the proliferation of MRC-5 cells and the expression of COL1α1 and COL1α2 in MRC-5 cells via the JAK/STAT3 signaling pathway. Mononuclear lymphocytes from children with asthma stimulated the proliferation and secretory function of fibroblasts by secreting IL-22. The present study suggested that IL-22 expression in peripheral blood of children with asthma is upregulated compared with the control group. Furthermore, the present study indicated that the IL-22/IL-22R1 signaling pathway promoted MRC-5 cell proliferation and collagen synthesis by activating the JAK/STAT3 signaling pathway, thereby potentially regulating airway subepithelial fibrosis.</AbstractText>
                <CopyrightInformation>Copyright: © Liu et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shang</LastName>
                    <ForeName>Biao</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bai</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, Nanchong Central Hospital, The Second Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Exp Ther Med</MedlineTA>
            <NlmUniqueID>101531947</NlmUniqueID>
            <ISSNLinking>1792-0981</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">JAK-STAT3 signaling pathway</Keyword>
            <Keyword MajorTopicYN="N">airway subepithelial fibrosis</Keyword>
            <Keyword MajorTopicYN="N">interleukin-22</Keyword>
            <Keyword MajorTopicYN="N">interleukin-22 receptor 1</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765690</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2020.8931</ArticleId>
            <ArticleId IdType="pii">ETM-0-0-08931</ArticleId>
            <ArticleId IdType="pmc">PMC7401847</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Mol Med Rep. 2018 Apr;17(4):5449-5453</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29393435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 Jun;143(6):2062-2074</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30579849</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cell Biochem. 2018 Nov 18;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30450713</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Res. 2019 Aug;86(2):181-187</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30464333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2019 Apr;155(4):816-824</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30414795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Immun. 2018 Sep 21;86(10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30104211</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Inflammopharmacology. 2019 Aug;27(4):731-748</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30470954</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2019 May;60(5):541-553</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30383396</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2011;6(11):e27473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22110656</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2019 Feb 19;14(2):e0212043</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30779748</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2019 Jan 1;202(1):37-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30530593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Cancer. 2020 Feb 19;11(9):2679-2687</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32201538</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Lung Res. 2018 Aug;44(6):288-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30428724</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Immunol. 2015 Jan;76(1):22-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25500255</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Res. 2018 Jul;6(7):788-797</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29764837</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Immunol Res. 2015 Nov;3(11):1227-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26130064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Histol Histopathol. 2019 May;34(5):537-552</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30407608</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2019 Mar;122(3):289-295</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30557617</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cancer Ther. 2020 Jan;19(1):211-220</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31534011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Dec 17;13(12):e0208553</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30557318</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2019 Feb 15;199(4):414-422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30571146</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2016 Sep 1;197(5):1877-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27456484</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Commun. 2018 Dec 12;9(1):5232</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30542075</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods. 2001 Dec;25(4):402-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11846609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res. 2018 Jun 15;78(12):3293-3305</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29572224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gastroenterology. 2018 Jul;155(1):144-155</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29621481</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2018 Sep;53(9):1171-1173</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29766674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2019 May;60(5):494-496</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30423254</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Tissue Res. 2017 Mar;367(3):551-569</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28190087</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 Jan;143(1):142-154</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30121291</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Hepatol. 2016 Jan;64(1):128-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26341825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 Feb;143(2):619-630.e7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29920352</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2019 May;143(5):1803-1810.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30554722</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765686</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1792-0981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>20</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental and therapeutic medicine</Title>
                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Correlation between asthmatic infants with rickets and vitamin D, inflammatory factors and immunoglobulin E.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2122-2126</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2020.8949</ELocationID>
            <Abstract>
                <AbstractText>Correlation between asthmatic infants with rickets and vitamin D, inflammatory factors and immunoglobulin was investigated. A total of 60 child patients with asthma who met the inclusion criteria and received treatment from January 2016 to October 2017 were collected. Among them, 17 asthmatic infants with rickets were set as observation group, while 43 child patients with simple asthma were regarded as the control group. Venous blood was drawn from the two groups of subjects after admission. The levels of interleukin-1 (IL-1), IL-6 and IL-17 in serum were determined by ELISA, vitamin D and immunoglobulin E levels in serum were detected using a fully-automatic biochemical analyzer, and wheezing duration during asthma attack was recorded. IL-1, IL-6, IL-17 and immunoglobulin E levels in serum of observation group were significantly higher than those of the control group (P&lt;0.05). The vitamin D level in the observation group was remarkably lower than that in the control group (P&lt;0.05). Wheezing duration in observation group was evidently longer than that in control group (P&lt;0.05). Moreover, IL-1, IL-6, IL-17 and immunoglobulin E levels in serum were positively related to wheezing duration, but the vitamin D level was negatively associated with wheezing duration. Infantile asthma with rickets is closely correlated with vitamin D, inflammatory factors and immunoglobulin E, which are major risk factors in infantile asthma with rickets.</AbstractText>
                <CopyrightInformation>Copyright: © Aierken et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aierken</LastName>
                    <ForeName>Aibibai</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yusufu</LastName>
                    <ForeName>Bweimaieryemu</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, First people's Hospital of Kashi, Kashi, Xinjiang 844000, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Peiru</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, P.R. China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pediatrics, The Xinjiang Uygur Autonomous Region Institute of Evidence-Based Medicine, Urumqi, Xinjiang 830054, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Exp Ther Med</MedlineTA>
            <NlmUniqueID>101531947</NlmUniqueID>
            <ISSNLinking>1792-0981</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">correlation</Keyword>
            <Keyword MajorTopicYN="N">rickets</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765686</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2020.8949</ArticleId>
            <ArticleId IdType="pii">ETM-0-0-8949</ArticleId>
            <ArticleId IdType="pmc">PMC7401696</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2009 May 1;179(9):765-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19179486</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2004 May;59(5):469-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15080825</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2009 Sep;39(9):1314-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19538496</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2009 Feb;119(2):387-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19139565</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 1995 May;151(5):1666-73; discussion 1673-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7735631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Thorac Dis. 2013 Oct;5(5):667-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24255781</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2012 Oct;11(10):763-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23023676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2007 Nov 8;357(19):1981; author reply 1981-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17992733</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mini Rev Med Chem. 2015;15(11):953-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25985946</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Res. 2006 Aug 18;7:110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16919161</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Invest. 2006 Jan;116(1):146-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16341266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2013 Dec 12;150(3):1062-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24432369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World J Gastroenterol. 2010 Feb 14;16(6):713-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20135719</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2000 Jan;55(1):19-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10607797</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2010 Jan 15;184(2):965-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20008294</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Immunobiology. 2016 Feb;221(2):182-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26454413</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Nutr Soc. 2012 Feb;71(1):50-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21849106</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Clin Immunol. 2016 Aug;12(8):839-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27014952</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Korean J Intern Med. 2011 Mar;26(1):8-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21437156</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Allergy Asthma Rep. 2011 Feb;11(1):1-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20922507</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnopharmacol. 2013 Oct 7;149(3):701-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23933317</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nutrients. 2013 Dec 16;5(12):5127-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24352091</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765663</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1792-0981</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>20</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental and therapeutic medicine</Title>
                <ISOAbbreviation>Exp Ther Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle><i>Synedrella nodiflora</i> (Linn.) Gaertn. inhibits inflammatory responses through the regulation of Syk in RAW 264.7 macrophages.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1153-1162</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/etm.2020.8750</ELocationID>
            <Abstract>
                <AbstractText><i>Synedrella nodiflora</i> (Linn.) Gaertn. (<i>S. nodiflora</i>) has long been used for the treatment of inflammatory diseases, including liver disease, asthma, rheumatism and earache, in tropical countries throughout America, Asia and Africa. However, the biological effects of <i>S. nodiflora</i> have not been extensively studied at the molecular level. Notably, it remains unclear how <i>S. nodiflora</i> exerts anti-inflammatory activity. In the present study, the anti-inflammatory mechanism of a methanol extract of <i>S. nodiflora</i> (MSN) in RAW 264.7 macrophages activated by lipopolysaccharide (LPS) was investigated. Non-cytotoxic concentrations of MSN (≤400 µg/ml) decreased the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), which resulted in a decrease in nitric oxide and prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) production. The mRNA expression of pro-inflammatory cytokines such as interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α was reduced upon MSN treatment. In addition, the activation of spleen tyrosine kinase (Syk) and Akt was suppressed by MSN. Taken together, these findings recommend the traditional medicinal application of <i>S. nodiflora</i> in the treatment of several inflammation-associated diseases and indicate the possibility of MSN as a novel therapeutic reagent of inflammation-related diseases.</AbstractText>
                <CopyrightInformation>Copyright © 2020, Spandidos Publications.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Le</LastName>
                    <ForeName>Hien Thi Thu</ForeName>
                    <Initials>HTT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jiyoung</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ha</LastName>
                    <ForeName>Jain</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kusumaningrum</LastName>
                    <ForeName>Susi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Pharmaceutical and Medical Technology, Deputy for Agroindustrial Technology and Biotechnology, The Agency for the Assessment and Application of Technology (BPPT), Tangerang, Banten 15310, Indonesia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paik</LastName>
                    <ForeName>Jin Hyub</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Biological Material Research Center, Korean Research Institute of Bioscience and Biotechnology, Daejeon 34141, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Sayeon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular and Pharmacological Cell Biology, College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Exp Ther Med</MedlineTA>
            <NlmUniqueID>101531947</NlmUniqueID>
            <ISSNLinking>1792-0981</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">inflammatory mediators</Keyword>
            <Keyword MajorTopicYN="N">lipopolysaccharide</Keyword>
            <Keyword MajorTopicYN="N">macrophages</Keyword>
            <Keyword MajorTopicYN="N">nuclear factor-κB</Keyword>
            <Keyword MajorTopicYN="N">spleen associated tyrosine kinase</Keyword>
            <Keyword MajorTopicYN="N">synedrella nodiflora</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765663</ArticleId>
            <ArticleId IdType="doi">10.3892/etm.2020.8750</ArticleId>
            <ArticleId IdType="pii">ETM-0-0-8750</ArticleId>
            <ArticleId IdType="pmc">PMC7388545</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Front Immunol. 2014 Oct 07;5:491</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25339958</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2007 Apr 1;109(7):2727-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17110449</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Young Pharm. 2010 Apr;2(2):137-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21264115</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Immunol. 2009;27:165-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19302038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med Res. 2007 Mar;5(1):19-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17456832</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2001 Sep 1;167(5):2911-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11509639</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Heart J. 2012 Apr;33(7):829-37, 837a-837d</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21890489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20066092</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Med. 2014 Dec;34(6):1706-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25242580</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2012 Jul 1;131(1):95-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21858809</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rheumatology (Oxford). 2013 May;52(5):800-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23325038</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Periodontol 2000. 2014 Feb;64(1):57-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24320956</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Des. 2008;14(14):1443-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18537667</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Med. 2018 Mar;41(3):1783-1791</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29328440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Proc Nutr Soc. 2010 Aug;69(3):273-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20569521</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mem Inst Oswaldo Cruz. 2005 Mar;100 Suppl 1:49-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15962098</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Environ Pathol Toxicol Oncol. 2016;35(1):29-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27279582</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Planta Med. 2006 Nov;72(14):1279-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17022001</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Basic Clin Physiol Pharmacol. 2015 Jul;26(4):383-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25720058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMB Rep. 2009 May 31;42(5):265-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19470239</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2009 Apr;22(2):240-73, Table of Contents</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19366914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Tradit Complement Med. 2011 Oct;1(1):8-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24716101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ghana Med J. 2016 Sep;50(3):163-171</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27752191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Pharmacol. 2006 Jan;147 Suppl 1:S232-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16402109</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2009;572:261-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20694698</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arterioscler Thromb Vasc Biol. 2011 May;31(5):986-1000</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21508345</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Endocrinology. 2006 Feb;147(2):773-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16254029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Targets Inflamm Allergy. 2002 Jun;1(2):137-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14561196</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biomed Rep. 2017 Jun;6(6):691-697</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28584643</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Complement Integr Med. 2011 Jan;8:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22754934</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Oxid Med Cell Longev. 2016;2016:1245049</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27478531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Emerg Med. 2003 Jan;41(1):134-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12514694</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Inflammopharmacology. 2010 Aug;18(4):169-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20532641</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMB Rep. 2019 Jun;52(6):360-372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31186085</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Nat Prod. 2009 Mar 27;72(3):581-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19099466</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mediators Inflamm. 2014;2014:561459</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24876674</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>FEBS Lett. 2009 Dec 17;583(24):3966-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19850042</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2014 Mar 27;157(1):121-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24679531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Drug Targets. 2011 Oct;12(11):1595-653</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21561421</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Genet. 2012 Mar 13;13(4):227-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22411467</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Mol Life Sci. 2009 Jun;66(11-12):1962-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19381435</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Biosyst. 2009 Dec;5(12):1512-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20023718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMB Rep. 2009 Sep 30;42(9):552-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19788855</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharm Bioallied Sci. 2012 Apr;4(2):140-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22557925</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Complement Altern Med. 2017 Aug 7;17(1):389</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28784133</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Surg Res. 2014 Jun 15;189(2):304-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24726062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Med Rep. 2014 Nov;10(5):2663-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25216192</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Jun 11;13(6):e0198943</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29889899</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22296764</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cold Spring Harb Perspect Biol. 2011 Mar 01;3(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21068150</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Ethnobiol Ethnomed. 2014 Jul 23;10:60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25056559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Microbiol Rev. 2003 Oct;16(4):637-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14557290</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biol Chem. 2012 Aug 3;287(32):26702-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22711534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2010 Mar 19;140(6):935-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20303881</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5842-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21685342</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods. 2001 Dec;25(4):402-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11846609</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2010 Jul;43(1):5-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19738160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Sci Signal. 2013 Aug 20;6(289):ra71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23962979</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Anesthesiol Clin. 2007 Spring;45(2):27-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17426506</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Manag Res. 2018 Nov 15;10:5709-5724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30532593</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Physiol Rev. 2007 Jan;87(1):315-424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17237348</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Cytokine Netw. 2011 Jun;22(2):82-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21628135</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neuromolecular Med. 2010 Jun;12(2):133-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19855947</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2010 Jan;116(1):117-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19854497</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Drug Des Devel Ther. 2014 Oct 16;8:1941-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25342887</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Urol. 2007 Feb;51(2):524-33; discussion 533</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16905241</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Med. 2016 Nov;38(5):1596-1604</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27666485</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Exp Ther. 2002 Dec;303(3):1001-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12438520</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765156</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1179-7266</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Pragmatic and observational research</Title>
                <ISOAbbreviation>Pragmat Obs Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The CHRONICLE Study of US Adults with Subspecialist-Treated Severe Asthma: Objectives, Design, and Initial Results.</ArticleTitle>
            <Pagination>
                <MedlinePgn>77-90</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/POR.S251120</ELocationID>
            <Abstract>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Approximately 5-10% of patients with asthma have severe disease. High-quality real-world studies are needed to identify areas for improved management.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">Aligned with the International Severe Asthma Registry, the CHRONICLE study (ClinicalTrials.gov: NCT03373045) was developed to address this need in the US.</AbstractText>
                <AbstractText Label="Study Design" NlmCategory="UNASSIGNED">Learnings from prior studies were applied to develop a real-world, prospective, noninterventional study of US patients with confirmed severe asthma who are treated by subspecialist physicians and require biologic or maintenance systemic immunosuppressant therapy or who are uncontrolled by high-dosage inhaled corticosteroids and additional controllers. Target enrollment is 4000 patients, with patient observation for ≥3 years. A geographically diverse sample of allergist/immunologist and pulmonologist sites approach all eligible patients under their care and report patient characteristics, treatment, and health outcomes every 6 months. Patients complete online surveys every 1-6 months.</AbstractText>
                <AbstractText Label="Initial Results" NlmCategory="UNASSIGNED">From February 2018 to February 2019, 102 sites screened 1428 eligible patients; 936 patients enrolled. Study sites (40% allergist/immunologist, 42% pulmonologist, 18% both) were similar to other US asthma subspecialist samples. Enrolled patients were 67% female with median ages at enrollment and diagnosis of 55 (range: 18-89) and 26 (0-80) years, respectively. Median body mass index was 31 kg/m<sup>2</sup>; 3% and 29% were current or former smokers, respectively, and &gt;60% reported ≥1 exacerbation in the prior year and suboptimal symptom control.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">CHRONICLE will provide high-quality provider- and patient-reported data from a large, real-world cohort of US adults with subspecialist-treated severe asthma.</AbstractText>
                <CopyrightInformation>© 2020 Ambrose et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ambrose</LastName>
                    <ForeName>Christopher S</ForeName>
                    <Initials>CS</Initials>
                    <Identifier Source="ORCID">0000-0003-4175-7336</Identifier>
                    <AffiliationInfo>
                        <Affiliation>US Medical Affairs, AstraZeneca, Gaithersburg, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chipps</LastName>
                    <ForeName>Bradley E</ForeName>
                    <Initials>BE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Capital Allergy &amp; Respiratory Disease Center, Sacramento, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moore</LastName>
                    <ForeName>Wendy C</ForeName>
                    <Initials>WC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary, Critical Care, Allergy, and Immunologic Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soong</LastName>
                    <ForeName>Weily</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Alabama Allergy &amp; Asthma Center, Birmingham, AL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trevor</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary, Allergy, &amp; Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ledford</LastName>
                    <ForeName>Dennis K</ForeName>
                    <Initials>DK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy and Immunology, University of South Florida, Tampa, FL, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carr</LastName>
                    <ForeName>Warner W</ForeName>
                    <Initials>WW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Allergy &amp; Asthma Associates of Southern California, Mission Viejo, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lugogo</LastName>
                    <ForeName>Njira</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pulmonary &amp; Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trudo</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>US Medical Affairs, AstraZeneca, Wilmington, DE, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tran</LastName>
                    <ForeName>Trung N</ForeName>
                    <Initials>TN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biopharmaceuticals Medical, Respiratory and Immunology, AstraZeneca, Gaithersburg, MD, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Panettieri</LastName>
                    <ForeName>Reynold A</ForeName>
                    <Initials>RA</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Institute for Translational Medicine and Science, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>ClinicalTrials.gov</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NCT03373045</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Pragmat Obs Res</MedlineTA>
            <NlmUniqueID>101688693</NlmUniqueID>
            <ISSNLinking>1179-7266</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">allergists</Keyword>
            <Keyword MajorTopicYN="N">asthma exacerbations</Keyword>
            <Keyword MajorTopicYN="N">biologic therapy</Keyword>
            <Keyword MajorTopicYN="N">longitudinal studies</Keyword>
            <Keyword MajorTopicYN="N">pulmonologists</Keyword>
        </KeywordList>
        <CoiStatement>Christopher S. Ambrose, Frank Trudo, and Trung N. Tran are employees of AstraZeneca. Bradley E. Chipps is an advisor for, received consultancy fees from, and is on the speakers’ bureau for AstraZeneca, Boehringer Ingelheim, Genentech, GlaxoSmithKline, Novartis, Regeneron, and Sanofi Genzyme. Wendy C. Moore is on advisory boards for and reports grant and personal fees from AstraZeneca, Sanofi Regeneron, Genentech, and GlaxoSmithKline. She is also a member of the writing and steering committee for the CHRONICLE study as well as a PI of the clinical trial at Wake Forest. Weily Soong is a consultant for and reports grants from AstraZeneca, Genentech, GlaxoSmithKline, Mandala, Novartis, Regeneron, Sanofi, and Teva; and is a speaker for AstraZeneca, GlaxoSmithKline, Regeneron, Sanofi, and Optinose. Jennifer Trevor is a consultant for AstraZeneca; and is on advisory boards for AstraZeneca, GlaxoSmithKline, and Boehringer Ingelheim. Dennis K. Ledford reports research support (paid to University) from Genentech/Roche, Novartis, and AstraZeneca. He reports royalties from Wolters Kluwer Health and Taylor and Francis. He is an Editor for the American Academy of Allergy, Asthma &amp; Immunology (AAAAI). He is also a consultant/speaker for and reports personal fees from ALK, AstraZeneca, Boehringer Ingelheim, Genentech/Roche, GlaxoSmithKline, Meda, Novartis, Sanofi/Regeneron, and Teva, and fees received for legal opinions on drug allergy, metal allergy, radiocontrast reaction, and asthma death. Warner W. Carr is a speaker for AstraZeneca, Teva, Boehringer Ingelheim, Regeneron, and Sanofi; and a consultant for AstraZeneca, Teva, Boehringer Ingelheim, Regeneron, Sanofi, Circassia, CSL Behring, Genentech, GlaxoSmithKline, Horizon Pharma, Kaleo, Mylan, Pfizer, Shire, Meda, Baxalta, Novartis, Greer Laboratories, Alcon Laboratories, Valeant Pharmaceuticals, Grifols, Optinose, and Aerocrine. Njira Lugogo is on advisory boards for AstraZeneca, Sanofi, Genentech, Novartis, Teva, and GlaxoSmithKline. She also reports clinical trial funding to her institution from AstraZeneca, GlaxoSmithKline, and Sanofi. Reynold A. Panettieri Jr is on advisory boards for and reports grant support/personal fees from AstraZeneca, Sanofi, Genentech, Regeneron, MedImmune, RIFM, Equillium, Theravance, Avillion, OncoArendi, Meresa, NIH, and Novartis. The authors report no other conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765156</ArticleId>
            <ArticleId IdType="doi">10.2147/POR.S251120</ArticleId>
            <ArticleId IdType="pii">251120</ArticleId>
            <ArticleId IdType="pmc">PMC7371434</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2014 Sep-Oct;2(5):544-52.e1-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25213047</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Ther. 2017 Nov;39(11):2216-2229</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29055500</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30179741</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma Allergy. 2018 Aug 29;11:193-204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30214247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 2018 May;131(5):484-491</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29355509</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2014 Feb;43(2):343-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24337046</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Asthma. 2018 Feb;55(2):208-219</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28586296</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2018 Oct 15;198(8):1012-1020</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29756989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Med (Lond). 2015 Oct;15(5):452-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26430184</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2004 Jan;92(1):32-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14756462</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2012 Aug;130(2):332-42.e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22694932</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2018 Dec 13;52(6):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30361247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Respir Med. 2006 Jul;100(7):1139-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16713224</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2015 Sep 15;163(6):461-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26259067</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Asthma Res Pract. 2017 Jan 6;3:1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28078100</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2019 Jan 26;12(1):100007</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30937132</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2002 Jan;19(1):61-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11843329</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):886-894.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29408439</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Epidemiol. 2008 Apr;61(4):344-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18313558</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet. 2013 Oct 19;382(9901):1360-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24041942</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2018 May;141(5):1590-1597.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28797732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2019 Apr 1;199(7):823-829</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30726120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Respir Care Rep. 2012 Dec;1(4):259-269</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23136642</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dtsch Arztebl Int. 2014 Dec 12;111(50):847-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25585581</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32765129</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1179-156X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Open access rheumatology : research and reviews</Title>
                <ISOAbbreviation>Open Access Rheumatol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transient Eosinophilic Granulomatosis with Polyangiitis-Like Vasculitis During Omalizumab Therapy: A Case Report.</ArticleTitle>
            <Pagination>
                <MedlinePgn>127-131</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/OARRR.S259746</ELocationID>
            <Abstract>
                <AbstractText>A 67-year-old Caucasian female presented in August 2019 to our rheumatology service, with 3 days history of severe neck pain and right-sided headache with aches in both shoulders and arms and mild stiffness. Other symptoms included mild jaw claudication. She had recently returned from Majorca after an uneventful two-week trip. She had a background of severe allergic asthma and allergic rhinitis, well controlled with omalizumab which was started in 2016, based on persistently high IgE. Her sister suffers from a type of vasculitis and is currently on steroids. The patient is an ex-smoker and drinks two bottles of wine a week. She had high inflammatory markers with raised eosinophilic count and was admitted for further work up to rule out infection and to commence steroid after for a likely diagnosis of eosinophilic granulomatosis with polyangiitis. Shortly after admission to the acute assessment unit, she became confused and febrile. An extensive work up ruled out infection, and she was started on steroids and treated for acute hyponatremia. Omalizumab was stopped. She improved and was discharged on a tapering dose of steroids and was weaned off completely within 4 months. Her inflammatory markers returned to normal as well as her eosinophilic count, with complete resolution of her presenting symptoms.</AbstractText>
                <CopyrightInformation>© 2020 Elhadari and Hamad.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Elhadari</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0002-0694-5246</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Acute Medicine Department, The James Cook University Hospital, Middlesbrough, TS4 3BW, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamad</LastName>
                    <ForeName>Mahir</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Acute Medicine Department, The James Cook University Hospital, Middlesbrough, TS4 3BW, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D002363">Case Reports</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Open Access Rheumatol</MedlineTA>
            <NlmUniqueID>101688698</NlmUniqueID>
            <ISSNLinking>1179-156X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ANCA</Keyword>
            <Keyword MajorTopicYN="N">Churg-Strauss syndrome</Keyword>
            <Keyword MajorTopicYN="N">EGPA</Keyword>
            <Keyword MajorTopicYN="N">anti-IgE antibodies</Keyword>
            <Keyword MajorTopicYN="N">eosinophilia</Keyword>
            <Keyword MajorTopicYN="N">vasculitis</Keyword>
        </KeywordList>
        <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32765129</ArticleId>
            <ArticleId IdType="doi">10.2147/OARRR.S259746</ArticleId>
            <ArticleId IdType="pii">259746</ArticleId>
            <ArticleId IdType="pmc">PMC7369362</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Arthritis Rheum. 1990 Aug;33(8):1094-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2202307</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Radiol. 2009 Nov;90(11 Pt 1):1737-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19953062</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2007;144(2):155-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17536214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arthritis Rheum. 2013 Jan;65(1):1-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23045170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2006 Sep 21;355(12):1281-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16990394</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2017 Mar;118(3):372-374.e1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28094120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2009 Aug;136(2):507-518</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19411292</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Rheumatol. 2015 Sep;2(3):129-130</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27708948</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2018 Dec 3;11(1):39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30524647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2008 Jan;121(1):253-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18206510</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2008;145(3):268</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17921677</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">32764994</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1178-6965</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>13</Volume>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of asthma and allergy</Title>
                <ISOAbbreviation>J Asthma Allergy</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical Features and Disease Course of Primary Angioedema Patients in a Tertiary Care Hospital.</ArticleTitle>
            <Pagination>
                <MedlinePgn>225-236</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/JAA.S245161</ELocationID>
            <Abstract>
                <AbstractText Label="Purpose" NlmCategory="UNASSIGNED">To give a better understanding of primary AE, the clinical characteristics and the possible therapeutic approaches.</AbstractText>
                <AbstractText Label="Background" NlmCategory="UNASSIGNED">Angioedema (AE) is a non-pitting, non-itching swelling of skin or mucosa. The symptom can become life-threatening if located in the airways. Primary (monosymptomatic) AE is a manifestation of several different diseases and the diagnosis is not always straight-forward. The aetiological and pathophysiological factors of primary AE are not completely clarified. There is a need for further investigation.</AbstractText>
                <AbstractText Label="Patients and Methods" NlmCategory="UNASSIGNED">This was a retrospective cohort study of patients referred to an outpatient dermatology clinic in a tertiary care hospital for clinical assessment due to primary AE in the period from 1996 to 2014.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 315 patients were identified with primary AE. The most frequent subtype was idiopathic AE (42.5%) and the second most common was angiotensin-converting enzymeinhibitor (ACEi)-induced AE (31.1%). Three patients were diagnosed with hereditary AE and one patient was diagnosed with acquired C1-inhibitor deficiency. At least 107 (34.0%) patients had established histaminergic AE. More than 1/3 of the patients were treated in an emergency room or hospitalized due to AE. A 98.1% of patients had experienced AE in the head and neck area. Seven patients were in the need of acute airway intervention. Six of these had ACEi-induced AE. Female sex and smoking were found to be risk factors for developing AE.</AbstractText>
                <AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The most frequent diagnoses were histaminergic-, non-histaminergic idiopathic AE and ACEi-induced AE, whereas complement C1-inhibitor deficiency was rare. Histaminergic AE made up a substantial group of patients with primary AE. Even though there are different pathophysiological causes of AE, many cases have overlapping clinical manifestations, which make diagnosis and treatment difficult.</AbstractText>
                <CopyrightInformation>© 2020 Pall et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Pall</LastName>
                    <ForeName>Amalie Hartvig</ForeName>
                    <Initials>AH</Initials>
                    <Identifier Source="ORCID">0000-0002-4389-2040</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lomholt</LastName>
                    <ForeName>Anne Fog</ForeName>
                    <Initials>AF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>von Buchwald</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">0000-0001-6753-8129</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bygum</LastName>
                    <ForeName>Anette</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0002-3004-0180</Identifier>
                    <AffiliationInfo>
                        <Affiliation>OPEN - Open Patient Data Explorative Network, Odense University Hospital, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology and Allergy Centre, Odense University Hospital, Odense 5000, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Research, University of Southern Denmark, Odense 5000, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasmussen</LastName>
                    <ForeName>Eva Rye</ForeName>
                    <Initials>ER</Initials>
                    <Identifier Source="ORCID">0000-0002-7282-8486</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>OPEN - Open Patient Data Explorative Network, Odense University Hospital, Odense, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>J Asthma Allergy</MedlineTA>
            <NlmUniqueID>101543450</NlmUniqueID>
            <ISSNLinking>1178-6965</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">angiotensin-converting enzyme inhibitors</Keyword>
            <Keyword MajorTopicYN="N">bradykinin</Keyword>
            <Keyword MajorTopicYN="N">hereditary angioedema</Keyword>
            <Keyword MajorTopicYN="N">primary angioedema</Keyword>
            <Keyword MajorTopicYN="N">urticaria</Keyword>
        </KeywordList>
        <CoiStatement>A. Pall has received one travel grant from CSL Behring. A. Bygum has been involved in clinical research and educational events involving CSL-Behring, Dyax, BioCryst and Shire/Takeda, reports payment for educational activities from Novartis, and grants and personal fees from CSL Behring and Shire (now part of Takeda), and personal fees from Novartis, outside the submitted work. E. Rasmussen has received research funding, travel grants and speakers fees from Shire, CSL Behring and Viropharma, reports personal fees from Shire-Takeda, outside the submitted work, and served on an advisory board on hereditary angioedema treatment for Shire-Takeda. The authors report no other possible conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>01</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>05</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32764994</ArticleId>
            <ArticleId IdType="doi">10.2147/JAA.S245161</ArticleId>
            <ArticleId IdType="pii">245161</ArticleId>
            <ArticleId IdType="pmc">PMC7373665</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2015 Jan 29;372(5):418-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25629740</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2019 Jul - Aug;7(6):1793-1802.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30772477</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Otol Rhinol Laryngol. 2010 Dec;119(12):836-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21250556</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2008 Aug;101(2):185-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18727475</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Orphanet J Rare Dis. 2015 Feb 06;10:11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25758562</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Rhinol (Providence). 2018 Apr 06;9:2152656718764139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29977650</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Ther Med. 2019 Feb;17(2):1068-1072</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30679975</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Acta Derm Venereol. 2012 Sep;92(5):475-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22791189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Intern Med. 2015 May;277(5):585-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25196353</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Intern Med. 2019 Jan;59:8-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30220453</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 2015 Jun;125(6):E198-202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25583256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 2009 Nov;161(5):1153-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19709101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2014;165(2):119-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25401373</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):744-749</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28377081</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):464-473.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26969268</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Eur Acad Dermatol Venereol. 2010 Jun;24(6):685-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19925599</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Pharmacol Sci. 2005 Sep;99(1):6-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16177542</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2014 May;69(5):602-16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24673465</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2018 Mar;141(3):1009-1017</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28601681</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Tidsskr Nor Laegeforen. 2012 Nov 12;132(21):2391-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23160589</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>World Allergy Organ J. 2008 Jun;1(6):103-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23282406</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Laryngoscope. 1992 Mar;102(3):256-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1545652</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Medicine (Baltimore). 2016 Aug;95(33):e4363</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27537564</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2006 May 19;343(4):1286-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16638441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mayo Clin Proc. 2000 Nov;75(11):1201-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11075752</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dan Med J. 2012 Jun;59(6):A4449</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22677247</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>CMAJ. 2006 Oct 24;175(9):1065-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17060655</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 1994 Dec;106(6):1922-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7988234</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2010 Aug 5;363(6):532-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20818888</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2018 Feb;73(2):442-450</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28795768</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Allergy Asthma Immunol. 2014 Dec;113(6):630-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25280464</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2013;162(2):149-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23921495</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1402-1409.e3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28552382</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Med. 1999 Jun;106(6):650-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10378623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Orphanet J Rare Dis. 2019 Mar 13;14(1):65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30866985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Adv Emerg Nurs J. 2018 Oct/Dec;40(4):267-277</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30365440</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Intern Med. 2005 Jul 25;165(14):1637-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16043683</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Dev Immunol. 2007;2007:26438</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18317527</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Dermatol. 2014 Feb;26(1):73-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24648689</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Exp Allergy. 2019 Feb;49(2):252-254</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30326160</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2017 Jul;140(1):242-248.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27913306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy. 2019 Dec;74(12):2479-2481</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31087670</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Emerg Med. 2013 Mar;31(3):634.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23380117</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Dermatol. 1969 Aug;81(8):588-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5801331</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Dermatol. 2014 Oct;53(10):e421-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25209993</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pan Afr Med J. 2017 Apr 19;26:213</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28690728</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Intern Med. 2019 May;285(5):553-561</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30618189</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20667117</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32764779</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>15</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2020</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Postnatal dexamethasone exposure and lung function in adolescents born very prematurely.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0237080</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0237080</ELocationID>
            <Abstract>
                <AbstractText>We previously demonstrated corticosteroid administration on the neonatal intensive care unit was associated with reduced lung function at 11 to 14 years of age in children born very prematurely. The objective of this observational study was to assess if lung function remained impaired at 16 to 19 years of age in those who had received postnatal corticosteroids and whether the trajectory of lung function with increasing age differed between those who had and had not received corticosteroids. One hundred and fifty-nine children born prior to 29 weeks of gestational age had comprehensive lung function measurements; 49 had received postnatal dexamethasone. Lung function outcomes were compared between those who had and had not received postnatal dexamethasone after adjustment for neonatal factors. Forced expiratory flow at 75%, 50%, 25% and 25-75% of the expired vital capacity, forced expiratory volume in one second, peak expiratory flow and forced vital capacity and lung volumes (total lung capacity and residual volume) were assessed. The majority of results were significantly lower in those who received dexamethasone (between 0.61 to 0.78 standard deviations). Lung function reduced as the number of courses of dexamethasone increased. Between 11 and 14 years and 16 to 19 years, lung function improved in the unexposed group, but forced expiratory flow at 75% of the expired vital capacity and forced expiratory volume in one second deteriorated in those who had received postnatal corticosteroids (p = 0.0006). These results suggest that prematurely born young people who received postnatal corticosteroids may be at risk of premature onset of chronic obstructive pulmonary disease.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Harris</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bisquera</LastName>
                    <ForeName>Alessandra</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Population Health and Environmental Sciences, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zivanovic</LastName>
                    <ForeName>Sanja</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lunt</LastName>
                    <ForeName>Alan</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Calvert</LastName>
                    <ForeName>Sandy</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Child Health, St George's Hospital, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marlow</LastName>
                    <ForeName>Neil</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>EGA Institute for Women's Health, Faculty of Population Health Sciences, University College London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peacock</LastName>
                    <ForeName>Janet L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Population Health and Environmental Sciences, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Centre at Guy's and St Thomas NHS Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greenough</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8672-5349</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Women and Children's Health, School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Asthma UK Centre for Allergic Mechanisms in Asthma, King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>NIHR Biomedical Centre at Guy's and St Thomas NHS Foundation Trust and King's College London, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>02</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32764779</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0237080</ArticleId>
            <ArticleId IdType="pii">PONE-D-20-04138</ArticleId>
            <ArticleId IdType="pmc">PMC7413559</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2017 Aug 24;8:CD002311</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28836266</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatr Pulmonol. 2008 Dec;43(12):1193-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18988256</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2018 Jul 9;13(7):e0200243</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29985964</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ther Adv Respir Dis. 2012 Apr;6(2):115-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22323441</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Nov;26(5):948-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16264058</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 1993 Aug;48(8):794-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8211868</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2017 Oct 24;10:CD001145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29063594</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11401896</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Aug;26(2):319-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16055882</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2014 Mar 20;370(12):1121-1130</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24645944</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2017 Jan 3;49(1):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28049168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2012 Nov 20;31(26):3089-103</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22865598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nicotine Tob Res. 2002 May;4(2):149-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12028847</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2006 Jan;117(1):75-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16396863</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Sep;26(3):511-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16135736</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Appl Physiol. 2015 Aug;115(8):1645-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25761732</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Stat Med. 2013 Apr 15;32(8):1429-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23027676</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Biol Neonate. 1995;68(4):229-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8580214</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 1966 Dec;41(220):613-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5927918</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2017 Jul 19;12(7):e0181176</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28723921</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463-1472</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29192835</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Emerg Themes Epidemiol. 2016 Jun 07;13:8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27279891</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pediatrics. 2007 Apr;119(4):716-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17403842</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2002 Aug 29;347(9):633-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12200550</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur Respir J. 2005 Jul;26(1):153-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15994402</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cochrane Database Syst Rev. 2017 Oct 24;10:CD001146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29063585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Thorax. 2015 Jun;70(6):574-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25825005</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Dis Child. 1966 Oct;41(219):454-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5957718</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2007 Jun 15;175(12):1304-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17545458</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dev Psychol. 2011 Sep;47(5):1389-1409</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21639623</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Crit Care Med. 2017 Jul 1;196(1):39-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28146643</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32764552</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>11</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A FACS-based approach to obtain viable eosinophils from human adipose tissue.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13210</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-70093-z</ELocationID>
            <Abstract>
                <AbstractText>Eosinophils have been widely investigated in asthma and allergic diseases. More recently, new insights into the biology of these cells has illustrated eosinophils contribute to homeostatic functions in health such as regulation of adipose tissue glucose metabolism. Human translational studies are limited by the difficulty of obtaining cells taken directly from their tissue environment, relying instead on eosinophils isolated from peripheral blood. Isolation techniques for tissue-derived eosinophils can result in unwanted cell or ribonuclease activation, leading to poor cell viability or RNA quality, which may impair analysis of effector activities of these cells. Here we demonstrate a technique to obtain eosinophils from human adipose tissue samples for the purpose of downstream molecular analysis. From as little as 2 g of intact human adipose tissue, greater than 10<sup>4</sup> eosinophils were purified by fluorescence-activated cell sorting (FACS) protocol resulting in ≥ 99% purity and ≥ 95% viable eosinophils. We demonstrated that the isolated eosinophils could undergo epigenetic analysis to determine differences in DNA methylation in various settings. Here we focused on comparing eosinophils isolated from human peripheral blood vs human adipose tissue. Our results open the door to future mechanistic investigations to better understand the role of tissue resident eosinophils in different context.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hernandez</LastName>
                    <ForeName>James D</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrinology, Diabetes and Metabolism, College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tew</LastName>
                    <ForeName>Ben Yi</ForeName>
                    <Initials>BY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrinology, Diabetes and Metabolism, College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gooden</LastName>
                    <ForeName>Gerald C</ForeName>
                    <Initials>GC</Initials>
                    <Suffix>2nd</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghannam</LastName>
                    <ForeName>Hamza</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrinology, Diabetes and Metabolism, College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masuda</LastName>
                    <ForeName>Mia</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrinology, Diabetes and Metabolism, College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Madura</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <Suffix>2nd</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Mayo Clinic Arizona, Scottsdale, AZ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salhia</LastName>
                    <ForeName>Bodour</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jacobsen</LastName>
                    <ForeName>Elizabeth A</ForeName>
                    <Initials>EA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Allergy, Asthma and Clinical Immunology, Mayo Clinic Arizona, Scottsdale, AZ, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De Filippis</LastName>
                    <ForeName>Eleanna</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Endocrinology, Diabetes and Metabolism, College of Medicine, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ, 85259, USA. defilippis.elena@mayo.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>AI132840-01A1</GrantID>
                    <Agency>National Institute of Allergy and Infectious Diseases</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>ADHS14-00003606</GrantID>
                    <Agency>Arizona Biomedical Research Commission</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32764552</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-020-70093-z</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-020-70093-z</ArticleId>
            <ArticleId IdType="pmc">PMC7413382</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol Methods. 2017 Oct;449:44-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28647456</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1093-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10856141</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Annu Rev Immunol. 2006;24:147-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16551246</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2016 Jan;54(1):13-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26267148</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Semin Respir Crit Care Med. 2006 Apr;27(2):117-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16612762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int Arch Allergy Immunol. 2018;177(1):16-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29879704</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2016 Sep;16(9):553-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27396447</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2018 Jul;104(1):69-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29672914</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Epigenetics. 2015 Sep 16;7:100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26380585</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2014 May;133(5):1439-47, 1447.e1-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24530099</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Mol Cell. 2018 Sep 20;71(6):882-895</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30241605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Immunol. 2016 Jun;17(6):636-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27111145</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2003 Jun 15;101(12):5014-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12609831</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol. 2007 Dec 15;179(12):8454-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18056392</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Genomics. 2017 Feb 23;18(1):202</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28231762</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2018;1773:1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29687376</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Vis Exp. 2010 Jul 10;(41):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20644514</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biotechnol. 2017 Nov 10;261:105-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28822795</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Diabetes Complications. 2018 Nov;32(11):1076-1084</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30190170</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2014;1178:13-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24986603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Mol Sci. 2015 Jul 08;16(7):15442-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26184157</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E885-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23482445</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genome Res. 2016 Feb;26(2):256-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26631489</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Diabetes. 2019 May;68(5):871-878</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31010878</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Allergy Clin Immunol. 2016 Dec;138(6):1741-1744.e9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27531074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 2013 Jan 31;387(1-2):130-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23085531</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2012;7(7):e41361</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22848472</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Biotechnol. 2010 Oct;28(10):1057-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20944598</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cytokine. 2012 Jan;57(1):169-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22079334</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2018 Jul;104(1):95-108</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29656559</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Jul 02;8(7):e67560</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23844029</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell. 2016 Jan 28;164(3):353-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26824653</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2014 Sep 1;30(17):2503-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24812344</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Genet. 2010 Apr;42(4):289-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20208534</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2018 May;6(5):322-324</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29496483</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Vis Exp. 2019 Dec 16;(154):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31885369</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Blood. 2012 Nov 8;120(19):3882-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22936660</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Protoc. 2006;1(6):2613-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17406516</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Protoc Immunol. 2019 Sep;126(1):e86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31483101</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Gastroenterol Hepatol. 2009 Jul;7(7):749-755.e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19345285</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Immunol Methods. 2018 Dec;463:47-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30217720</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Methods Mol Biol. 2019;1951:33-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30825142</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Immunol. 2007 Oct;37(10):2797-802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17823986</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Nat Rev Immunol. 2017 Dec;17(12):746-760</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28891557</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 2011 Apr 8;332(6026):243-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21436399</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Epigenomics. 2018 Jun;10(6):797-811</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29683333</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Genes (Basel). 2019 Nov 15;10(11):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31731604</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Bioinformatics. 2011 Jun 1;27(11):1571-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21493656</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Metabolism. 2014 Sep;63(9):1188-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24996265</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Leukoc Biol. 2020 Jul;108(1):43-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">32134149</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013 Jul 02;8(7):e67907</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23844124</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Respir Med. 2018 May;6(5):379-388</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29496485</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">32764390</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1660-4601</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>16</Issue>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>05</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of environmental research and public health</Title>
                <ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dispensing Practices of Fixed Dose Combination Controller Therapy for Asthma in Australian Children and Adolescents.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">E5645</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph17165645</ELocationID>
            <Abstract>
                <AbstractText>The Australian Asthma Handbook does not recommend use of fixed dose combination (FDC) controller medicines for asthma in children aged ≤5 years. FDCs are only recommended in children and adolescents (aged 6-18 years) not responding to initial inhaled corticosteroid (ICS) therapy. Using Pharmaceutical Benefits Scheme dispensing claims from 2013-2018, we examined the annual incident FDC dispensing and the incident FDC dispensing without prior ICS up to 365 days. We also determined cost of FDCs to government and patients. During 2013-2018, there were 35,635 FDC initiations and 31,368 (88%) did not have a preceding ICS dispensing. The annual incidence of FDC dispensing declined from 14.7 to 7.2/1000 children. Incidence of FDC dispensing/1000 children without a preceding ICS declined from 2.1 to 0.5 in children aged 1-2 years, 7.2 to 1.7 in 3-5 years, 14.8 to 5.1 in 6-11 years, and 18.6 to 11.9 in ≥12years. The cost of FDCs was 7.8 million Australian dollars (AUD); of which 4.4 million AUD was to government and 3.3 million AUD was to patient. Despite inappropriate dispensing of FDCs in children aged ≤5 years, incidence of FDC dispensing and more importantly incidence without a preceding ICS is declining in Australia.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Homaira</LastName>
                    <ForeName>Nusrat</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">0000-0003-3341-7964</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Discipline of Paediatrics, School of Women's and Children's Health, Faculty of Medicine, The University of New South Wales, Sydney 2052, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Department, Sydney Children's Hospital, Sydney 2031, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Daniels</LastName>
                    <ForeName>Benjamin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medicines Policy Research Unit, Centre for Big Data Research in Health, Sydney 2052, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pearson</LastName>
                    <ForeName>Sallie</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">0000-0001-7137-6855</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medicines Policy Research Unit, Centre for Big Data Research in Health, Sydney 2052, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaffe</LastName>
                    <ForeName>Adam</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">0000-0002-1963-5415</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Discipline of Paediatrics, School of Women's and Children's Health, Faculty of Medicine, The University of New South Wales, Sydney 2052, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Respiratory Department, Sydney Children's Hospital, Sydney 2031, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>PS44657</GrantID>
                    <Agency>Rotary Club of Sydney Cove</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Switzerland</Country>
            <MedlineTA>Int J Environ Res Public Health</MedlineTA>
            <NlmUniqueID>101238455</NlmUniqueID>
            <ISSNLinking>1660-4601</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">asthma controller</Keyword>
            <Keyword MajorTopicYN="N">children</Keyword>
            <Keyword MajorTopicYN="N">dispensing pattern</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2020</Year>
                <Month>06</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32764390</ArticleId>
            <ArticleId IdType="pii">ijerph17165645</ArticleId>
            <ArticleId IdType="doi">10.3390/ijerph17165645</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">32764114</PMID>
        <DateRevised>
            <Year>2020</Year>
            <Month>08</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1399-3003</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Aug</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The European respiratory journal</Title>
                <ISOAbbreviation>Eur. Respir. J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Long-term trends of asthma, allergic rhinitis and atopic eczema in Finnish young men: a retrospective analysis, 1926‒2017.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">1902144</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.02144-2019</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To assess the long-term time trends of the prevalence of asthma, allergic rhinitis and atopic eczema in Finnish young men.</AbstractText>
                <AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective analysis of cross-sectional data using statistics and reports of Finnish Defence Forces.</AbstractText>
                <AbstractText Label="SETTING" NlmCategory="METHODS">Call-up examinations of candidates for military conscription. Examinations of conscripts discharged from service because of poor health.</AbstractText>
                <AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">Roughly 1.7 million men, aged 18‒19 years, 98% of men of conscription age, examined in 1966‒2017. A proportional but unknown number of young men examined in 1926‒1961.</AbstractText>
                <AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Asthma recorded at call up examination as the main diagnosis in 1926‒2017 and any diagnosis in 1997‒2017. Exemption from military service, and discharge from military service due to asthma. Allergic rhinitis and atopic eczema recorded as the main diagnosis in 1966‒2017 and any diagnosis in 1997‒2017.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">During 1926-61 the prevalence of asthma remained low at between 0.02% and 0.08%. A linear rise began between 1961 and 1966, the prevalence increasing from 0.29% in 1966 to 3.44% in 2001, a 12-fold rise. Thereafter, prevalence of asthma as the main diagnosis stabilised but continued to increase to 5.19% in 2017, if also secondary diagnoses of asthma were included. Exemption rates from military service due to asthma have similarly increased but fluctuated more. The prevalence of allergic rhinitis increased from 0.06% to 10.70% and atopic eczema from 0.15% to 2.90% in 1966‒2017.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In Finland, increase in asthma and allergic conditions among young men became evident in mid 1960s. The increase slowed down in 2000s and may be levelling off in 2020s.</AbstractText>
                <CopyrightInformation>Copyright ©ERS 2020.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Reijula</LastName>
                    <ForeName>Jere</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pulmonology, Helsinki University Central Hospital, Helsinki University Department of Public Health, Helsinki, Finland jere.reijula@hus.fi.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Latvala</LastName>
                    <ForeName>Jari</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Finnish Institute of Occupational Health, Oulu, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mäkelä</LastName>
                    <ForeName>Mika</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siitonen</LastName>
                    <ForeName>Simo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Finnish Defence Forces, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saario</LastName>
                    <ForeName>Mari</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Finnish Defence Forces, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haahtela</LastName>
                    <ForeName>Tari</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Allergology and Venereology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2020</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Eur Respir J</MedlineTA>
            <NlmUniqueID>8803460</NlmUniqueID>
            <ISSNLinking>0903-1936</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2020</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2020</Year>
                <Month>8</Month>
                <Day>9</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">32764114</ArticleId>
            <ArticleId IdType="pii">13993003.02144-2019</ArticleId>
            <ArticleId IdType="doi">10.1183/13993003.02144-2019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>